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ABSTRACT: This dissertation will describe the development of three transition metal-
catalyzed syntheses of nonracemic organoboronates.  The first chapter explains the 
development of a palladium-catalyzed enantiotopic-group-selective cross-coupling of 
geminal bis(boronates) with alkenyl electrophiles.  This process enables the synthesis of 
highly valuable nonracemic disubstituted allylic boronates.  Chapter two describes a 
palladium-induced 1,2-metallate rearrangement of vinylboron “ate” complexes.  The 
newly developed process incorporates an alternative route for the transmetallation step of 
Suzuki-Miyaura cross-couplings.  Lastly, an enantioselective platinum-catalyzed 
hydrosilylation of alkenyl boronates is disclosed.  This reaction enables the synthesis of 
nonracemic geminal silylboronates for the divergent synthesis of functionalized 
stereocenters.  
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 CHAPTER 1 
Development of an Enantiotopic-Group-Selective Cross-Coupling of 
Geminal Bis(Boronates) with Alkenyl Halides 
 
 
 
1.1 Introduction  
The synthesis of alkyl organoboronates has become a widely-studied area of synthetic 
organic chemistry, with regards to the synthesis of nonracemic and even racemic 
organoboronates.  There are a plethora of methods being developed to target these 
compounds such as borylation of halides, borylation of p-systems, C-H borylation, 
amongst many of other technologies.1  Organoboronates attract this much attention due to 
the organoboronate having the ability to be transformed into a wide variety of functional 
groups, as well as participate in metal-catalyzed reactions.  In this respect, Suzuki-Miyaura 
cross-couplings have become one of the most widely used organometallic reactions.2 The 
utility of this reaction has also grown exponentially in the pharmaceutical industry for the 
construction of advanced pharmaceutical intermediates of biological significance.2 
                                                
1 Fernandez, E.; Whiting, A. Synthesis and Applications of Organoboron Compounds 2015, Springer, New 
York, 49, pp. 331. ISBN 978-3319130538	
2 a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457-2483 b) Yasuda, N.; King, A. O. Topic 
Organomet. Chem. 2004, 6, 205-245 c) Torborg, C.; Beller, M. Adv. Synth. Catal. 2009, 351, 3027-3043 d) 
Budaran, V. L.; Shuttleworth, P. S.; Clark, J. H.; Luque, R. Current Organic Synthesis 2010, 7, 614-627 e) 
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 The ability to expand Suzuki-Miyaura cross-couplings into the realm of asymmetric 
catalysis could potentially have a large impact in synthetic organic chemistry and its 
development is highly desirable.  Typical enantioselective Suzuki-Miyaura cross-
couplings involve the synthesis of chiral biaryl compounds, which are used for the 
synthesis of chiral phosphine ligands and natural products.3  The ability to employ the 
enantioselective Suzuki-Miyaura reaction for the cross-coupling of alkyl organoboronates 
would be a significance advance.  This chapter will discuss approaches to enantioselective 
Suzuki-Cross coupling reactions and the development of an enantiotopic-group-selective 
cross-coupling of geminal bis(boronates) for the synthesis of nonracemic allylic boronates.   
 
1.2 Background  
1.2.1 Enantioselective Suzuki-Miyaura Cross-Couplings and 
Asymmetric Catalysis with Geminal Bis(Boronates) 
The synthesis of organoboronates has received much attention from the synthetic 
organic chemistry community.  This stems from the fact that, depending on the nature of 
the organoboronate ligands, these molecules can be stable to air and moisture.  In addition 
to stability, organoboronates possess inherent reactivity.  Upon activation by addition of a 
nucleophile to their vacant p-orbital, the newly formed organoboron “ate” complex can 
react with electrophiles.  In one example (Scheme 1.1), activation of the organoboronate 
by addition of a nucleophile with an appended leaving group will promote a 1,2-migration 
                                                
Suzuki, A. Angew. Chem. Int. Ed. 2011, 50, 6723-6737 f) Navarro, O.; Maluenda, I. Molecules 2015, 20, 
7528-7557  
3 a) Ma, Y. –N.; Yang, S. –D. Chem. Eur. J. 2015, 21, 6673-6677 and references within b) Hassan, J.; 
Sevignon, M.; Gozzi, C.; Schulz, E.; Lemaire, M. Chem. Rev. 2002, 102, 1359-1460 c) Linton, E. C.; 
Morgan, B. J.; Kozlowski, M. C. Chem. Soc. Rev. 2009, 38, 3193-3207 
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of the carbon-boron bond to displace the leaving group and produce a new carbon-
nucleophile bond.4 An important feature of the 1,2-migration of organoboron “ate” 
complexes is that if the organoboronate is nonracemic, the 1,2-rearrangement occurs with 
stereoretention at the migrating carbon.   
Scheme 1.1 Stereoretentive 1,2-Migration of Organoboron “Ate” Complexes 
 
This type of reactivity occurs with a wide variety of nucleophiles and therefore 
allows heteroatoms and p-systems to be incorporated into products.5 Stereospecific 1,2-
metallate shifts enable oxidation (1.5) and amination (1.6) of organoboronates while the 
Matteson homologation (1.7) can extend the functional organoboron handle by a one- 
carbon homologation.  A variety of olefination reactions have been reported, such as the 
Zweifel olefination (1.8), as well as an alkynylation by Aggarwal (1.10).5a A wide variety 
of stereospecific cross-couplings (1.11) of organoboronates have been also developed5b, 
and a stereoinvertive electrophilic displacement (1.12) of organoboron “ate” complexes 
has been developed by Aggarwal.5a  These examples show the versatile reactivity of 
organoboron “ate” complexes, and highlight the powerful methods by which 
organoboronates can be further functionalized.  The versatility of organoboronates has 
inspired synthetic chemists to develop methods for their synthesis in a nonracemic fashion.   
 
                                                
4 Matteson, D. S. Stereodirected Synthesis with Organoboranes. Springer, Berlin, 1995, 48-92. 
5 a) Sandford, C.; Aggarwal, V. K. Chem. Commun. 2017, 53, 5481-5494 b) Rygus, J. P. G.; Crudden, C. 
M. J. Am. Chem. Soc. 2017, 139, 18124-18137 
R1 R2
(OR)2B Nu-LG
R1 R2
(OR)2B
Nu
LG
R1 R2
Nu
B(OR)2- LG
1.1 1.2 1.3
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Scheme 1.2 Reactions of Organoboron “Ate” Complexes   
 
 Potentially inspired by the Nobel Prize winning hydroboration of alkenes6, the 
development of catalytic methods for the synthesis of nonracemic organoboronates has 
largely focused on the addition of boron reagents across p-systems.  Specific examples of 
these reactions include but are not limited to the metal-catalyzed asymmetric hydroboration 
and diboration of alkenes (Scheme 1.3, eq. 1), allylic substitution (Scheme 1.3, eq. 2), and 
conjugate borylation (Scheme 1.3, eq. 3).7  In contrast to this approach, the synthesis of 
nonracemic organoboronates by the Suzuki-Miyaura cross-couplings is underdeveloped.   
                                                
6 Herbert C. Brown - Nobel Lecture: From Little Acorns to Tall Oaks - from Boranes through 
Organoboranes". Nobelprize.org. Nobel Media AB 2014. Web. 12 Mar 2018. 
<http://www.nobelprize.org/nobel_prizes/chemistry/laureates/1979/brown-lecture.html> 
7	a) Collins, B. S. L.; Wilson, C. M.; Myers, E. L.; Aggarwak, V. K. Angew. Chem. Int. Ed. 2017, 56, 
11700-11733 b) Calow, A. D. J.; Whiting, A. Org. Biomol. Chem. 2012, 10, 5485-5497  c) Schiffner, J. A.; 
Muther, K.; Oestreich, M. Angew. Chem. Int. Ed. 2010, 49, 1194-1196	
R1 R2
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R1 R2
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R1 R2
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R1 R2R1 R2
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Scheme 1.3 General Methods for the Catalytic, Enantioselective Synthesis of 
Organoboronates 
 
 Typically, employing Suzuki-Miyaura cross-couplings for asymmetric catalysis 
consumes the organoboron reagent in the process of forming a new carbon stereocenter.  
Such is the case in pioneering work done by Buchwald and coworkers for the construction 
of functionalized nonracemic biaryls through an enantioselective Suzuki-Miyaura cross-
coupling (Scheme 1.4, eq. 1).8 Numerous other groups further advanced the synthesis of 
nonracemic biaryls through enantioselective Suzuki-Miyaura cross-couplings.3 Willis and 
coworkers developed an enantioselective desymmetrization of bis(alkenyl) triflates 
through a Suzuki-Miyaura cross-coupling with aryl boronic acids (Scheme 1.4, eq. 2).9  
The reaction occurred with good yields and enantioselectivity.  Lastly, Fu and coworkers 
pioneered a stereoconvergent enantioselective alkyl-alkyl Suzuki-Miyaura cross-coupling 
that uses nickel-catalysis to produce hydrocarbons in good yields and enantioselectivity 
(Scheme 1.4, eq. 3).10   
                                                
8 a) Yin, J.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 12051-12052 b) For the first reported synthesis 
on nonracemic biaryls see: Crepy, K. V. L.; Cammidge, A. N. Chem. Commun. 2000, 1723-1724 
9 Powell, L. H. W.; Claverie, C. K.; Watson, S. J.; Willis, M. C. Angew. Chem. Int. Ed. 2004, 43, 1249-
1251	
10 Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 6694-6695	
R1
R1 Me
B(OR)2chiral catalyst
R1
B(OR)2
B(OR)2HB(OR)2
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B2(OR)2
LG
R1
B(OR)2
R1
R1
O
R2
R1
O
R2
B(OR)2
hydroboration diboration
allylic substitution
conjugate borylation
(1)
(2)
(3)
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Scheme 1.4 Examples of Enantioselective Suzuki-Miyaura Cross-Couplings 
 
Our group was interested in developing an enantioselective Suzuki-Miyaura cross-
coupling which would furnish a versatile boron-containing stereocenter.  This idea is 
conceptually related to pioneering work done by Shibasaki and coworkers on the cross-
coupling of prochiral bis(boranes), as well as Shibata, Endo and coworkers on the cross-
coupling of geminal bis(boronates).  Shibasaki and coworkers reported the first example 
of an enantioselective intramolecular Suzuki-Miyaura cross-coupling of bis(borane) 1.15 
to furnish cyclopentylidene alcohol 1.17 after oxidation (Scheme 1.5).11  Although the yield 
and enantioselectivity were modest, this pioneering example showed the potential for an 
enantioselective Suzuki-Miyaura cross-coupling while still retaining an organoborane in 
the product for further functionalization.   
                                                
11 Cho, S. Y.; Shibasaki, M. Tetrahedron: Asymmetry 1998, 9, 3751-3754 
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Scheme 1.5 First Example of an Enantioselective Intramolecular Suzuki-Miyaura 
Cross-Coupling 
 
 Work done by Shibata, Endo and coworkers on the cross-coupling of geminal 
bis(boronates) extended this concept further.  As depicted in Scheme 1.6 (eq. 1), subjecting 
geminal bis(boronate) 1.18 to a palladium-catalyzed cross-coupling with p-iodoanisole 
1.19 resulted in the mono- cross-coupled benzylic boronate 1.20.12  The reaction occurred 
with good yield over a short reaction time under mild conditions.  The efficiency of this 
cross-coupling of an alkyl organoboronate at room temperature over two hours was quite 
surprising.  Typically, palladium-catalyzed Suzuki-Miyaura cross-couplings of alkyl 
organoboronates require more forcing conditions.  The remarkable reactivity of geminal 
bis(boronates) is exemplified by the competitive cross-coupling of geminal bis(boronate) 
1.21 and electrophile 1.22, a compound containing an appended mono-alkyl 
organoboronate (Scheme 1.6, eq. 2).  Subjecting these partners to the same reaction 
conditions resulted in exclusive cross-coupling of the geminal bis(boronate) moiety as 
depicted in product 1.23.  This result clearly demonstrates that geminal bis(boronates) have 
enhanced reactivity in Suzuki-Miyaura cross-couplings relative to mono-alkyl 
organoboronates.    
 
                                                
12	Ohkubo, T.; Hirokami, M.; Endo, K.; Shibata, T. J. Am. Chem. Soc. 2010, 132, 11033-11035	
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Scheme 1.6 Palladium-Catalyzed Cross-Coupling of Geminal Bis(Boronates) 
 
 Shibata, Endo and coworkers carried out 11B-NMR experiments to probe the 
reactivity of geminal bis(boronates) depicted in Scheme 1.7.  Geminal bis(boronate) 1.24 
showed full formation of the boron “ate” complex 1.25 by 11B-NMR (Scheme 1.7, eq. 1).  
The silicon analogue, geminal silylboronate 1.26, showed no formation of the boron “ate” 
complex (Scheme 1.7, eq. 2).  Additionally, mono-alkyl organoboronate 1.28 showed no 
boron “ate” complex formation (Scheme 1.7, eq. 3), consistent with the result of the 
competition experiment in Scheme 1.6 (eq. 2).  Lastly, vicinal bis(boronate) 1.30 displayed 
some boron “ate” complex formation (Scheme 1.7, eq. 4); however, conversion was much 
less than geminal bis(boronate) 1.24.  These data show that the enhanced reactivity of 
geminal bis(boronates) in cross-couplings may come from the enhanced formation of boron 
“ate” complexes, which are required for transmetallation 
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Scheme 1.7 11B-NMR experiments of Organoboron “Ate” Complex Formation of 
Various Organoboronates 
 
 Shibata and Endo employed DFT to calculate the geminal bis(boronate) LUMO 
maps; this shows a large LUMO distribution around the B-B moiety resulting in assistance 
of the neighboring boron for boron “ate” complex formation.  Alternatively, a driving force 
for the transmetallation step might be the formation of a-boryl palladium intermediate 1.33 
(Scheme 1.8, eq. 1).  By allowing hyperconjugation of the carbon-palladium bond into the 
vacant p-orbital on the adjacent boron, the a-boryl group may be a stabilizing feature.13  
This stabilizing feature is conceptually similar to the zinc insertion into a-haloboronates 
as studied by Knochel (Scheme 1.8, eq. 2).14  Knochel hypothesized that the remarkably 
easy zinc insertion reflects upon the participation of the organoboronate group for the 
formation of the organometallic.  Related to boronate stabilization observed with geminal 
bis(boronates) in cross-coupling reactions, Morken and coworkers studied the deborylative 
                                                
13 Leonori, D.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2015, 54, 1082-1096 
14 Knochel, P. J. Am. Chem. Soc. 1990, 112, 7431-4433 
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formation of a-boryl anions (Scheme 1.8, eq. 3).15  Treatment of geminal bis(boronates) 
with potassium tert-butoxide under mild conditions allowed for the formation of an a-boryl 
anion.  The a-boryl anion was stabilized sufficiently where the species could be observed 
by 13C-NMR.  The formed a-boryl anion was then trapped with a variety of electrophiles.  
These two examples, in addition to the cross-coupling of geminal bis(boronates), attest to 
the stabilizing feature of a-boryl organometallic species.  This stabilizing feature can be 
considered a driving force for organometallic reactions, and also might govern 
regioselectivity for the formation of an a-boryl metal intermediate. 
Scheme 1.8 a-Boryl Stabilized Organometallic Compounds and Related Species  
 
 With the reactivity of geminal bis(boronates) towards palladium-catalyzed cross-
couplings understood, our group wondered whether this reaction could be accomplished in 
an enantioselective fashion.  This mode of reactivity would in fact constitute an 
enantioselective Suzuki-Miyaura cross-coupling which produces a new boron-containing 
carbon stereocenter for further functionalization.  Employing a TADDOL-based 
phosphoramidite ligand, a palladium catalyst and aryl electrophiles, Morken and coworkers 
                                                
15 Hong, K.; Liu, X.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 10581-10584	
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were able to develop an enantiotopic-group-selective cross-coupling of geminal 
bis(boronates) (Scheme 1.9).16 This method was shown to be quite broad with respect to 
different functionality on the geminal bis(boronate) and the aryl electrophile.  In addition 
to a broad scope, the cross-coupling occurred with good yields and enantioselectivity.   
Scheme 1.9 Enantiotopic-Group-Selective Cross-Coupling of Geminal Bis(Boronates) 
with Aryl Electrophiles  
 
 The utility of this cross-coupling was demonstrated by a formal synthesis of 
pharmaceutically-relevant (R)-tolterodine, a drug marketed by Pfizer for the treatment of 
overactive bladder (Scheme 1.10).  After cross-coupling of the geminal bis(boronate) 1.35 
with iodobenzene, a stereospecific cross-coupling of benzylic boronate (1.36) developed 
by Crudden was employed.17 Subsequent benzyl deprotection furnished alcohol 1.37, a 
known precursor18 for the synthesis of (R)-tolterodine.   
 
 
 
 
 
                                                
16 Sun, C.; Potter, B.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 6534-6537 
17 Imao, D.; Glasspoole, B. W.; Laberge, V. S.; Crudden, C. M. J. Am. Chem. Soc. 2009, 131, 5024 
18 Jonsson, N. A.; Spark, B. A.; Mikiver, L.; Moses, P. Nilvebrant, L.; Glas, G. U.S. Patent 5,382,600 A1, 
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Scheme 1.10 Formal Synthesis of (R)-tolterodine  
 
 The cross-coupling of geminal bis(boronates) with aryl electrophiles was further 
developed by Hall and coworkers (Scheme 1.11).19  The subsequent work employed 
slightly different reactions conditions and a different TADDOL-derived phosphoramidite 
ligand.  The modified reaction conditions produced comparable yields and 
enantioselectivity as the first report. 
Scheme 1.11 Hall Conditions for Cross-Coupling of Geminal Bis(Boronates) 
 
 It was not until work was done by Wang and coworkers that the cross-coupling of 
geminal bis(boronates) with alkenyl electrophiles was realized.  Employing palladium-
phosphine complexes and alkenyl bromides effected the cross-couplings depicted in 
Scheme 1.12.20 However, under these reaction conditions, the allylic boronate product was 
                                                
19 Sun, H. –Y.; Kubota, K.; Hall, D. G. Chem. Eur. J. 2015, 21, 19186-19194	
20 Li, H.; Zhang, Z.; Shanggaun, X.; Huang, S.; Chen, J.; Zhang, Y; Wang, J. Angew. Chem. Int. Ed. 2014, 
53, 11921-11925 
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susceptible to additional cross-coupling to produce a diene (Scheme 1.12, eq. 1).  Although 
asymmetric catalysis is precluded because the product is achiral, this method is a powerful 
route to skipped dienes.  Employing alkenyl dibromides demonstrated an efficient 
synthesis of substituted allenes as well (Scheme 1.12, eq. 2).  
Scheme 1.12 Cross-Coupling of Geminal Bis(Boronates) with Alkenyl Electrophiles 
  
 In addition to palladium-catalyzed cross-couplings, new developments have been 
made employing copper catalysis in reactions with geminal bis(boronates).  These efforts 
were pioneered by the Meek and Hoveyda labs.  Meek and coworkers have developed a 
copper-catalyst that effects a deborylative addition of bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)methane (1.40) to aldehydes.  This reaction produces syn 1,2-
hydroxyboronates in good yields with excellent diastereo- and enantioselectivity (Scheme 
1.13, eq. 1).21  The newly developed method was also extended to additions to a-ketoesters 
which furnished tertiary b-hydroxy boronates.22 In addition to reactions with carbonyl 
compounds, Hoveyda and coworkers used copper-NHC catalysis to engage 1.40 in allylic 
substitution.  This reaction produced a-hydroxy allylic stereocenters with excellent 
                                                
21 Joannou, M. V.; Moyer, B. S.; Meek, S. J. J. Am. Chem. Soc. 2015, 137, 6176-6179 
22 Murray, S. A.; Green, J. C.; Tailor, S. B.; Meek, S. J. Angew. Chem. Int. Ed. 2016, 55, 9065-9069 
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enantioselectivity (Scheme 1.13, eq. 2).23 The copper-catalyzed allylic substitution was 
further extended for the synthesis of a natural product. 
Scheme 1.13 Enantioselective Copper-Catalysis with Geminal Bis(Boronates) 
 
   
 
1.2.2 Catalytic, Enantioselective Synthesis of Allylic Boronates 
 The development of methods for the synthesis of nonracemic allylic boronates has 
received much recent attention in the field of synthetic organic chemistry.24  This interest 
stems from the fact that, in addition to typical stereospecific transformations of 
organoboronates, allylic boronates have additional modes of reactivity. Allylic boronates 
can undergo a stereospecific functionalization with a variety of reagents to provide a broad 
range of reaction products (i.e. oxidation, amination, etc.) (Scheme, 1.14, eq. 1).  In 
                                                
23 Shi, Y.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2016, 55, 3455-3458 
24 Diner, C.; Szabo, K. J. J. Am. Chem. Soc. 2017, 139, 2-14 
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addition to direct functionalization, allylic boronates can undergo well-precedented 
allylation reactions with carbonyl compounds to produce two contiguous stereocenters 
(Scheme 1.14, eq. 2.).  Related nitrosobenzene-mediated oxidation reaction with allylic 
transposition produces highly valuable tertiary allylic alcohols (Scheme 1.14, eq. 3).25  
Allylic boronates also have the propensity to undergo subsequent metal-catalyzed 
stereospecific cross-couplings, with either a- or g- selectivity (Scheme 1.14, eq. 4).26  
Lastly, a newly developed method by Aggarwal and coworkers shows that activation of 
allylic boronates with a non-transferable aryl lithium can promote the stereospecific g-
selective electrophilic substitution with a wide variety of electrophiles (Scheme 1.14, eq. 
5).27		 
Scheme 1.14 Stereospecific Transformations of Nonracemic Allylic Boronates 
  
                                                
25 Kyne, R. E. Ryan, M. C.; Kliman, L. T.; Morken, J. P. Org Lett. 2010, 12, 3796-3799 
26 a) Chausset-Boissarie, L.; Ghozati, K.; LaBine, E.; Chen, J. L. – Y.; Aggarwal, V. K.; Crudden, C. M. 
Chem. Eur. J. 2013, 19, 17698-17701 b) Yang, Y.; Buchwald, S. L.; J. Am. Chem. Soc. 2013, 135, 10642-
10645 c) Potter, B.; Edelstein, E. K.; Morken, J. P. Org. Lett. 2016, 18, 3286-3289 
27 Garcia-Ruiz, C; Chen, J. L. – Y.; Sandford, C.; Feeny, K; Lorenzo, P.; Berionni, G; Mayr, H; Aggarwal, 
V. K. J. Am. Chem. Soc. 2017, 139, 15324-15327 
pinB
R1 R3
R2
Nu
R1 R3
R2Nu LG
R1
Ph
OH
R2 R3
PhCHO
Pd/L Ar
R1 R3
R2
R1
R2
R3
Aror
Naphthyllithium
R1
F
R3
R2
PhNO
NH4OH
R1 R3
HO R2
(1)
(2)
(3)
(4)
(5)
Ar-X
then 
Selectfluor
 16 
 Pioneering studies done by Matteson and coworkers on the synthesis of nonracemic 
allylic boronates used chiral ligands on boron.28  Work done by Sawamura, Ito and 
coworkers realized a catalytic synthesis of chiral allylic boronates.  Employing a copper 
catalyst promoted a stereospecific borylation of nonracemic allylic carbonate 1.43 (Scheme 
1.15, eq. 1).29  The reaction was shown to be g-selective and occurred with good yield and 
enantiospecificity.  Sawamura and Ito expanded upon this work by using a chiral copper-
QuinoxP catalyst to render the borylation of (Z)-allylic carbonates enantioselective.30   This 
was the first example of this type of reaction, and it occurred with good yields and excellent 
enantioselectivity (Scheme 1.15, eq. 2). 
Scheme 1.15 Synthesis of Nonracemic Organoboronates by Sawamura and Ito 
 
 After this pioneering work on the catalytic synthesis of nonracemic allylic 
boronates through allylic substitution, Hall, Hoveyda and McQuade greatly expanded upon 
the strategy.   Hall and coworkers showed that allylic chloride 1.45 could undergo 
substitution reactions with a copper-phosphoramidite complex with good 
                                                
28 Sadhu, K. M.; Hurst, G. D.; Kurosky, J. M.; Matteson, D. S.; Organometallics 1988, 3, 804-806 
29 Kawakami, C.; Ito, H.; Sawamura, M. J. Am. Chem. Soc. 2005, 127, 16034-16035	
30	Ito, S.; Sasaki, Y.; Matsuura, K.; Ito, H.; Sawamura, M. J. Am. Chem. Soc. 2007, 129, 14856-14857	
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enantioselectivity (Scheme 1.16, eq. 1).31 A significant contribution to allylic substitution 
was done by Hoveyda and coworkers.  Employing a Cu-NHC complex converted 
substituted allylic carbonates into tertiary allylic boronates in a stereoconvergent manner 
and with excellent enantioselectivity (Scheme 1.16, eq. 2).32  This reaction was shown to 
be very broad and is a powerful method for the synthesis of nonracemic tertiary 
organoboronates.  Lastly, McQuade and coworkers employed a Cu-NHC catalyst for a 
stereoconvergent synthesis of nonracemic allylic boronates from aryl allylic ether 
electrophiles (Scheme, 1.16, eq. 3).33 The allylic substitution of aryl allylic ether 
electrophiles proceeded with good yields and excellent enantioselectivity.  
 
 
 
 
 
 
 
 
 
 
 
                                                
31 Carosi, L. Hall, D. G. Angew. Chem. Int. Ed. 2007, 46, 5913-5915	
32 Guzman-Martinez, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10634-10637 
33 Park, J. K.; Lackey, H. H.; Ondrusek, B. A.; McQuade, D. T. J. Am. Chem. Soc. 2011, 133, 2410-2413 
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Scheme 1.16 Advances in the Synthesis of Nonracemic Allylic Boronates through 
Allylic Substitution  
 
 While all of these methods are efficient and selective for the synthesis of terminally 
substituted allylic boronates, the ability to synthesize more substituted allylic boronates in 
one catalytic step is highly desirable.  Because many natural products contain more 
substituted allylic alcohol stereocenters (Figure 1.1), the ability to synthesize these types 
of allylic motifs in a catalytic fashion would be useful. 
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Figure 1.1 Natural Products Containing Substituted Allylic Alcohol Stereocenters 
 
 Early work in dimetallation reactions by Morken and Moberg began to address this 
area in catalysis.  Morken and coworkers used a palladium-phosphoramidite catalyst to 
affect an enantioselective diboration of allenes (Scheme 1.17, eq. 1).34 The allylic boronate 
products contain a useful alkenyl boron and were produced in high yields and 
enantioselectivity.  These products exhibit versatile reactivity: they undergo stereospecific 
allylation of aldehydes and imines as well as diastereoselective hydroboration-cross-
coupling sequences.35  In addition to diboration, Moberg and coworkers developed an 
asymmetric silaboration of cyclohexadiene (1.52) that furnished cyclic nonracemic allylic 
boronate 1.54 with good enantioselectivity (Scheme 1.17, eq. 2).36  It is worth noting that 
the scope of this reaction was limited to cyclohexadiene. 
                                                
34	a) Pelz, N. F.; Woodward, A. R.; Burks, H. E.; Sieber, J. D.; Morken, J. P. J. Am. Chem. Soc. 2004, 126, 
16328-16239 b) Burks, H. E.; Liu, S.; Morken, J. P. J. Am. Chem. Soc. 2007, 129, 8766-8773 
35 a) Woodward, A. R.; Burks, H. E.; Chan, L. M.; Morken, J. P. Org. Lett. 2005, 7, 5505-5507 b) Seiber, J. 
D.; Morken. J. P. J. Am. Chem. Soc. 2006, 128, 74-75 c) Pelz, N. F.; Morken, J. P. Org. Lett. 2006, 8, 4557-
4559 
36 Gerdin, M.; Moberg, C. Adv. Synth. Catal. 2005, 347, 749-753 
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Scheme 1.17 Catalytic Dimetallation Reactions for the Synthesis of Nonracemic 
Allylic Boronates 
  
 With regards to a general method for the synthesis of g-substituted nonracemic 
allylic boronates through mono-borylation, the Yun group developed an asymmetric 
hydroboration using a copper-DTBM Segphos catalyst (Scheme 1.18, eq. 1).37 One 
example of a diene hydroboration was demonstrated which produced nonracemic g-aryl 
allylic boronate 1.56 in good yield and enantioselectivity.  As a general route to g-
substituted allylic boronates, an elegant conjugate borylation of dienone and dienoesters 
was developed by Kobayashi and coworkers.38  In water, a copper-diamine catalyst 
produced nonracemic allylic boronates in good yields and excellent enantioselectivity 
(Scheme 1.18, eq. 2).  This work enabled the synthesis of tertiary nonracemic g-substituted 
allylic boronates. More recently, Watson and coworkers employed a nickel catalyst to 
accomplish a stereodivergent borylation of nonracemic allylic carbonates (Scheme 1.18, 
                                                
37 Noh, D.; Yoon, S. K.; Won, J.; Lee, J. Y.; Yun, J. Chem Asian. J. 2011, 6, 1967-1969 
38	Kitanosono, T.; Xu, P.; Kobayashi, S. Chem. Commun. 2013, 49, 8184-8186	
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eq. 3).39  Depending upon the ligand and solvent chosen affected both stereoretentive and 
stereoinvertive borylations with excellent enantiospecificities.  Although similar to 
Sawamura’s first report, this method demonstrates one of the most general approaches for 
the synthesis of nonracemic g-aryl allylic boronates.  Moreover, it occurs with readily 
available starting materials and is an efficient reaction with divergent stereochemical 
outcomes. 
Scheme 1.18 Synthesis of g-Substituted Nonracemic Allylic Boronates 
  
 With regards to the synthesis of highly valuable nonracemic g,g-disubstituted allylic 
boronates, there a few catalytic methods developed.  The first report was by Sawamura, Ito 
and coworkers on a copper-catalyzed enantioconvergent allylic borylation of cyclic ethers 
(Scheme 1.19, eq. 1).40  An advantage of this method is that employing racemic allylic 
                                                
39	Zhou, Q.; Srinivas, H. D.; Zhang, S.; Watson, M. P. J. Am. Chem. Soc. 2016, 138, 11989-11995	
40 Kunii, S.; Sawamura, M.; Ito, H. Nat. Chem. 2010, 2, 972-976 
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ethers results in convergence to one product enantiomer with high stereoselectivity.  
However, the reaction is restricted to cyclic substrates.  The synthesis of linear, nonracemic 
g,g-disubstituted allylic boronates was elusive until 2012.  Morken and coworkers 
developed a platinum-catalyzed enantioselective 1,2-diboration of substituted 1,3-dienes 
(Scheme 1.19, eq. 2).41  The diboration provided nonracemic allylic boronates with good 
yields and excellent enantioselectivity.  The synthetic utility was demonstrated by the 
allylation of aldehydes and by tandem double allylation reactions to synthesize cyclic 
molecules that bear four contiguous stereocenters.42  Lastly, an expansion of the 
conjunctive cross-coupling developed by Morken and coworkers43 allowed for the 
synthesis of nonracemic g,g-disubstituted allylic boronates.  Employing bis(alkenyl) boron 
“ate” complexes, the palladium-induced 1,2-migration of alkenyl groups provides 
nonracemic allylic boronate in good yields and enantioselectivity (Scheme 1.19, eq. 3).44   
 
 
 
 
 
 
 
                                                
41 Kliman, L. T.; Mlynarski, S. N.; Ferris, G. E.; Morken, J. P. Angew. Chem. Int. Ed. 2012, 51- 521-524 
42 Ferris, G. E.; Hong, K.; Roundtree, I. A.; Morken, J. P. J. Am. Chem. Soc. 2013, 135, 2501-2504 
43 Zhang, L.; Lovinger, G. L.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P.; Morken, J. P. Science 
2016, 351, 70-74 
44 Edelstein, E. K.; Namirembe, S.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 5027-5030	
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Scheme 1.19 Catalytic, Enantioselective Synthesis of  g,g-Disubstituted Allylic 
Boronates 
  
 The catalytic synthesis of nonracemic allylic boronates has been elaborated.  The 
immense synthetic utility of these reagents highlights the need for new methods to be 
developed. The next part of this chapter will explain the development of an enantioselective 
Suzuki-Miyaura cross-coupling for the synthesis of nonracemic g,g-disubstituted allylic 
boronates. 
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1.3 Development of an Enantiotopic-Group-Selective Suzuki-Miyaura 
Cross-Coupling of Geminal Bis(Boronates) with Alkenyl 
Electrophiles45 
 
1.3.1 Synthesis of Geminal Bis(Boronates) 
 Geminal bis(boronates) are increasingly being incorporated in enantioselective, 
catalytic reactions.  Consequently, the development of new catalytic methods for the 
synthesis of geminal bis(boronates) is highly desirable.46  The first reported synthesis of 
geminal bis(boronates) by Matteson and coworkers, involves the double-lithiation of 
dichloromethane (Scheme 1.20, eq. 1).  Subsequent addition to trimethyl borate and 
esterification with pinacol provides methylene bis(boronate) 1.61.47  The synthesis of 
substituted geminal bis(boronates) was realized by Matteson and coworkers through the 
deprotonation and alkylation of methylene bis(boronate) 1.61 (Scheme 1.20, eq. 2).45b A 
catalytic method for the synthesis of geminal bis(boronates) was elusive until the report by 
Endo, Shibata and coworkers in 2009.  A rhodium catalyst and pinacolborane promoted 
the double hydroboration of alkynes (Scheme 1.20, eq. 3).48  An advantage of this catalytic 
system using pinacolborane is the ideal atom-economy of the boron reagent. It will become 
apparent that newer catalytic methods generally use two equivalents of diboron reagents 
                                                
45 Potter, B.; Szymaniak, A. A.; Edelstein, E. K. J. Am. Chem. Soc. 2014, 136, 17918-17921 
46 For a review see: a) Shimizu, M.; Hiyama, T. Proc. Jpn. Acad., Ser. B 2008, 84, 75-85  b) Nallagona, R.; 
Padala, K.; Masarwa, A. Org. Biomol. Chem. 2018, 16, 1050-1064 c) Miralles, N.; Maza, R. J.: Fernandez, 
E. Adv. Synth. Catal. 2018, Early View. DOI: 10.1002/adsc.201701390 
47 a) Castle, R. B.; Matteson, D. S. J. Am. Chem. Soc. 1968, 90, 2194 b) Moody, R. J.; Matteson, D. S. 
Organometallics 1982, 1, 20-28 
48 a) Shibata, T.; Endo, K. Synlett 2009, 8, 1331-1335 b) For the double hydroboration of alkynes with BCl3 
see: Soundararajan, R.; Matteson, D. S. Organometallics 1995, 14, 4157-4166 
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and thus suffer from inefficient boron-atom-economy.  It is worth noting that for the double 
hydroboration of alkynes, newer methods with copper by Yun and coworkers, and cobalt 
by Huang and coworkers have been developed.44 The cobalt-catalyzed hydroboration of 
alkenyl boronates has also been reported by Chirik and coworkers for the synthesis of 
geminal bis(boronates).44 After the seminal catalytic report, the diborylation of 
dibromoalkanes was then developed independently by Ito and coworkers in addition to 
Steel, Marder, Liu and coworkers.49  Employing different copper-catalysts and reaction 
conditions allowed for the synthesis of geminal bis(boronates) from readily available 
geminal dihaloalkanes (Scheme 1.20, eq. 4).  It is worth noting that using modified 
conditions of the copper borylation, Morken and coworkers were able to scale the 
diborylation of dibromomethane.15 Consequently, methylene bis(boronate) 1.61 is now 
commercially available.   Lastly, Wang and coworkers developed a transition-metal free 
diborylation of in situ generated diazo compounds (Scheme 1.20, eq. 5).50   The diazo 
diborylation allowed for the synthesis of geminal bis(boronates) in two simple steps from 
readily available aldehydes.  It is worth noting that the diborylation of diazo compounds 
with a platinum-catalyst had been previously developed by Srebnik and coworkers.51 
 
 
 
 
 
                                                
49	a) Kubota, K.; Ito, H. Org. Lett. 2012, 14, 890-893 b) Steel, P. G.; Marder, T. B., Liu, L. Angew. Chem. 
Int. Ed. 2012, 51, 528-532	
50	Li, H.; Shangguan, X.; Zhang, Z; Huang, S.; Zhang, Y.; Wang, J. Org. Lett. 2014, 16, 448-451	
51 Ali, H. A.; Goldberg, I.; Srebnik, M. Organometallics 2001, 20, 3962-3965 
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Scheme 1.20 Synthesis of Geminal Bis(Boronates)  
 
 While the aforementioned reports represent efficient routes for the synthesis of 
geminal bis(boronates), newer methods are continuously being developed.  The 
development of newer methods emphasizes the synthetic utility of geminal bis(boronates).  
As depicted in Scheme 1.21 (eq. 1), Cook and coworkers reported a diborylation of 
dibromo- or dichloroalkanes employing low-loadings of a manganese catalyst.52  The 
manganese system demonstrates an expansion and improvement upon the aforementioned 
copper-catalyzed borylation of dibromoalkanes.  Chirik and coworkers reported a benzylic 
C-H diborylation with a cobalt-bis(imine) catalyst for the synthesis of benzylic geminal 
bis(boronates) (Scheme 1.21, eq. 2).53  The cobalt-catalyst represents an extension of 
Hartwig’s iridium-catalyzed benzylic borylation employing an earth-abundant catalyst.54  
                                                
52 Atack, T. C.; Cook, S. P. J. Am. Chem. Soc. 2016, 138, 6139-6142 
53 a) Palmer, W. N.; Obligacion, J. V.; Pappas, I.; Chirik, P. J. J. Am. Chem. Soc. 2016, 138, 766-769 b) 
Palmer, W. N.; Zarate, C.; Chirik, P. J. J. Am. Chem. Soc. 2017, 139, 2589-2592 
54 Cho, S. W.; Hartwig, J. F. Chem. Sci. 2014, 5, 694-698 
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More recently, Lan, Liu and coworkers reported a copper-catalyzed direct diborylation of 
aldehydes through the intermediacy of an a-hydroxyboronate (Scheme 1.21, eq. 3).55  The 
aldehyde diborylation is an improvement upon the diazo and dihaloalkane diborylations as 
it does not involve the intermediate formation of a hydrazone or dihaloalkane, respectively.  
Lastly, Fu and coworkers developed an efficient diborylation of alkenes with an earth- 
abundant nickel catalyst (Scheme 1.21, eq. 4).56  The alkene diborylation highlights the 
ability synthesize geminal bis(boronates) from simple, feedstock chemicals.  In addition to 
incorporating feedstock chemicals, the alkene diborylation might be viewed as an 
improvement upon the double hydroboration of alkynes.  The continuous development of 
new, catalytic methods for the synthesis of geminal bis(boronates) underscores the 
importance of these reagents for synthetic organic chemistry. 
 
 
 
 
 
 
 
 
 
 
                                                
55Wang, L.; Zhang, T.; Sun, W.; He, Z.; Xia, C.; Lan, Y.; Liu, C. J. Am. Chem. Soc. 2017, 139, 5257-5264 
56 Li, L.; Gong, T; Lu, X; Xiao, B.; Fu, Y. Nature Communications 2017, 8:345, 1 
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Scheme 1.21 New Methods for the Synthesis of Geminal Bis(Boronates) 
 
 
 
1.3.2 Reaction Discovery, Optimization, and Scope45 
 As described earlier, the cross-coupling of geminal bis(boronates) is an appealing 
approach for the development of an enantioselective Suzuki-Miyaura cross-coupling.  The 
ability to expand an enantioselective cross-coupling to alkenyl electrophiles would provide 
nonracemic allylic boronates.  The synthesis of nonracemic allylic boronates from readily 
prepared geminal bis(boronates) could be highly impactful. 
 To initiate studies on the cross-coupling of alkenyl electrophiles, 1-bromo-2-methyl 
propene (1.63) was incorporated in a catalytic cross-coupling of geminal bis(boronates) 
using the same conditions as with aryl electrophiles.  As depicted in Scheme 1.22, the 
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reaction resulted in no formation of allylic boronate product 1.64.  Only recovered starting 
material or protodeboration of the starting material was observed.   
Scheme 1.22 Initial Investigation of Reactivity for Geminal Bis(Boronate) Cross-
Coupling with Alkenyl Electrophiles and Monodentate Ligands  
 
 
 It was hypothesized that the lack of reaction might be due to employing a 
monodentate ligand resulting in an open coordination site on palladium.  Combining an 
open coordination site with a less bulky alkenyl electrophile (c.f. an aryl electrophile) might 
allow for Lewis-basic adducts to coordinate to palladium and inhibit transmetallation.  
Lewis-basic adducts might include another equivalent of ligand, solvent, or pinacol from 
hydrolysis of the geminal bis(boronate).57  In addition to Lewis-basic coordination, an open 
coordination site after oxidative addition with alkenyl electrophiles might allow for 
palladium disproportionation (Scheme 1.23).58  The tendency of palladium 
disproportionation might be more facile with alkenyl electrophiles compared to aryl 
electrophiles due to the steric environment.  After oxidation addition, an open coordination 
site might allow for 1.64 to dimerize and form adduct 1.65.  Subsequent disproportionation 
allows for the formation of bis(alkenyl) palladium species 1.66 and PdBr2.  Reductive 
                                                
57 Employing a deuterated pinacol derived geminal bis(boronate) in a competition experiment, it was shown 
in the aryl electrophile cross-coupling paper that the geminal bis(boronates) are readily hydrolyzed. 
58 Gushin, V. V.; Alper, H. Organometallics 1993, 12, 1890-1901 
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elimination then yields the alkenyl electrophile dimerization product 1.67 from the 
undesired reactivity.  
Scheme 1.23 Disproportionation of Pd-II Oxidative Addition Adduct with 
Monodentate Ligands  
 
 To address the hypothetical inhibition process, a bidentate ligand was employed 
with alkenyl electrophile 1.63.  A bidentate ligand would create a more hindered palladium 
(II) oxidative addition adduct without an open coordination site for binding an inhibitor.  
Upon conducting the reaction of 1.63 with palladium-1,1’-
bis(diphenylphosphino)ferrocene, an appreciable amount of allylic alcohol 1.68 was 
observed after oxidation (Scheme 1.24).  The production of the desired allylic alcohol 
supports the hypothesis for inhibition.  However, diene product 1.69 (plus the a-coupling 
isomer) was also observed. 
Scheme 1.24 Initial Investigation of Reactivity for Geminal Bis(Boronate) Cross-
Coupling with Alkenyl Electrophiles 
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 As described earlier, it has been shown that allylic boronates are highly reactive 
towards cross-coupling reactions.26 This heightened reactivity arises upon activation of the 
organoboronate and binding to palladium, the intermediate can form a favorable six-
membered transition state (Scheme 1.25, eq. 1).  The formation of a six-membered 
transition state allows for delivery of a palladium to the g-carbon by a syn SE2’ 
transmetallation.  Subsequent reductive elimination then furnishes the g-selective cross-
coupling product.  It was hypothesized that increasing the steric component of the alkenyl 
electrophile might be an approach to slow down the allylic boronate cross-coupling 
pathway (Scheme 1.25, eq. 2).  Increasing the steric hindrance to an unfavorable six-
membered transition state might suppress this pathway for the cross-coupling of the desired 
allylic boronate product.  
Scheme 1.25 g-Selective Cross-Coupling of Allylic Boronates  
 
 However, the presence of the diene product in Scheme 1.24 showed that even while 
using a relatively bulky alkenyl electrophile (c.f. trans-1-bromo-1-propene), over-coupling 
of the allylic boronate product is an issue.  Consequently, a catalyst for the desired reaction 
needed to be developed that can not only suppress the product double-coupling pathway, 
but also render the cross-coupling enantioselective.   
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(1.70) and (S)-iPr-Phox (1.71) furnished no allylic alcohol product 1.68 in the cross-
coupling reaction (Table 1.1, entries 1-2).  It was not until (R)-MeO-Biphep (1.72) was 
used that product 1.65 was observed, although it was formed in moderate enantioselectivity 
(Table 1.1, entry 3).   In addition to selectivity, ligand 1.72 suffered from low 
chemoselectivity as increased amount of diene products were observed.  (R)-p-tol-BINAP 
(1.73) produced low levels of reactivity (Table 1.1, entry 4), while (R,R)-QuinoxP (1.74) 
produced low chemoselectivity in modest enantioselectivity (Table 1.1, entry 5).  
Surveying ferrocene-based chiral bidentate ligands, (S,S,R)-Mandyphos (1.75) gave a non-
reactive catalyst (Table 1.1, entry 6).  (R,R)-WalPhos (1.76) afforded good reactivity, 
although low chemoselectivity and very low enantioselectivity (Table 1.1, entry 7).  (R,R)-
TaniaPhos (1.77) produced low reactivity and moderate enantioselectivity (Table 1.1, entry 
8).  It was not until investigating the ferrocene-based Josiphos ligand class where promising 
results were observed.  Employing Josiphos ligand 1.78 afforded good reactivity and 
chemoselectivity, with moderate enantioselectivity (Table 1.1, entry 9).  Simply increasing 
the steric component of the ferrocenyl phosphine substituents from dicyclohexyl to di-tert-
butyl (1.79) resulted in an increase in reactivity and chemoselectivity (Table 1.1, entries 9 
vs. 10).  In addition to good chemoselectivity, the enantioselectivity was also greatly 
increased to a 90:10 ratio (Table 1.1, entry 10). 
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Table 1.1 Initial Ligand Investigation of Chiral Bidentate Ligands  
 
Entry Ligand Yield 1.68 (%)a Yield 1.69 (%)a e.r.b 
1 1.70 < 5 < 5 n.d. 
2 1.71 < 5 < 5 n.d. 
3 1.72 10 30 27:73 
4 1.73 < 10 < 5 n.d. 
5 1.74 10 20 30:70 
6 1.75 < 5 < 5 n.d. 
7 1.76 22 22 52:48 
8 1.77 10 < 5 72:28 
9 1.78 47 13 65:35 
10 1.79 60 < 5 10:90 
 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios determined using chiral SFC analysis of the allylic alcohol 1.68 
 
 
 Having found a relatively efficient and selective ligand (1.79) that is commercially 
available, an exhaustive survey of conditions was undertaken to further increase reactivity 
and enantioselectivity.  As depicted in Table 1.2, the impact of the solvent and base was 
analyzed.  Employing different ethereal solvents such as THF produced similar levels of 
reactivity and enantioselectivity as 1,4-dioxane (Table 1.2, entry 1 vs. 2).  The less polar 
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ethereal solvent MTBE completely inhibited the reaction likely due to insolubility of the 
bis(boron) “ate” complex (Table 1.2, entry 3).  Switching to more polar solvents like DMF 
and MeCN resulted in either lower reactivity or no reactivity (Table 1.2, entries 4-5).  
Changing the base to NaOH showed an increase in reactivity but slight decrease in 
enantioselectivity (Table 1.2, entry 6).  Further analysis of the base with CsOH or LiOH 
produced lower reactivity but similar enantioselectivity as KOH (Table 1.2, entries 7-8).   
Table 1.2 Solvent and Base Surveying for Cross-Coupling of Geminal Bis(Boronates) 
with Alkenyl Bromide and Ligand 1.79 
 
Entry Solvent Base Yield 1.68 
(%)a 
Yield 1.69 
(%)a 
e.r.b 
1 1,4-dioxane KOH 60 < 5 91:9 
2 THF KOH 40 < 5 91:9 
3 MTBE KOH < 5 < 5 n.d. 
4 DMF KOH 34 < 5 88:12 
5 MeCN KOH < 5 < 5 n.d. 
6 1,4-dioxane NaOH 80 < 5 88:12 
7 1,4-dioxane CsOH 50 < 5 90:10 
8 1,4-dioxane LiOH 45 < 5 91:9 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios determined using chiral SFC analysis of the allylic alcohol 1.68 
 
With 1,4-dioxane as the solvent and KOH as the optimal base, further perturbations 
of the reaction conditions were conducted.  As depicted in Table 1.3, adjusting the amount 
of geminal bis(boronate) produced similar results (Table 1.3, entries 1-4).  Varying the 
amounts of base resulted in diminished reactivity and enantioselectivity (Table 1.3, entry 
1 vs. entries 5-6).  Lastly, decreasing the reaction temperatures resulted in an increase in 
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enantioselectivity with slightly diminished efficiency (Table 1.3, entry 1 vs. entries 7-9).  
At this point, it was considered that higher enantioselectivity at lower temperatures could 
be combined with a more efficient catalyst for an optimal reaction.   
Table 1.3 Varying Substrate Equivalents and Temperature of the Cross-Coupling of 
Geminal Bis(Boronates) with Alkenyl Bromide and Ligand 1.79  
 
Entry Diboron 
Equiv. 
Base 
Equiv. 
Temperature 
(°C) 
Yield 
1.68 (%)a 
Yield 
1.69 (%)a 
e.r.b 
1 1 4.5 r.t. 58 < 5 91:9 
2 1.1 4.5 r.t. 45 < 5 91:9 
3 1.5 4.5 r.t. 46 < 5 91:9 
4 2 4.5 r.t. 58 < 5 91:9 
5 1 3 r.t. 33 < 5 88:12 
6 1 9 r.t. 42 < 5 88:12 
7 1 4.5 5 43 < 5 94:6 
8 1 4.5 10 49 < 5 93:7 
9 1 4.5 15 62 < 5 92:8 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios determined using chiral SFC analysis of the allylic alcohol 1.68 
 
Before undertaking a ligand investigation, altering the alkenyl electrophiles with 
optimal ligand 1.79 was tested.  As depicted in Scheme 1.26, either cis- or trans-substituted 
alkenyl bromides did not afford the desired product, but only the over-coupled products 
(Scheme 1.26, eq. 1-2).  1,1-Disubstituted alkenyl bromides were unreactive to the depicted 
reaction conditions (Scheme 1.26, eq. 3).  More substituted alkenyl bromides (Scheme 
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of electrophile substitution, it was decided that the original choice of electrophile was 
optimal.  
Scheme 1.26 Analysis of Alkenyl Electrophiles for the Cross-Coupling of Geminal 
Bis(Boronates) with Alkenyl Bromide and Ligand 1.79  
 
 In addition to substitution, the nature of the electrophile was also investigated as 
depicted in Table 1.4.  Compared to alkenyl bromides, alkenyl chlorides produced lower 
reactivity but comparable enantioselectivity (Table 1.4, entries 1 vs. 2).  Alkenyl iodides 
reacted with much worse chemoselectivity and, surprisingly, enantioselectivity.  Similar 
enantioselectivity for the alkenyl chloride and bromide suggests the convergence to a 
palladium (II) hydroxide intermediate for transmetallation.  However, lower 
enantioselectivity for the alkenyl iodide substrate might be a result of competitive 
transmetallation of a palladium (II) iodide intermediate.  
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Table 1.4 Electrophile Survey for the Cross-Coupling of Geminal Bis(Boronates) with 
Alkenyl Bromide and Ligand 1.79  
 
Entry X = Yield 1.80 (%)a Yield 1.81 (%)a e.r.b 
1 Br 40 < 5% 88:12 
2 Cl 23 < 5% 86:14 
3 I 16 35 73:27 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios determined using chiral SFC analysis of the allylic alcohol 1.80 
  
 While surveying reaction conditions revealed that lower temperature increases 
enantioselectivity, the reaction efficiency needed to be addressed.  To address this, the 
effect of the ligand was investigated.  As previously elaborated, the di-tert-butylphosphino 
substituent on the ferrocene was essential for chemoselectivity and enantioselectivity 
(Table 1.1, entry 9 vs. 10).  Taking this into account, the effect of altering the electronic 
and steric properties of the diarylphosphino group were of interest.  It is worth noting that 
ligands with dialkyl substituents (i.e -PtBu2, -PCy2) produced inferior results as compared 
to the diphenylphosphino substituent.  To begin ligand synthesis, efficient routes developed 
by Busacca, Senanayake and coworkers were utilized for the synthesis of secondary 
phosphines (Scheme 1.27, eq. 1).59  Simple Grignard additions to diethyl phosphite (1.82), 
followed by DiBAL-H reduction afforded secondary aryl phosphines with good yields.  
With phosphine in hand, the subsequent synthesis employed commercially available Ugi’s 
                                                
59 Busacca, C. A.; Senanayake, C. H. et al. Org. Lett. 2005, 7, 4277-4280 
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amine (1.83), or readily prepared and resolved through chiral recrystallization.60 Directed 
lithiation of Ugi’s amine and trapping with chlorodi-tert-butylphosphine produced amino-
phosphinoferrocene 1.84 on large scale (Scheme 1.27, eq. 2).61  Treatment with acetic acid 
and the external secondary phosphine resulted in substitution of the phosphine for the 
desired Josiphos ligand.  
Scheme 1.27 Synthesis of Secondary Phosphines and Josiphos Ligands 
 
 With an efficient procedure for the synthesis of Josiphos ligands adapted, a variety 
of ligands were subjected to the standard reaction conditions.  Increasing the steric bulk of 
the phosphine at different positions of the benzene ring resulted in a less chemoselective 
and enantioselective reactions (Table 1.5, entries 1-4).  Even increasing the steric bulk at 
the remote para position (1.85) resulted in a large reduction in efficiency and 
enantioselectivity (Table 1.5, entry 2).  The same trend was observed with steric bulk at 
the ortho and meta positions (Table 1.5, entries 3-4).  From the observed sensitivity of the 
reaction to the steric environment of the benzene ring, it was hypothesized a smaller 
phosphine aryl substituent might be more efficient.   Ligand 1.88 was synthesized 
incorporating a 2-furylphosphino substituent and employed in the reaction.  Supporting the 
hypothesis that incorporating a smaller aryl substituent, the reaction was more efficient but 
                                                
60 Gokel, G. W.; Ugi, I. K.  J. Chem. Ed. 1972, 49, 294-296 
61 Mejia, E.; Aardoom, R.; Togni, A. Eur. J. Inorg. Chem. 2012, 31, 5021-5032	
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less selective than diphenylphosphino (Table 1.5, entries 1 vs. 5).  With the steric effect 
investigated, the electronic properties of the diarylphosphino group were modified.  More 
electron-rich p-methoxyphenyl ligand 1.89 suffered from very poor efficiency and a slight 
decrease in enantioselectivity (Table 1.5, entry 6).  The lower reactivity might be a 
consequence of a more electron rich palladium slowing down the proposed 
transmetallation. Altering the ligand to include inductively-withdrawing substituents (p-
fluorophenyl substituted ligands 1.90, 1.91) reestablished efficiency and enantioselectivity. 
(Table 1.5, entries 7-8).  Ligand 1.91 was extremely efficient but slightly less selective, 
potentially due to small changes in the meta substitution steric parameters (Table 1.5, 
entries 4 vs. 8).  It was hypothesized that a less sterically demanding but electron-
withdrawing diarylphosphino ligand would be optimal for the reaction.  To test these two 
features, p-trifluoromethylphenyl ligand 1.92 was synthesized and analyzed in the reaction 
conditions.  Ligand 1.92 afforded the desired product in excellent efficiency and 
maintained high enantioselectivity (Table 1.5, entry 9).   
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Table 1.5 Ligand Investigation for the Cross-Coupling of Geminal Bis(Boronates) 
with Alkenyl Bromide  
 
Entry Ligand Yield 1.68 (%)a Yield 1.69 (%)a e.r.b 
1 1.79 60 < 5 90:10 
2 1.85 22 < 5 82:18 
3 1.86 14 < 5 63:37 
4 1.87 29 22 52:48 
5 1.88 85 < 5 76:24 
6 1.89 16 10 85:15 
7 1.90 44 < 5 90:10 
8 1.91 97 < 5 85:15 
9 1.92 95 < 5 91:9 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios determined using chiral SFC analysis of the allylic alcohol 1.68 
 
 
 Having discovered a ligand capable of high reactivity and enantioselectivity, a brief 
reanalysis of conditions was conducted.  However, no increase in enantioselectivity was 
observed at lower temperatures or by varying the reaction conditions.  To maximize the 
efficiency of the reaction set-up, a palladium dichloride-Josiphos complex was synthesized 
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(Scheme 1.28, eq. 1).  Using Josiphos×PdCl2 complex in the reaction allowed the reaction 
to be run with 1% catalyst loading without the aid of a glove-box (Scheme 1.28, eq. 2).  
The Josiphos×PdCl2 complex at reduced loadings provided a slight boost in 
enantioselectivity with excellent efficiency 
Scheme 1.28 Synthesis of Josiphos×PdCl2 Complex and Incorporation into the Cross-
Coupling of Geminal Bis(Boronates) with Alkenyl Bromide 
 
 Having developed an efficient and enantioselective catalyst for the cross-coupling 
of geminal bis(boronates) with alkenyl bromides, the generality of the reaction was 
explored.  Substrates with a variety of alkyl substituents on the geminal bis(boronate) 
substrate (1.64, 1.94, 1.95, 1.96) reacted in good yields and high enantioselectivity.  A 
variety of functional groups such as protected alcohols (1.97), aryl chlorides (1.98), alkyl 
bromides (1.99) and amides (1.100) were tolerated under the reaction conditions.  In 
regards to the scope of the alkenyl electrophile, a variety of unsymmetrical b,b-
disubstituted alkenyl bromides (1.101, 1.102) reacted with similar efficiency and 
selectivity in the reaction.  Cyclic alkenyl bromides (1.103) also produced excellent results.  
the Supporting Information). To simplify the experimental
setup, the palladium dichloride complex with ligand L6 was
prepared, and a crystal structure is depicted in Figure 1.
Importantly, when air-stable L6·PdCl2 was used as the catalyst,
lower catalyst loadings could be employed and the reaction
exhibit d a slight improvement in selectivity (entry 8). Of
paramount importance, with L6·PdCl2, the reactions could be set
up without the aid of a drybox and required only 1 mol % catalyst
for ef fective reaction.
The scope of t e enantiotopic-group-selective cross-coupling
in the presence of L6·PdCl2 was examined with a variety of
vinyl bromides and geminal bis(boronates) (Table 2). While
phenyl-containing substrates were processed eﬀectively and
provided reaction products 3, 4, and 5, aromatic substituents
were not required, as demonstrated by the production of
compounds 6−8. Of note, the reaction tolerated the presence
of a silyl ether (7), aryl chloride (9), and amide (10).
Moreover, even though Pd catalysis of alkyl bromide
dehydrohalogenation can be eﬃcient,10 the cross-coupling
process described here is quite tolerant of an alkyl bromide
substituent (compound 8). With regard to the electrophile,
vinyl bromides with diﬀerentiated β substituents underwent
smooth coupling (compounds 11, 12, and 14−16), and a cyclic
vinyl bromide could also be employed eﬀectively (product 13).
In the case of 2-monosubstitued vinyl bromides, only a
substrate with a bulky tert-butyl group aﬀorded useful levels of
monoaddition (product 16); with the current catalyst system,
smaller monosubstituted vinyl bromides aﬀord signiﬁcant
amounts of biscoupling products (data not shown).
As mentioned above, chiral allyl boronates participate in a
range of useful reactions. To probe whether these apply to
unpuriﬁed products that arise from enantiotopic-group-
selective cross-couplings, the transformations in Scheme 2
were conducted. In the ﬁrst experiment, geminal bis(boronate)
1 and 1-bromo-2-methyloctene were linked by cross-coupling
in the presence of 1 mol % L6·PdCl2 complex. After ﬁltration
and a solvent swap, oxidation with NaOH/H2O2 furnished
allylic alcohol 17 in excellent yield and enantiomeric purity. In a
second experiment, addition to benzaldehyde was examined:
Table 1. Survey of Ligands in the Cross-Coupling of
Bis(boronate) 1 an 1-Bromo-2-methylpropenea
entry ligand 2 (% yield)b 3 (% yield)b er 3c
1 none <2 <2 −
2 L1 <2 <2 −
3 L2 27 21 57:43
4 L3 13 49 65:35
5 L4 <2 55 90:10
6 L5 <2 14 63:37
7 L6 <2 95 91:9
8d L6 <2 95 (86) 93:7
aSee the Supporting Information for the reaction conditions. bYields
were determined by NMR analysis in comparison to an internal
standard and may include small amounts of the regioisomeric 1,4-
dienes. cEnantiomer ratios (er) were determined by chiral SFC
analysis of the corresponding secondary alcohols. dWith 1 mol % L6·
PdCl2.
Figure 1. Crystal structure of L6·PdCl2. The structure was obtained
from a crystal of the racemic complex in the presence of CH2Cl2.
Coordinates have been deposited at the Cambridge Crystallographic
Data Centre under CCDC 1035172.
Table 2. Substrate Scope in the Asymmetric Cross-Coupling
of Vinylic Halides and Geminal Bis(boronates)a
aSee the Supporting Information for the reaction conditions. Yields
are isolated yields of puriﬁed materials and are averages of two
experiments. er values were determined by chiral SFC analysis of the
corresponding secondary allylic or homoallylic alcohols. bYield
determined by 1H NMR analysis versus an internal standard.
Journal of the American Chemical Society Communication
dx.doi.org/10.1021/ja510266x | J. Am. Chem. Soc. 2014, 136, 17918−1792117919
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Increasing the steric bulk of the unsymmetrical b,b-disubstituted alkenyl bromides (1.104, 
1.105) resulted in slightly diminished enantioselectivity.  Employing trans-disubstituted 
alkenyl bromides (1.106) required a bulky tert-butyl group to suppress over-coupling of 
the allylic boronate product.  The cross-coupling proceeded in good efficiency and 
enantioselectivity.   
Table 1.6 Substrate Scope for the Enantiotopic-Group Selective Cross-Coupling of 
Geminal Bis(Boronates) with Alkenyl Electrophiles 
 
1.5 equiv. diboron reagent, 4.5 equiv. KOH. Yields reported are isolated yields that are the average of two 
experiments.  Enantiomer ratios are the average of two experiments and determined using chiral SFC 
analylsis of oxidized allylic alcohol, or the alcohol as a result of benzaldehyde allylation.  
(See experimental section) 
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In regards to challenging substrates for the cross-coupling, b-branching of the 
geminal bis(boronate) (1.107) resulted in sluggish reactivity (Table 1.7).  Short-chained 
alkyl groups (1.108) also suffered from poor reactivity.  The low reactivity might be due 
to insolubility of the bis(boron) “ate” complexes as the reaction forms a gel.  Subsequent 
studies conducted in our laboratory24c found that increasing the catalyst loading could 
overcome the reactivity problem of substrates 1.107 and 1.108.  Any types of coordinating 
p-bonds (1.109, 1.110) resulted in diminished, efficiency potentially due to binding of 
palladium and inhibiting catalysis.  Distal alkyl boronates (1.111) also resulted in inhibition 
of catalysis.  As alluded to, having a less bulky trans-disubstituted alkenyl bromide (1.112) 
resulted in predominant over coupling of the allylic boronate.  Lastly, under these 
optimized reaction conditions, more substituted alkenyl bromides (1.113) did result in 
product formation but with low efficiency. 
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Table 1.7 Challenging Substrates for the Enantiotopic-Group Selective Cross-
Coupling of Geminal Bis(Boronates) with Alkenyl Electrophiles 
 
Yield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
  
 
1.3.3 Synthetic Utility and Mechanistic Considerations45 
After exploring the scope of the palladium-catalyzed cross-coupling of geminal 
bis(boronates) with alkenyl electrophiles, the synthetic utility of the allylic boronate 
products was investigated.  As depicted in Scheme 1.29, oxidation of the allylic boronate 
in a one-pot process afforded nonracemic g,g-disubstituted allylic alcohol 1.115 in good 
yield and enantioselectivity.  Treatment of the nonracemic allylic boronate product with 
benzaldehyde and heating promoted a stereospecific allylation reaction to afford 1.116 with 
complete stereospecificity.  The synthetic utility of nonracemic g,g-disubstituted allylic 
boronates was highlighted as the allylation reaction produced two contiguous 
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stereocenters.  Lastly, nitrosobenzene-mediated oxidation25 with allylic transposition 
afforded highly valuable nonracemic tertiary allylic alcohol 1.117 with good 
enantiospecificity. 
Scheme 1.29 Transformations of Nonracemic Allylic Boronate Products  
  
 To further expand the synthetic utility of the cross-coupling, a large-scale 
preparation of geminal bis(boronate) 1.62 was performed.   A subsequent gram-scale cross-
coupling without the aid of a glove-box afforded nonracemic allylic boronate 1.64 with 
good yield and enantioselectivity (Scheme 1.30, eq. 1).  The gram scale reaction produced 
similar efficiency and enantioselectivity to the smaller-scale reaction conducted.  
Subsequent work done by Morken and coworkers involved the cross-coupling of the 
nonracemic allylic boronate products with a wide-variety of aryl and alkenyl electrophiles 
(Scheme 1.30, eq. 2).24c The cross-coupling efficiently synthesized all carbon quaternary 
stereocenters with good yields and enantiospecificities. 
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Scheme 1.30 Synthetic Utility of Cross-Coupling and Sequential Allylic Boronate 
Cross-Coupling  
 
 With the synthetic utility of the nonracemic allylic boronate products demonstrated, 
the mechanism of the cross-coupling was studied.  The catalytic cycle is proposed to begin 
with phosphine ligated palladium (0) (1.119) oxidative addition with the alkenyl bromide 
(1.63, Figure 2).  Oxidative addition forms palladium (II) halide complex (1.121), which 
under basic aqueous conditions is in equilibrium with a palladium (II) hydroxide species 
(1.120).  Activation of geminal bis(boronate) to the bis(boron) “ate” complex promotes the 
enantiodetermining transmetallation to palladium (II) intermediate 1.123.  Subsequent 
reductive elimination furnishes the desired nonracemic allylic boronate product 1.64.  
Further undesired cross-coupling of the allylic boronate results in the formation of diene 
products 1.69.   
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Figure 1.2 Proposed Mechanism for the Cross-Coupling of Geminal Bis(Boronates) 
with Alkenyl Bromide 
  
 Since the geminal bis(boron) “ate” complex is involved in the enantiodetermining 
transmetallation, the nature of this complex was of interest.  To explore the nature the 
bis(boron) “ate” complex, two geminal bis(boronates) with differing diol ligands on boron 
were synthesized.  Employing neopentyl glycol-derived substrate (1.124) and 2,4-
dimethylpentanediol-derived substrate (1.125) in the cross-coupling with alkenyl bromide 
1.63 produced sluggish reactivity and lower enantioselectivity (Scheme 1.31, eqs. 1-3). 
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Scheme 1.31 Boron Ligand Experiments to Identify Active Species for 
Transmetallation 
 
 The lower observed enantioselectivity in Scheme 1.31 (eqs. 2-3) suggest that the 
different geminal bis(boronate) substrates do not converge to the same active species for 
transmetallation.  Consequently, the activated bis(boronic) acid intermediate 1.126 does 
not appear to provide the observed enantioselectivity (Figure 1.3).  The lower yields for 
substrates 1.124 and 1.125 could be a result of facile hydrolysis to the inactive geminal 
bis(boronic) acid.  However, distinguishing between activated intermediates 1.62 and 
1.127 (Figure 1.3) with the data from the geminal bis(boronate) diol studies is challenging.  
While it has been shown that the geminal bis(boronates) readily hydrolyze in basic aqueous 
conditions, species 1.62 and 1.127 are likely in equilibrium.  From this equilibrium, the 
geminal bis(boronic) ester 1.62 could be the active species for transmetallation.  
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Figure 1.3 Active Species of Geminal Bis(Boronate) for Transmetallation 
  
 After investigating the active species for transmetallation, the nature of 
transmetallation was of interest.  To probe whether the transmetallation was stereoretentive 
or stereoinvertive, the synthesis of a 10B and 11B labeled geminal bis(boronate) 1.128 was 
conducted.  The 10B-11B labeled geminal bis(boronate) was then subjected to the standard 
reaction conditions to probe the stereochemistry of transmetallation.  Employing the (S,R)- 
Josiphos×PdCl2 complex, if the reaction occurred with retention of configuration the 11B 
enriched product 1.129 would be observed.  Conversely, if the reaction occurred through 
inversion the 10B enriched product 1.130 would be observed (Scheme 1.29, eq. 1).  Analysis 
of the reaction product by mass spectrometry analysis found the values to match very 
closely to the calculated relative intensities for the stereoinvertive transmetallation product 
1.130.  The same analysis was done employing the opposite enantiomer of catalyst, the 
(R,S)-Josiphos×PdCl2 complex.  Again, the data was consistent for the stereoinvertive 
transmetallation product 1.132 (Scheme 1.32, eq. 2).   
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Scheme 1.32 Stereochemistry of Transmetallation Mechanistic Experiment  
 
Reaction run using standard conditions: 1% Pd-Josiphos complex, 1.5 equiv. diboron, 4.5 equiv. KOH, 
dioxane/H2O, r.t., 18 h 
 
  
The cross-coupling of a geminal bis(boronate) occurring by a stereoinvertive 
pathway has been previously reported by Hall and coworkers.  However, a stereoinvertive 
transmetallation required a b-ester group to assist by coordination to boron (Scheme 1.33, 
eq. 1).62  The carbonyl coordination to boron in a stereoinvertive transmetallation has also 
been reported by Suginome for the cross-coupling of a-aminoboronates and Molander for 
the cross-coupling of a b-amido organoboronates.63  However, these examples entail the 
cross-coupling on nonracemic mono-organoboronates.  While coordination of the adjacent 
boron might be present in the cross-coupling of geminal bis(boronates), it would require 
the formation of a four-membered ring through binding of the pinacol oxygen to the 
                                                
62 Lee, J. C. H.; McDonald, R.; Hall, D. G. Nat. Chem. 2011, 3, 894-899 
63 a) Awano. T.; Ohmura, T.; Suginome, M. J. Am. Chem. Soc. 2010, 132, 13191-13193 b) Sandrock, D. L.; 
Jean-Gerard, L.; Chen, C. – Y.; Dreher, S. D.; Molander, G. A. J. Am. Chem. Soc. 2010, 132, 17108-17110 
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adjacent boron (Scheme 1.33, eq. 2).  The formation of a four-membered ring seems 
energetically less favorable than the five-membered ring formation proposed by Hall and 
coworkers. 
Scheme 1.33 Stereoinvertive Transmetallation of Unsymmetrical Nonracemic 
Geminal Bis(Boronates) 
 
 With the knowledge that the transmetallation goes through a stereoinvertive 
pathway two specific mechanisms appear reasonable.  One pathway could be an outer-
sphere, stereoinvertive transmetallation without coordination to palladium through a SE2-
type substitution (Scheme 1.34).  An outer-sphere mechanism might be consistent with the 
observation that a more electron deficient ligand (i.e. p-trifluoromethylphenylphosphino) 
provides higher reactivity.  A more electron deficient ligand would make palladium more 
electrophilic and facilitate a SE2-type substitution.  Employing a more electron-rich ligand 
(i.e. p-methoxyphenyl) did result it much lower reactivity potentially supporting the 
hypothesis that increased electrophilicity leads to higher reactivity.  
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Scheme 1.34 Outer-sphere, Stereoinvertive Transmetallation  
   
An SE2-type substitution is also supported by work done by Aggarwal and 
coworkers.64  Activation of an organoboronate with a non-transferable electron deficient 
aryllithium affords an activated boron “ate” complex that reacts by a stereoinvertive SE2 
substitution with a wide variety of electrophiles (Scheme 1.35).  
Scheme 1.35 Boron “Ate” Complexes as Nucleophiles in Organic Synthesis  
 
 In addition to an outer-sphere transmetallation, neighboring group participation by 
the adjacent organoboronate of the geminal bis(boronate) must be considered.  
Coordination to the adjacent organoboronate by the palladium (II) oxidative addition 
adduct would lead to an inner-sphere, stereoinvertive transmetallation (Scheme 1.36).  A 
more electron deficient palladium would assist in the coordination of the neighboring 
oxygen to palladium.  In-depth kinetic analysis is required to determine the rate-
                                                
64 Larouche-Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 16794-16797 
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determining step of the reaction, which might shed light on the mechanism of 
transmetallation.  
Scheme 1.36 Inner-sphere, Stereoinvertive Transmetallation  
  
 With the potential mechanisms for the stereoinvertive transmetallation elaborated, 
it was of interest to understand the stereochemical outcome.  A stereochemical model is 
proposed based off the Josiphos-PdCl2 crystal structure for the enantiodetermining 
transmetallation step (Figure 1.4).  From the crystal structure, the di-tert-butylphosphino 
group has a large steric effect with one tert-butyl group almost protruding above the 
palladium center.  The other tert-butyl group essentially blocks the bottom, back quadrant 
relative to the palladium center.  After oxidative addition, the alkenyl substituent might be 
directed towards the diarylphosphino group.  This would avoid a steric penalty of having 
the alkenyl group interact with the bulky di-tert-butylphosphino group.   Having previously 
described multiple mechanisms for transmetallation, it is assumed an inner-sphere 
transmetallation is operating.  This mode of transmetallation has the advantage that the 
neighboring boron moiety is assisting in bringing the two molecules together to promote a 
stereoinvertive transmetallation.  Additionally, it is assumed the species for 
transmetallation is a mono-boronic acid, mono-boronic ester geminal bis(boronate).  This 
species would have the advantage of a smaller steric environment close to the di-tert-
butylphosphino group.  The configuration of the geminal bis(boronate) is such that the C-
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B bond of the boron “ate” complex is aligned with the palladium center.  Additionally, the 
R substituent might be directed away to avoid a steric penalty with the alkenyl group on 
palladium.  Taking into account this configuration of the geminal bis(boronate) is 
consistent with the stereochemical outcome for a stereoinvertive transmetallation.  
Figure 1.4 Stereochemical Model for the Cross-Coupling of Geminal Bis(Boronates) 
with Alkenyl Electrophiles  
 
 
1.4 Conclusion  
 An enantioselective Suzuki-Miyaura cross-coupling of geminal bis(boronates) with 
alkenyl electrophiles has been presented.  This method highlights an addition to the 
increasing utility of the geminal bis(boronates) in asymmetric catalysis.  This method also 
contributes a powerful method for the synthesis of nonracemic allylic boronates, more 
specifically challenging g,g-disubstituted allylic boronates.  The reaction was able to 
efficiently synthesize highly valuable nonracemic allylic boronates with high 
enantioselectivity.  The nonracemic allylic boronate products have been shown to be 
versatile in synthetic organic chemistry.  Mechanistic investigations into the reaction have 
shown that the reaction occurs through a stereoinvertive transmetallation  
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 Future efforts to further expand the substrate scope to include a variety of alkenyl 
electrophile substitution patterns is of interest.  In addition to alkenyl electrophiles, the 
incorporation of alkyl electrophiles in the cross-coupling would represent a powerful 
addition to the utility of geminal bis(boronates) in transition-metal catalysis.   
 
 
1.5 Experimental  
 1.5.1 General Information  
 1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), Varian 
Inova-500 (500 MHz), or Varian Gemini-600 (600 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CHCl3: 7.26 ppm). 
Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, m = multiplet), and coupling constants (Hz). 13C 
NMR spectra were recorded on either a Varian Gemini-500 (125 MHz), or Varian Gemini-
600 (150 MHz) spectrometer with complete proton decoupling. Chemical shifts are 
reported in ppm with the solvent resonance as the internal standard (CDCl3: 77.16 ppm). 
31P NMR spectra were recorded on a Varian Gemini-500 (202 MHz), or Varian Gemini-
600 (240 MHz) spectrometer. Chemical shifts are reported in ppm using phosphoric acid 
as the external standard (H3PO4: 0.0 ppm). 11B NMR spectra were recorded on a Varian 
Gemini-500 (128 MHz) spectrometer. 19F NMR spectra were recorded on a Varian Gemini-
500 (470 MHz) spectrometer. Infrared (IR) spectra were recorded on a Bruker alpha-P 
Spectrometer. Frequencies are reported in wavenumbers (cm-1) as follows: strong (s), broad 
(br), medium (m), and weak (w). Optical rotations were measured on a Rudolph Analytical 
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Research Autopol IV Polarimeter. High-resolution mass spectrometry (ESI+) was 
performed at the Mass Spectrometry Facility, Boston College, Chestnut Hill, MA.  
 Liquid chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 230 x 450 Mesh) purchased from Silicycle. Thin layer chromatography 
(TLC) was performed on 25 µm silica gel glass backed plates from Silicycle. Visualization 
was performed using ultraviolet light (254 nm) and ceric ammonium molybdate (CAM) in 
ethanol.  Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector with 
isopropanol or methanol as the modifier.  
 All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), diethyl ether (Et2O), 
dichloromethane (CH2Cl2), and toluene were purified using Pure Solv MD-4 solvent 
purification system, from Innovative Technology, Inc., by passing the solvent through two 
activated alumina columns after purging with argon. Hexane was purified using a Glass 
Contour solvent purification system custom manufactured by SG Waters, LLC (Nashua, 
NH). Bis(pinacolato)diboron was generously donated by Allychem Co., Ltd. and used 
without further purification. Chemicals were purchased from Sigma Aldrich, Alfa Aeser, 
Acros Organics, Fisher Scientific, Oakwood Chemical, Combi-Blocks, TCI America, 
Matrix Scientic and used without further purification.  
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 1.5.2 Ligand Synthesis and Characterization 
 
 
Dimethyl{(S)-1-[(R)-2-(di-tert-
butylphosphanyl)ferrocenyl]ethyl}amine (1.84) Prepared according 
to a literature precedent with slight modification.60 To a 100-mL 
round-bottom flask equipped with a magnetic stir bar and reflux condenser was added (S)-
Ugi’s amine59 (1.32 g, 5.12 mmol). The amine was azeotroped with benzene (3 x 100 µL) 
and placed under N2. Et2O (33 mL) was added and the reaction was cooled to -78oC. tBuLi 
(3.60 mL, 6.14 mmol, 1.7M in pentanes) was cautiously added dropwise. The reaction was 
stirred at -78oC for 30 minutes and then warmed to room temperature for 1 hour. The 
reaction was re-cooled to -78oC and di-tert-butylchlorophosphine (1.07 mL, 5.60 mmol) 
was added as a solution in Et2O (1 mL) via syringe. The reaction stirred at -78oC for 5 
minutes before warming to room temperature. After stirring for 18 hours, the reaction was 
quenched with a saturated solution of Na2CO3 (10 mL). The reaction was poured into a 
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separatory funnel with Et2O (30 mL). The layers were separated and the organic layer was 
successively washed with H2O (20 mL) and brine (20 mL). The organic layer was dried 
over Na2SO4(s), filtered and concentrated in vacuo. The crude material was purified by 
silica gel chromatography (5% ethyl acetate/hexanes to 30% ethyl acetate/hexanes) to 
afford the title compound as a red solid (1.36 g, 66% yield), which was stored in an Ar-
filled drybox. Rf = 0.05 in 50% ethyl acetate/hexanes on TLC.  1H NMR (500 MHz, CDCl3) 
δ  4.54 (s, 1H), 4.38 (t, J = 2.0 Hz, 1H), 4.26 (s, 1H), 4.16 (s, 5H), 3.60 (dq, J = 10.0, 6.0 
Hz, 1H), 2.19 (s, 6H), 1.50 (d, J = 12.0 Hz, 9H), 1.46 (d, J = 7.0 Hz, 3H), 0.92 (d, J = 11.5 
Hz). 13C NMR (150 MHz, CDCl3) δ 101.60 (d, J = 25.5 Hz), 77.21, 72.25 (d, J = 5.7 Hz), 
70.09, 68.39 (d, J = 4.5 Hz), 68.20, 56.75 (d, J = 12.7 Hz), 41.91, 33.26 (d, J = 20.8 Hz), 
31.84 (d, J = 18.5 Hz), 30.87 (d, J = 15.1 Hz), 30.39 (d, J = 13.9 Hz), 16.85. 31P NMR (202 
MHz, CDCl3) δ 14.21. IR (neat) νmax  3097 (w), 2970 (m), 2940 (m), 2888 (m), 2857 (s), 
2813 (m), 2769 (m), 1473 (m), 1455 (s), 1384 (w), 1359 (s), 1262 (w), 1240 (w), 1194 (w), 
1176 (w), 1154 (s), 1109 (s), 1089 (s), 1061 (m), 1041 (s), 1002 (s), 929 (s), 817 (s) cm-1.  
HRMS (ESI+) calc. for C22H37FeNP [M+H]+  402.2013, found 402.2008. [α]20D: +260.2 (c 
= 0.722, CHCl3, l = 50 mm). Melting point: 47-51 oC. 
 
 (S)-1-[(R)-2-(Ditertbutylphosphanyl)ferrocenyl]ethyldi[4-
(trifluoromethyl)phenyl]phosphine (1.92). Prepared according to 
a literature precedent with slight modification.2 In an Ar-filled 
drybox, an oven-dried 2-dram vial with magnetic stir bar was 
charged with 1.84 (330 mg, 0.82 mmol). The vial was sealed with a rubber septum and 
removed from the glove box. Freshly degassed (via constant bubbling with N2 for one hour 
FetBu2P
P
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prior to use) glacial AcOH (500 µL) was added under an atmosphere of N2. The reaction 
was stirred and bis(4-trifluoromethlphenyl)phosphine (278 mg, 0.86 mmol) was added in 
a solution of glacial AcOH (500 µL) via syringe. The reaction was heated to 80oC for 18 
hours. The reaction was cooled to room temperature and the solvent removed in vacuo. 
The mixture was diluted with CH2Cl2 (30 mL) and poured into a separatory funnel 
containing a saturated solution of Na2CO3 (15 mL). The layers were separated and the 
organic layer was successively washed with H2O (20 mL) and brine (20 mL). The organic 
layer was dried over Na2SO4(s), filtered and concentrated in vacuo. The crude material was 
purified by silica gel chromatography (hexanes to 3% ethyl acetate/hexanes) to afford the 
title compound as a red solid (306.2 mg, 55% yield, 95% purity), which was stored in an 
Ar-filled drybox. Rf = 0.5 in 10% ethyl acetate/hexanes on TLC.  1H NMR (600 MHz, 
CDCl3) δ  7.58-7.46 (m, 8H), 4.34 (m, 2H), 4.18 (s, 5H), 4.10 (s, minor conformer), 4.00 
(s, 1H), 3.91 (s, minor conformer), 3.62 (m, 1H), 1.53 (d, J = 12.0 Hz, 9H), 1.44 (t, J = 7.8 
Hz, 3H), 1.04 (d, J = 10.8 Hz, 9H). 13C NMR (150 MHz, CDCl3) δ 143.50 (d, J = 22.0 Hz), 
141.06 (d, J = 23.2 Hz), 136.07 (d, J = 20.8 Hz), 132.25 (d, J = 15.1 Hz), 131.52 (q, J = 
32.4 Hz), 129.85 (q, J = 32.4 Hz), 125.03 (m), 124.85 (m), 98.87 (dd, J = 27.7, 18.4 Hz), 
77.87 (dd, J = 36.9, 3.5 Hz), 72.67 (d, J = 5.9 Hz), 70.31, 68.85 (dd, J = 11.6, 4.7 Hz), 
68.49, 33.46 (d, J = 20.8 Hz), 32.15 (d, J = 19.6 Hz), 31.03 (dd, J = 13.9, 2.4 Hz), 30.70 
(d, J = 13.9 Hz), 29.38 (dd, J = 17.3, 12.7 Hz), 20.34 (dd, J = 4.7 Hz). 31P NMR (242 MHz, 
CDCl3) δ 13.13 (d, J = 17.5 Hz), -0.32 (d, J = 16.3 Hz). 19F NMR (470 MHz, CDCl3) δ -
62.76, -62.82. IR (neat) νmax  3092 (w), 2971 (w), 2942 (w), 2891 (w), 2861 (w), 1606 (m), 
1395 (m), 1321 (s), 1164 (m), 1125 (s), 1107 (m), 1059 (s), 1015 (m), 908 (w), 826 (s), 
733 (m), 699 (m) cm-1.  HRMS (ESI+) calc. for C34H39F6FeP2 [M+H]+  679.1781, found 
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679.1779. [α]20D: +75.4 (c = 0.740, CHCl3, l = 50 mm). Melting point: 156-163 oC 
(decomposition). 
 
 1.93×PdCl2.  In an Ar-filled glove box, an oven-dried 100-mL 
round bottom flask with magnetic stir bar was charged with 
(ACN)2PdCl2 (290 mg, 1.12 mmol) and 1.92 (758 mg, 1.12 
mmol). The flask was removed from the drybox. Toluene (60 mL) 
was added and the reaction was heated to 70oC for 3 hours under N2. The reaction was 
cooled to room temperature and the solvent removed in vacuo. CH2Cl2 (10 mL) was added 
and the solution was filtered through a plug of Celite. The solvent was removed in vacuo 
and the solid washed with Et2O (3 x 4 mL). The red solid was dried under vacuum for 12 
hours to afford the title compound as a red solid (921 mg, 96% yield), which was stored 
under air in a dessicator. 1H NMR (600 MHz, CDCl3) δ  8.26 (t, J = 9.0 Hz, 2H), 7.79 (dd, 
J = 11.4, 7.8 Hz, 2H), 7.67 (d, J = 7.2 Hz, 2H), 7.60 (d, J = 6.6 Hz, 2H), 4.99 (s, 1H), 4.73 
(m, 2H), 4.23 (s, 5H), 3.61 (dq, J = 14.4, 7.2 Hz, 1H), 2.10 (d, J = 15.6 Hz, 9H), 1.39 (dd, 
J = 13.8, 7.2 Hz, 3H), 1.10 (d, J = 14.4 Hz, 9H). 31P NMR (242 MHz, CDCl3) δ 53.75 (d, 
J = 4.6 Hz), 43.91 (d, J = 4.6 Hz). 19F NMR (470 MHz, CDCl3) δ -63.04, -63.37. IR (neat) 
νmax  3080 (w), 2960 (w), 2898 (w), 2870 (w) 1608 (w), 1458 (w), 1396 (m), 1321 (s), 1281 
(w), 1168 (m), 1128 (s), 1061 (s), 1015 (m), 909 (m), 830 (m), 729 (m) cm-1.  HRMS 
(ESI+) calc. for C34H38ClF6FeP2Pd [M-Cl]+  819.0426, found 819.0432. [α]20D: -401.3 (c = 
1.03, CHCl3, l = 50 mm). Melting point: 204-219 oC (decomposition).  
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 1.5.3 Full Ligand Optimization 
 JosiPhos ligands were either purchased according to the general information or 
prepared according to the procedures above (1.5.2). 
Method A. An oven-dried 2-dram vial with magnetic stir bar was charged with (S,R)-
JosiPhos (0.0055 mmol) and geminal bis(boronate) 1.62 (74.0 mg, 0.20 mmol) in an Ar-
filled drybox. The vial was sealed with rubber septum and removed from the drybox. 
Pd(OAc)2 in dioxane (500 µL, 0.005 mmol, 0.01M) was added via syringe and the reaction 
stirred at room temperature under N2 for 1 hour. Then 1-bromo-2-methylprop-1-ene (10.2 
µL, 0.10 mmol) and 8M KOH(aq)65 (56 µL, 0.45 mmol) were added sequentially via syringe. 
The reaction was stirred under an atmosphere of N2 at room temperature for 18 hours. The 
reaction was diluted with Et2O (2 mL) and filtered through a plug of Celite with additional 
Et2O (5 mL). The filtrate was concentrated in vacuo. 1,1,2,2-Tetrachloroethane was added 
as an internal standard (~10 mg) and yield was determined by 1H-NMR analysis. THF (3 
mL) was added to a scintillation vial containing the crude filtrate and equipped with a stir 
bar. The vial was sealed with a septum and an exit needle inserted. The reaction was cooled 
to 0oC, and H2O2 (500 µL, 30 wt% in H2O) and 3M NaOH (500 µL) were added 
sequentially via syringe. The reaction was warmed to room temperature and stirred for no 
less than 3 hours. The reaction was re-cooled to 0oC and quenched with a saturated solution 
of Na2S2O3 (200 µL). The reaction was warmed to room temperature, diluted with Et2O (3 
mL), and then filtered through a plug of silica gel with additional Et2O (5 mL). The solvent 
was removed in vacuo and the crude mixture was purified by silica gel chromatography 
                                                
65 KOH(aq.) was sparged with N2 for 30 min at room temperature before use. 
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(10% ethyl acetate/hexanes) to afford secondary allylic alcohol 1.68. The enantiomeric 
excess was determined by chiral SFC analysis (for full characterization see below). 
Table 1.8 Extensive Ligand Optimization  
 
Entry R1 R2 
Yield 1.68 
(%)a 
Yield 1.69 
(%)a er
b 
1 3,5-xylyl Ph 22 27 57:43 
2 Cy Ph 21 13 54:46 
3 Cy 3,5-di(Me)-4-OMe-phenyl 
14 20 64:36 
4 Cy Cy 40 5 68:32 
5 tBu Cy 50 <2 69:31 
6 Ph Cy 50 15 65:35 
7 Ph iPr 40 <2 78:22 
8 Ph 1-Adamantyl 24 <2 62:38 
9 Ph tBu 60 <2 91:9 
10 2-Me-phenyl tBu 14 <2 63:37 
11 4-F-phenyl tBu 44 <5 90:10 
12 4-OMe-phenyl tBu 16 10 85:15 
13 3,5-di(OMe)phenyl tBu 45 <2 79:21 
14 4-Me-phenyl tBu 22 <5 82:18 
15 3-Me-phenyl tBu 48 10 83:17 
16 3,5-xylyl tBu 29 22 52:48 
17 2-furyl tBu 85 <5 76:24 
18 2-naphthyl tBu 27 10 70:30 
19 Benzo[b]phosphindole tBu 20 23 55:45 
20 tBu tBu 25 <2 57:43 
21 Cy tBu <10 <2 n.d. 
22 4-CF3-phenyl tBu 95 <2 91:9 
23 2-CF3-phenyl tBu 89 <2 75:25 
24 3,4,5-tri(F)phenyl tBu 97 <2 85:15 
aYield was determined by 1H-NMR in comparison to 1,1,2,2-tetrachloroethane as an internal standard. 
cEnantiomer ratio determined by chiral SFC analysis of corresponding alcohol.  
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 1.5.4 Synthesis and Characterization of Geminal Bis(Boronates) 
 Geminal bis(boronates) were prepared according to literature procedures.15,16  
Method B.  Prepared according to a literature precedent with slight modification.47b In an 
Ar-filled drybox, an oven-dried 50-mL round bottom flask with magnetic stir bar was 
charged with lithium 2,2,6,6-tetramethylpiperidide (440 mg, 3.0 mmol). The flask was 
sealed with a rubber septum, removed from the drybox. THF (10 mL) was added and the 
reaction was cooled to 0 °C. A solution of bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methane (804 mg, 3.0 mmol) in THF (5 mL) was added via syringe and the mixture was 
allowed to stir at 0 °C for 5 minutes. Then a solution of the corresponding alkyl bromide 
(3.3 mmol) in THF (5 mL) was added. The reaction mixture was allowed to warm to room 
temperature and stir for 2 hours. The reaction was diluted with Et2O (10 mL) and filtered 
through Celite with Et2O (10 mL). The solvent was removed in vacuo and the crude mixture 
was purified by silica gel chromatography.  
 
 2,2'-(4-Phenylpentane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (1.135) Prepared according to Method B with (4-
bromobutyl)benzene66 as the electrophile. The crude mixture was purified by silica gel 
chromatography (5% ethyl acetate/hexanes, stain in CAM) to afford the title compound as 
a white solid (43%). Rf = 0.5 in 10% ethyl acetate/hexanes on TLC. 1H NMR (500 MHz, 
CDCl3) δ 7.27-7.21 (m, 2H), 7.18-7.12 (m, 3H), 2.59 (t, J = 7.0 Hz, 2H), 1.59 (m, 4H), 
1.32 (m, 2H), 1.22 (s, 12H), 1.20 (s, 12H), 0.72 (t, J = 7.5 Hz, 1H). 13C NMR (125 MHz, 
                                                
66 Hardouin, C.; Kelso, M. J.; Romero, F. A.; Rayl, T. J.; Leung, D.; Hwang, I.; Cravatt, B. F.; Boger, D. L. 
J. Med. Chem., 2007, 50, 3359-3368 
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CDCl3) δ 1.43.13, 128.59, 128.27, 125.56, 83.03, 35.94, 32.26, 31.50, 25.70, 24.96, 24.66. 
11B NMR (160 MHz, CDCl3) δ 33.85. IR (neat) νmax 3085 (w), 3061 (w), 3026 (w), 2976 
(s), 2928 (m), 2856 (m), 1584 (w), 1454 (m), 1354 (s), 1308 (s), 1265 (s), 1214 (m), 1137 
(s), 969 (s), 849 (s), 745 (m), 698 (s) cm-1. HRMS (ESI+) calc. for C23H39B2O4 [M+H]+  
401.3034, found 401.3014. Melting point: 41-42 oC. 
 
       2,2'-(5-Bromopentane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,3,2 
dioxaborolane) (1.136) Prepared according to Method B with 1,4-
dibromobutane as the electrophile. The crude mixture was purified by silica gel 
chromatography (5% ethyl acetate/hexanes, stain in CAM) to afford the title compound as 
a white solid (52%).  Rf = 0.5 in 10% ethyl acetate/hexanes on TLC. 1H NMR (500 MHz, 
CDCl3) δ 3.39 (t, J = 7.0 Hz, 2H), 1.84 (p, J = 7.0 Hz, 2H), 1.57 (q, J = 8.0 Hz, 2H), 1.42 
(m, 2H), 1.23 (s, 12H), 1.22 (s, 12H), 0.72 (t, J = 8.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) 
δ 83.13, 34.21, 33.03, 31.08, 25.01, 24.99, 24.66. 11B NMR (160 MHz, CDCl3) δ 33.81. 
IR (neat) νmax 2976 (s), 2930 (m), 2861 (w), 1459 (w), 1354 (s), 1306 (s), 1245 (s), 1213 
(m), 1164 (s), 1004 (w), 968 (s), 905 (w), 849 (s), 734 (w)  cm-1. HRMS (ESI+) calc. for 
C17H37B2BrNO4 [M+NH4]+  420.2092, found 402.2100. Melting point: 48-50 oC. 
 
  2,2'-(3-(2-Chlorophenyl)propane-1,1-diyl)bis(4,4,5,5-
tetramethyl-1,3,2-dioxaborolane) (1.137) Prepared according to 
Method A with 2-chlorophenethylbromide as the electrophile. The crude mixture was 
purified by silica gel chromatography (10% ethyl acetate/hexanes, stain in CAM) to afford 
the title compound as a white solid (75%). Rf = 0.3 in 10% ethyl acetate/hexanes on TLC. 
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1H NMR (500 MHz, CDCl3) δ 7.29 (dd, J = 7.5, 1.5 Hz, 1H), 7.22 (dd, J = 8.0, 2.0 Hz, 
1H), 7.14 (dt, J = 7.0, 1.5 Hz, 1H), 7.08 (dt, J = 8.0, 2.0 Hz, 1H), 2.73-2.79 (m, 2H), 1.87 
– 1.82 (m, 2H), 1.24 (s, 12H), 1.23 (s, 12H), 0.83 (t, J = 8.0 Hz, 1H). 13C NMR (125 MHz, 
CDCl3) δ 140.54, 134.01, 130.71, 129.35, 127.07, 126.64, 83.15, 36.18, 26.25, 25.05, 
24.65. 11B NMR (160 MHz, CDCl3) δ 33.82. IR (neat) νmax 2977 (w), 2929 (w), 2865 (w), 
1474 (w), 1356 (m), 1310 (s), 1258 (m), 1215 (s), 1137 (s), 1105 (w), 970 (m), 846 (m), 
755 (m), 679 (w) cm-1. HRMS (ESI+) calc. for C21H34B2ClO4 [M+H]+  407.2332, found 
407.2340. Melting point: 87-90 oC. 
 
 
 
 
N,N-Dibenzyl-6-bromohexanamide (1.139) To an oven-dried,      
100-mL round-bottom flask equipped with a magnetic stir bar under an atmosphere of N2, 
was added CH2Cl2 (18 mL), triethylamine (1.2 mL, 8.4 mmol) and dibenzylamine (1.6 mL, 
8.4 mmol) via syringe. The reaction was stirred and cooled to 0oC. 6-Bromohexanoyl 
chloride (1.1 mL, 7.0 mmol) was added dropwise via syringe over a period of 10 minutes. 
The reaction was warmed to room temperature and stirred for 4 hours under N2. The 
reaction was quenched by addition of H2O (4 mL) and poured into a separatory funnel 
containing 3M NaOH (15 mL). The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 x 15 mL). The organic layers were combined, dried over 
Na2SO4(s), filtered, and concentrated in vacuo. The crude mixture was purified by silica gel 
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chromatography (25% ethyl acetate/hexanes, stain in CAM) to afford the title compound 
as a yellow oil (2.3g, 88%).  Rf = 0.2 in 20% ethyl acetate/hexanes on TLC.  
 
 
N,N-Dibenzyl-7,7-bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)heptanamide (1.140) Prepared according 
to Method B with N,N-dibenzyl-6-bromohexanamide as the electrophile. The crude mixture 
was purified by silica gel chromatography (25% ethyl acetate/hexanes, stain in CAM) to 
afford the title compound as a yellow oil (55%).  Rf = 0.2 in 20% ethyl acetate/hexanes on 
TLC. 1H NMR (500 MHz, CDCl3) δ 7.39-7.24 (m, 8H), 7.20 (d, J = 7.5 Hz, 2H), 7.14 (d, 
J = 7.0 Hz, 2H), 4.59 (s, 2H), 4.43 (s, 2H), 2.39 (t, J = 8.0 Hz, 2H), 1.70 (p, J = 7.5 Hz, 
2H), 1.53 (q, J = 7.0 Hz, 2H), 1.35-1.22 (m, 4H), 1.21 (s, 6H), 1.20 (s, 6H), 0.69 (t, J = 7.5 
Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 173.87, 137.68, 136.77, 129.00, 128.64, 128.35, 
127.63, 127.37, 126.49, 82.95, 49.99, 48.06, 33.47, 32.40, 29.63, 25.66, 25.57, 24.94, 
24.60. 11B NMR (160 MHz, CDCl3) δ 33.71. IR (neat) νmax 3029 (w), 2978 (m), 2929 (w), 
2858 (w), 1641 (m), 1452 (m), 1358 (m), 1311 (s), 1267 (m), 1213 (m), 1137 (s), 969 (m), 
908 (s), 849 (m), 726 (s), 698 (m) cm-1. HRMS (ESI+) calc. for C33H50B2NO5 [M+H]+ 
562.3875, found 562.3861.  
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 1.5.5 Synthesis and Characterization of Alkenyl Bromides 
 Method C. Prepared according to a literature precedent with slight modification.67 
In an Ar-filled drybox, an oven-dried 100-mL round bottom flask was charged with 
Cp2ZrCl2 (640 mg, 2.2 mmol). The flask was removed from the drybox and CH2Cl2 (15 
mL) was added followed cautiously by trimethylaluminium (2.9 mL, 30 mmol) via syringe. 
The reaction was cooled to -23oC and water (270 µL, 15 mmol) was added dropwise with 
vigorous stirring. After stirring for 10 minutes, the corresponding alkyne (10 mmol) was 
added in a solution of CH2Cl2 (5 mL). The reaction was stirred for an additional 10 minutes 
at -23oC before adding NBS (5.3 g, 30 mmol) as a solid. The reaction was allowed to warm 
to room temperature and stirred under N2 for 12 hours. The reaction was cooled to 0oC and 
carefully quenched with a saturated solution of K2CO3 (3 mL). After stirring for 10 
minutes, excess Na2SO4(s) was added. The mixture was filtered through a short pad of silica 
and concentrated in vacuo. The crude mixture was purified by silica gel chromatography.  
 
 (E)-1-Bromo-2-methylbut-1-ene (1.141) Prepared according to a literature 
precedent with slight modification.67 In an Ar-filled drybox, to an oven-dried 
2-neck 100-mL round bottom flask equipped with a magnetic stirbar was charged with 
Cp2ZrCl2 (643 mg, 2.2 mmol). The flask was sealed with rubber septa and removed from 
the drybox. Under a constant pressure of N2, one septum was replaced a Dewar condenser. 
CH2Cl2 (15 mL) was added to the reaction vessel followed cautiously by 
trimethylaluminium (2.88 mL, 30 mmol) via syringe. The reaction was cooled to -23oC 
and water (270 µL, 15 mmol) was added dropwise with vigorous stirring. After stirring for 
                                                
67 Lim, S.; Wipf, P. Angew. Chem. Int. Ed. Engl. 1993, 32, 1068-1071 
Et
Me
Br
1.141
 68 
10 minutes, the Dewar condenser was cooled to -78 oC and butyne (0.9 mL, 10 mmol) was 
added dropwise via the condenser. The reaction was stirred for an additional 10 minutes at 
-23oC before adding NBS (5.3 g, 30 mmol) as a solid. The reaction was allowed to warm 
to room temperature and stirred under N2 for 12 hours. The reaction was cooled to 0oC and 
carefully quenched with a saturated solution of K2CO3 (3 mL). After stirring for 10 
minutes, excess Na2SO4(s) was added. The mixture was filtered through a short pad of silica 
and concentrated in vacuo. The crude mixture was purified on silica gel (pentane, stain in 
CAM) to afford a clear, colorless oil (44% yield). Rf = 0.9 in pentanes on TLC. The spectral 
data matched those reported in the literature.68  
 
 (E)-1-Bromo-2-methyloct-1-ene (1.142) Prepared according to Method 
C. The crude reaction mixture was purified by silica gel chromatography 
(pentanes, stain in CAM) to afford a clear, colorless oil (64% yield). Rf = 0.9 in pentanes 
on TLC. 1H NMR (500 MHz, CDCl3) δ 5.88 (s, 1H), 2.09 (t, J = 7.5 Hz, 2H), 1.78 (s, 3H), 
1.42 (p, J = 7.0 Hz, 2H), 1.36-1.21 (m, 6H), 0.89 (t, J = 7.5 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 142.18, 100.98, 38.48, 31.77, 28.89, 27.62, 22.72, 19.16, 14.20. IR (neat) νmax 
3070 (w), 2955 (m), 2926 (s), 2856 (m), 1632 (w), 1458 (m), 1377 (m), 1283 (m), 1160 
(m), 771 (m), 712 (s) cm-1. HRMS (ESI+) calc. for C9H18Br [M+H]+  205.0592, found 
205.0595.  
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 (Bromomethylene)cycloheptane (1.143) Prepared according to a 
literature precedent with slight modification.69 A 50-mL round-bottom 
flask equipped with a magnetic stir bar was charged with 
(bromomethyl)triphenylphosphonium bromide70 (1.13 g, 2.60 mmol). The flask was 
purged with N2 for 5 minutes and THF (7 mL) was added. The reaction was cooled to -
78oC and a solution of KOtBu (292 mg, 2.60 mmol) in THF (3 mL) was added dropwise. 
The reaction was stirred at -78oC for 5 minutes before warming to room temperature over 
30 minutes. Cycloheptanone (236 µL, 2.00 mmol) was added neat and the reaction was 
stirred under N2 at room temperature for 16 hours. The reaction was diluted with Et2O (10 
mL) and quenched with H2O (10 mL). The mixture was added to a separatory funnel and 
the layers separated. The aqueous layer was then extracted with Et2O (3 x 10 mL). The 
organic layers were combined, dried over Na2SO4(s), filtered, and concentrated in vacuo. 
The crude mixture was purified by silica gel chromatography (pentanes, stain in CAM) to 
afford a clear, colorless oil (64% yield). Rf = 0.9 in pentanes on TLC. 1H NMR (500 MHz, 
CDCl3) δ 5.92 (s, 1H), 2.37 (t, J = 6.0 Hz, 2H), 2.31 (t, J = 6.0 Hz, 2H), 1.69-1.47 (m, 8H). 
13C NMR (125 MHz, CDCl3) δ 147.47, 101.14, 36.50, 33.40, 30.11, 29.31, 28.85, 26.18. 
IR (neat) νmax 3070 (w), 2921 (s), 2850 (m), 1614 (w), 1441 (m), 1291 (m), 1159 (w), 763 
(s), 729 (m), 682 (m) cm-1. HRMS (ESI+) calc. for C8H14Br [M+H]+  189.0279, found 
189.0273.  
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  (E)-(1-Bromoprop-1-en-2-yl)cyclohexane (1.144). Prepared according to 
Method C. The crude reaction mixture was purified by silica gel 
chromatography (pentanes, stain in CAM) to afford a clear, colorless oil (47% yield). Rf = 
0.9 in pentanes on TLC. 1H NMR (500 MHz, CDCl3) δ 5.92 (s, 1H), 2.02 (m, 1H), 1.8-
1.65 (m, 7H), 1.33-1.09 (m, 6H). 13C NMR (125 MHz, CDCl3) δ 146.92, 101.12, 47.07, 
31.71, 26.60, 26.27, 17.75. IR (neat) νmax  3069 (w), 2924 (s), 2852 (s), 1624 (m), 1447 (s), 
1377 (m), 1306 (m), 1280 (m), 1165 (m), 1033 (m), 898 (m), 773 (s), 712 (s) cm-1. HRMS 
(ESI+) calc. for C9H16Br [M+H]+  203.0435, found 203.0435. 
 
 (E)-1-Bromo-2,3,3-trimethylbut-1-ene (1.145) Prepared according to 
Method C. The crude reaction mixture was purified by silica gel 
chromatography (pentanes, stain in CAM) to afford a clear, colorless oil (25% yield). Rf = 
0.9 in pentanes on TLC. The spectral data matched those reported in the literature.71 
 
 (E)-1-Bromo-3,3-dimethylbut-1-ene (1.146) Prepared according to a 
literature precedent with slight modification.72 To an oven-dried 25 mL 
round-bottom flask equipped with a magnetic stir bar under N2 was added 3,3-dimethylbut-
1-yne (370 µL, 3.0 mmol). DIBAL-H (3.3 mL, 3.3 mmol, 1.0 M in hexanes) was added via 
syringe and the reaction was stirred for 15 minutes at room temperature before heating to 
50oC for 5 hours. The reaction was cooled to room temperature and Et2O (2 mL) was added. 
The reaction was further cooled to -78oC and NBS (640 mg, 3.6 mmol) was added as a 
solid. Upon warming to room temperature, the reaction was stirred for 16 hours. To quench, 
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the reaction was poured into a mixture of 6M HCl (10 mL), pentanes (20 mL), and ice. The 
layers were separated in a separatory funnel, and the aqueous layer was extracted with 
pentanes (3 x 20 mL). The organic layers were combined and washed successively with 
1M NaOH (10 mL) and a saturated solution of Na2S2O3 (10 mL). The organic layer was 
dried over Na2SO4(s), filtered, and concentrated in vacuo. The crude mixture was purified 
by silica gel chromatography (pentanes, stain in KMnO4) to afford a clear, colorless oil 
(160 mg, 33% yield). Rf = 0.9 in pentanes on TLC. 1H NMR (500 MHz, CDCl3) δ 6.22 (d, 
J = 14.0 Hz, 1H), 5.98 (d, J = 13.5 Hz, 1H), 1.04 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 
148.64, 102.02, 35.83, 29.133. IR (neat) νmax 3085 (w), 2961 (m), 2932 (w), 2905 (w), 
2868 (w), 1614 (w), 1463 (w), 1364 (m), 1263 (m), 945 (m), 906 (s), 774 (m)  cm-1. HRMS 
(ESI+) calc. for C6H12Br [M+H]+  163.0122, found 163.0125.  
 
 1.5.6 Procedures for Enantiotopic-Group-Selective Suzuki 
Coupling 
 
 Method D. A 2-dram vial with magnetic stir bar was charged with 1.90×PdCl2 (0.9 
mg, 0.0010 mmol) and 1,1-diborylalkane (0.15 mmol). The vial was sealed with rubber 
septum, and purged with N2 for 10 minutes. Dioxane (250 µL) was added and the reaction 
stirred for 5 minutes. Then a solution of vinyl bromide in dioxane (250 µL, 0.10 mmol, 
0.4M) and 8M KOH(aq)65 (56 µL, 0.45 mmol) were added sequentially via syringe. The 
reaction was stirred under an atmosphere of N2 at room temperature for 18 hours. The 
reaction was diluted with Et2O (2 mL) and filtered through a plug of Celite with additional 
Et2O (5 mL). The filtrate was concentrated in vacuo and purified by silica gel 
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chromatography to afford the desired compound. The enantiomeric ratio was determined 
for the alcohol obtained from subjecting the purified allyl boronate product to either 
hydrogen peroxide oxidation (Method E) or benzaldehyde allylation (Method F). 
 Method E, oxidation to secondary allylic alcohol. THF (3 mL) was added to the 
purified allylic boronate in a scintillation vial equipped with a stir bar. The vial was sealed 
with a septum and an exit needle inserted. The reaction was cooled to 0oC, and H2O2 (500 
µL, 30 wt% in H2O) and 3M NaOH (500 µL) were added sequentially via syringe. The 
reaction was warmed to room temperature and stirred for no less than 3 hours. The reaction 
was re-cooled to 0oC and quenched with a saturated solution of Na2S2O3 (200 µL). The 
reaction was warmed to room temperature, diluted with Et2O (3 mL), and then filtered 
through a plug of silica gel with additional Et2O (5 mL). The solvent was removed in vacuo 
and the crude mixture was purified by silica gel chromatography to afford the 
corresponding secondary allylic alcohol. 
 Method F, allylboration with benzaldehyde. Toluene (500 µL) was added to the 
purified allylic boronate in a 2-dram vial equipped with a stir bar under N2. The reaction 
was stirred and benzaldehyde (50 µL, 0.5 mmol) was added. The reaction was heated to 
60oC for 24 hours under N2. Upon cooling to room temperature, the reaction was diluted 
with Et2O (3 mL) and filtered through a short pad of Celite with additional Et2O (5 mL). 
The solvent was removed in vacuo and the crude mixture was purified by silica gel 
chromatography to afford the corresponding secondary homoallylic alcohol. 
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 1.5.7 Characterization of Reaction Products and Analysis of 
Stereochemistry 
 
 (S)-4,4,5,5-Tetramethyl-2-(5-methyl-1-phenylhex-4-en-3-yl)-
1,3,2-dioxaborolane (1.64). The reaction was performed according 
to the Representative Procedure (Method D). The crude mixture was purified by silica gel 
chromatography (20% CH2Cl2/hexanes, stain in CAM) to afford a clear, colorless oil 
(27.9mg, 93% yield). Rf = 0.6 in 50% CH2Cl2/hexanes on TLC. 1H NMR (500 MHz, 
CDCl3) δ 7.27-7.24 (m, 2H), 7.17-7.13 (m, 3H), 5.09 (d, J = 9.5 Hz, 1H), 2.64 (ddd, J = 
13.5, 10.5, 5.5 Hz, 1H), 2.53 (ddd, J = 13.0, 10.5, 6.0 Hz, 1H), 1.99 (q, J = 8.5 Hz, 1H),  
1.83 (ddt, J = 13.0, 10.0, 6.0 Hz, 1H), 1.72 (s, 3H), 1.67 (m, 1H), 1.59 (s, 3H), 1.23 (s, 6H), 
1.22 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 143.06, 131.31, 128.63, 128.32, 125.65, 
125.06, 83.09, 35.64, 33.71, 24.92, 24.69, 18.4. 11B NMR (160 MHz, CDCl3) δ 33.06. IR 
(neat) νmax 3084 (w), 3062 (w), 3026 (m), 2976 (s), 2924 (s), 2856 (m), 1603 (s), 1495 (m), 
1453 (m), 1369 (s), 1315 (s), 1269 (m), 1214 (m), 1141 (s), 1105 (m), 967 (s), 838 (m), 
698 (s) cm-1. HRMS (ESI+) calc. for C19H30BO2 [M+H]+  301.2339, found 301.2335. 
[α]20D: +1.73 (c = 0.925, CHCl3, l =50 mm). 
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Gram Scale Procedure 
 A 50-mL round bottom flask with magnetic stir bar was charged with 1.93×PdCl2 
(42.8 mg, 0.050 mmol) and geminal bis(boronate) 1.62 (2.79 g, 7.5 mmol). The flask was 
sealed with rubber septum, and purged with N2 for 20 minutes. Dioxane (25 mL) was added 
and the reaction stirred for 5 minutes. 1-Bromo-2-methylprop-1-ene (512 µL, 5.0 mmol)73 
and 8M KOH(aq)65 (2.80 mL, 22.5 mmol) were added sequentially via syringe. The reaction 
was stirred under an atmosphere of N2 at room temperature for 18 hours. The reaction was 
diluted with Et2O (15 mL) and poured into a separatory funnel with Et2O (10 mL). The 
layers were separated and the aqueous layer was extracted with Et2O (2 x 20 mL). The 
organic layers were combined, dried over Na2SO4(s), filtered, and concentrated in vacuo. 
The crude material was purified by silica gel chromatography (20% CH2Cl2/hexanes, stain 
in CAM) to afford the title compound as a yellow oil (1.06 g, 71% yield) which co-eluted 
with protodeboration of the starting material (380 mg). The spectral data matched those 
above. 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the corresponding geminal bis(boronate) according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
 
 
                                                
731-Bromo-2-methylprop-1-ene was sparged with N2 for 30 min at room temperature before use. 
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Racemic 
 
Reaction product 
 
 
 (S)-5-Methyl-1-phenylhex-4-en-3-ol (1.68). The reaction was 
performed according to the Representative Procedure (Method E). 
The crude mixture was purified by silica gel chromatography (8% ethyl acetate/pentanes, 
stain in CAM) to afford a clear, colorless oil. Rf = 0.4 in 7/2/1 hexanes/CH2Cl2/ethyl acetate 
on TLC. 1H NMR (500 MHz, CDCl3) δ 7.29-7.26 (m, 2H), 7.20-7.17 (m, 3H), 5.22 (d, J = 
9.0 Hz, 1H), 4.37 (q, J = 9.0 Hz), 1H), 2.67 (m, 2H), 1.92 (ddt, J = 13.5, 9.5, 6.5 Hz, 1H), 
1.76 (ddt, J = 13.0, 10.0, 6.0 Hz, 1H), 1.74 (s, 3H), 1.66 (s, 3H), 1.34 (s, 1H). 13C NMR 
(125 MHz, CDCl3) δ 142.21, 135.75, 128.53, 128.47, 128.06, 125.89, 68.31, 39.30, 31.95, 
25.94, 18.41. IR (neat) νmax 3359 (br), 3061 (w), 3026 (w), 2968 (w), 2926 (s), 2856 (m), 
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1495 (m), 1453 (s), 1376 (m), 1042 (s), 1006 (m), 746 (m), 698 (s) cm-1. HRMS (ESI+) 
calc. for C13H17 [M+H-H2O]+  173.1330, found 173.1338. [α]20D: -36.1 (c = 0.400, CHCl3, 
l =50 mm). The absolute stereochemistry was assigned by comparing the optical rotation 
with a reported value in the literature for (S)-1.68, [α]20D: -28.3 (c = 0.05, CDCl3, 90:10 
er).74 
 
 (S)-4,4,5,5-Tetramethyl-2-(2-methyl-7-phenylhept-2-en-4-
yl)-1,3,2-dioxaborolane (1.94) The reaction was performed 
according to the Representative Procedure (Method D). The crude mixture was purified by 
silica gel chromatography (20% CH2Cl2/hexanes, stain in CAM) to afford a clear, colorless 
oil (26.4 mg, 84% yield). Rf = 0.7 in 50% CH2Cl2/hexanes on TLC.  1H-NMR (500 MHz, 
CDCl3) δ 7.24-7.27 (m, 2H), 7.14-7.17 (m, 3H), 5.03 (d, J = 9.5 Hz, 1H), 2.54-2.63 (m, 
2H), 1.97 (q, J = 8.0 Hz, 1H), 1.69 (s, 3H), 1.52-1.66 (m, 6H), 1.39-1.45 (m, 1H), 1.22 (s, 
6H), 1.21 (s, 6H).  13C-NMR (125 MHz, CDCl3) δ 143.06, 130.87, 128.53, 128.33, 125.64, 
125.33, 83.04, 36.21, 31.48, 31.20, 26.01, 24.89, 24.69, 18.32. 11B-NMR (160 MHz, 
CDCl3) δ 33.03.  IR (neat) νmax 3026 (m), 2977 (s), 2926 (s), 2855 (s), 1603 (w) 1496 (m), 
1453 (m) 1370 (s), 1317 (s), 1272 (m), 1214 (m), 1143 (s), 1106 (m), 968 (m), 886 (m), 
835 (m), 747 (m), 698 (s).  HRMS (ESI) calc. for C20H32B1O2 [M+H]+ 315.2495, found 
315.2490.  [α]20D: +8.67 (c = 0.870, CHCl3, l = 50 mm).   
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Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the corresponding geminal bis(boronate) according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction product 
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 (S)-2-Methyl-7-phenylhept-2-en-4-ol (1.147). The reaction was 
performed according to the Representative Procedure (Method E). 
The crude mixture was purified by silica gel chromatography (20% ethyl acetate/hexanes, 
stain in CAM) to afford a clear, colorless oil.  Rf = 0.5 in 20% ethyl acetate/hexanes on 
TLC.  1H-NMR  (500 MHz, CDCl3) δ 7.26-7.29 (m, 2H), 7.16-7.19 (m, 3H), 5.16 (d, J = 
8.5 Hz, 1H), 4.36 (m, 1H), 2.63 (t, J = 7.0 Hz, 2H), 1.72 (s, 3H), 1.59-1.69 (m, 6H), 1.44-
1.51 (m, 1H), 1.26 (d, J = 3.0 Hz, 1H).  13C-NMR  (125 MHz, CDCl3) δ 142.58, 135.41, 
128.56, 128.42, 128.24, 125.85, 68.72, 37.43, 36.03, 27.43, 25.92, 18.39.  IR (neat) νmax 
3358 (br), 3063 (w), 3026 (m), 2923 (s), 2855 (s), 1673 (m), 1584 (m), 1553 (m), 1496 (s), 
1452 (s), 1375 (s), 1056 (s), 985 (s), 747 (s), 698 (s).  HRMS (ESI) calc. for C14H19 [M+H-
H2O]+ 187.1486, found 187.1480.  [α]20D: -6.53 (c = 0.575, CHCl3, l = 50 mm). 
 
 (S)-4,4,5,5-Tetramethyl-2-(2-methyl-8-phenyloct-2-en-4-yl)-
1,3,2-dioxaborolane (1.95) The reaction was performed 
according to the Representative Procedure (Method D). The crude mixture was purified by 
silica gel chromatography (20% CH2Cl2/hexanes, stain in CAM) to afford a clear, colorless 
oil (26.3mg, 80%). Rf = 0.8 in 50% CH2Cl2/hexanes on TLC. 1H-NMR  (500 MHz, CDCl3) 
δ 7.24-7.27 (m, 2H), 7.14-7.17 (m, 3H), 5.03 (d, J = 9.0 Hz, 1H), 2.54-2.63 (m, 2H), 1.91-
1.95 (q, J =  8.0 Hz, 1H), 1.69 (s, 3H), 1.51-1.63 (m, 5H), 1.25-1.44 (m, 4H), 1.21 (s, 6H), 
1.19 (s, 6H). 13C-NMR  (125 MHz, CDCl3) δ 143.06, 130.76, 128.56, 128.31, 125.63, 
125.50, 83.00, 36.05, 31.68, 31.64, 29.01, 25.99, 24.85, 24.67, 18.29. 11B-NMR  (160 
MHz, CDCl3) δ 33.01. IR (neat) νmax 3026 (w), 2976 (s), 2925 (s), 2855 (s), 1604 (w), 1453 
(m), 1370 (s), 1316 (s), 1266 (m), 1214 (m), 1143 (s), 1107 (m), 967 (m), 838 (m) 746 (m), 
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698 (s). HRMS (ESI) calc. for C21H34B1O2 [M+H]+ 329.2651, found 329.2664. [α]20D: 
+10.7 (c = 0.680, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the corresponding geminal bis(boronate) according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 5% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction product 
 
 
 80 
 (S)-2-Methyl-8-phenyloct-2-en-4-ol (1.148) The reaction was 
performed according to the Representative Procedure (Method E). 
The crude mixture was purified by silica gel chromatography (20% ethyl acetate/hexanes, 
stain in CAM) to afford a clear, colorless oil.  Rf = 0.5 in 20% ethyl acetate/hexanes on 
TLC. 1H-NMR (500 MHz, CDCl3) δ 7.26-7.29 (m, 2H), 7.17-7.19 (m, 3H), 5.16 (d, J = 8.5 
Hz, 1H), 4.31-4.36 (m, 1H), 2.60-2.63 (t, J = 8.5 Hz, 2H), 1.72 (s, 3H), 1.59-1.68 (m, 6H), 
1.31-1.50 (m, 3H), 1.28 (d, J = 3.5 Hz, 1H).  13C-NMR (125 MHz, CDCl3) δ 142.81, 
135.31, 128.54, 128.40, 128.35, 125.78, 68.80, 37.68, 36.10, 31.65, 25.92, 25.33, 18.37. 
IR (neat) νmax 3344 (br), 3063 (w), 3026 (m), 2927 (s), 2855 (s), 1673 (m), 1603 (m), 1495 
(m), 1452 (s), 1375 (m), 1051 (s), 999 (s), 840 (m), 745 (s), 697 (s), 510 (m). HRMS (ESI) 
calc. for C12H21 [M+H-H2O]+ 201.1643, found 201.1653. [α]20D: -10.1 (c = 0.440, CHCl3, 
l = 50 mm). 
 
 (S)-4,4,5,5-Tetramethyl-2-(2-methylnon-2-en-4-yl)-1,3,2-
dioxaborolane (1.96) The reaction was performed according to the 
Representative Procedure (Method D). The crude mixture was purified by silica gel 
chromatography (10% CH2Cl2/hexanes, stain in CAM) to afford a clear, colorless oil (17.6 
mg, 66% yield). Rf = 0.7 in 50% CH2Cl2/hexanes on TLC. 1H NMR (500 MHz, CDCl3) δ 
5.03 (d, J = 9.5 Hz, 1H), 1.92 (q, J = 7.5 Hz, 1H), 1.69 (s, 3H), 1.59 (s, 3H), 1.49 (m, 1H), 
1.36-1.28 (m, 19H), 0.86 (t, J = 6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 130.60, 125.68, 
82.97, 32.11, 31.77, 29.06, 25.99, 24.88, 24.69, 22.76, 18.29, 14.21. 11B NMR (160 MHz, 
CDCl3) δ 33.01. IR (neat) νmax 2976 (w), 2960 (w), 2923 (m), 2855 (w), 1458 (w), 1369 
(m), 1314 (s), 1269 (w), 1215 (w), 1142 (s), 967 (m), 881 (w), 836 (m), 672 (w) cm-1. 
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HRMS (ESI+) calc. for C16H32BO2 [M+H]+  267.2495, found 267.2492. [α]20D: +14.7 (c = 
0.875, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary homoallylic alcohol. The racemic alcohol was prepared analogously with 
racemic 1.79 and the corresponding geminal bis(boronate) according to Methods A and F. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction product 
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 (R,E)-2,2-Dimethyl-1-phenylnon-3-en-1-ol (1.149) The 
reaction was performed according to the Representative 
Procedure (Method F). The crude mixture was purified by silica gel chromatography (20% 
CH2Cl2/pentanes, stain in CAM) to afford a colorless oil. Rf = 0.1 in 20% CH2Cl2/pentanes 
on TLC. 1H NMR (500 MHz, CDCl3) δ 7.31-7.23 (m, 5H), 5.49-5.46 (m, 2H), 4.38 (d, J = 
2.5 Hz, 1H), 2.08-2.02 (m, 3H), 1.41-1.24 (m, 6H), 0.99 (s, 3H), 0.93 (s, 3H), 0.90 (t, J = 
7.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 141.01, 136.61, 130.56, 127.99, 127.54, 
127.41, 80.95, 41.63, 33.00, 31.58, 29.41, 25.29, 22.68, 21.74, 14.21. IR (neat) νmax 3460 
(br), 3063 (w), 3028 (w), 2957 (s), 2925 (s), 2855 (m), 1453 (m), 1380 (w), 1186 (w), 1041 
(m), 979 (m), 740 (m), 701 (s) cm-1. HRMS (ESI+) calc. for C17H25 [M+H-H2O]+  229.1956, 
found 229.1958. [α]20D: +39.7 (c = 0.375, CHCl3, l =50 mm). 
 
 (S)-tert-Butyldimethyl((5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hex-4-en-1-yl)oxy)silane (1.97) The reaction 
was performed according to the Representative Procedure (Method D). The crude mixture 
was purified by silica gel chromatography (40% CH2Cl2/hexanes, stain in CAM) to afford 
a clear, colorless oil (22.0 mg, 62% yield). Rf = 0.5 in 50% CH2Cl2/hexanes on TLC. 1H 
NMR (500 MHz, CDCl3) δ 5.01 (d, J = 9.5 Hz, 1H), 3.56 (m, 2H), 2.03 (q, J = 8.5 Hz, 1H), 
1.75 (tt, J = 13.5, 7.0 Hz, 1H), 1.68 (s, 3H), 1.62-1.50 (m, 4H), 1.22 (s, 6H), 1.21 (s, 6H), 
0.88 (s, 9H), 0.03 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 131.29, 124.79, 83.05, 62.75, 
34.63, 26.15, 25.96, 24.87, 24.68, 18.53, 18.31, -5.11, -5.13. 11B NMR (160 MHz, CDCl3) 
δ 32.95. IR (neat) νmax 2976 (w), 2956 (m), 2928 (s), 2857 (s), 1471 (m), 1360 (s), 1315 
(s), 1252 (s), 1143 (s), 1093 (s), 1005 (m), 935 (m), 833 (s), 773 (s), 664 (m) cm-1. HRMS 
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(ESI+) calc. for C19H40BO3Si [M+H]+  355.2839, found 355.2843. [α]20D: +21.6 (c = 1.05, 
CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary homoallylic alcohol. The racemic alcohol was prepared analogously with 
racemic 1.79 and the corresponding geminal bis(boronate) according to Methods A and F. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 5% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction product 
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 (R,E)-6-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-1-
phenylhex-3-en-1-ol (1.150) The reaction was performed 
according to the Representative Procedure (Method F). The crude mixture was purified by 
silica gel chromatography (3% ethyl acetate/hexanes, stain in CAM) to afford a clear, 
colorless oil. Rf = 0.3 in 5% ethyl acetate/hexanes on TLC. 1H NMR (500 MHz, CDCl3) 
7.33-7.23 (m, 5H), 5.54 (d, J = 16.5 Hz, 1H), 5.48 (dt, J = 16.0, 7.0 Hz, 1H), 4.37 (d, J = 
3.0 Hz, 1H), 3.65 (t, J = 7.0 Hz, 2H), 2.29 (q, J =  6.5 Hz, 2H), 2.12 (d, J = 3.0 Hz, 1H), 
1.00 (s, 3H), 0.93 (s, 3H), 0.90 (s, 9H), 0.06 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 140.96, 
138.90, 128.00, 127.55, 127.43, 126.85, 80.81, 63.15, 41.80, 36.64, 26.14, 25.17, 21.55, 
18.55, -5.09. IR (neat) νmax 3446 (br), 3086 (w), 3028 (m), 2955 (s), 2928 (s), 2857 (s), 
1493 (m), 1384 (m), 1360 (m), 1254 (s), 1187 (m), 1097 (s), 1044 (m), 834 (s), 775 (s), 
702 (m) cm-1. HRMS (ESI+) calc. for C20H33OSi [M+H-H2O]+  317.2301, found 317.2317. 
[α]20D: +40.0 (c = 0.470, CHCl3, l =50 mm). 
 
 (S)-2-(8-Bromo-2-methyloct-2-en-4-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (1.99) The reaction was performed according 
to the Representative Procedure (Method D). The crude mixture was purified by silica gel 
chromatography (20% CH2Cl2/hexanes, stain in CAM) to afford a clear, colorless oil (17.2 
mg, 52% yield). Rf = 0.7 in 50% CH2Cl2/hexanes on TLC. 1H NMR (500 MHz, CDCl3) δ 
5.01 (d, J = 9.5 Hz, 1H), 3.39 (t, J = 6.5 Hz, 2H), 1.93 (q, J = 7.5 Hz, 1H), 1.84 (p, J = 6.5 
Hz, 2H), 1.69 (s, 3H), 1.60 (s, 3H), 1.58-1.33 (m, 4H), 1.23 (s, 6H), 1.22 (s, 6H). 13C NMR 
(125 MHz, CDCl3) δ 131.00, 124.89, 82.95, 33.94, 32.92, 30.66, 27.73, 25.83, 24.73, 
24.53, 18.16. 11B NMR (160 MHz, CDCl3) δ 32.93. IR (neat) νmax 2977 (s), 2927 (s), 2856 
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(m), 1447 (w), 1370 (s), 1318 (s), 1272 (m), 1213 (w), 1144 (s), 1106 (w), 968 (m), 837 
(m), 684 (w) cm-1. HRMS (ESI+) calc. for C15H29BBrO2 [M+H]+  331.1444, found 
331.1437. [α]20D: +15.5 (c = 0.580, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary homoallylic alcohol. The racemic alcohol was prepared analogously with 
racemic 1.79 and the corresponding geminal bis(boronate) according to Methods A and F. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction product 
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 (R,E)-8-Bromo-2,2-dimethyl-1-phenyloct-3-en-1-ol 
(1.151) The reaction was performed according to the 
Representative Procedure (Method F). The crude mixture was purified by silica gel 
chromatography (3% ethyl acetate/hexanes, stain in CAM) to afford a clear, colorless oil. 
Rf = 0.2 in 5% ethyl acetate/hexanes on TLC. 1H NMR (500 MHz, CDCl3) δ 7.33-7.24 (m, 
5H), 5.52 (d, J = 15.5 Hz, 1H), 5.42 (dt, J = 16.0, 7.0 Hz, 1H), 4.40 (d, J = 2.0 Hz, 1H), 
3.41 (t, J = 7.0 Hz, 2H), 2.09 (q, J = 6.5 Hz, 2H), 1.98 (d, J = 3.0 Hz, 1H), 1.86 (p, J = 7.0 
Hz, 2H), 1.56-1.48 (m, 2H), 1.00 (s, 3H), 0.94 (s, 3H).  13C NMR (125 MHz, CDCl3) δ 
141.08, 137.47, 129.16, 127.95, 127.60, 127.50, 81.10, 41.62, 33.87, 32.38, 32.08, 28.17, 
25.12, 22.04. IR (neat) νmax  3455 (br), 3085 (w), 3062 (w), 3028 (w), 2960 (s), 2928 (s), 
2856 (m), 1729 (w), 1585 (w), 1492 (w), 1452 (s), 1362 (m), 1249 (m), 1186 (m), 1082 
(w), 1040 (s), 1003 (m), 978 (s), 740 (s), 702 (s) cm-1. HRMS (ESI+) calc. for C16H22Br 
[M+H-H2O]+  293.0905, found 293.0905. [α]20D: +32.4 (c = 0.200, CHCl3, l =50 mm). 
 
 (S)-2-(1-(2-Chlorophenyl)-5-methylhex-4-en-3-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (1.98) The reaction was 
performed according to the Representative Procedure (Method C). The crude mixture was 
purified by silica gel chromatography (30% DCM/hexanes, stain in CAM) to afford a clear, 
colorless oil (28.3 mg, 85% yield). Rf = 0.3 in 50% DCM/hexanes on TLC. 1H NMR (500 
MHz, CDCl3) δ 7.30 (d, J = 8.0 Hz, 1H), 7.19 (dd, J = 7.0, 1.5 Hz, 1H), 7.15 (t, J = 7.5, 
1H), 7.09 (dt, J = 7.0, 2.0 Hz, 1H), 5.11 (dd, J = 9.5, 1.5 Hz, 1H), 2.77 (ddd, J = 14.0, 11.0, 
5.5 Hz, 1H), 2.64 (ddd, J = 13.5, 11.0, 5.5 Hz, 1H), 2.02 (q, J = 8.5 Hz, 1H), 1.83 (ddt, J = 
12.0, 10.0, 5.5 Hz, 1H), 1.73 (s, 3H), 1.71–1.60 (m, 4H), 1.24 (s, 6H), 1.23 (s, 2H). 13C 
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NMR (125 MHz, CDCl3) δ 140.57, 134.06, 131.49, 130.57, 129.47, 127.14, 126.73, 
124.92, 83.15, 33.30, 31.74, 26.02, 24.93, 24.71, 18.38. 11B NMR (160 MHz, CDCl3) δ 
32.97. IR (neat) νmax 3066 (w), 2976 (m), 2925 (m), 2858 (m), 1572 (w), 1474 (m), 1443 
(m), 1370 (s), 1341 (s), 1317 (s), 1268 (m), 1244 (m), 1215 (m), 1165 (m), 1141 (s), 1102 
(m), 1053 (m), 986 (w), 876 (w), 855 (w), 838 (w), 750 (s), 679 (m) cm-1. HRMS (ESI+) 
calc. for C19H29BClO2 [M+H]+  335.1949, found 335.1945. [α]20D: +2.70 c = 1.130, CHCl3, 
l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the corresponding geminal bis(boronate) according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
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Reaction product 
 
 
 (S)-1-(2-Chlorophenyl)-5-methylhex-4-en-3-ol (1.152) The 
reaction was performed according to the Representative 
Procedure (Method D). The crude mixture was purified by silica gel chromatography (20% 
ethyl acetate/hexanes, stain in CAM) to afford a clear, colorless oil. Rf = 0.3 in 7/2/1 
hexanes/CH2Cl2/ethyl acetate on TLC. 1H NMR (500 MHz, CDCl3) δ 7.33 (dd, J = 7.0, 1.0 
Hz, 1H), 7.23 (dd, J = 7.0, 1.5 Hz, 1H), 7.18 (dt, J = 7.0, 1.0 Hz, 1H), 7.13 (dt, J = 8.0, 2.0 
Hz, 1H), 5.23 (dt, J = 9.0, 1.5 Hz, 1H), 4.42 (dtd, J = 10.2, 6.6, 3.6 Hz, 1H), 2.85-2.71 (m, 
2H), 2.00 (t, J = 7.2 Hz, 2H), 1.91 (ddt, J = 12.6, 9.6, 6.0 Hz, 1H), 1.76 (ddt, J = 11.4, 9.6, 
5.4 Hz, 1H), 1.66 (s, 3H), 1.41 (p, J = 7.2 Hz, 2H), 1.37 (d, J = 7.8 Hz, 1H), 1.32-1.24 (m, 
6H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 139.81, 135.86, 134.09, 
130.45, 129.60, 127.93, 127.40, 126.88, 68.41, 37.55, 29.83, 25.92, 18.41 IR (neat) νmax 
3347 (br), 3066 (w), 3014 (w), 2967 (m), 2928 (m), 2863 (w), 1675 (w), 1571 (w), 1474 
(m), 1443 (m), 1376 (w), 1051 (s), 1035 (m), 1003 (w), 9112 (w), 844 (w), 823 (w), 750 
(s), 681 (w) cm-1. HRMS (ESI+) calc. for C13H16Cl [M+H-H2O]+  207.0941, found 
207.0938. [α]20D: -34.8 (c = 0.680, CHCl3, l =50 mm). 
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  (S)-N,N-Dibenzyl-9-methyl-7-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)dec-8-enamide (1.100) The 
reaction was performed according to the Representative Procedure (Method D).  The crude 
reaction mixture was purified by column chromatography on SiO2 (10% ethyl acetate in 
hexanes, stain in CAM) to afford an inseparable mixture of the title compound and 
protodeboration of the geminal bis(boronate) 1.140. The mixture was oxidized according 
to the Representative Procedure (Method E) to 1.153 as follows. 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the corresponding geminal bis(boronate) according to Method A. 
Chiral SFC (AD-H, Chiraldex, 3 mL/min, 20% MeOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
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 (S)-N,N-Dibenzyl-7-hydroxy-9-methyldec-8-
enamide (1.153). The reaction was performed 
according to the Representative Procedure (Method E).  The crude reaction mixture was 
purified by column chromatography on SiO2 (25% ethyl acetate in hexanes, stain in CAM) 
to afford a clear, colorless oil.  Rf = 0.29 in 40% ethyl acetate/hexanes on TLC.  1H-NMR  
(500 MHz, CDCl3) δ 7.35-7.38 (t, J = 6.5 Hz, 2H), 7.28-7.32 (m, 4H), 7.21 (d, J = 7.0 Hz, 
2H), 7.15 (d, J = 7.0 Hz, 2H), 5.14 (d, J = 9.0 Hz, 1H), 4.60 (s, 2H), 4.44 (s, 2H), 4.31 (q, 
J = 6.5 Hz, 1H), 2.41 (t, J = 7.5 Hz, 2H), 1.70-1.75 (m, 1H) 1.72 (s, 3H), 1.67 (s, (3H), 
1.60-1.54 (m, 1H), 1.26-1.43 (m, 7H). 13C-NMR  (125 MHz, CDCl3) δ 173.76, 137.70, 
136.80, 135.26, 129.08, 128.73, 128.44, 128.33, 127.72, 127.50, 126.51, 68.78, 50.04, 
48.24, 37.71, 33.31, 29.53, 25.92, 25.53, 25.41, 18.39. IR (neat) νmax 3422 (br), 3062 (w), 
3029 (w), 2926 (s), 2855 (m), 2363 (w), 2341 (w), 1637 (s), 1494 (m), 1451 (s), 1361 (m), 
1301 (w), 1215 (m), 1077 (m), 1011 (m), 954 (w), 732 (m), 699 (s).  HRMS (ESI) calc. for 
C25H33NO [M+H-H2O]+ 362.2484, found 362.2472.  [α]20D: -11.4 (c = 0.280, CHCl3, l = 
50 mm). 
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 (S)-4,4,5,5-Tetramethyl-2-(5-methyl-1-phenylhex-4-en-3-yl)-
1,3,2-dioxaborolane (1.101) The reaction was performed according 
to the Representative Procedure (Method D). The crude mixture was purified by silica gel 
chromatography (30% CH2Cl2/hexanes, stain in CAM) to afford a clear, colorless oil (25.2 
mg, 80% yield). Rf = 0.6 in 50% CH2Cl2/hexanes on TLC. 1H NMR (500 MHz, CDCl3) δ 
7.29-7.23 (m, 2H), 7.20-7.13 (m, 3H), 5.08 (d, J = 10.0 Hz, 1H), 2.65 (ddd, J = 13.5, 10.0, 
5.0 Hz, 1H), 2.54 (ddd, J = 14.0, 10.5, 6.0 Hz, 1H), 2.06-1.96 (m, 3H), 1.85 (ddt, J = 13.5, 
10.5, 6.5 Hz, 1H), 1.69 (ddt, J = 13.5, 8.5, 5.0 Hz, 1H), 1.60 (s, 3H), 1.23 (s, 6H), 1.22 (s, 
6H), 1.00 (t, J = 7.5 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ 143.06, 137.01, 128.64, 
128.32, 125.64, 123.72, 83.04, 35.64, 33.65, 32.79, 24.88, 24.65, 16.48, 13.34. 11B NMR 
(160 MHz, CDCl3) δ 32.92. IR (neat) νmax 3084 (w), 3063 (w), 3026 (w), 2975 (s), 2926 
(s), 2855 (m), 1739 (w), 1604 (w), 1496 (w), 1455 (m), 1370 (s), 1317 (s), 1270 (m), 1192 
(m), 1143 (s), 1108 (m), 1072 (w), 967 (m), 876 (w), 847 (m), 748 (m), 699 (s) cm-1. HRMS 
(ESI+) calc. for C20H32BO2 [M+H]+  315.2495, found 315.2499. [α]20D: +3.21 (c = 0.650, 
CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the vinyl bromide 1.141 according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 3% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
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 (S,E)-5-Methyl-1-phenylhept-4-en-3-ol (1.154) The reaction was 
performed according to the Representative Procedure (Method E). 
The crude mixture was purified by silica gel chromatography (20% ethyl acetate/hexanes, 
stain in CAM) to afford a clear, colorless oil. Rf = 0.3 in 7/2/1 hexanes/CH2Cl2/ethyl acetate 
on TLC. 1H NMR (500 MHz, CDCl3) 7.30-7.25 (m, 2H), 7.22-7.16 (m, 3H), 5.21 (dd, J = 
8.5, 1.0 Hz, 1H), 4.40 (dq, J = 9.5, 3.0 Hz, 1H), 2.74-2.61 (m, 2H), 2.03 (q, J = 7.5 Hz, 
2H), 1.93 (ddt, J = 13.0, 9.5, 6.5 Hz, 1H), 1.77 (ddt, J = 12.5, 10.0, 6.0 Hz, 1H), 1.66 (s, 
3H), 1.33 (d, J = 3.0 Hz, 1H), 1.02 (t, J = 7.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
142.23, 141.05, 128.53, 128.47, 126.40, 125.89, 68.25, 39.36, 32.39, 31.98, 16.72, 12.62. 
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IR (neat) νmax  3258 (br), 3024 (w), 3000 (w), 2948 (m), 2926 (m), 2880 (w), 2834 (w), 
1608 (m), 1510 (s), 1445 (m), 1341 (w), 1301 (m),  1243 (s), 1176 (m), 1023 (m), 1002 
(m), 833 (m), 820 (m), 701 (m) cm-1. HRMS (ESI+) calc. for C14H19 [M+H-H2O]+  
187.1487, found 187.1487. [α]20D: -23.8 (c = 0.375, CHCl3, l =50 mm). 
 
 (S,E)-4,4,5,5-Tetramethyl-2-(5-methyl-1-phenylundec-4-en-3-
yl)-1,3,2-dioxaborolane (1.102) The reaction was performed 
according to the Representative Procedure (Method D). The crude mixture was purified by 
silica gel chromatography (20% CH2Cl2/hexanes, stain in CAM) to afford a clear, colorless 
oil (32.2 mg, 87% yield). Rf = 0.6 in 50% CH2Cl2/hexanes on TLC. 1H NMR (500 MHz, 
CDCl3) δ 7.28-7.22 (m, 2H), 7.18-7.13 (m, 3H), 5.07 (d, J = 9.5 Hz, 1H), 2.65 (ddd, J = 
13.0, 10.0, 5.0 Hz, 1H), 2.52 (ddd, J = 13.5, 10.5, 6.0 Hz, 1H), 2.00 (m, 3H), 1.84 (ddt, J 
= 13.0, 10.0, 6.5 Hz, 1H), 1.68 (ddt, J = 14.5, 10.5, 5.5 Hz, 1H), 1.57 (s, 3H), 1.41-1.19 
(m, 20H), 0.88 (t, J = 6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 143.09, 135.29, 128.65, 
128.32, 125.64, 125.00, 83.05, 40.00, 35.67, 33.68, 31.99, 28.96, 28.22, 24.90, 24.69, 
22.85, 16.48, 14.29. 11B NMR (160 MHz, CDCl3) δ 33.08. IR (neat) νmax 3085 (w), 3062 
(w), 3026 (w), 2976 (m), 2957 (m), 2925 (s), 2856 (s), 1604 (w), 1496 (w), 1479 (m), 1370 
(s), 1317 (s), 1269 (m), 1214 (m), 1143 (s), 1108 (m), 968 (m), 847 (m), 747 (m), 699 (s) 
cm-1. HRMS (ESI+) calc. for C24H40BO2 [M+H]+  371.3121, found 371.3124. [α]20D: +6.60 
(c = 1.39, CHCl3, l =50 mm). 
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Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the vinyl bromide 1.142 according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 4% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction Product 
 
 
 (S,E)-5-Methyl-1-phenylundec-4-en-3-ol (1.155) The reaction 
was performed according to the Representative Procedure (Method 
E) without the need to first purify the allylic boronate by silica gel chromatography. The 
crude oxidation mixture was purified by silica gel chromatography (20% ethyl 
n-hexyl
MeOH
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acetate/hexanes, stain in CAM) to afford a clear, colorless oil (21.3 mg, 82% yield). Rf = 
0.4 in 7/2/1 hexanes/CH2Cl2/ethyl acetate on TLC. 1H NMR (500 MHz, CDCl3) δ 7.31-
7.25 (m, 2H), 7.24-7.15 (m, 3H), 5.22 (d, J = 8.5 Hz, 1H), 4.39 (q, J = 7.0 Hz, 1H), 2.67 
(m, 2H), 2.00 (t, J = 7.5 Hz, 2H), 1.93 (ddt, J = 13.5, 9.5, 6.5 Hz, 1H), 1.76 (ddt, J = 13.5, 
10.0, 6.5 Hz, 1H), 1.64 (s, 3H), 1.45-1.24 (m, 9H), 0.89 (t, J = 5.5 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 142.24, 139.62, 128.53, 128.47, 127.59, 125.89, 68.26, 39.73, 39.37, 
31.98, 31.88, 29.09, 27.84, 22.78, 16.71, 14.24. IR (neat) νmax 3432 (br), 3084 (w), 3062 
(w), 3026 (w), 2954 (m), 2925 (s), 2856 (s), 1667 (w), 1603 (w), 1495 (m), 1454 (s), 1379 
(m), 1300 (w), 1272 (w), 1052 (m), 1030 (m), 1006 (m), 914 (w), 746 (m), 724 (m), 698 
(s) cm-1. HRMS (ESI+) calc. for C18H27 [M+H-H2O]+  243.2113, found 243.2122. [α]20D: -
18.4 (c = 0.540, CHCl3, l =50 mm). 
 
 (S)-2-(1-Cycloheptylidene-4-phenylbutan-2-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (1.103) The reaction was 
performed according to the Representative Procedure (Method D). The crude mixture was 
purified by silica gel chromatography (30% CH2Cl2/hexanes, stain in CAM) to afford a 
clear, colorless oil (31.2 mg, 88% yield). Rf = 0.7 in 50% CH2Cl2/hexanes on TLC. 1H 
NMR (500 MHz, CDCl3) δ 7.28-7.23 (m, 2H), 7.19-7.13 (m, 3H), 5.10 (d, J = 10 Hz), 1H), 
2.67 (ddd, J = 13.5, 10.5, 5.5 Hz, 1H), 2.54 (ddd, J = 14.0, 11.0, 6.5 Hz, 1H), 2.22 (m, 4H), 
1.99 (q, J = 9.0 Hz, 1H), 1.84 (ddt, J = 12.5, 10.0, 6.0 Hz, 1H), 1.69 (ddt, J = 14.0, 10.0, 
5.5 Hz, 1H), 1.62-1.47 (m, 8H), 1.24 (s, 6H), 1.23 (s, 6H).  13C NMR (125 MHz, CDCl3) δ 
143.05, 140.95, 128.64, 128.31, 125.64, 125.52, 83.04, 38.06, 35.73, 33.63, 30.65, 30.04, 
30.03, 29.32, 27.13, 24.91, 24.69. 11B NMR (160 MHz, CDCl3) δ 33.85. IR (neat) νmax 
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3084 (w), 3062 (w), 3026 (w), 2976 (m), 2921 (s), 2852 (m), 1603 (w), 1496 (w), 1454 
(m), 1355 (s), 1316 (s), 1270 (m), 1214 (w), 1142 (s), 1106 (m), 967 (m), 852 (m), 837 
(m), 748 (m), 699 (s) cm-1. HRMS (ESI+) calc. for C23H36BO2 [M+H]+  355.2808, found 
355. 2805. [α]20D: +15.3 (c = 1.28, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the vinyl bromide 1.143 according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 10% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction product 
 
 97 
 (S)-1-Cycloheptylidene-4-phenylbutan-2-ol (1.156) The 
reaction was performed according to the Representative Procedure 
(Method E). The crude mixture was purified by silica gel chromatography (20% ethyl 
acetate/hexanes, stain in CAM) to afford a clear, colorless oil. Rf = 0.4 in 7/2/1 
hexanes/CH2Cl2/ethyl acetate on TLC. 1H NMR (500 MHz, CDCl3) δ 7.30- 7.15 (m, 5H), 
5.23 (d, J = 8.5 Hz, 1H), 4.39 (q, J = 7.0 Hz, 1H), 2.69 (m, 4H), 2.32-2.2 (m, 4H), 1.92 
(ddt, J = 13.0, 10.0, 6.5 Hz, 1H), 1.76 (ddt, J = 13.5, 10.0, 6.0 Hz), 1.66-1.48 (m, 8H), 1.37 
(s, 1H). 13C NMR (125 MHz, CDCl3) δ 145.28, 142.26, 128.52, 128.46, 128.20, 125.88, 
67.90, 39.37, 37.97, 32.04, 30.32, 29.73, 29.13, 29.09, 27.48. IR (neat) νmax 3420 (br), 3085 
(w), 3061 (w), 3026 (w), 2920 (s), 2851 (s), 2676 (w), 1726 (w), 1655 (w), 1495 (m), 1453 
(s), 1276 (w), 1179 (w), 1043 (s), 1030 (m), 996 (m), 914 (w), 746 (s), 698 (s) cm-1. HRMS 
(ESI+) calc. for C17H23 [M+H-H2O]+  227.1800, found 227.1801. [α]20D: -34.6 (c = 0.635, 
CHCl3, l =50 mm). 
 
 (S,E)-2-(5-Cyclohexyl-1-phenylhex-4-en-3-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (1.104) The reaction was 
performed according to the Representative Procedure (Method D). The crude mixture was 
purified by silica gel chromatography (30% CH2Cl2/hexanes, stain in CAM) to afford a 
clear, colorless oil (30.2 mg, 82% yield). Rf = 0.6 in 50% CH2Cl2/hexanes on TLC. 1H 
NMR (500 MHz, CDCl3) δ 7.28-7.22 (m, 2H), 7.18-7.12 (m, 3H), 5.06 (d, J = 9.0 Hz, 1H), 
2.64 (ddd, J = 14.5, 10.5, 5.5 Hz, 1H), 2.52 (ddd, J = 13.5, 10.5, 6.5 Hz, 1H), 1.99 (q, J = 
9.0 Hz, 1H), 1.90-1.78 (m, 2H), 1.77-1.60 (m, 6H), 1.56 (s, 3H), 1.35-1.06 (m, 17H). 13C 
NMR (125 MHz, CDCl3) δ 143.07, 140.57, 128.67, 128.31, 125.64, 123.11, 82.99,  47.79, 
OH
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35.64, 33.58, 32.34, 32.30, 26.96, 26.58, 24.86, 24.61, 14.94. 11B NMR (160 MHz, CDCl3) 
δ 32.78. IR (neat) νmax 3084 (w), 3062 (w), 3026 (w), 2977 (m), 2924 (s), 2852 (s), 1603 
(w), 1496 (w), 1480 (m), 1370 (s), 1317 (s), 1270 (m), 1215 (w), 1143 (s), 987 (m), 844 
(m), 748 (m), 699 (s) cm-1. HRMS (ESI+) calc. for C24H38BO2 [M+H]+  369.2965, found 
369.2965. [α]20D: +10.1 (c = 0.955, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.96 and the vinyl bromide 1.144 according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 6% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
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 Reaction product 
 
 
 (S,E)-5-Cyclohexyl-1-phenylhex-4-en-3-ol (1.157) The reaction 
was performed according to the Representative Procedure (Method 
E). The crude mixture was purified by silica gel chromatography (20% ethyl 
acetate/hexanes, stain in CAM) to afford a clear, colorless oil. Rf = 0.6 in 20% ethyl 
acetate/hexanes on TLC. 1H NMR (500 MHz, CDCl3) δ 7.30-7.24 (m, 2H), 7.21-7.15 (m, 
3H), 5.21 (d, J = 8.0 Hz, 1H), 4.39 (q, J = 7.0 Hz, 1H), 2.66 (m, 2H), 1.93 (ddt, J = 13.0, 
9.5, 6.5 Hz, 1H), 1.85 (m, 1H), 1.81-1.64 (m, 6H), 1.62 (s, 3H), 1.36-1.09 (m, 6H).  13C 
NMR (125 MHz, CDCl3) δ 144.53, 142.26, 128.54, 128.47, 125.89, 125.88, 68.18, 47.37, 
39.38, 31.99, 31.97, 26.80, 26.47, 15.19. IR (neat) νmax 3329 (br), 3084 (w), 3062 (w), 3026 
(w), 2924 (s), 2852 (s), 1662 (w), 1603 (w), 1495 (w), 1382 (m), 1265 (w), 1189 (w), 1052 
(m), 1030 (m), 1006 (m), 746 (m), 698 (s) cm-1. HRMS (ESI+) calc. for C18H25 [M+H-
H2O]+  241.1956, found 241.1951. [α]20D: -13.8 (c = 0.600, CHCl3, l =50 mm). 
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 (S,E)-4,4,5,5-Tetramethyl-2-(5,6,6-trimethyl-1-phenylhept-4-en-
3-yl)-1,3,2-dioxaborolane (1.105) The reaction was performed 
according to the Representative Procedure (Method D). The crude mixture was purified by 
silica gel chromatography (30% CH2Cl2/hexanes, stain in CAM) to afford a clear, yellow 
oil (23.5 mg, 69% yield). Rf = 0.6 in 50% CH2Cl2/hexanes on TLC. 1H NMR (500 MHz, 
CDCl3) δ 7.27-7.21 (m, 2H), 7.17-7.12 (m, 3H), 5.11 (d, J = 9.0 Hz, 1H), 2.63 (ddd, J = 
15.0, 10.0, 5.5 Hz, 1H), 2.53 (ddd, J = 13.0, 6.5, 3.0 Hz, 1H), 1.99 (q, J = 8.5 Hz, 1H), 1.85 
(ddt, J = 13.5, 10.0, 7.0 Hz 1H) 1.71 (dtd, J = 13.5, 9.5, 5.5 Hz, 1H), 1.59 (s, 3H), 1.21 (s, 
6H), 1.20 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 143.03, 128.65, 128.31, 125.64, 121.72, 
82.95, 36.33, 35.71, 33.57, 29.38, 24.80, 24.58, 13.50. 11B NMR (128 MHz, CDCl3) δ 
32.76. IR (neat) νmax 3085 (w), 3062 (w), 3026 (w), 2966 (s), 2930 (s), 2861 (m), 1735 (w), 
1604 (w), 1495 (w), 1478 (m), 1455 (m), 1357 (s), 1315 (s), 1263 (m), 1214 (m), 1199 (m), 
1143 (s), 1106 (m), 967 (m), 847 (m), 748 (m), 698 (s) cm-1. HRMS (ESI+) calc. for 
C22H36BO2 [M+H]+  343.2808, found 343.2806. [α]20D: +14.2 (c = 1.175, CHCl3, l =50 
mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the vinyl bromide 1.145 according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
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Racemic 
 
Reaction product 
 
 
 (S,E)-5,6,6-Trimethyl-1-phenylhept-4-en-3-ol (1.158). The 
reaction was performed according to the Representative Procedure 
(Method E). The crude mixture was purified by silica gel chromatography (20% ethyl 
acetate/hexanes, stain in CAM) to afford a clear, colorless oil. Rf = 0.4 in 7/2/1 
hexanes/CH2Cl2/ethyl acetate on TLC. 1H NMR (500 MHz, CDCl3) 7.30-7.24 (m, 2H), 
7.22-7.15 (m, 3H), 5.27 (dd, J = 8.5, 1.0 Hz, 1H), 4.40 (q, J = 7.0 Hz, 1H), 2.74-2.60 (m, 
2H), 1.94 (ddt, J = 13.0, 9.5, 7.0 Hz, 1H), 1.77 (ddt, J = 13.5, 10.0, 6.0 Hz, 1H), 1.65 (s, 
3H), 1.05 (s, 9H) . 13C NMR (125 MHz, CDCl3) δ 147.00, 142.27, 128.54, 128.49, 125.90, 
tBu
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124.74, 68.62, 39.44, 36.28, 32.02, 29.10, 13.30.  IR (neat) νmax 3402 (br), 3085 (w), 3062 
(w), 3026 (w), 2954 (s), 2867 (m), 1654 (w), 1603 (w), 1495 (m), 1478 (m), 1454 (m), 
1377 (m), 1360 (m), 1259 (w), 1052 (m), 1071 (s), 1005 (m), 914 (w), 841 (w), 746 (m), 
698 (s) cm-1. HRMS (ESI+) calc. for C16H23 [M+H-H2O]+  215.1800, found 215.1807. 
[α]20D: -22.5 (c = 0.485, CHCl3, l =50 mm). 
 
 (S,E)-2-(6,6-Dimethyl-1-phenylhept-4-en-3-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (1.106). The reaction was 
performed according to the Representative Procedure (Method D). The crude mixture was 
purified by silica gel chromatography (30% CH2Cl2/hexanes, stain in CAM) to afford a 
white solid (24.6 mg, 75% yield). Rf = 0.6 in 7:2:1 hexanes/CH2Cl2/ethyl acetate on TLC. 
1H NMR (500 MHz, CDCl3) δ 7.28-7.23 (m, 2H) 7.19 – 7.13 (m, 3H), 5.47 (dd, J = 15.5, 
1.0 Hz, 1H), 5.26 (dd, J = 15.5, 8.5 Hz, 1H), 2.63 (ddd, J = 14.0, 9.5, 5.5 Hz, 1H) 2.55 
(ddd, J = 13.5, 10.0, 5.5 Hz, 1H), 1.88-1.75 (m, 2H), 1.70 (ddt, J = 12.0, 6.0, 4.5 Hz, 1H) 
1.24 (s, 6H), 1.23 (s, 6H), 0.99 (s, 9H) . 13C NMR (126 HMz, CDCl3) δ 143.06, 141.70, 
128.66, 128.34, 125.67, 124.94, 83.15, 35.52, 33.15, 33.09, 30.07, 24.88, 24.66. 11B NMR 
(160 MHz, CDCl3) δ 33.01.  IR (neat) νmax 3085 (w), 3063 (w), 3026 (w), 2976 (s), 2957 
(s), 2930 (s), 2862 (m), 1604 (w), 1496 (w), 1456 (m), 1360 (s), 1320 (s), 1266 (m), 1214 
(m), 1143 (s), 1108 (w), 970 (s), 854 (m), 747 (m), 699 (s) cm-1. HRMS (ESI+) calc. for 
C21H34BO2 [M+H]+  329.2652, found 329.2661. [α]20D: +10.6 (c = 0.665, CHCl3, l =50 
mm). Melting point: 48-51 oC. 
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Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis of the corresponding 
secondary allylic alcohol. The racemic alcohol was prepared analogously with racemic 
1.79 and the vinyl bromide 1.146 according to Method A. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
 
Reaction product 
 
 
 (S,E)-6,6-Dimethyl-1-phenylhept-4-en-3-ol (1.159) The reaction 
was performed according to the Representative Procedure (Method 
E). The crude mixture was purified by silica gel chromatography (20% ethyl 
tBu
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acetate/hexanes, stain in CAM) to afford a clear, colorless oil. Rf = 0.5 in 7/2/1 
hexanes/CH2Cl2/ethyl acetate on TLC. 1H NMR (500 MHz, CDCl3) δ 7.30-7.24 (m, 2H), 
7.22-7.16 (m, 3H), 5.67 (d, J = 15.5 Hz, 1H), 5.39 (dd, J = 15.5, 7.0 Hz, 1H), 4.10-4.04 
(m, 1H), 2.75-2.62 (m, 2H), 1.93-1.76 (m, 2H), 1.45 (d, J = 3.0 Hz, 1H), 1.02 (s, 9H). 13C 
NMR (125 MHz, CDCl3) δ 143.56, 142.19, 128.60, 128.50, 127.64, 125.92, 72.83, 39.07, 
32.95, 31.99, 29.67.  IR (neat) νmax 3356 (br), 3085 (w), 3062 (w), 3026 (w), 2956 (s), 2863 
(s), 1661 (w), 1603 (w), 1496 (m), 1455 (m), 1390 (w), 1362 (m), 1267 (w), 1202 (w), 
1100 (w), 1031 (m), 973 (s), 911 (m), 746 (s), 698 (s) cm-1. HRMS (ESI+) calc. for C15H21 
[M+H-H2O]+  201.1643, found 201.1632. [α]20D: -7.94 (c = 0.500, CHCl3, l =50 mm) 
 
        1.5.8 Transformations of Allylic Boronate Products   
 
  (1R,2R)-2-Methyl-1-phenyl-2-((E)-4-phenylbut-1-en-1-
yl)octan-1-ol (1.116). After performing the enantiotopic-group-
selective cross-coupling (Method D), the crude mixture containing 
1.102 was diluted with Et2O (3 mL) and filtered through Celite with additional Et2O (5 
mL). The solvent was removed in vacuo and the crude residue transferred to a 2-dram vial 
with Et2O. The solvent was again removed under vacuum, and the vial equipped with a 
magnetic stir bar. After purging with N2, toluene (500 µL) was added. The reaction was 
stirred and benzaldehyde (50 µL, 0.5 mmol) was added. The reaction was heated to 60oC 
for 24 hours under N2. Upon cooling to room temperature, the reaction was diluted with 
Et2O (3 mL) and filtered through a short pad of Celite with additional Et2O (5 mL). To 
simplify purification, the residue was further oxidized according to Method E and the title 
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compound was obtained by silica gel chromatography (30% CH2Cl2/hexanes) as a clear, 
colorless oil (28.0 mg, 80% yield). Rf = 0.4 in 50% CH2Cl2/hexanes on TLC. 1H NMR (500 
MHz, CDCl3) δ 7.30-7.63 (m, 10H), 5.47 (dt, J = 15.5, 6.5 Hz, 1H), 5.34 (d, J = 16.0 Hz, 
1H), 4.29 (s, 1H), 2.74 (t, J = 7.5 Hz, 2H), 2.44 (q, J = 7.0 Hz, 2H), 1.88 (s, 1H), 1.36-1.04 
(m, 10H), 0.87 (t, J = 7.0 Hz, 3H), 0.83 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 141.84, 
140.73, 136.74, 130.86, 128.62, 128.51, 128.22, 127.49, 127.36, 126.06, 80.32, 45.24, 
38.07, 36.06, 34.89, 32.03, 30.24, 24.15, 22.82, 17.28, 14.22. IR (neat) νmax 3453 (br), 3085 
(w), 3062 (w), 3027 (w), 2954 (m), 2927 (s), 2856 (m), 1495 (w), 1453 (m), 1377 (w), 
1037 (m), 981 (m), 745 (s), 699 (s) cm-1. HRMS (ESI+) calc. for C25H33 [M+H-H2O]+  
333.2582, found 333.2576. [α]20D: +34.1 (c = 1.19, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis. The racemic alcohol was 
prepared analogously with racemic 1.79. 
Chiral SFC (OJ-H, Chiraldex, 3 mL/min, 7% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
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Reaction product 
 
 
 
 (R,E)-5-methyl-1-phenylundec-3-en-5-ol (1.117)25 After 
performing the enantiotopic-group-selective cross-coupling 
(Method D), the crude mixture containing 1.102 was diluted with Et2O (3 mL) and filtered 
through Celite with additional Et2O (5 mL). The solvent was removed in vacuo and the 
crude residue transferred to a 2-dram vial with Et2O. The solvent was again removed under 
vacuum, and the vial equipped with a magnetic stir bar. After purging with N2, THF (1 mL) 
was added and the reaction was cooled to 0oC. Nitrobenzene (32.1 mg, 0.30 mmol) was 
added as a solution in THF (1 mL) via syringe. The reaction was warmed to room 
temperature and stirred under N2 for one hour. The reaction was re-cooled to 0oC and 3M 
NH4OH(aq) (500 µL, 1.6 mmol) was added. The reaction was warmed to room temperature 
and stirred under N2 for 16 hours. To quench, the reaction was diluted with Et2O (3 mL) 
and filtered through a plug of silica with additional Et2O (5 mL). The solvent was removed 
under vacuum. To simplify purification, the crude residue was further oxidized according 
to Method E, and the title compound was obtained by silica gel chromatography (20% 
Ph hexyl
HO Me
1.117
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CH2Cl2/hexanes to 40% CH2Cl2/hexanes) as a clear, yellow oil (16.4 mg). Rf = 0.3 in 50% 
CH2Cl2/hexanes on TLC. 1H NMR (500 MHz, CDCl3) δ 7.29-7.25 (m, 2H), 7.20-7.15 (m, 
3H), 5.63 (dtd, J = 15.5, 6.5, 2.0 Hz, 1H), 5.51 (dd, J = 15.5, 1.5 Hz, 1H), 2.70 (t, J = 8.0 
Hz, 2H), 2.36 (ddd, J = 15.5, 8.0, 1.0 Hz, 2H), 1.46 (m, 2H), 1.32-1.20 (m, 12H), 0.89 (t, 
J = 6.0 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ 141.96, 137.96, 128.62, 128.39, 126.96, 
125.92, 72.92, 43.00, 36.00, 34.19, 31.96, 29.88, 28.08, 24.10, 22.78, 14.22. IR (neat) νmax 
3470 (br), 3026 (w), 2956 (m), 2928 (s), 2856 (m), 1454 (m), 1375 (w), 971 (m), 746 (m), 
698 (s)  cm-1. HRMS (ESI+) calc. for C18H27 [M+H-H2O]+  243.2113, found 243.2102. 
[α]20D: -0.704 (c = 0.690, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
The enantiomeric ratio was determined by chiral SFC analysis. The racemic alcohol was 
prepared analogously with racemic 1.79. 
Chiral SFC (OD-H, Chiraldex, 3 mL/min, 5% iPrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
Racemic 
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 Reaction product 
 
 
 1.5.9 Structure Proof of Product 1.117 
 The absolute structure of 1.117 was determined by ozonolysis/reduction to the 
corresponding diol 1.160, and subsequent comparison with the Sharpless Asymmetric 
Dihydroxylation75 product of 2-methyloct-1-ene, which is known to afford the (R) isomer 
utilizing AD-Mix-b.76  Racemic 1.160 was prepared according to a literature procedure.77 
 
 
 (R)-2-Methyloctane-1,2-diol (1.160) A 4-dram vial was charged with 
1.115 (55 mg, 0.21 mmol), CH2Cl2 (2 mL), and MeOH (2 mL). The reaction 
was stirred and cooled to -78oC. A stream of O3 was bubbled into the reaction for 
approximately 3 minutes as the color changed from bright yellow to red/brown. NaBH4 (76 
                                                
75 Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.; Kwong, H.; 
Morikawa, K.; Wang, Z.; Xu, D.; Zhang, X. J. Org. Chem. 1992, 57, 2768. 
76 Arasaki, H.; Iwata, M.; Nishimura, D.; Itoh, A.; Masaki, Y. Synlett 2004, 3, 546. 
77 Albert, B. J.; Sivaramakrihnan, A.;Naka, T.; Czaicki, N.L.; Koide, K. J. Am. Chem. Soc. 2007, 129, 
2648.  
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mg, 2.0 mmol) was added as a solid. The reaction stirred at -78oC for 5 minutes before 
warming to room temperature and further stirring for 12 hours. H2O (2 mL) was added and 
the reaction was poured into a separatory funnel with ethyl acetate (10 mL). The layers 
were separated and the aqueous layer was extracted with ethyl acetate (4 x 10 mL). The 
organic layers were combined, dried over Na2SO4(s), filtered and concentrated in vacuo. 
The crude material was purified by silica gel chromatography (20% ethyl acetate/hexanes 
to 30% ethyl acetate/hexanes) to afford the title compound as a clear, colorless oil (11.7 
mg, 38% yield). Rf = 0.3 in 50% ethyl acetate/hexanes on TLC. The spectral data matched 
those reported in the literature.78  
Analysis of Stereochemistry: 
The enantiomer ratio was determined by chiral GC analysis of the corresponding acetonide 
which was prepared as follows:  The diol was combined with dimethoxypropane (1 mL) 
and a single crystal of p-TsOH, and heated to 60°C for 20 minutes.  The reaction was 
cooled to room temperature, filtered through a pad of silica gel with diethyl ether (5 mL), 
and concentrated in vacuo to afford pure acetonide.  
Chiral GC (b-Dex 120, Supelco, 100°C for 5 minutes, then ramp 1.0°C/min, 20 psi)-
analysis of the reaction product. 
 
 
 
 
 
                                                
78 Park, J.; Pedersen, S. F. Tetrahedron, 1992, 48, 2069. 
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        1.5.10 Cross-Coupling of (S)-10B-1.128 
 
(S)-10B-1.128 was prepared according to a literature procedure.16 
1. Using (S,R)-Complex and assuming inversion during coupling: 
note: bis(boronate) starting material ((S)-10B-1.128) = 98:2 er 
 cross-coupling reaction selectivity = 93:7 er 
 natural abundance of boron is 10B:11B = 19.9:80.1  
 
n-pentyl Bpin
10Bpin
1.128
98%
n-pentyl Bpin
10Bpin
1.128
2%
(S,R)-Pd-complex 1.93 (1%)
KOH, H2O/dioxane
Me
Br
Me
n-pentyl
Bpin
1.132
(0.98)(0.07)=0.0686
n-pentyl
10Bpin
1.131
(0.02)(0.07)=0.0014
Me
Me
Me
Me
n-pentyl
10Bpin
1.130
(0.98)(0.93)=0.9114
n-pentyl
Bpin
1.129
(0.02)(0.93)=0.0186
Me
Me
Me
Me
10B = (0.199)(0.0686) + 0.9114 + 0.0014 + (0.199)(0.0186) = 0.930
11B = (0.801)(0.0686) + (0.801)(0.0186) = 0.070
Relative [M+H] distributions for 10B:
12C16H3210BO2 [M+H]:            266.3   0.842
12C1513CH3210BO2 [M+H]:      267.3   0.146
12C1413C2H3210BO2 [M+H]:     268.3   0.012
Relative [M+H] distributions for 11B:
12C16H3211BO2 [M+H]:            267.3   0.842
12C1513CH3211BO2 [M+H]:      268.3   0.146
12C1413C2H3211BO2 [M+H]:     269.3   0.012
Calculated Relative Intensities:                          
[M+H] for 266 amu = (0.930)(0.842) = 0.783         
[M+H] for 267 amu = (0.930)(0.146) + (0.070)(0.842) = 0.195
[M+H] for 268 amu = (0.930)(0.012) + (0.070)(0.146) = 0.021
[M+H] for 269 amu = (0.070)(0.012) = 0.001
Found:
0.783
0.195
0.021
<0.01
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 2. Using (R,S)-Complex assuming inversion during coupling: 
note:   bis(boronate) starting material ((S)-10B-1.128) = 98:2 er 
 cross-coupling reaction selectivity = 93:7 er 
 natural abundance of boron is 10B:11B = 19.9:80.1  
 
Spectrum 1: Mass Spectrum corresponding to the cross-coupling of (S)-10B-1.128 
with (S,R)-1.93.PdCl2  
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n-pentyl Bpin
10Bpin
1.128
98%
n-pentyl Bpin
10Bpin
1.128
2%
(R,S)-Pd-complex 1.93 (1%)
KOH, H2O/dioxane
Me
Br
Me
n-pentyl
Bpin
1.132
(0.98)(0.93)=0.9114
n-pentyl
10Bpin
1.131
(0.02)(0.93)=0.0186
Me
Me
Me
Me
n-pentyl
10Bpin
1.130
(0.98)(0.07)=0.0686
n-pentyl
Bpin
1.129
(0.02)(0.07)=0.0014
Me
Me
Me
Me
10B = (0.199)(0.9114) + 0.0686 + 0.0186 + (0.199)(0.0014) = 0.269
11B = (0.801)(0.9144) + (0.801)(0.0014) = 0.731
Relative [M+H] distributions for 10B:
12C16H3210BO2 [M+H]:            266.3   0.842
12C1513CH3210BO2 [M+H]:      267.3   0.146
12C1413C2H3210BO2 [M+H]:     268.3   0.012
Relative [M+H] distributions for 11B:
12C16H3211BO2 [M+H]:            267.3   0.842
12C1513CH3211BO2 [M+H]:      268.3   0.146
12C1413C2H3211BO2 [M+H]:     269.3   0.012
Calculated Relative Intensities:                          
[M+H] for 266 amu = (0.269)(0.842) = 0.226        
[M+H] for 267 amu = (0.269)(0.146) + (0.731)(0.842) = 0.655
[M+H] for 268 amu = (0.269)(0.012) + (0.731)(0.146) = 0.110
[M+H] for 269 amu = (0.731)(0.012) = 0.009
Found:
0.269
0.623
0.101
0.007
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 1.5.11 Compound Spectra  
 
 
 
Spectrum 2: Mass Spectrum corresponding to the cross-coupling of (S)-10B-1.128 
with (R,S)- 1.93.PdCl2  
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CHAPTER 2 
Development of an Enantioselective Catalytic-Conjunctive Cross-
Coupling Enabled by a Metal-Induced Metallate Rearrangement 
 
 
 
2.1 Introduction  
 Transition-metal catalysis has become one of the major focuses for methods 
development in synthetic organic chemistry.1  Transition-metal catalysis allows for the 
exploration of new bonds to be broken and formed.  In the realm of transition-metal 
catalysis, palladium has received much attention in the discovery of new C-C bond forming 
reactions.  Examples of these types of palladium-catalyzed reactions include the Heck 
reaction, Suzuki-Miyaura cross-coupling, Negishi cross-coupling, Hiyama cross-coupling 
amongst other reactions.2  The utility of these reactions is highlighted by the 2010 Nobel 
Prize being awarded to Heck, Negishi and Suzuki for development of palladium catalyzed 
cross-coupling reactions.   
                                                
1 Bolm, M.; Bellar, M. Transition Metals for Organic Synthesis: Building Blocks and Fine Chemicals. 
Second Revised and Enlarged Edition 2004, Wiley-VCH, 662 pp. (Vol. 1), 652 pp (Vol. 2) ISBN 3-
52730613-7 
2 Johansson Seechurn, C. C. C.; Kitching, M. O.; Colacot, T. J.; Snieckus, V. Angew. Chem. Int. Ed. 2012, 
51, 5062-5085 
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 The Suzuki-Miyaura cross-coupling has become one of the most widely developed 
and utilized reactions in academia.3 The pharmaceutical industry has employed the Suzuki-
Miyaura cross-coupling even more so for the synthesis of biologically relevant molecules.3  
As a consequence, the Suzuki-Miyaura reaction has been extensively studied and the 
mechanism is becoming well understood.  The ability to incorporate a new elementary step 
in the catalytic cycle for the Suzuki-Miyaura cross-coupling would represent a powerful 
advancement in the area of palladium catalysis.  This chapter will describe the development 
of a palladium-catalyzed conjunctive-cross-coupling, which incorporates an alternative 
transmetallation step into the Suzuki-Miyaura cross-coupling. 
 
2.2 Background  
 
2.2.1 Suzuki-Miyaura Cross-Coupling and Alkenyl Boron “Ate” 
Complex 1,2 Metallate Rearrangements  
 
 The Suzuki-Miyaura cross-coupling has become one of the most widely used 
transition-metal catalyzed reactions and the mechanistic details have been extensively 
studied.  Elegant work done by Soderquist4, Hartwig5, Amatore and Jutland,6 Lloyd-Jones7 
                                                
3 a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457-2483 b) Yasuda, N.; King, A. O. Topic 
Organomet. Chem. 2004, 6, 205-245 c) Torborg, C.; Beller, M. Adv. Synth. Catal. 2009, 351, 3027-3043 d) 
Budaran, V. L.; Shuttleworth, P. S.; Clark, J. H.; Luque, R. Current Organic Synthesis 2010, 7, 614-627 e) 
Suzuki, A. Angew. Chem. Int. Ed. 2011, 50, 6723-6737 f) Navarro, O.; Maluenda, I. Molecules 2015, 20, 
7528-7557	
4Matos, K.; Soderquist, J. A. J. Org. Chem. 1998, 63, 461-470 
5Carrow, B. P.; Hartwig, J. F. J. Am. Chem. Soc. 2011, 133, 2116-2119  
6Le Duc, G.; Amatore, C.; Jutland, A. Chem. Eur. J. 2012, 18, 6616-6625 
7Lenox, A. J. J.; Lloyd-Jones, G. C. Angew. Chem. Int. Ed. 2013, 52-7362-7370 
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and Denmark8 has shed light on the mechanism of the reaction.  Most of the focus of these 
studies has been on the transmetallation step of the Suzuki-Miyaura cross-coupling.  The 
transmetallation step is one of the fundamental steps of transition-metal cross-coupling 
catalytic cycles.  Taking into account the mechanistic work, the general reaction 
mechanism for a Suzuki-Miyaura cross-coupling is depicted in Scheme 2.1.  The catalytic 
cycle begins with oxidative addition of ligated palladium (0) (2.1) with the electrophile to 
form palladium (II)-halide adduct 2.2.  The next transmetallation step could occur by one 
of two pathways.  One possibility (pathway “a”) proceeds through the formation of a 
palladium (II)-hydroxide intermediate (2.3) where addition to the organoboron reagent 
forms activated transmetallation intermediate 2.4.  Alternatively, external activation of the 
organoboronate (pathway “b”) and addition to palladium (II)-halide intermediate 2.2 forms 
the activated transmetallation intermediate 2.4.  Subsequent transmetallation then forms 
palladium (II) intermediate 2.5.  Reductive elimination furnishes the desired product while 
reforming palladium (0) to restart the catalytic cycle.  With the general mechanism of the 
Suzuki-Miyaura cross-coupling elaborated, the ability to introduce alternative steps into 
the catalytic cycle would represent a powerful addition to transition-metal catalysis.   
 
 
 
 
 
                                                
8 a) Thomas, A. A.; Denmark, S. E. Science 2016, 352, 329-332 b) Thomas, A. A.; Wang, H.; Zahrt, A. F.; 
Denmark, S. E. J. Am. Chem. Soc. 2017, 139, 3805-3821 
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Scheme 2.1 General Mechanism of the Suzuki-Miyaura Cross-Coupling  
 
 To probe the idea for new modes of catalysis, employing vinyl organoboron “ate” 
complexes was considered.  Reactions of organoboronates with alkenyl nucleophiles 
generally form alkenyl organoboron “ate” complexes (2.7, Scheme 2.2).  To induce a 1,2-
metallate rearrangement of alkenyl organoboron “ate” complexes typically requires the use 
of a stoichiometric electrophilic activator of the p-system.  After migration, a new C-C 
bond and new carbon-electrophile bond are formed (2.8).  However, these adducts (2.8) 
are generally unstable and typically undergo elimination under the reaction conditions to 
reestablish unsaturation.   
Scheme 2.2. General Reactions of Alkenylboron “Ate” Complexes 
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 The Zweifel olefination is a widely-utilized reaction and illustrates the reactivity of 
alkenyl organoboron “ate” complexes (Scheme 2.3).9  In this reaction, activation of the 
vinyl organoboron “ate” complex with iodine results in the formation of iodonium species 
2.10. The iodonium intermediate then undergoes a 1,2-migration to form a new carbon-
carbon bond and new carbon-iodine bond (2.11).  Subsequent treatment with sodium 
methoxide induces the elimination to form the net vinylation product 2.12.   
Scheme 2.3 Zweifel Olefination  
 
 While the Zweifel olefination has been extensively developed,10 alternative 
electrophilic activators that divert from the 1,2-migration-elimination reaction sequence 
are lacking.  Work done by Utimoto and coworkers realized a new reaction of vinyl 
organoboron “ate” complexes avoiding elimination of the organoboron group.11  The newly 
developed reaction showed that vinyl organoboron “ate” complexes can undergo a 1,2-
migration and addition sequence to aldehydes (Scheme 2.4, eq. 1).  The products of the 
reaction are synthetically useful g-hydroxy organoboronates, a precursor to 1,3-diol motifs. 
However, under these reaction conditions employing organolithium or organomagnesium 
reagents, only low levels of diastereoselectivity were observed.  Deng and coworkers were 
able to expand upon the vinyl organoboron “ate” complex reactivity to promote a 1,2-
                                                
9 a) Jesthi, P. K.; Matteson, D. S. J. Organomet. Chem. 1976, 110, 25-37 b) Matteson, D. S. Synthesis 1975, 
147-159 c) Thomas, R. C.; Walker, J. A.; Evans, D. A. Tetrahedron Lett. 1976, 17, 1427-1430 d) 
Crawford, T. C.; Thomas, R. C.; Evans, D. A. J. Org. Chem. 1976, 41, 3947-3953 
10 Armstrong, R. J.; Aggarwal, V.K. Synthesis 2017, 49, 3323-3336 
11	Uchida, K.; Nozaki, H.; Utimoto, K. Tetrahedron 1977, 33, 1949-1952	
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migration and addition sequence to carbon dioxide to synthesize b-boryl carboxylic acids 
(Scheme 2.4, eq. 2).12 
Scheme 2.4 Previous Work of Nucleophilic 1,2-Migrations of Vinylboron “Ate” 
Complexes  
 
 Based on the previous work with vinyl organoboron “ate” complexes, it was 
hypothesized that 1,2-metallate rearrangements might be incorporated into transition-metal 
catalysis.  Instead of a stoichiometric activator, a transition-metal might activate the alkenyl 
organoboron “ate” complex for a 1,2-metallate rearrangement (Scheme 2.5, eq. 1).  The 
newly formed carbon-metal bond could be further functionalized in the course of catalytic 
reactions.  Choosing palladium to promote the 1,2-metallate rearrangement might allow 
for incorporation into Suzuki-Miyaura cross-coupling reactions.  After oxidative addition, 
and dissociation of the counterion would generate a cationic palladium (II) complex. The 
newly formed cationic palladium (II) intermediate might then be a sufficient p-activator to 
induce a 1,2-metallate rearrangement (Scheme 2.5, eq. 2).  Subsequent reductive 
elimination would furnish a new carbon-carbon bond.  More importantly, incorporating a 
chiral catalyst to distinguish the enantiotopic faces of the vinyl organoboron “ate” complex 
                                                
12 Lu, D. –A.; Xu, W. –H.; Deng, M. –Z. J. Chem. Soc., Chem. Commun. 1985, 0, 1478-1479 
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could render the reaction enantioselective.  The aforementioned catalytic process would 
result in the formation of two new carbon-carbon bonds and a boron-containing carbon 
stereocenter in one-step from simple starting materials. 
Scheme 2.5 Transition-Metal Induced 1,2-Metallate Rearrangements  
  
  
 
2.2.2 Previous Work on Metal-Induced 1,2-Rearrangements   
 The development of an enantioselective metal-induced 1,2-metallate rearrangement 
would represent a powerful addition to transition-metal catalysis.  Consequently, there have 
been reports of alkynyl organoboron “ate” complexes undergoing similar modes of 
reactivity.  Early work done by Deng and coworkers demonstrated that alkynyl trialkyl 
organoborane “ate” complexes undergo addition to palladium (II) p-allyl electrophiles. 
(Scheme 2.6, eq. 1).13  While other interpretations of the mechanism are possible, the 
reaction might go through a palladium-induced 1,2-metallate rearrangement.  As depicted 
in Scheme 2.6 (eq. 1), palladium (II) activation of the alkynyl organoborane “ate” 
complexes induces a 1,2-migration of the R group onto the alkyne.  Murakami and 
coworkers expanded upon the reactivity of alkynyl organoboron “ate” complexes by 
                                                
13 Chen, Y.; Li, N. –S.; Deng, M. –Z. Tetrahedron Lett. 1990, 31, 2405-2406 
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employing a different palladium catalyst and allyl bromide electrophiles.14  Murakami and 
coworkers also reported the cross-coupling of alkynyl triphenylborane “ate” complexes 
with a variety of aryl electrophiles (Scheme 2.6, eq. 2).15  However, under the newly 
developed reaction conditions by Murakami the (Z)-isomer was observed to be the major 
product.     
Scheme 2.6 Previous Work of Metal-Induced Metallate Rearrangements of Alkynyl 
Triorganoborane “Ate” Complexes  
 
 To explain the observed stereochemical outcome, Murakami and coworkers 
proposed an alternative mechanism to the metal-induced 1,2-metallate rearrangement 
depicted in Scheme 2.6, eq. 1.  The formation of the (Z)-isomer was rationalized by 
coordination of palladium (II) to the alkynyl organoboron “ate” complex (2.17) and syn 
carbopalladation to form intermediate 2.18 (Scheme 2.7, eq. 1).  Subsequent intramolecular 
transmetallation (2.19) and reductive elimination furnishes the major (Z)-isomer of 
product.  The proposed intramolecular transmetallation was tentatively supported through 
                                                
14 Ishida, N.; Shinmoto, T.; Sawano, S.; Miura, T.; Murakami, M. Bull. Chem. Soc. Jpn. 2010, 83, 1380-
1385 
15 Ishida, N.; Muira, T.; Murakami, M. Chem. Commun. 2007, 4381-4383 
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a cross-over experiment (not pictured).  However, under these reaction conditions the 
minor (E)-isomer of product was observed in statistically significant amounts.   The (E)-
isomer was proposed to arise by a syn carbopalladation (2.18), followed by reductive 
displacement of palladium by the organoboron “ate” complex (Scheme 2.7, eq. 2).  
Alternatively, the (E)-isomer might be produced by a palladium-induced 1,2-metallate 
rearrangement in analogy to the work by Deng and coworkers in Scheme 2.6, eq. 1.  In the 
development of an enantioselective, palladium-induced 1,2-metallate rearrangement of 
vinyl organoboronate “ate” complexes, these possible mechanistic pathways have to be 
taken into consideration.   
Scheme 2.7 Alternative Mechanisms for the Palladium Cross-Coupling of Alkynyl 
Triphenylborane “Ate” Complexes  
  
More recently, Murakami and coworkers and expanded upon the first report to 
include the cross-coupling of 9-BBN derived alkynyl organoborane “ate” complexes 
(Scheme 2.8, eq. 1).16  For the observed major stereochemical outcome, Murakami invokes 
a syn carbopalladation-reductive displacement sequence in analogy to the previous report 
                                                
16 Ishida, N.; Shimamoto, Y.; Murakami, M. Org. Lett. 2009, 11, 5434-5437 
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(Scheme 2.7, eq. 2).  An alternative mechanistic pathway consistent with the 
stereochemical outcome is a palladium-induced 1,2-metallate rearrangement (Scheme 2.8).  
Scheme 2.8 Previous work on Palladium-Induced Metallate Rearrangements  
 
   
 
2.3 Development of an Enantioselective Palladium-Induced Metallate 
Rearrangement of Vinylboron “Ate” Complexes17 
 
 2.3.1 Reaction Discovery, Optimization, and Scope17  
 
To begin the investigation for an enantioselective palladium-induced metallate 
rearrangement of vinyl organoboron “ate” complexes, careful analysis of the reaction 
parameters was necessary.  With regards to the aryl electrophile for the reaction, aryl 
triflates were chosen.  The triflate anion is known to be non-coordinating and readily 
dissociates from palladium to form cationic palladium.  Access to cationic palladium might 
be crucial due to the increased ability to bind the alkene of the vinyl organoboron “ate” 
complex and promote the desired 1,2-metallate rearrangement.  The nature of the 
                                                
17 Zhang, L.; Lovinger, G. L.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P. Science 2016, 351, 70-
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organoboronate was considered likely to have an impact upon the reactivity and practicality 
of the methodology.  Organoboronic esters were chosen as they are generally air and 
moisture stable as well as configurationally stable.  In addition to stability, nucleophilicity 
parameter studies done by Mayr and Aggarwal have shown that neopentyl diol-derived 
organoboron “ate” complexes are most nucleophilic.  The increased nucleophilicity is 
proposed to be a consequence of the steric environment as compared to pinacol boronic 
esters.18  Taking the nucleophilicity into account, vinyl boronic acid neopentyl ester was 
chosen to explore the reactivity of a metal-induced metallate rearrangement.  
 With regards to the ligand for palladium, it was hypothesized that bidentate 
phosphines have the highest potential to promote the desired palladium-induced 1,2-
metallate rearrangement.  A larger steric environment might help promote alkene binding 
over binding to the oxygen on the neopentyl diol boron ligand.  Binding to the more 
sterically encumbered neopentyl oxygen might be a possible mechanism to promote 
undesired direct Suzuki-Miyaura cross-coupling.   In addition to oxygen binding, a wide-
bite-angle bidentate ligand might aid in facilitating reductive elimination over b-
elimination.  To investigate the proposed reactivity for a palladium-induced 1,2-metallate 
rearrangement of vinyl organoboron “ate” complexes, the reactions depicted in Scheme 2.9 
were conducted.  Employing monodentate tricyclohexylphosphine as the ligand resulted in 
no product formation under the depicted catalytic conditions (Scheme 2.9, eq. 1).  A 1,1’-
bis(diphenylphosphino)ferrocene palladium dichloride catalyst afforded trace 
organoboronate product 2.22 in addition to Suzuki-Miyaura products (Scheme 2.9, eq. 1).  
To explore other ferrocene-based bidentate phosphine ligands, the use of a palladium 
                                                
18 a) Berionni, G. Leonov, L. I.; Mayer, P.; Ofial, A. R.; Mayr, H.; Angew. Chem. Int. Ed. 2015, 54, 2780-
2783 b) Feeney, K.; Berrionni, G.; Mayr, H.; Aggarwal, V. Org. Lett. 2015, 17, 2614-2617 
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acetate pre-catalyst was necessary.  By employing ligand 2.23 and palladium acetate for 
catalyst formation, an appreciable amount of alcohol product 2.24 was isolated after 
oxidation.  In addition to the desired product, Suzuki-Miyaura products (n-butyl benzene 
and styrene) were also observed.  The observation of Suzuki-Miyaura products shows that 
the chiral catalyst needs to have the ability to chemoselectivity engage in alkene binding 
for the desired 1,2-metallate rearrangement.  In addition to chemoselectivity, the catalyst 
must differentiate the enantiotopic faces of the vinyl organoboron “ate” complex.  
Scheme 2.9 Initial Investigations for the Discovery of a Palladium-Induced Metallate 
Rearrangement of Vinylboron “Ate” Complexes 
  
 To render the palladium-induced 1,2-metallate rearrangement enantioselective, a 
survey of chiral bidentate phosphine ligands was undertaken.  Employing commonly used, 
small-bite-angle chiral bidentate ligands like (S,S)-QuinoxP (2.25) and (S,S)-Me-DuPhos 
(2.26) showed no reactivity in the desired palladium-induced 1,2-metallate rearrangement 
(Table 2.1, entries 1-2).  Analyzing (S)-MeO-furyl BIPHEP (2.27) as the ligand afforded 
the desired product albeit in modest enantioselectivity (Table 2.1, entry 3).  Since the initial 
discovery employed achiral ferrocene-based phosphine ligands, chiral variants of these 
ligands were of interest.  Josiphos ligand 2.28 produced comparable yields to (S)-MeO-
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furyl BIPHEP and also an increase in enantioselectivity (Table 2.1, entries 3 vs. 4).  With 
the increase in enantioselectivity, a survey of commercially available Josiphos ligands was 
carried out.  Varying the electronics of the phosphino group on the ferrocene ring to 
diphenylphosphino (2.29) resulted in diminished yield and enantioselectivity (Table 2.1, 
entry 5).  Maintaining an electron-rich phosphine group on the ferrocene while changing 
the electronic properties of the other phosphine group was analyzed with Josiphos ligand 
2.30.  Varying the electronics of the other phosphine group gave excellent reactivity, 
however an almost racemic reaction occurred (Table 2.1, entry 6).  Decreasing the size of 
the diarylphosphino substitution (2.31) resulted in lower reactivity and increased 
enantioselectivity (Table 2.1, entry 7).  From these data, altering the dialkylphosphino 
substitutions in Josiphos ligand 2.28 were ineffective (Table 2.1, entry 4).  An entirely 
different ferrocene-based bidentate phosphine class was of interest and the Mandyphos 
ligand class was analyzed.   Mandyphos ligand 2.32 produced a very efficient reaction and 
proceeded with excellent enantioselectivity (Table 2.1, entry 8).  From the substantial 
increase in enantioselectivity, the Mandyphos ligand class was further investigated.    
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Table 2.1 Initial Chiral Ligand Investigation for the Palladium-Induced Metallate 
Rearrangement of Vinylboron “Ate” Complexes 
 
Entry Ligand Yield 2.24 (%)a e.r.b 
1 2.25 < 10 n.d. 
2 2.26 < 5 n.d. 
3 2.27 30 72:28 
4 2.28 39 18:82 
5 2.29 24 34:66 
6 2.30 85 47:53 
7 2.31 39 65:35 
8 2.32 77 96:4 
aYield calculated by H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios (er) determined using chiral SFC analysis of alcohol 2.24. 
 
 
 Increasing the steric bulk of the diarylphosphino substituent to o-tolyl (2.33) 
resulted in a decrease in enantioselectivity (Table 2.2, entry 1 vs. 2).  Decreasing the steric 
bulk of the diarylphosphino to diphenylphosphino (2.34) resulted in a significant decrease 
in efficiency and slight decrease in enantioselectivity (Table 2.2, entry 3).  Varying the 
steric and electronic properties to dicyclohexylphopshino (2.35) resulted in a drastic 
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decrease in efficiency and enantioselectivity (Table 2.2, entry 4).  An inductively-
withdrawing diarylphosphino group with 3,5-ditrifluoromethylphenyl (2.36) resulted in 
complete inhibition of the reaction (Table 2.2, entry 5).  Lastly, varying the electronic 
properties of optimal 3,5-xylyl (2.32) ligand to 4-methoxy-3,5-dimethylphenyl (2.37) 
resulted in higher enantioselectivity (Table 2.2, entry 6).  
Table 2.2 Investigation into the Mandyphos Ligand Class for the Palladium-Induced 
Metallate Rearrangement of Vinylboron “Ate” Complexes 
 
Entry Ligand Yield 2.24 (%)a e.r.b 
1 2.32 77 96:4 
2 2.33 78 84:16 
3 2.34 42 92:8 
4 2.35 23 80:20 
5 2.36 < 5 n.d. 
6 2.37 77 98:2 
aYield calculated by H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios (er) determined using chiral SFC analysis of alcohol 2.24. 
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 Having discovered an efficient and selective catalyst for the palladium-induced 1,2-
metallate rearrangement, the reaction conditions were further investigated.  It was of 
interest to analyze whether more widely available aryl halide electrophiles are competent 
in the reaction.  Employing chlorobenzene in the reaction with optimal ligand 2.37 resulted 
in no conversion to the desired product (Table 2.3, entry 2).  Bromobenzene and 
iodobenzene showed very low conversion but gave comparable enantioselectivity (Table 
2.3, entries 3-4).  Employing different sulfonate electrophiles such as phenyl mesylate or 
phenyl tosylate showed no conversion to the desired product (Table 2.3, entries 5-6).  
Interestingly, adding 1% lithium iodide to a reaction with phenyl triflate as the electrophile 
severely inhibited the reaction resulting in only 13% conversion (Table 2.1, entry 7).  These 
data demonstrate that the initial choice to use aryl triflate electrophiles was crucial for high 
reactivity.  Any incorporation of halide impurities (i.e. 1% LiI) shut down the reaction, 
presumably by binding to the cationic palladium intermediate.  In addition to lithium iodide 
additives, aryl halide electrophiles are not effective in the reaction due to the generation of 
lithium halide co-products of the reaction.  
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Table 2.3 Investigation into Aryl Electrophiles for the Palladium-Induced Metallate 
Rearrangement of Vinylboron “Ate” Complexes 
 
Entry X = Yield 2.24 (%)a e.r.b 
1 OTf 77 98:2 
2 Cl < 5 n.d. 
3 Br 9 96:4 
4 I 9 96:4 
5 OTs < 5 n.d. 
6 OMs < 5 n.d. 
7c OTf 13 98:2 
aYield calculated by H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratios (er) determined using chiral SFC analysis of alcohol 2.24. 
c1% LiI added into reaction 
 
 With the optimal reaction conditions and catalyst developed, the scope of the 
palladium-induced metallate rearrangement, termed “conjunctive cross-coupling” was 
explored.  Commercially available organolithium reagents and vinyl boronic acid 
neopentyl ester (2.20) were employed to synthesize the vinyl organoboron “ate” complex 
for the reaction.  In addition to phenyl (2.41) as the migrating group, a variety of alkyl 
migrating groups produced efficient reactions and excellent enantioselectivity (2.38, 2.39, 
2.40).  Trimethylsilyl methyllithium (2.42) required the use of vinyl boronic acid pinacol 
ester to achieve higher efficiency and as a result slightly lower levels of enantioinduction 
were observed.  For aryl electrophiles and pinacol organoboronates, more efficient and less 
enantioselective reactions are typically observed for the palladium-catalyzed cross-
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coupling of vinyl organoboron “ate” complexes.  A variety of substituents on the aryl 
triflate (2.43, 2.48) could be tolerated and the reactions occurred with high levels of 
efficiency and enantioselectivity.  Varying the electronic properties of the electrophile to 
electron-rich (2.44, 2.49) and electron-deficient (2.45) maintained excellent results.  
Increasing the steric encumbrance of the electrophile with 2-methylphenyl triflate (2.46) 
required higher temperatures for good reactivity.  It was not until 2,6-dimethylphenyl 
triflate (2.47) was employed that lower enantioselectivity was observed.  It is worth noting 
that an aryl electrophile containing reactive functional groups, such as an aldehyde (2.50), 
was tolerated.  This can be rationalized by the fact that the organolithium is trapped by the 
organoboronate to form the “ate” complex before being exposed to the electrophile.  
Catalysis with the vinyl organoboron “ate” complex is then faster than any side reactions 
with the aldehyde.  1,1-Disubstituted alkenyl triflate reagents (2.51, 2.52, 2.53, 2.54) were 
productive in the reaction with good yields and enantioselectivity.  Employing vinyl 
boronic acid pinacol ester was shown to produce better reactivity and enantioselectivity 
with alkenyl electrophiles.  Varying the substitution of the alkenyl triflate electrophiles 
(2.55, 2.56) produced good yields and enantioselectivity and a a,b-unsaturated ester triflate 
(2.57) was tolerated.    
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Table 2.4 Substrate Scope of the Palladium-Induced Metallate Rearrangement of 
Vinylboron “Ate” Complexes  
 
Isolated yields and enantiomer ratios are the average of two experiments.  Enantiomer ratio determined on 
the alcohol product using chiral SFC analysis.  aVinyl boronic acid pinacol ester used in place of 2.20.  
bReaction carried out at 80°C 
  
 An appealing feature of the conjunctive cross-coupling is that the vinyl 
organoboron “ate” complex is formed in a convergent manner. It has been demonstrated 
that commercially available organolithium reagents and vinyl boronic esters produce an 
organoboron “ate” complex that engages in the reaction.  An alternative method to produce 
the vinyl organoboron “ate” complex would entail using vinyllithium and an 
organoboronate.  Employing this “ate” complex formation strategy would be a powerful 
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addition by allowing for broad expansion of the scope of migrating groups.  However, to 
accomplish the alternative “ate” complex formation requires halide free vinyllithium due 
to halide inhibition of catalysis.  Typical lithium-halogen exchange with vinyl halide 
reagents represents a problematic pathway for the preparation of vinyllithium as some 
lithium halide byproducts are generally produced.  Employing vinyl iodide 2.58 and n-
butyllithium to generate vinyllithium, the reaction suffered from a significant drop in 
efficiency with 1% catalyst loading (Scheme 2.10).  Even increasing the catalyst loading 
five-fold resulted in only a moderate boost in efficiency while maintaining high 
enantioselectivity.   
Scheme 2.10 Generation of Vinyllithium from Lithium-Halogen Exchange for the 
Palladium-Induced Metallate Rearrangement of Vinylboron “Ate” Complexes 
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enantioselectivity.  A less labor-intensive method to produce halide free vinyllithium 
involves lithium-tin exchange with tetravinyltin (Scheme 2.11, eq. 1).  This alternative 
method only requires pentane washes to obtain suitable quality vinyllithium for the 
standard reaction.   
Scheme 2.11 Generation of Higher Purity Vinyllithium for the Palladium-Induced 
Metallate Rearrangement of Vinyl Organoboron “Ate” Complexes 
 
 With the preparation of higher quality vinyllithium established, the scope of the 
reaction was explored employing the alternative method for vinyl organoboron “ate” 
complex formation.  A variety of alkyl migrating groups (2.24, 2.63, 2.64) provided the 
desired product with high efficiency and excellent enantioselectivity.  Polyaromatic (2.65) 
and electron-rich aryl (2.66, 2.67) migrating groups maintained excellent results.  
However, inductively-withdrawing migrating groups (2.68) resulted in no reaction product.  
The high reactivity of electron-donating migrating groups and absence in reactivity for 
electron-withdrawing migrating groups might support the build up of anionic charge on the 
migrating carbon.  The p-trifluoromethylphenyl group was inductively withdrawing 
enough to stabilize the anionic character on the migrating carbon and shut down the 1,2-
migration.  Aryl chloride (2.69), heteroatom-substituted (2.70) and heterocyclic (2.71) 
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migrating groups provided excellent results.  A variety of arene substitutions (2.72, 2.73) 
maintained excellent efficiency and enantioselectivity.  However, a 2,6-dimethylphenyl 
migrating group (2.74) contains too much steric encumbrance resulting in lower 
enantioselectivity.   
Table 2.5 Scope of Migrating Groups in the Palladium-Induced Metallate 
Rearrangement of Vinylboron “Ate” Complexes 
 
 
Isolated yields and enantiomer ratios are the average of two experiments.  Enantiomer ratio determined on 
the alcohol product using chiral SFC analysis 
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2.3.2 Mechanism of Conjunctive Cross-Coupling17 
The proposed catalytic cycle for the conjunctive cross-coupling begins with 
Mandyphos-ligated palladium (0) (2.75) undergoing oxidative addition with the 
electrophile to form palladium (II) intermediate 2.76.  Dissociation of the leaving group 
counterion forms the desired cationic palladium (II)-alkene complex (2.77).  The alkene-
bound complex might be in equilibrium with the oxygen-bound palladium complex 2.78.  
The oxygen-bound complex might be an intermediate that leads to typical Suzuki-Miyaura 
cross-coupling products.  From alkene-bound complex 2.77, the desired 1,2-migration 
forms the carbon-bound palladium (II) intermediate 2.79.  Subsequent reductive 
elimination furnishes the desired conjunctive cross-coupling product and regenerates the 
palladium (0) catalyst to restart the catalytic cycle.   
Figure 2.1 Proposed Mechanism of the Conjunctive cross-coupling 
 
 A stereochemical model for the enantioselective palladium-catalyzed conjunctive 
cross-coupling is proposed based off a similar PdCl2-Mandyphos crystal structure obtained 
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by Hayashi and Ito (Figure 2.2).19  The dimethylamino groups and aryl substituents have 
been removed, and the phenyl group on palladium altered for simplicity.  The 
enantiodetermining step is thought to be the metallate rearrangement based off of kinetic 
studies done in our laboratory.  It is proposed that palladium binds the alkene such to have 
the large four-coordinate boron group directed away from the diarylphosphino substituent.  
Upon a palladium induced 1,2-metallate rearrangement affords the desired product 
consistent with the stereochemical outcome observed.  
Figure 2.2 Stereochemical Model for the Conjunctive Cross-Coupling  
 
 
2.4 Conclusion  
 The development of an enantioselective, catalytic palladium-induced 1,2-metallate 
rearrangement involving vinyl organoboron “ate” complexes leads to conjunctive cross-
coupling.  This method represents a powerful new tool to synthesize nonracemic 
organoboronates by merging two nucleophiles and an electrophile under enantioselective, 
catalytic conditions.  The conjunctive cross-coupling also illustrates a new alternative to 
the transmetallation step in asymmetric Suzuki-Miyaura cross-coupling reactions.  This 
                                                
19 a) Hayashi, T.; Yamamoto, A.; Hojo, M.; Ito, Y. J. Chem. Soc., Chem. Commun. 1989, 495 b) Hayashi, 
T.; Yamamoto, A.; Hojo, M.; Kishi, K.; Ito, Y.; Nishioka, E.; Miura, H.; Yanagi, K. J. Organomet. Chem. 
1989, 370, 129 
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method was shown to be very broad with regards to the scope of the reaction and applicable 
for the synthesis pharmaceutically relevant molecules.  
 The discovery of new catalytic steps in transition-metal catalysis allows for the 
potential to develop new reactions.  The aforementioned metal-induced 1,2-metallate 
arrangement is powerful since it could be inserted into a wide-array of metal-catalyzed 
reactions.  Further studies into new types of reactions and employing new metals for the 
1,2-metallate rearrangement could have a profound impact on synthetic organic and 
organometallic chemistry.   
 
2.5 Experimental  
2.5.1 General Information 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), Varian 
Gemini-600 (600 MHz), or Varian Inova-500 (500 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.24 ppm). 
Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, m = multiplet), and coupling constants (Hz). 13C 
NMR spectra were recorded on either a Varian Gemini-500 (125 MHz), Varian Gemini-
600 (150 MHz) or a Varian Inova-500 (125 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the internal 
standard. 11B NMR spectra were recorded on a Varian Gemini-500 (128 MHz) or Varian 
Gemini-600 (160 MHz) spectrometer. 19F NMR spectra were recorded on a Varian Gemini-
500 (470 MHz) spectrometer. Infrared (IR) spectra were recorded on a Bruker alpha-P 
Spectrometer. Frequencies are reported in wavenumbers (cm-1) as follows: strong (s), broad 
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(br), medium (m), and weak (w). Optical rotations were measured on a Rudolph Analytical 
Research Autopol IV Polarimeter. High-resolution mass spectrometry (DART) was 
performed at the Mass Spectrometry Facility, Boston College, Chestnut Hill, MA. Liquid 
chromatography was performed using forced flow (flash chromatography) on silica gel 
(SiO2, 230 x 450 Mesh) purchased from Silicycle. Thin layer chromatography (TLC) was 
performed on 25 µm silica gel glass backed plates from Silicycle. Visualization was 
performed using ultraviolet light (254 nm), ceric ammonium molybdate (CAM) in ethanol 
or phosphomolybdic acid, and cerium(IV) sulfate in ethanol with sulfuric acid (Seebach). 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector with 
isopropanol or methanol as the modifier.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), diethyl ether (Et2O), 
dichloromethane (DCM) and toluene were purified using Pure Solv MD-4 solvent 
purification system, from Innovative Technology, Inc., by passing the solvent through two 
activated alumina columns after purging with argon. Palladium (II) acetate, (Sp,Sp)-2.37, 
and 1,1′-Bis(dicyclohexyl-phosphino)ferrocene were purchased from Strem Chemicals, 
Inc. and used without further purification. Vinyl boronic acid pinacol ester was purchased 
from Combi Blocks and used without further purification. Boronic acids were purchased 
from Aldrich and used without further purification. Neopentyl glycol was purchased from 
Aldrich and used without further purification. 4-methoxyphenyltrifluoromethanesulfonate 
and 2-naphthyl trifluoromethanesulfonate were purchased from Aldrich and used without 
further purification. Phenyl triflluoromethanesulfonate and Trifluoromethansulfonic 
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anhydride were purchased from Oakwood Chemicals and used without further purification. 
All other reagents were purchased from either Aldrich, Alfa Aesar or Acros and used 
without further purification.  
 
2.5.2 Experimental Procedures 
 
1. General Procedures for the Preparation of Boronic Esters 
 To an oven-dried round bottom flask with magnetic stir bar was added boronic acid 
(1.0 eq) and pentane. The suspension was cooled to 0 and 2,2-dimethyl-1,3-propanediol 
(neopentyl glycol) (1.05 eq) was added neat and the reaction solution was allowed to warm 
to room temperature and stirred at room temperature for 3 hours. If a water layer was 
observed it was removed and the resulting pentane solution was dried with over Na2SO4, 
filtered with Et2O, and the solvent was removed under reduced pressure. The resulting 
residue was purified on silica gel (plug using CH2Cl2 as the eluent). 
 
5,5-dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20)  To an oven-dried 250 
mL round bottom flask with magnetic stir bar under N2 was added 
trimethylborate (9.95 g, 95.80 mmol, 1.78 eq) and 50 ml of THF. The reaction flask was 
cooled to -78 and vinyl magnesium bromide (60 ml, 0.90M, 54 mmol, 1.0 eq) was added 
over 2 hours via syringe pump. After addition of vinyl magnesium bromide the reaction 
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solution was allowed to warm to room temperature and stir for 8 hours, after which 1M 
HCl (aq) (30 mL) was added followed by 25 mL of deionized water and the reaction 
solution was allowed to stir at room temperature for 2 hours. The reaction solution was 
extracted with 6 x 50 mL of Et2O and the combined organic layers were washed with 50 
mL of deionized water, and 50 mL of brine, dried over Na2SO4, filtered with Et2O and the 
solvent was removed under reduced pressure. The resulting oil was subjected to general 
procedure for the preparation of boronic esters and the crude product was purified by 
vacuum distillation (under house vac) while heating to 83°C.  The product was isolated as 
a clear colorless oil (5.81 g, 77 % yield). All spectral data was in accordance with the 
literature.20 
 
2-butyl-5,5-dimethyl-1,3,2-dioxaborinane (2.83). To an oven-
dried 250 mL round bottom flask with magnetic stir bar under N2 
was added trimethylborate (11.21 g, 106.8 mmol, 1.78 eq) and 50 mL of THF. The reaction 
flask was cooled to -78 and nBuLi (23.72 mL, 2.53M, 60 mmol, 1.0 eq) was added over 
2 hours via syringe pump. After addition of nBuLi the reaction solution was allowed to 
warm to room temperature and stirred at room temperature for 8 hours, after which 1M 
HCl (aq) (30 ml) was added and the reaction solution was allowed to stir at room 
temperature for 2 hours. The reaction solution was extracted with 4 x 20 mL of Et2O and 
the combined organic layers were washed with brine, dried with sodium sulfate, filtered 
                                                
20 Clark, D.A.; Wilson, R. J.; Kaminsky, L. Org. Lett. 2015, 17, 3126-3129 
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with Et2O and the solvent was removed under reduced pressure. The resulting oil was 
subjected to the general procedure for preparation of boronic esters. The product was 
isolated as a clear colorless oil (5.26 g, 52% yield). All spectral data was in accordance 
with the literature.21 
 
5,5-dimethyl-2-phenyl-1,3,2-dioxaborinane (2.84)  Prepared 
according to the general procedure above with phenylboronic acid 
(0.268 g, 22.0 mmol), neopentyl glycol (2.41 g, 23.1 mmol), and pentane (60 mL). The 
resulting white solid (4.18 g, quantitative yield) was used without further purification. All 
spectral data was in accordance with the literature.22 This compound is also commercially 
available [CAS: 5123-13-7]. 
 
2-(4-methoxyphenyl)-5,5-dimethyl-1,3,2-dioxaborinane (2.85) 
Prepared according to the general procedure above with 4-
methoxyphenylboronic acid (0.4559 g, 3.0 mmol), neopentyl glycol (0.328 g, 3.15 mmol) 
and pentane (9.0 mL). The crude residue was purified on a silica gel plug with CH2Cl2 to 
afford the product as a white solid (0.650 g, 98%). All spectral data was in accordance with 
the literature.23 
 
                                                
21 Vater, H. D.; Marsden, S. P.; Blakemore, P. R. Org. Lett. 2006, 8, 773-776 
22 Chatani, N. Remond, E.; Kita, Y.; Kinuta, H.; Tobisu, M. J. Am. Chem. Soc. 2012, 134, 115-118	
23 Percec, V.; Huang, C.; Rosen, B. M. Org. Lett. 2008, 10, 2597-2600 
B
O
O Me
Me
2.84
B
O
O Me
Me
MeO
2.85
 187 
2-(4-chlorophenyl)-5,5-dimethyl-1,3,2-dioxaborinane (2.86) 
Prepared according to the general procedure above with 4-
chlorophenylboronic acid (0.4691 g, 3.0 mmol), neopentyl glycol (0.328 g, 3.15 mmol), 
and pentane (9 mL). The crude residue was purified on a silica gel plug with CH2Cl2 to 
afford the product as a white solid (0.667 g, 99% yield). All spectral data was in accordance 
with the literature.24 
 
5,5-dimethyl-2-(o-tolyl)-1,3,2-dioxaborinane (2.87) Prepared 
according to the general procedure above with o-tolylboronic acid 
(0.4079 g, 3.0 mmol), neopentyl glycol (0.328 g, 3.15 mmol), and 
pentane (9.0 mL). The crude residue was purified on a silica gel plug with CH2Cl2 to afford 
the product as a colorless oil (0.611 g, quantitative yield). All spectral data was in 
accordance with the literature.25 
 
2-(2,6-dimethylphenyl)-5,5-dimethyl-1,3,2-dioxaborinane (2.86) 
Prepared according to the general procedure above with 2,6-
dimethylphenylboronic acid (0.4499 g, 3.0 mmol), neopentyl glycol 
(0.328 g, 3.15 mmol), and pentane (9.0 mL). The crude residue was purified on silica gel 
plug with CH2Cl2 to afford the product as a white solid (0.558 g, 85%). 1H NMR (600 
MHz, CDCl3) δ 7.09 (1H, t, J = 7.8 Hz), 6.93 (2H, d, J = 7.8 Hz), 3.78 (4H, s), 2.38 (6H, 
s), 1.09 (6H, s). ). 13C NMR (150 MHz, CDCl3) δ 140.58, 128.59, 126.48, 77.37, 77.16, 
                                                
24 Snieckus, V.; Zhao, Y. Angew. Chem. Int. Ed. 2014, 356, 1527-1532 
25 Iwasaw, N.; Takya, J.; Aoki, M.; Ukai, K. J. Am. Chem. Soc. 2006, 128, 8706-8707	
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76.95, 72.38, 31.79, 22.40, 22.37. 11B NMR (192 MHz, CDCl3) δ 26.25. IR (neat) νmax 
3056.7 (w), 2960.3 (w), 2931.5 (w), 1596.3 (w), 1475.0 (m), 1455.3 (m), 1292.4 (s), 1246.2 
(m), 1029.0 (w), 768.6 (m), 694.3 (m), 699.1 (m) cm-1. HRMS (DART) for C13H20BO2 
[M+H]+ calculated: 219.1556, found: 219.1557. 
 
2-(3,5-dimethylphenyl)-5,5-dimethyl-1,3,2-dioxaborinane (2.89) 
Prepared according to the general procedure above with 3,5-
dimethylphenylboronic acid (0.4499 g, 3.0 mmol), neopentyl glycol 
(0.328 g, 3.15 mmol), and pentane (9.0 mmol). The crude residue was purified with silica 
gel plug with CH2Cl2 to afford the product as a white solid (0.479 g, 73%). All spectral 
data was in accordance with the literature.25 
 
5,5-dimethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborinane (2.90) 
Prepared according to the general procedure above with 2-
napthylboronic acid (2.00 g, 11.6 mmol), neopentyl glycol (1.27 g, 12.18 mmol), and 
pentane (100.0 mL). The crude residue was purified on a silica gel plug with CH2Cl2 to 
afford the product as a white solid (2.79 g, quantitative yield). All spectral data was in 
accordance with the literature.25 
 
4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-N,N-
diphenylaniline (2.91) Prepared according to the general 
procedure above with 4-(diphenylamino)phenylboronic acid (0.4935 g, 1.7 mmol, 1 
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equiv.), neopentyl glycol (0.187 g, 1.79 mmol, 1.05 equiv.), and pentane (10 mL). The 
crude residue was purified on a silica gel plug with CH2Cl2 to afford the product as a white 
solid (0.466 g, 77%). All spectral data was in accordance with the literature.26 
 
2-cyclohexyl-5,5-dimethyl-1,3,2-dioxaborinane (2.92)  Prepared 
according to the general procedure above with cycylohexylboronic acid 
(1.98 g, 15.5 mmol), neopentyl glycol (1.70 g, 16.28 mmol), and pentane 
(100 mL). The crude residue was purified on a silica gel plug with CH2Cl2 to afford the 
product as a colorless oil (3.00 g, 99% yield). All spectral data was in accordance with the 
literature.27 
 
2-isobutyl-5,5-dimethyl-1,3,2-dioxaborinane (2.93) Prepared 
according to the general procedure above with (2-
methylpropyl)boronic acid (0.3058 g, 3.0 mmol), neopentyl glycol (0.328 g, 3.15 mmol), 
and pentane (9.0 mL). The crude residue was purified on a silica gel plug with CH2Cl2 to 
afford the product as a colorless oil (0.398 g, 78% yield). All spectral data was in 
accordance with the literature.28 
 
 
                                                
26 Williams, J. A.; Goodall, W. Chem. Commun. 2001, 23, 2514-2515 
27 Bose, S. K.; Fucke, K.; Liu, L.; Steel, P. G.; Marder, T. B. Angew. Chem. Int. Ed. 2014, 53, 1799-1803	
28 Barsamian, A. L.; Wu, Z.; Blakemore, P. R. Org. Biomol. Chem. 2015, 13, 3781-3786 
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5,5-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,3,2-
dioxaborinane (2.94) Prepared according to the general 
procedure above with 3,4,5-trimethoxyphenylboronic acid (1.91 
g, 9.0 mmol), neopentyl glycol (0.984 g, 9.45 mmol), and pentane (100.0 mL). The crude 
residue was purified on a silica gel plug with CH2Cl2 to afford the product as a white solid 
(2.52 g, quantitative yield). 1H NMR (600 MHz, CDCl3) δ 7.04 (2H, s), 3.89 (6H, s), 3.87 
(3H, s), 3.76 (4H, s), 1.02 (6H, s). 13C NMR (150 MHz, CDCl3) δ 152.78, 140.34, 110.31, 
72.32, 60.75, 56.02, 31.86, 21.89. 11B NMR (160 MHz, CDCl3) δ 26.49. IR (neat) νmax 
29589.0 (w), 2936.7 (w), 2889.3 (w), 1576.9 (m), 1477.2 (m), 1337.3 (s), 1229.9 (s), 
1123.4 (s), 1004.0 (m), 688.1 (m) cm-1. HRMS (DART) for C14H22BO5 [M+H]+ calculated: 
281.1560, found: 281.1551. 
 
5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-1-methyl-1H-indole 
(2.95) Prepared according to the general procedure above with (1-
methyl-1H-indol-5-yl)boronic acid (0.500 g, 2.772 mmol), neopentyl 
glycol (0.306 g, 2.910 mmol), and pentane (100.0 mL). The crude residue was purified on 
a silica gel plug with CH2Cl2 to afford the product as a white solid (0.4739 g, 70 % yield). 
1H NMR (500 MHz, CDCl3) δ 8.12 (1H, s), 7.65 (1H, d, J = 7.0 Hz), 7.29 (1H, d, J = 7.0 
Hz), 7.00 (1H, d, J = 2.5 Hz), 6.48 (1H, d, J = 2.5 Hz), 3.78 (4H, s), 3.77 (3H, s), 1.02 (6H, 
s). 13C NMR (150 MHz, CDCl3) δ 138.65, 128.85, 128.40, 127.87, 127.07, 108.577, 
101.79, 72,52, 32.97, 32.13, 22.16. 11B NMR (160 MHz, CDCl3) δ 27.15. IR (neat) νmax 
2960.4 (w), 2939.3 (w), 2895.9 (w), 2874.6 (w), 1608.0 (w), 1513.9 (w),1 4.78.8 (w), 
1333.1 (m), 1304.9 (s), 1271.5 (m), 1245.4 (m), 1185.2 (m), 1118.03 (m), 717.99 (w), 
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692.0 (w), 678.88 (w) cm-1. HRMS (DART) for C14H19BNO2 [M+H]+ calculated: 
244.1509, found: 244.1519. 
 
2. Procedures for Preparation of Alkenyl Trifluoromethanesulfonates 
 
 (E)-non-1-en-1-yl trifluoromethanesulfonate (2.96) The 
title compound was prepared according to a literature precedence with slight 
modification.29 In an Ar-filled glove box, CsF (5.01 g, 33.0 mmol, 3.0 equiv.) and N-
Phenyl-bis(trifluoromethanesulfonimide) (7.86 g, 22.0 mmol, 2.0 equiv.) were placed in a 
large pressure vessel and sealed. Outside the glovebox the flask was briefly opened and a 
solution of 1-nonen-1-yl trimethylsilyl ether30 (95/5 mixture of E/Z isomers, 2.36 g, 11 
mmol) in dimethoxyethane (30 mL) was added. After addition, the pressure vessel was 
quickly sealed with a screw cap. The solution was stirred vigorously at room temperature 
for 4 hours after which the pressure was released and the reaction mixture was diluted with 
pentane (100 mL), washed twice with water and once with brine, dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude oil was purified by silica gel 
chromatography (100% pentane) to afford the title compound as a clear colorless oil (1.51 
g, 50% yield). All spectral data was in accordance with the literature.31 
 
                                                
29 McCammant, M. S.; Liao, L.; Sigman, M. S. J. Am. Chem. Soc. 2013, 135, 4167-4170 
30 Matsuzawa, S.; Horiguchi, Y.; Nakamura, E.; Kuwajima, I. Tetrahedron 1989, 35, 349-362	
31 Shirakawa, E.; Imazaki, Y.; Hayashi, T. Chem. Commun. 2009, 34, 5088-5090 
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oct-1-en-2-yl trifluoromethanesulfonate (2.97) The title 
compound was prepared according to the procedure reported in the 
literature.32 All spectral data was in accordance with the literature. 
 
cyclohexylidenemethyl trifluoromethanesulfonate (2.98) The title 
compound was prepared according to the procedure reported in the 
literature.33 All spectral data was in accordance with the literature. 
 
1-cyclohexylvinyl trifluoromethanesulfonate (2.99) The title compound 
was prepared according to the procedure reported in the literature.34 All 
spectral data was in accordance with the literature. 
 
cyclohex-1-en-1-yl trifluoromethanesulfonate (2.100) The title compound 
was prepared according to the procedure reported in the literature.35 All 
spectral data was in accordance with the literature. 
 
5-((tert-butyldimethylsilyl)oxy)pent-1-en-2-yl 
trifluoromethanesulfo-nate (2.101) Prepared following a published 
procedure with slight modifications.33  4-Pentyn-1-ol (1.44 mL, 15.5 mmol, 1.0 equiv.) was 
                                                
32 Takai, K.; Sakogawa, K.; Kataoka, Y.; Oshima, K.; Utimoto, K. Org. Synth. 1995, 72, 180 
33 Treptow, W.; Stang, P. J. Synthesis 1980, 283-284 
34 Al-huniti, M. H.; Lepore, S. D. Org. Lett. 2014, 16, 4154-4157 
35 Lim, B. Y.; Jung, B. E.; Cho, C. G. Org. Lett. 2014, 16, 4492-4495	
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placed in a flame-dried round bottom flask and dissolved in dry pentane (15 mL). The 
solution was cooled to - 40 and triflic acid (2.5 mL, 27.8 mmol, 1.6 equiv.) was added 
dropwise with stirring. The mixture was stirred for 10 minutes at -40 and allowed to 
warm to room temperature over 30 minutes. The mixture was quenched with water (10 
mL), extracted with diethyl ether and washed with saturated sodium bicarbonate solution 
and brine. The crude mixture was dried over Na2SO4, concentrated under reduced pressure 
and filtered through a plug of neutral alumina with CH2Cl2. The resulting triflate, obtained 
as a clear yellow oil (1.84 g, 7.8 mmol, 1 equiv.) was placed in a flame dried round bottom 
flask with imidazole (1.10 g, 16 mmol, 2 equiv.) and dissolved in CH2Cl2 (20 mL). The 
solution was flushed with N2 and cooled to 0. tert-Butyldimethylsilyl chloride (1.18 g, 
7.8 mmol, 1.0 equiv.) was added as a solution in CH2Cl2 (10 mL). The mixture was stirred 
at room temperature for 2 hours after which 1M HCl solution (5 mL) were added. The 
mixture was extracted with CH2Cl2 and washed with sodium bicarbonate solution and 
brine, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
mixture was purified by silica gel chromatography (1% ethyl acetate in hexane) to afford 
the title compound as a clear colorless oil (2.10 g, 40 % yield over two steps). 1H NMR 
(600 MHz, CDCl3) δ 5.11 (1H, d, J = 3.0 Hz), 4.95 (1H, d, J = 3.0 Hz), 3.65 (2H, t, J =  6.0 
Hz), 2.44 (2H, t, J = 7.8 Hz), 1.75 (2H, q, J = 6.6 Hz), 0.89 (9H, s), 0.05 (6H, s).13C NMR 
(125 MHz, CDC3) δ 156.9, 104.4, 61.4, 30.6, 29.3, 25.7, 18.4, -5.3. IR (neat) νmax 2995.9 
(s), 2931.6 (s), 2894.4 (s), 2859.8 (s), 1671.0 (s), 1473.0 (s), 1253.3 (s), 1209.3 (s), 1141.1 
(s), 1104.7 (s), 945.0 (s), 835.9 (s), 776.7 (s), 611.56 (s) cm-1. HRMS-(DART) for: 
C12H24F3O4S1Si1 [M+H]+: calculated: 349.1117, found: 349.1114. 
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5-hydroxypent-1-en-2-yl trifluoromethanesulfonate (2.102) The title 
compound was prepared according to the procedure reported in the 
literature.36 All spectral data was in accordance with the literature. 
 
 
3. General Procedure for the Synthesis of Aryl Trifluoromethanesulfonates  
 Aryl Trifluoromethansulfonates were made according to literature procedure with 
slight modification.37 To a solution of the corresponding phenol and pyridine in CH2Cl2 at 
0, a solution of trifluoromethanesulfonic anhydride in CH2Cl2 was added dropwise. The 
mixture was then warmed to room temperature and allowed to stir for 1 hour. The mixture 
was diluted with Et2O, quenched with 3M HCl (aq) and washed successively with NaHCO3 
(aq, sat.) and brine. The solution was dried over Na2SO4, filtered with Et2O, and the solvent 
was removed under reduced pressure. The residue was purified on silica gel 
chromatography to afford aryl trifluoromethanesulfonates. 
 
4-(trifluoromethyl)phenyl trifluoromethanesulfonate (2.103) 
Prepared according to the general procedure above with 4-
trifluoromethylphenol (0.630 g, 3.8 mmol), trifluoromethanesulfonic anyhydride (0.774 
mL, 4.6 mmol), pyridine (0.615 mL, 7.6 mmol), and CH2Cl2 (6.0 mL). The crude residue 
was purified on silica gel chromatography (10% ethyl acetate in hexanes) to afford the 
                                                
36 Logan, A. W. J.; Parker, J. S.; Hallside, M. S.; Burton, J. W. Org. Lett. 2012, 14, 2940-2943 
37 Goosen, L. J.; Linder, C.; Rodriguez, N.; Lange, P. P. Chem. Eur. J. 2009, 15, 9336-9349	
O
OMe
OTf
2.102
TfO
CF3
2.103
 195 
product as a colorless oil (1.180 g, 98% yield). All spectral data was in accordance with 
the literature.38 
 
2,4-dimethylphenyl trifluoromethanesulfonate (2.104) Prepared 
according to the general procedure above with 2,4-dimethylphenol (0.906 
mL, 7.5 mmol), trifluoromethanesulfonic anhydride (1.50 mL, 9.0 mmol), pyridine (1.2 
mL, 15.0 mmol), and CH2Cl2 (13.0 mL). The crude residue was purified with silica gel 
chromatography (5% ethyl acetate in hexanes) to afford the product as a colorless oil (1.680 
g, 88% yield). All spectral data was in accordance with the literature.39 
 
2,6-dimethylphenyl trifluoromethanesulfonate (2.105) Prepared according 
to the general procedure above with 2,6-dimethylphenol (0.611 g, 5.0 mmol), 
trifluoromethanesulfonic anhydride (1.0 mL, 6.0 mmol), pyridine (0.809 mL, 
10.0 mmol), and CH2Cl2 (8.0 mL). The crude residue was purified with silica gel 
chromatography (17% ethyl acetate in hexanes) to afford the product as a yellow oil (1.124 
g, 88% yield). All spectral data was in accordance with the literature.40 
 
3,4,5-trimethoxyphenyl trifluoromethanesulfonate (2.106) Prepared 
according to the general procedure above with 3,4,5-trimethoxyphenol 
(0.921 g, 5.0 mmol), trifluoromethanesulfonic anhydride (1.0 mL, 6.0 
                                                
38 Gill, D.; Hester, A. J.; Lloyd-Jones, G. C. Org. Biomol. Chem. 2004, 2, 2547-2548 
39 Radivoy, G. ; Alonso, F.; Yus, M. Tetrahedron 1999, 55, 14479-14490 
40 Mori, H.; Matsuo, T.; Yoshioka, Y.; Katsumura, S. J. Org. Chem. 2006, 71, 9004-9012	
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mmol), pyridine (0.809 mL, 10.0 mmol), and CH2Cl2 (8.0 mL). The crude residue was 
purified with silica gel chromatography (20% ethyl acetate in hexanes) to afford the 
product as an off white solid (1.552 g, 98% yield). All spectral data was in accordance with 
the literature.41 
 
benzo[d][1,3]dioxol-5-yl trifluoromethanesulfonate (2.107) Prepared 
according to the general procedure above with sesamol (1.04 g, 7.5 
mmol), trifluoromethansulfonic anhydride (1.5 mL, 9.0 mmol), pyridine (1.2 mL, 15.0 
mmol), and CH2Cl2 (13.0 mL). The crude residue was purified with silica gel 
chromatography (5% ethyl acetate in hexanes) to afford the product as colorless oil (1.89 
g, 94%). All spectral data as in accordance with the literature.42 
 
3-formylphenyl trifluoromethanesulfonate (S-27). Prepared 
according to the general procedure above with 3-hydroxybenzaldehyde 
(916 mg, 7.5 mmol), trifluoromethanesulfonic anhydride (1.5 mL, 9.0 
mmol), pyridine (1.2 mL, 15.0 mmol), and CH2Cl2 (10 mL). The crude residue was purified 
by silica gel chromatography (10% ethyl acetate in hexanes) to afford the product as a 
colorless oil (1.47 g, 77% yield). All spectral data was in accordance with the literature.37 
 
 
                                                
41 Anderson, D.; MacMillan, D. W. Org. Lett. 2004, 6, 4569-4662 
42 Stille, J. K.; Echavarren, A. M. J. Am. Chem. Soc. 1987, 109, 5478-5486	
TfO
O
O
2.107
TfO
O
H
2.108
 197 
4. Procedure for Preparation of Vinyllithium 
 
 To an oven-dried 250 mL round bottom flask with magnetic stir bar in an Ar-filled 
glovebox was added vinyl iodide (12.1670 g, 76.6611 mmol, 1.00 eq) and pentane (35 ml). 
The reaction flask was sealed with a rubber septa, removed from the glovebox, cooled to -
78 under argon, and maintained at this temperature while nBuLi (29.7 ml, 75.1410 
mmol, 0.98 eq) was added via syringe pump over two hours. Vinyllithium formation was 
observed as a white suspension in the reaction flask within 2-3 minutes of initial nBuLi 
addition. Upon completion of slow addition, the reaction solution was allowed to stir for 
an additional hour at between -50 and -78. The vinyllithium suspension was transferred 
via cannula in two portions to an oven-dried Schlenck filter under argon and filtered, 
washed with pentane, and dried in the following manner: After transfer of the first half of 
the vinyllithium suspension in pentane, the pentane was removed under positive pressure 
by slightly reducing the pressure in the bottom chamber of the filter while maintaining 
constant positive pressure of argon in the upper portion of the filter. (Caution, positive 
pressure must be maintained at all times in the top chamber to prevent air from entering 
the schlenk filter and reacting with the pyrophoric vinyllithium). After the pentane was 
removed, a white powdery layer of solid vinyllithium was observed on top of the Schlenk 
filter frit. The second half of the vinyllithium suspension was transferred and the pentane 
removed in the same manner. To ensure thorough removal of soluble impurities (n-BuLi, 
n-BuI, vinyl iodide) the white powdery pad of vinyllithium left after initial filtration was 
rinsed three times with 20 mL of dried, distilled, and degassed pentane by adding the 
I
n-BuLi (0.98 equiv.)
pentane, -78ºC, 3 h
Li
2.58 2.59
 198 
pentane to the top chamber of the Schlenk filter and agitating the vinyllithium for two 
minutes and removal of pentane as described above. The solid vinyllithium was then dried 
for 15 minutes under positive pressure of argon by reducing the pressure in the bottom 
chamber of the filter while maintaining positive pressure in the upper chamber of the filter. 
The receiving 250 ml round bottom flask with pentane washes was replaced via quick-
switch with an oven-dried 100 ml 2-neck round bottom flask under argon. The solid 
vinyllithium was dissolved using 48 ml of diethyl ether and was rinsed into the receiving 
flask by reducing the pressure of the lower chamber of the filter as described above. The 
resulting clear yellow solution was titrated using BHT with 1,10-phenanthroline in THF 
and the yield (72.8280 mmol, 95 % yield) was calculated based on the measured molarity 
(1.58 M) and the measured volume of the solution upon transfer to a single-necked 100 ml 
round bottom flask (At this point the vinyllithium can be used directly in a conjunctive 
coupling with 5 mol % catalyst loading and the coupling product can be obtained in 69% 
yield, 98:2 er.).  
 The freshly prepared solution of vinyllithium (1.58 M) was immediately 
recrystallized three times from diethyl ether by cooling the solution to -45 over 1 h using 
a Cryocool and maintaining this temperature overnight (10 h) and then reducing the 
temperature to -78 for 6 hours using a dry ice acetone bath. Solid vinyllithium was 
observed to form as clear, glassy, crystals. After the recrystallization period the supernatant 
diethyl ether was removed, and the round bottom flask was allowed to warm to room 
temperature, and 10 ml of fresh diethyl ether was added to the flask. The recrystallization 
was repeated two more times, resulting in an overall 47 % yield of vinyllithium, evaluated 
as before, as a clear, nearly colorless solution in diethyl ether. 
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5. Procedures for Conjunctive Cross-Coupling 
Method A: 
 
 To an oven-dried 2-dram vial equipped with a magnetic stir bar in an Ar-filled 
glovebox was added vinyl boronic ester (0.30 mmol, 1.00 equiv.) and diethyl ether (0.3 
mL), sealed with a septum cap, and removed from the glovebox. The reaction vial was 
cooled to 0, and an alkyl/aryl lithium solution (0.30 mmol, 1.0 equiv.) was added at 0. 
The reaction vial was allowed to warm to room temperature and stirred for 30 minutes. 
Then, the solvent was carefully removed under reduced pressure, and the reaction vial was 
brought back into the glovebox. To a separate oven-dried 2-dram vial equipped with a 
magnetic stirbar in the glovebox was added Pd(OAc)2 (0.003 mmol, 0.01 equiv.), (Sp, Sp)-
2.37 (0.0036 mmol, 0.012 equiv.), and THF (0.3 mL). The Pd(OAc)2/(Sp, Sp)-2.37 solution 
was allowed to stir for 20 minutes at room temperature. Then the Pd(OAc)2/(Sp, Sp)-2.37 
solution was transferred into the reaction vial, followed by THF (0.9 mL), and aryl/vinyl 
triflate (0.33 mmol, 1.10 equiv.). The reaction vial was sealed with a polypropylene cap, 
taped, and brought out of the glovebox where it was allowed to stir at 60 for 14 hours. 
The resulting mixture was cooled to room temperature, filtered through a silica gel plug 
with diethyl ether, and concentrated under reduced pressure. The reaction mixture was 
diluted with THF (3 mL), cooled to 0, 3M NaOH (2 mL) was added, followed by 30% 
H2O2 (1.0 mL), dropwise.  The reaction mixture was allowed to warm to room temperature, 
and was allowed to stir for 4 hours.  The reaction mixture was cooled to 0 and saturated 
aq. Na2S2O3 (3 mL) was added dropwise.  The reaction mixture was allowed to warm to 
B(OR)2
R1-Li
Et2O
0ºC - r.t., 30 min
Pd(OAc)2 (1%)
(Sp,Sp)-Ligand 2.37 (2%)
R2-OTf (1.1 equiv.)
THF, 60ºC, 14 h
R1
R2
OHH2O2
NaOH
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room temperature and the aqueous layer was extracted with ethyl acetate (3 x 20 mL).  The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure, and subsequently purified via silica gel column chromatography to afford the 
desired products. 
Method B: 
 
 To an oven-dried 2-dram vial equipped with a magnetic stir bar in an Ar-filled 
glovebox was added alkyl/aryl boronic ester (0.30 mmol, 1.0 equiv.) and diethyl ether (0.3 
mL), sealed with a septum cap, and removed from the glovebox. The reaction vial was 
cooled to 0, and a vinyl lithium solution (0.30 mmol, 1.0 equiv.) was added at 0. The 
reaction vial was allowed to warm to room temperature and stirred for 30 minutes. Then, 
the solvent was carefully removed under reduced pressure, and the reaction vial was 
brought back into the glovebox. To a separate oven-dried 2-dram vial equipped with a 
magnetic stir bar in the glovebox was added Pd(OAc)2 (0.006 mmol, 0.02 equiv.), (Sp, Sp)-
2.37 (0.0072 mmol, 0.024 equiv.), and THF (0.6 mL). The Pd(OAc)2/(Sp, Sp)-2.37 solution 
was allowed to stir for 20 minutes at room temperature. Then the Pd(OAc)2/(Sp, Sp)-2.37 
solution was transferred into the reaction vial, followed by THF (0.6 mL), and aryl/vinyl 
triflate (0.33 mmol, 1.10 equiv. ) was added. The reaction vial was sealed with a 
polypropylene cap, taped, and brought out of the glovebox where it was allowed to stir at 
60 for 14 hours. The resulting mixture was cooled to room temperature, filtered through 
a silica gel plug with diethyl ether, concentrated under reduced pressure. The reaction 
Li
Et2O
0ºC - r.t., 30 min
Pd(OAc)2 (1%)
(Sp,Sp)-Ligand 2.37 (2%)
R2-OTf (1.1 equiv.)
THF, 60ºC, 14 h
R1
R2
OHH2O2
NaOH
R1-B(OR)2
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mixture was diluted with THF (3 mL), cooled to 0, 3M NaOH (2 mL) was added, 
followed by 30% H2O2 (1.0 mL), dropwise.  The reaction mixture was allowed to warm to 
room temperature, and was allowed to stir for 4 hours.  The reaction mixture was cooled 
to 0 and saturated aq. Na2S2O3 (3 mL) was added dropwise.  The reaction mixture was 
allowed to warm to room temperature and the aqueous layer was extracted with ethyl 
acetate (3 x 20 mL).  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure, and subsequently purified via silica gel column 
chromatography to afford the desired products. 
 
2.5.3 Characterization of Conjunctive-Cross-Coupling Products 
and Analysis of Stereochemistry 
 
 (R)-1,2-diphenylethan-1-ol (2.41) The reaction was performed according to 
the general procedure (Method A) with 5,5-dimethyl-2-vinyl-1,3,2-
dioxaborinane (2.20) (42.0 mg, 0.30 mmol, 1.00 equiv.), phenyllithium (0.167 mL, 1.9M 
in dibutyl ether, 0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 
mmol, 1.10 equiv.), palladium (II) acetate (0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-
2.37 (3.80 mg, 0.0036 mmol) in THF (1.2 mL, 0.25 M, 0.012 equiv.). The crude mixture 
was purified by silica gel chromatography (5% ethyl acetate in hexanes, stain in CAM) to 
afford a white solid (49.37 mg, 83% yield). 1H NMR (600 MHz, CDCl3) δ 7.26-7.21 (4H, 
m), 7.20-7.15 (3H, m), 7.14-7.0 (1H, m), 7.10-7.07 (2H, m), 4.78 (1H, ddd, J = 6.6, 4.2, 
2.4 Hz), 2.93 (1H, dd, J = 13.8, 4.8 Hz), 2.87 (1H, dd, J = 14.4, 9.0 Hz), 1.84 (1H, br s). 
2.41
Ph
Ph
OH
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13C NMR (150 MHz, CDCl3) δ 143.95, 138.17, 129.66, 128.66, 128.56, 127.76, 126.77, 
126.04, 75.49, 46.25. HRMS (DART) for C14H13 [M+H-H2O]+  calculated: 181.1017, 
found: 181.1021. [α]20D: +11.787 (c = 0.635, CHCl3, l =50 mm) (lit: [α]20D = +12.5 (c = 
1.01, CHCl3, 98:2 e.r.).43 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
vinyl boronic acid pinacol ester, and Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexyl-
phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry was determined 
by single crystal X-ray diffraction.  
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-1,2-diphenylethan-1-ol 
Racemic Material             Standard Conditions            Crystal Structure 
                                                                                                               
    
                                                
43 Guo, J.; Chen, J.; Lu, Z. Chem. Commun. 2015, 51, 5725-5727 
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 (R)-2-(1,2-diphenylethyl)-5,5-dimethyl-1,3,2-dioxaborinane (2.109) The 
reaction was performed according to the general procedure (Method A) 
without oxidation step with 5,5-dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20) 
(42.0 mg, 0.30 mmol, 1.00 equiv.), phenyllithium (0.167 mL, 1.9M in dibutyl ether, 0.30 
mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 1.10 equiv.), 
palladium (II) acetate (0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 
mmol) in THF (1.2 mL, 0.25 M, 0.012 equiv.). The crude mixture was purified by silica 
gel chromatography (30% CH2Cl2 in pentane, stain in CAM) to afford a colorless solid 
(67.0mg, 76% yield). 1H NMR (600 MHz, CDCl3) δ 7.25-7.24 (4H, m), 7.24-7.19 (2H, m), 
7.16 (2H, d, J = 7.85 Hz), 7.14-7.10 (2H, m), 3.53 (4H, s), 3.19 (1H, dd, J = 13.2, 9.6 Hz), 
2.92 (1H, dd, J = 13.8, 7.2 Hz), 2.57 (1H, t, J = 7.2 Hz), 0.79 (6H, s). 11B NMR (160 MHz, 
CDCl3) δ 29.47. 13C NMR (150 MHz, CDCl3) δ 143.96, 142.55, 128.98, 128.42, 128.40, 
128.19, 125.71, 125.31, 72.27, 38.52, 31.79, 21.88. IR (neat) νmax 3081.9 (w), 3025.2 (w), 
2960.3 (w), 1599.6 (w), 1475.8 (m), 1376.3 (m), 1279.3 (m), 1199.7 (s), 1069.8 (s), 770.6 
(m), 696.9 (s), 524.5 (m), 493.4 (m) cm-1. HRMS (DART) for C19H24BO2 [M+H]+ 
calculated: 295.1869, found: 295.1872. [α]20D: -48.214 (c = 2.975, CHCl3, l =50 mm). 
 
 (R)-3-methyl-1-phenylbutan-2-ol (2.39) The reaction was performed 
according to the general procedure (Method A) with 5,5-dimethyl-2-
vinyl-1,3,2-dioxaborinane (2.20) (42.0 mg, 0.30 mmol), isopropyllithium (0.441 mL, 
0.68M in pentane, 0.30 mmol), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol), 
palladium (II) acetate (0.670 mg, 0.003 mmol), (Sp, Sp)-2.37 (3.80 mg, 0.0036 mmol) in 
THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel chromatography (30% 
2.109
Ph
Ph
B
OO
Me Me
i-propyl
Ph
OH
2.39
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CH2Cl2 in hexanes) to afford a yellow oil. (32.5 mg, 66% yield).  1H NMR  (600 MHz, 
CDCl3) δ 7.30 (2H, t, J = 7.2 Hz), 7.21-7.24 (3H, m), 3.57-3.59 (1H, m), 2.84 (1H, dd, J = 
13.8, 3.0 Hz), 2.32 (1H, dd, J = 13.2, 9.0 Hz,), 1.77-1.72 (1H, m), 1.42 (1H, d, J = 3.6 Hz), 
0.99 (3H, s), 0.98 (3H, s).  13C NMR (150 MHz, CDCl3) δ 139.39, 129.59, 128.82, 126.62, 
77.72, 41.02, 33.37, 19.16, 17.64.  IR (neat) νmax 3241 (br), 3027 (w), 2957 (m), 2927 (m), 
2981 (m), 1494 (m), 1467 (m), 1031 (m), 995 (s) 741 (m), 698 (s) cm-1.  HRMS (DART) 
for  C11H20NO [M+NH4]+: calculated: 182.1545, found: 182.1547.   [α]20D: +15.74 (c = 
0.535, CHCl3, l = 50 mm). 
Analysis of Stereochemistry 
Racemic compound was prepared according to the general procedure (Method A) with 
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, and Pd(OAc)2 (5 mol%) and 1,1’-
Bis(dicyclohexyl-phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40).   
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35°C, 210-270 nm) – analysis 
of (R)-3-methyl-1-phenylbutan-2-ol. 
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Racemic Material               Standard Conditions  
                     
  
 
 
 (S)-1-phenylhexan-2-ol (2.24) The reaction was performed according to 
the general procedure (Method A) with 5,5-dimethyl-2-vinyl-1,3,2-
dioxaborinane (2.20) (42.0 mg, 0.30 mmol, 1.00 equiv.), n-butyllithium (0.120 mL, 2.5M 
in hexanes, 0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 
mmol, 1.10 equiv.), palladium (II) acetate (0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-
2.37 (3.80 mg, 0.0036 mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture 
was purified by silica gel chromatography (50% CH2Cl2 in pentane, stain in CAM) to 
afford a colorless oil (39.5 mg, 74 % yield). 1H NMR (600 MHz, CDCl3) δ 7.30 (2H, t, J 
= 7.2 Hz), 7.24-7.18 (3H, m), 3.80 (1H, dddd, J = 12.6, 8.4, 4.8 Hz), 2.82 (1H, dd, J = 13.2, 
4.2 Hz), 2.63 (1H, dd, J = 13.2, 8.4 Hz). 1.56-1.28 (6H, m), 0.90 (3H, t, J = 7.2 Hz). 13C 
NMR (150 MHz, CDCl3) δ 138.80, 129.57, 128.69, 126.57, 72.84, 44.20, 36.68, 28.08, 
n-butyl
Ph
OH
2.24
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22.85, 14.21. HRMS (DART) for C12H17 [M+H-H2O]+  calculated: 161.1330, found: 
161.1335. [α]20D: +14.786 (c = 0.510, CHCl3, l =50 mm). (lit: [α]28D: +6.3, c = 1.0, CHCl3, 
68:32 e.r.).44  
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
vinyl boronic acid pinacol ester, and Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexyl-
phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry was determined 
by comparison to the literature.43 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-1,2-diphenylethan-1-ol 
  Racemic Material   Standard Conditions 
                                    
 
                                                
44 Ema, T.; Ura, N; Yoshii, M.; Korenaga, T.; Sakai, T. Tetrahedron 2009, 65, 9583-9591 
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  (S)-1-phenyloctan-2-ol (2.40) The reaction was performed according 
to the general procedure (Method A) with 5,5-dimethyl-2-vinyl-1,3,2-
dioxaborinane (2.20) (42.0 mg, 0.30 mmol, 1.00 equiv.), hexyllithium (0.130 mL, 2.3M in 
hexanes, 0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 
1.10 equiv.), palladium (II) acetate (0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-2.37 
(3.80 mg, 0.0036 mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was 
purified by silica gel chromatography (50% CH2Cl2 in pentane, stain in CAM) to afford a 
white solid (47.0 mg, 76% yield. HRMS (DART) for C14H26NO [M+NH4]+  calculated: 
224.2014, found: 224.2016. [α]20D: +11.444 (c = 1.645, CHCl3, l =50 mm). (lit: [α]20D = 
+8.222 (c = 2.043, CHCl3, l = 50 mm 96:4 e.r.). All spectral data was in accordance with 
the literature.45 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the literature.44 Absolute stereochemistry 
was determined by comparison to the literature.44  
Chiral SFC (Chiracel OD-H, 3% IPA, 5 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-1-phenyloctan-2-ol 
   
 
 
 
 
                                                
45 Mlynarski, S. N.; Schuster, C. H.; Morken. J. P Nature 2014, 505, 386-390 
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 (R)-1-phenyl-3-(trimethylsilyl)propan-2-ol (2.42) The reaction was 
performed according to the general procedure (Method A) with vinyl 
boronic acid pinacol ester (46.20 mg, 0.30 mmol, 1.00 equiv.), 
(trimethylsilyl)methyllithium (0.300 mL, 1.0M in pentane, 0.30 mmol, 1.00 equiv.), 
phenyltrifluoromethanesulfonate (74.6 mg, 0.33 mmol, 1.10 equiv.), palladium (II) acetate 
(0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 mmol, 0.012 equiv.) 
in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel chromatography 
(5% ethyl acetate in pentane, stain in CAM) to afford a colorless oil (35.20 mg, 56% yield). 
1H NMR (600 MHz, CDCl3) δ 7.30 (2H, t, J = 7.2 Hz), 7.24-7.18 (3H, m), 3.98 (1H, ddd, 
J = 13.2, 13.2, 9.0 Hz), 2.84 (1H, dd, J = 13.8, 4.2 Hz), 2.63 (1H, dd, J = 13.2, 7.8 Hz), 
1.44 (1H, br s), 0.96-0.86 (2H, m), 0.06 (9H, s). 13C NMR (150 MHz, CDCl3) δ 138.98, 
Ph
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129.56, 128.73, 126.63, 71.08, 47.70, 25.99, -0.57.  IR (neat) νmax 3582.1 (br), 3441.2 (br) 
3062.7 (w), 3028.2 (w), 2951.4 (w), 2917.7 (w), 1495.6 (w), 1454.0 (w), 1247.0 (s), 1076.0 
(m), 1056.2 (m), 1018.7 (m), 854.8 (s), 837.4 (s), 743.8 (s), 698.5 (s) cm-1.  HRMS (DART) 
for C12H24NOSi [M+NH4]+  calculated: 226.1627, found 226.1622. [α]20D: +3.850 (c = 
1.135, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
vinyl boronic acid pinacol ester, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
Chiral SFC (Chiracel OD-H, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of   (R)-1-phenyl-3-(trimethylsilyl)propan-2-ol. 
Racemic Material          Standard Conditions 
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 (R)-2-(naphthalen-2-yl)-1-phenylethan-1-ol (2.43) The reaction 
was performed according to the general procedure (Method A) with 
5,5-dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20) (42.0 mg, 0.30 mmol, 1.00 equiv.), 
phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), 2-
naphthyltrifluoromethanesulfonate (91.20 mg, 0.33 mmol, 1.10 equiv.), palladium (II) 
acetate (0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-2.37 (3.8 mg, 0.0036 mmol, 0.012 
equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel 
chromatography (50% CH2Cl2 in pentane, stain in CAM) to afford a white solid (50.70 mg, 
68% yield). 1H NMR (600 MHz, CDCl3) δ 7.81 (1H, d, J = 6.6 Hz), 7.78 (1H, d, J = 8.4 
Hz), 7.48-7.42 (2H, m), 7.38 (2H, d, J = 7.2 Hz) 7.30-7.26 (4H, m) 4.99 (1H, ddd, J = 7.8, 
4.2, 2.4 Hz), 3.20 (1H, dd, J = 14.4, 4.8 Hz), 3.15 (1H, dd, J = 13.8, 9.0 Hz), 1.99 (1H, d, 
J = 3.0 Hz). 13C NMR (150 MHz, CDCl3) δ 143.94, 135.68, 133.67, 132.48, 128.61, 
128.27, 128.23, 127.92, 127.80, 127.79, 127.71, 126.20, 126.05, 125.69, 75.37, 46.42. IR 
(neat) νmax 3365.3 (br), 3056.4 (w), 3029.5 (w), 2912.3 (w), 1631.0 (w), 1528.0 (w), 1454.0 
(w), 1199.7 (w), 1055.4 (m), 1012.9 (m), 811.1 (s), 747.7 (m), 724.3 (m), 699.4 (s) 478.4 
(m) cm-1. HRMS (DART) for C18H15 [M+H-H2O]+  calculated: 231.1174, found 231.1167. 
[α]20D: -2.8194 (c = 0.770, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
vinyl boronic acid pinacol ester, and Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexyl-
phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry was assigned by 
analogy (see products 2.41, 2.24, and 2.40). 
Ph
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Chiral SFC (Chiracel OD-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-2-(naphthalen-2-yl)-1-phenylethan-1-ol. 
Racemic Material          Standard Conditions 
                                          
 
 
 
 (R)-2-(4-methoxyphenyl)-1-phenylethan-1-ol (2.44) The reaction 
was performed according to the general procedure (Method A) with 
5,5-dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20) (42.0 mg, 0.30 mmol, 1.00 equiv.), 
phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), 4-
methoxyphenyl trifluoromethanesulfonate (84.5 mg, 0.33 mmol, 1.10 equiv.), palladium 
(II) acetate (0.67 mg, 0.003 mmol, 0.01 equiv.), and (Sp, Sp)-2.37 (3.8 mg, 0.0036 mmol, 
0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel 
column chromatography (10% ethyl acetate in hexanes) to afford a colorless oil (57.4 mg, 
84% yield). 1H NMR (600 MHz, CDCl3) δ 7.34-7.31 (4H, m), 7.28-7.24 (1H, m), 7.09 (2H, 
d, J = 9.0 Hz), 6.83 (2H, d, J = 8.4 Hz), 4.84 (1H, ddd, J = 7.8, 4.8, 2.4 Hz), 3.78 (3H, s), 
Ph
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2.98 (1H, dd, J = 13.8, 4.8 Hz), 2.91 (1H, dd, J= 14.4, 9.0 Hz), 1.97 (1H, s); 13C NMR (150 
MHz, CDCl3) δ 158.6, 144.0, 130.6, 130.1, 128.6, 127.7, 126.0, 114.1, 75.6, 55.4, 45.3; IR 
(neat) νmax 3407.9 (br), 2999.5 (m), 2834.9 (m), 1611.0 (m), 1583.6 (w), 1510.0 (s), 1453.3 
(m), 1242.4 (s), 1176.6 (m), 1031.5 (s), 820.1 (m), 699.1 (s) cm-1; HRMS-(DART) for: 
C15H15O1 [M+H-H2O]+: calculated: 211.1123, found: 211.1130. [a]D20 = 4.081 (c = 1.470, 
CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexyl-phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of   (R)-2-(4-methoxyphenyl)-1-phenylethan-1-ol  
Racemic Material         Standard Conditions 
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 (R)-1-phenyl-2-(4-(trifluoromethyl)phenyl)ethan-1-ol (2.45) The 
reaction was performed according to the general procedure (Method 
A) with 5,5-dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20) (42.0 mg, 0.30 mmol, 1.00 
equiv.), phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), 4-
(trifluoromethyl)phenyl trifluoromethanesulfonate (2.103) (97.1 mg, 0.33 mmol, 1.10 
equiv.), palladium (II) acetate (0.67 mg, 0.003 mmol, 0.01 equiv.), and (Sp, Sp)-2.37 (3.8 
mg, 0.0036 mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified 
by silica gel column chromatography (5% ethyl acetate in hexanes) to afford a colorless oil 
(40.9 mg, 51% yield). 1H NMR (600 MHz, CDCl3) δ 7.52 (2H, d, J = 8.4 Hz), 7.36-7.27 
(6H, m), 4.90 (1H, ddd, J = 8.4, 5.4, 3.0 Hz), 3.08 (1H, dd, J = 13.2, 7.2 Hz), 3.05 (1H, dd, 
J= 13.2, 5.4 Hz), 1.92 (1H, s). 13C NMR (150 MHz, CDCl3) δ 143.6, 142.4, 130.1, 129.2, 
128.9, 128.7, 128.1, 126.0, 125.4 (q, J = 3.5 Hz), 75.3, 45.7. IR (neat) νmax 3343.5 (br), 
2928.8 (w), 1618.3 (w), 1494.5 (m), 1417.9 (m), 1322.6 (s), 1237.4 (m), 1161.6 (m), 1119.4 
(s), 1108.1 (s), 1019.1 (m), 841.8 (m), 700.1 (m), 650.7 (m) cm-1. HRMS-(DART) for: 
C15H12F3 [M+H-H2O]+: calculated: 249.0891, found: 249.0900. [a]D20 = 5.360 (c = 1.535, 
CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexyl-phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
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Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-1-phenyl-2-(4-(trifluoromethyl)phenyl)ethan-1-ol 
Racemic Material              Standard Conditions 
                                                         
   
 
 (R)-2-(2,4-dimethylphenyl)-1-phenylethan-1-ol (2.46) The 
reaction was performed according to the general procedure (Method 
A, slight modification at 80°C) with 5,5-dimethyl-2-vinyl-1,3,2-
dioxaborinane (2.20) (42.0 mg, 0.30 mmol), phenyllithium (0.167 mL, 1.9M in dibutyl 
ether, 0.30 mmol), 2,4-dimethylphenyl trifluoromethanesulfonate (2.104) (83.90 mg, 0.33 
mmol), palladium (II) acetate (0.670 mg, 0.003 mmol), (Sp, Sp)-2.37 (3.80 mg, 0.0036 
mmol) in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel 
chromatography (40% CH2Cl2 in hexanes) to afford a clear oil. (34.6 mg, 51% yield).  1H 
NMR  (600 MHz, CDCl3) δ 7.33-7.37 (4H, m), 7.27 (1H, t, J = 7.2 Hz), 7.04 (1H, d, J = 
7.8 Hz), 6.98 (1H, s), 6.95 (1H, d, J = 7.8 Hz), 4.86-4.86 (1H, m), 3.00 (1H, dd, J = 14.4, 
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4.2 Hz), 2.94 (1H, dd, J = 13.8, 9.0 Hz), 2.29 (3H, s), 2.26 (3H, s), 1.92 (1H, d, J = 2.4 
Hz); 13C NMR  (150 MHz, CDCl3) δ 144.4, 136.8, 136.5, 133.3, 131.5, 130.4, 128.6, 127.7, 
126.9, 125.9, 74.6, 43.2, 21.1, 19.7  IR (neat) νmax 3418 (br), 3027 (w), 3004 (w), 2921 (m), 
2856 (w), 1493 (w), 1451 (m), 1026 (s), 805 (s), 699  (s), 567 (m) cm-1;  HRMS-(DART): 
for C16H17 [M+H-H2O]+: calculated: 209.1330, found: 209.1329.  [α]20D = + 3.99 (c = 
0.450, CHCl3, l = 50 mm). 
Analysis of Stereochemistry 
Racemic compound was prepared according to the general procedure (Method A) with  
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, and Pd(OAc)2 (5 mol%) and 1,1’-
Bis(dicyclohexyl-phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40).  
Chiral SFC (Chiracel OJ-H, 5% IPA, 3 mL/min, 100 bar, 35°C, 210-270 nm) – analysis of 
(R)-2-(2,4-dimethylphenyl)-1-phenylethan-1-ol. 
Racemic Material Standard Conditions  
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 (R)-2-(2,6-dimethylphenyl)-1-phenylethan-1-ol (2.47) The reaction 
was performed according to the general procedure (Method A) with 5,5-
dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20) (42.0 mg, 0.30 mmol, 1.00 
equiv.), phenyllithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), 2,6-
dimethylphenyl trifluoromethanesulfonate (2.105) (83.90 mg, 0.33 mmol, 1.10 equiv.), 
palladium (II) acetate (0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 
mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica 
gel chromatography (30% CH2Cl2 in pentane, stain in CAM) to afford a white solid (50.50 
mg, 44% yield. 1H NMR (600 MHz, CDCl3) δ 7.38-7.32 (4H, m), 7.30-7.26 (1H, m), 7.07-
7.00 (3H, m), 4.91 (1H, ddd, J = 7.8 4.8, 1.8 Hz). 3.15 (1H, dd, J = 13.8, 9.0 Hz), 2.98 (1H, 
dd, J = 13.8, 4.8 Hz), 2.31 (6H, s), 1.85 (1H, d, J = 2.4 Hz). 13C NMR (150 MHz, CDCl3) 
δ 144.64, 137.58, 135.07, 128.58, 128.53, 127.70, 126.64, 125.70, 74.19, 39.96, 20.55. IR 
(neat) νmax 3534.5 (br), 3416.7 (br), 3064.4 (w), 3027.0 (w), 2956.3 (w), 2921.1 (w), 1550.7 
(w), 1493.0 (m), 1379.0 (m), 1049.2 (w), 1024.6 (m), 758.0 (s), 700.2 (s) cm-1. HRMS 
(DART) for C16H17 [M+H-H2O]+  calcualted: 209.1330, found: 209.1332. [α]20D: +1.419 (c 
= 0.435, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
vinyl boronic acid pinacol ester, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
Chiral SFC (Chiracel OD-H, 8% IPA, 3 mL/min, 150 bar, 35 °C, 210-270 nm) – analysis 
of   (R)-2-(2,6-dimethylphenyl)-1-phenylethan-1-ol. 
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Racemic Material         Standard Conditions 
                                           
 
 
 (R)-2-(benzo[d][1,3]dioxol-5-yl)-1-phenylethan-1-ol (2.48) The 
reaction was performed according to the general procedure (Method 
A) with 5,5-dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20) (42.0 mg, 0.30 mmol), 
phenyllithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol), benzo[d][1,3]dioxol-5-yl 
trifluoromethanesulfonate (2.107) (88.50 mg, 0.33 mmol), palladium (II) acetate (0.67 mg, 
0.003 mmol), (Sp, Sp)-2.37 (3.8 mg, 0.0036 mmol) in THF (1.2 mL, 0.25 M). The crude 
mixture was purified by silica gel chromatography (5% EtOAc in hexanes) to afford a 
white solid. (35.6 mg, 49% yield).  1H NMR  (600 MHz, CDCl3) δ 7.33 (4H, d, J = 4.8 
Hz), 7.25-7.29 (1H, m), 6.72 (1H, d, J  = 7.8 Hz), 6.68 (1H, d, J = 1.2 Hz), 6.62 (1H, dd, J 
= 8.4, 1.8 Hz), 5.91 (2H, s), 4.82 (1H, dd, J = 7.8, 4.2 Hz), 2.94 (1H, dd, J = 13.8, 4.2 Hz), 
2.88 (1H, dd, J = 13.8, 8.4 Hz,), 1.99 (1H, brs,); 13C NMR  (150 MHz, CDCl3) δ 147.9, 
146.5, 143.9, 131.9, 128.6, 127.8, 126.0, 122.6, 110.0, 108.4, 101.1, 75.6, 45.9; IR (neat) 
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νmax 3411 (br), 3062 (w), 3028 (w), 2919 (m), 1607 (w), 1501 (s), 1440 (s), 1243 (s), 1187 
(m), 1187 (m), 1036 (s), 928 (s), 699 (s), 537 (m) cm-1;  HRMS-(DART): for C15H13O2 
[M+H-H2O]+: calculated: 225.0915, found: 225.0916.  [α]20D = + 1.35 (c = 1.025, CHCl3, 
l = 50 mm).  
Analysis of Stereochemistry 
Racemic compound was prepared according to the general procedure (Method A) with   
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, Pd(OAc)2 (5 mol%) and 1,1’-
Bis(dicyclohexyl-phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40).  
Chiral SFC (Chiracel OJ-H, 8% IPA, 3 mL/min, 100 bar, 35°C, 210-270 nm) – analysis of 
(R)-2-(benzo[d][1,3]dioxol-5-yl)-1-phenylethan-1-ol.  
 
Racemic Material  Standard Conditions  
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 (R)-1-phenyl-2-(3,4,5-trimethoxyphenyl)ethan-1-ol (2.49) The 
reaction was performed according to the general procedure (Method 
A) with 5,5-dimethyl-2-vinyl-1,3,2-dioxaborinane (2.20) (42.0 mg, 
0.30 mmol, 1.00 equiv.), phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 
equiv.), 3,4,5-trimethoxyphenyl trifluoromethanesulfonate (2.106).  (104.4 mg, 0.33 mmol, 
1.10 equiv.), palladium (II) acetate (0.670 mg, 0.003 mmol, 0.010 equiv.), (Sp, Sp)-2.37 
(3.80 mg, 0.0036 mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was 
purified by silica gel chromatography (15-20% ethyl acetate in pentane, stain in CAM) to 
afford a white solid (75.20 mg, 87% yield). 1H NMR (600 MHz, CDCl3) δ 7.37-7.30 (4H, 
m), 7.28-7.24 (1H, m), 6.35 (2H, s), 4.86 (1H, dd, 8.4, 5.4 Hz), 3.81 (3H, s), 3.78 (6H, s), 
2.96 (1H, dd, J = 13.8, 5.4 Hz), 2.90 (1H, dd, J = 13.2, 7.8 Hz), 2.07 (1H, br s). 13C NMR 
(150 MHz, CDCl3) δ 153.26, 143.82, 136.83, 133.64, 128.52, 127.74, 126.05, 106.52, 
75.30, 60.95, 56.16, 46.53. IR (neat) νmax 3446.9 (br), 3027.2 (w), 2937.9 (w), 2837.3 (w), 
1589.0 (m), 1506.9 (m), 1454.5 (m), 1421.1 (m), 1333.8 (w), 1236.7 (m), 1122.1 (s), 
1041.9 (w), 1007.9 (m), 701.5 (m) cm-1. HRMS (DART) for C17H19O3 [M+H-H2O]+  
calcualted: 271.1334, found: 271.1345. [α]20D: +6.128 (c = 2.890, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
vinyl boronic acid pinacol ester, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
Chiral SFC (Chiracel OD-H, 10% MeOH, 3 mL/min, 150 bar, 35 °C, 210-270 nm) – 
analysis of   (R)-1-phenyl-2-(3,4,5-trimethoxyphenyl)ethan-1-ol. 
Ph
OH
OMe
OMe
OMe
2.49
 220 
Racemic Material  Standard Conditions 
                                    
      
 
 (R)-3-(2-hydroxy-2-phenylethyl)benzaldehyde (2.50) The 
reaction was performed according to the general procedure (Method 
A) with 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (46.2 mg, 0.30 mmol, 1.00 
equiv.) phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), 3-
formylphenyl trifluoromethanesulfonate.(2.108) (83.9 mg, 0.33 mmol, 1.10 equiv.), 
palladium (II) acetate (0.670 mg, 0.003 mmol, 0.01 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 
mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica 
gel chromatography (20% EtOAc in Hexanes) to afford a clear colorless oil (45 mg, 66% 
yield). 1H NMR (600 MHz, CDCl3) δ 9.97 (1H, s), 7.48-7.70 (2H, m), 7.46-7.26 (6H, m), 
4.94 (1H, t, J = 6.5 Hz), 3.12-3.10 (2H, m), 1.98 (1H, s). 13C NMR (125 MHz, CDCl3) δ 
192.4, 143.5, 139.3, 136.5, 135.8, 130.6, 129.0, 128.5, 127.9, 125.8, 75.2, 45.4. IR (neat) 
νmax 3423.5 (br), 3062.1 (s), 3029.5 (s), 2922.1 (m), 2850.5 (s), 1691.3 (s), 1603.0 (d), 
1451.7 (s), 1241.1 (s), 1143.8 (s), 1048.0 (s), 698.8 (s) cm-1.HRMS-(DART) for: 
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C15H18N1O1 [M+NH4]+: calculated: 244.1339, found: 244.1338. [α]D20: +3.63 (c = 0.84, 
CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
vinyl boronic acid pinacol ester, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
Chiral SFC (Chiracel AS-H, 7% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-3-(2-hydroxy-2-phenylethyl)benzaldehyde.  
                        Racemic Material                                Standard Conditions 
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 (R)-3-cyclohexyl-1-phenylbut-3-en-1-ol (2.53) The reaction was 
performed according to the general procedure (Method A) with 
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (46.2 mg, 0.30 mmol, 1.00 equiv.), 
phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), 1-
cyclohexylvinyl trifluoromethanesulfonate (2.99) (85.2 mg, 0.33 mmol, 1.10 equiv.), 
palladium (II) acetate (0.67 mg, 0.003 mmol, 0.01 equiv.), and (Sp, Sp)-2.37 (3.8 mg, 0.0036 
mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica 
gel column chromatography (5% ethyl acetate in hexane) to afford a colorless oil (50.2 mg, 
73% yield). 1H NMR (600 MHz, CDCl3) δ 7.38-7.32 (4H, m), 7.27-7.24 (1H, m), 4.93 (1H, 
t, J = 1.2 Hz), 4.88 (1H, d, J = 0.6 Hz), 4.77 (1H, ddd, J = 10.2, 3.6, 2.4 Hz), 2.50 (1H, 
ddd, J = 13.8, 3.6, 1.2 Hz), 2.36 (1H, dd, J= 13.2, 9.0 Hz), 2.20 (1H, s), 1.88-1.75 (5H, m), 
1.70-1.67 (1H, m), 1.29-1.05 (5H, m). 13C NMR (150 MHz, CDCl3) δ 152.0, 144.3, 128.5, 
127.6, 126.0, 111.1, 71.9, 46.1, 44.0, 32.9, 32.4, 27.0, 26.8, 26.5. IR (neat) νmax 3390.4 (br), 
2932.5 (s), 2851.3 (m), 1639.0 (m), 1493.6 (m), 1449.2 (m), 1028.4 (m), 888.1 (m), 755.2 
(m), 699.0 (s), 556.4 (m) cm-1. HRMS-(DART) for: C16H21 [M+H-H2O]+: calculated: 
213.1643, found: 213.1641. [a]D20 = +44.267 (c = 2.140, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with  
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexyl-phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-3-cyclohexyl-1-phenylbut-3-en-1-ol 
OH
Ph
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 (R)-2-(cyclohex-1-en-1-yl)-1-phenylethan-1-ol (2.51) The reaction 
was performed according to the general procedure (Method A) with 
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (46.2 mg, 0.30 mmol, 1.00 equiv.) phenyl 
lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), cyclohex-1-en-1-yl 
trifluoromethanesulfonate (2.100) (76.0 mg, 0.33 mmol, 1.10 equiv.), palladium (II) 
acetate (0.670 mg, 0.003 mmol, 0.01 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 mmol, 0.012 
equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel 
chromatography (30% CH2Cl2 in pentane) to afford a clear colorless oil (52.3 mg, 86% 
yield). 1H NMR (600 MHz, CDCl3) δ 7.39-7.34 (3H, m), 7.28-7.23 (1H, m), 5.60 (1H, s), 
4.76 (1H, dd, J = 9.0, 4.2 Hz), 2.36 (1H, m), 2.30 (1H, dd, J = 18.8, 9.6 Hz), 2.17 (1H, s), 
2.09-2.05 (3H, m),  1.94-1.92 (1H, m), 1.68-1.64 (2H, m), 1.61-1.57 (2H, m). 13C NMR 
(125 MHz, CDC3) δ 144.5, 134.6, 128.5, 127.4, 125.9, 125.9, 71.4, 49.1, 28.4, 25.5, 23.0, 
Ph
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22.4. IR (neat) νmax  3406.1 (br), 3028.27 (m), 2922.0 (s), 2922.5 (s), 2855.4 (s), 2833.9 (s), 
1493.2 (s) 1451.1 (m), 1050.2 (m), 1006.6 (s), 753.4 (m), 699.0 (s), 547.2 (s) cm-1. HRMS-
(DART) for: C14H17 [M+H-H2O]+: calculated: 185.1330, found: 185.1329. [α]D20: +72.35 
(c = 0.74, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-2-(cyclohex-1-en-1-yl)-1-phenylethan-1-ol. 
                     Racemic Material                           Standard Conditions 
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 (R)-3-cyclohexylidene-1-phenylpropan-1-ol (2.56) The reaction was 
performed according to the general procedure (Method A) with 
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (46.2 mg, 0.30 mmol, 1.00 equiv.), 
phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), 
cyclohexylidenemethyl trifluoromethanesulfonate (2.98) (80.6 mg, 0.33 mmol, 1.10 
equiv.), palladium (II) acetate (0.67 mg, 0.003 mmol, 0.01 equiv.), and (Sp, Sp)-2.37 (3.8 
mg, 0.0036 mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). The crude mixture was purified 
by silica gel column chromatography (3 % ethyl acetate in hexane) to afford a colorless oil 
(48.5 mg, 75% yield). 1H NMR (600 MHz, CDCl3) δ 7.36-7.31 (4H, m), 7.26-7.23 (1H, 
m), 5.01 (1H, t, J = 7.8 Hz), 4.65 (1H, ddd, J = 7.8, 4.8, 3.0 Hz), 2.48 (1H, ddd, J = 14.4, 
7.8, 7.8 Hz), 2.41 (1H, ddd, J= 12.6, 6.0, 6.0 Hz), 2.11-2.07 (4H, m), 2.01 (1H, t, J = 3.0 
Hz), 1.53-1.49 (4H, m), 1.44-1.36 (2H, m); 13C NMR (150 MHz, CDCl3) δ 144.4, 144.3, 
128.5, 127.5, 126.1, 116.4, 74.2, 37.5, 29.1, 28.8, 28.0, 27.0; IR (neat) νmax 3343.5 (br), 
2923.4 (s), 2851.6 (m), 1494.2 (m), 1447.4 (m), 1266.0 (m), 1232.4 (m), 1027.8 (m), 849.9 
(m), 758.2 (m), 698.8 (s), 551.8 (m) cm-1; HRMS-(DART) for: C15H19 [M+H-H2O]+: 
calculated: 199.1487, found: 199.1496. [a]D20 = +41.066 (c = 0.540, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, and Pd(OAc)2 (5 mol%) and 1,1′-
Bis(dicyclohexyl-phosphino)ferrocene (6 mol%) as the catalyst.  Absolute stereochemistry 
was assigned by analogy (see products 2.41, 2.24, and 2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-3-cyclohexylidene-1-phenylpropan-1-ol 
Ph
OH
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 (R)-3-methylene-1-phenylnonan-1-ol (2.52) The reaction was 
performed according to the general procedure (Method A) with 4,4,5,5-
tetramethyl-2-vinyl-1,3,2-dioxaborolane (46.2 mg, 0.30 mmol, 1.00 equiv.) phenyl lithium 
(0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), oct-1-en-2-yl 
trifluoromethanesulfonate (2.97) (85.9 mg, 0.33 mmol, 1.10 equiv.), palladium (II) acetate 
(0.670 mg, 0.003 mmol, 0.01 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 mmol, 0.012 equiv.) 
in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel chromatography 
(30% CH2Cl2 in pentane) to afford a clear colorless oil (60.0 mg, 86% yield). 1H NMR 
(600 MHz, CDCl3) δ 7.39-7.34 (4H, m), 7.29-7.26 (1H, m), 4.94 (1H, s), 4.91 (1H, s), 4.80 
(1H, dd, J = 1.8, 9.6 Hz), 2.47 (1H, ddd, J = 13.8, 4.20 Hz), 2.40 (1H, ddd, J = 14.9, 9.6 
Hz), 2.17 (1H, d, J = 1.8 Hz), 2.08 (1H, t, J = 7.8 Hz), 1.51-1.42 (2H, m), 1.34-1.26 (6H, 
Ph
OH n-hex
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m), 0.90 (3H, t, J = 6.6). 13C NMR (125 MHz, CDCl3) δ 146.7, 144.24, 128.5, 127.6, 125.9, 
125.9, 112.9, 71.7, 46.9, 35.9, 31.9, 30.5, 29.2, 29.2, 27.8, 22.8, 14.2. IR (neat) νmax 3383.7 
(w), 2955.3 (s), 2924.0 (s), 2854.0 (s), 1493.7 (s), 1454.3 (m), 1041.5 (m), 968.8 (s), 755.9 
(s), 699.1 (s) cm-1. HRMS-(DART) for: C16H23 [M+H-H2O]+: calculated: 215.1800, found: 
215.1801. [α]D20: +36.69 (c = 1.23, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-3-methylene-1-phenylnonan-1-ol.  
                        Racemic Material                      Standard Conditions 
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 (R,E)-1-phenylundec-3-en-1-ol (2.55) The reaction was performed 
according to the general procedure (Method A) with 4,4,5,5-
tetramethyl-2-vinyl-1,3,2-dioxaborolane (46.2 mg, 0.30 mmol, 1.00 equiv.) phenyl lithium 
(0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 1.00 equiv.), (E)-non-1-en-1-yl 
trifluoromethanesulfonate (2.96) (90.5 mg, 0.33 mmol, 1.10 equiv.), palladium (II) acetate 
(0.670 mg, 0.003 mmol, 0.01 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 mmol, 0.012 equiv.) 
in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel chromatography 
(30% CH2Cl2 in pentane) to afford a clear colorless oil (39.9 mg, 54% yield). 1H NMR 
(600 MHz, CDCl3) δ 7.35-7.345 (4H, m), 7.28-7.26 ( 1H, m),  5.58 (1H, ddd, J = 14.4,  6.6  
Hz), 5.40 (1H, ddd, J =  15.6, 7.2 Hz), 4.69-4.67 (1H, m), 2.47 (1H, ddd, J = 10.8, 5.4 Hz), 
2.41 (1H, ddd, J = 14.4, 7.8 Hz), 2.07 (1H, s), 2.02 (2H, q,  J = 7.2 Hz), 1.37-1.21 (10H, 
m), 0.89 (3H, t, J = 7.2 Hz,). 13C NMR (125 MHz, CDCl3) δ 144.2, 135.5, 128.5, 127.5, 
126.0, 125.5, 73.6, 43.0, 32.8, 33.0, 29.6, 29.3, 29.3, 14.3. IR (neat) νmax 3389.8 (w), 3065.9 
(s), 3029.0 (s), 2925.9 (s), 2855.9 (s), 1643.6 (s), 1453.3 (m), 1049.7 (m), 889.7 (s), 698.0 
(s) cm-1. HRMS-(DART) for: C17H25 [M+H-H2O]+: calculated: 229.1956, found: 
229.1953. [α]D20: +26.66 (c = 0.36, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R,E)-1-phenylundec-3-en-1-ol. 
Ph
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 (R)-6-(tert-butyldimethylsilyloxy)-3-methylene-1-phenylhexan-1-ol 
(2.54) The reaction was performed according to the general procedure 
(Method A) with 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (46.2 
mg, 0.30 mmol, 1.00 equiv.) phenyl lithium (0.167 mL, 1.9M in dibutyl ether, 0.30 mmol, 
1.00 equiv.), 5-((tert-butyldimethylsilyl)oxy)pent-1-en-2-yl trifluoromethanesulfonate 
(2.101) (115.0 mg, 0.33 mmol, 1.10 equiv.), palladium (II) acetate (0.670 mg, 0.003 mmol, 
0.01 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). 
The crude mixture was purified by silica gel chromatography (3% ethyl acetate in hexanes) 
to afford a clear colorless oil (43.3 mg, 45% yield). 1H NMR (600 MHz, CDCl3) δ 7.39-
7.31 (4H, m), 7.28-7.22 (1H, m), 4.95 (1H, s), 4.92 (1H, s), 4.81 (1H, dd, J = 9.5, 4.1 Hz), 
3.63 (2H,  t, J = 6.4), 2.37 (1H, dd, J = 14.1, 4.0 Hz), 2.41 (1H, dd, J = 14.1, 9.5 Hz), 2.16-
2.12 (3H, m), 1.74-1.64 (2H, m), 0.90 (9H, s), 0.05 (6H, s). 13C NMR (125 MHz, CDCl3) 
δ 146.2, 144.2, 128.6, 127.6, 125.9, 113.1, 71.7, 62.8, 47.1, 32.1, 31.0, 47.1, 32.1, 31.0, 
26.1, 18.52, -5.1. IR (neat) νmax 3438.3(br), 2952.8 (s), 2929.3 (s), 2886.0 (m), 2856.5 (s), 
Ph
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1644.4 (s), 1492.5 (m), 1454.1 (s), 1254.3 (s), 1101.3 (s), 835.4 (s), 775.2 (s), 699.2 (s) cm-
1.HRMS-(DART) for: C19H31O1Si1 [M+H-H2O]+: calculated: 303.2144, found: 303.2154. 
[α]D20: +22.00 (c = 0.26, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  6-((tert-butyldimethylsilyl)oxy)-3-methylene-1-phenylhexan-1-ol.  
                      Racemic Material                   Standard Conditions 
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 (R)-methyl 2-(2-hydroxy-2-phenylethyl)cyclopent-1-
enecarboxylate (2.57) The reaction was performed according to the 
general procedure (Method A)  with 4,4,5,5-tetramethyl-2-vinyl-1,3,2-
dioxaborolane (46.2 mg, 0.30 mmol, 1.00 equiv.) phenyl lithium (0.167 mL, 1.9M in 
dibutyl ether, 0.30 mmol, 1.00 equiv.), 5-hydroxypent-1-en-2-yl trifluoromethanesulfonate 
(2.102) (90.5 mg, 0.33 mmol, 1.10 equiv.), palladium (II) acetate (0.670 mg, 0.003 mmol, 
0.01 equiv.), (Sp, Sp)-2.37 (3.80 mg, 0.0036 mmol, 0.012 equiv.) in THF (1.2 mL, 0.25 M). 
Oxidation was performed at pH 7 over 24 hours. A phosphate buffer solution was used 
instead of 3M NaOH solution. The crude mixture was purified by silica gel 
chromatography (40% CH2Cl2 in Hexanes) to afford a clear colorless oil (39.9 mg, 54% 
yield). 1H NMR (600 MHz, CDCl3) δ 7.40 (2H, d, J = 12 Hz), 7.34 (2H, t, J = 6.0 Hz,7.27-
7.24 (1H, m), 4.91 (1H, m), 3.75 (3H, s), 3.11 (1H, dd, J = 13.2, 3.9 Hz), 2.79 (1H, dd, J= 
13.3, 3.9 Hz), 2.66-2.62 (2H, m), 2.54-2.48 (1H, m), 2.32-2.25 (1H, m) 1.81 (2H, q, J = 
7.6 Hz). 13C NMR (125 MHz, CDCl3) δ 168.0, 157.0, 145.0, 130.3, 128.4, 127.4, 125.6, 
125.6, 73.32, 51.6, 40.37, 39.36, 33.60, 21.74. IR (neat) νmax 3451.0 (br), 2952.0 (s), 2924.9 
(s), 2854.8 (s), 1705.3 (s), 1636.0 (s), 1434.7 (m), 1266.5 (m), 1198.3 (s), 1116.4 (s), 
1054.1 (s), 768.6 (s), 701.9 (s) cm-1. HRMS-(DART) for: C15H17O2 [M+H-H2O]+: 
calculated: 229.1230, found: 229.1229. [α]D20: +73.65 (c = 0.68, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method A) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Ph
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Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – Methyl 
(R)-2-(2-hydroxy-2-phenylethyl)cyclopent-1-ene-1-carboxylate. 
                     Racemic Material                                   Standard Conditions 
                                       
          
 
 (S)-4-methyl-1-phenylpentan-2-ol (2.63) The reaction was performed 
according to the general procedure (Method B) with 2-isobutyl-5,5-
dimethyl-1,3,2-dioxaborinane (2.202) (51.0 mg, 0.30 mmol), vinylllithium (0.211 mL, 
1.42M in diethyl ether, 0.30 mmol), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 
mmol), palladium (II) acetate (1.34 mg, 0.006 mmol), (Sp, Sp)-2.37 (7.60 mg, 0.0072 mmol) 
in THF (1.2 mL, 0.25 M). The crude mixture was purified by silica gel chromatography 
(40% CH2Cl2 in hexanes) to afford a clear oil. (31.6 mg, 59% yield).  1H NMR  (600 MHz, 
CDCl3) δ 7.30 (2H, t, J = 7.2 Hz), 7.20-7.24 (3H, m), 3.87-3.89 (1H, m), 2.80 (1H, dd, J = 
13.2, 3.6 Hz), 2.61 (1H, dd, J = 13.2, 8.4 Hz), 1.78-1.85 (1H, m), 1.41-1.48 (2H, m), 1.27-
1.31 (1H, m), 0.93 (3H, d, J = 6.6 Hz), 0.90 (3H, d, J = 8.4 Hz);  13C NMR  (150 MHz, 
CDCl3) δ 138.8, 129.6, 128.7, 126.6, 70.9, 46.2, 44.8, 24.8, 23.6, 22.2;  IR (neat) νmax 3387 
i-butyl
Ph
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(br), 3027 (w), 2953 (m), 2921 (m), 2868 (w), 2362 (w), 1512 (w), 1466 (m), 1346 (w), 
1136 (w), 1078 (m), 1019 (m), 743 (s), 697 (s), 603 (w) cm-1; HRMS-(DART) for C12H17 
[M+H-H2O]+ : calculated: 161.1330, found: 161.1337.  [α]20D = +4.736 (c = 0.285, CHCl3, 
l = 50 mm). 
Analysis of Stereochemistry 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1’-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40).  
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35°C, 210-270 nm) – analysis 
of  (S)-4-methyl-1-phenylpentan-2-ol. 
                  Racemic Material Standard Conditions  
           
  
 
 
 234 
 (R)-1-cyclohexyl-2-phenylethan-1-ol (2.64) The reaction was  performed 
according to the general procedure (Method B) with 2-cyclohexyl-5,5-
dimethyl-1,3,2-dioxaborinane (2.201) (58.8 mg, 0.30 mmol, 1.00 equiv.), vinyl lithium 
(0.210 mL, 1.42 M in Et2O, 0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate 
(74.60 mg, 0.33 mmol, 1.10 equiv.), palladium (II) acetate (1.30 mg, 0.0060 mmol, 0.020 
equiv.), (Sp, Sp)-2.37 (7.60 mg, 0.0072 mmol,0.024 equiv.) in THF (1.20 mL, 0.25 M).  The 
crude mixture was purified by silica gel chromatography (5% ethyl acetate in hexanes, 
stain in CAM) to afford a white solid (49.2 mg, 80% yield). 1H NMR (600 MHz, CDCl3) 
δ 7.31-7.28 (2H, m), 7.23-7.18 (3H, m), 3.57 (1H, ddd, J = 9.6, 6.0, 3.6 Hz), 2.87 (1H, dd, 
J = 13.2, 3.0 Hz), 2.58 (1H, dd, J = 13.2, 9.0 Hz), 1.92-1.88 (1H, m), 1.80-1.62 (3H, m), 
1.70-1.64 (1H, m), 1.44-1.38 (2H, m), 1.28-1.04 (5H, m). 13C NMR (150 MHz, CDCl3) δ 
139.39, 129.53, 128.72, 126.51, 76.95, 43.35, 40.95, 29.49, 28.16, 26.71, 26.47, 26.33. IR 
(neat) νmax 3327.3 (br), 3024.8 (w), 2923.1 (s), 2852.3 (m), 1493.7 (w), 1444.5 (w), 1401.3 
(m), 1085.0 (w), 1059.6 (m), 1001.9 (m), 749.5 (s), 698.2 (s) cm-1. HRMS (DART) for 
C14H24NO [M+NH4]+  calculated: 222.1858, found: 222.1858. [α]20D: +23.326 (c = 1.445, 
CHCl3, l =50 mm).  
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst. Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis  
(R)-1-cyclohexyl-2-phenylethan-1-ol. 
2.64
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 (R)-1-(naphthalen-2-yl)-2-phenylethan-1-ol (2.65) The reaction was  
performed according to the general procedure (Method B) with 5,5-
dimethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborinane (2.90) (72.0 mg, 
0.30 mmol, 1.00 equiv.), vinyl lithium (0.210 mL, 1.42 M in Et2O, 0.30 mmol, 1.00 equiv.), 
phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 1.10 equiv.), palladium (II) 
acetate (1.30 mg, 0.0060 mmol, 0.020 equiv.), (Sp, Sp)-2.37 (7.60 mg, 0.0072 mmol,0.024 
equiv.) in THF (1.20 mL, 0.25 M).  The crude mixture was purified by silica gel 
chromatography (15% ethyl acetate in hexanes, stain in CAM) to afford a white solid (69.0 
mg, 93% yield). 1H NMR (600 MHz, CDCl3) δ7.84-7.78 (4H, m), 7.51-7.45 (3H, m), 7.29 
(2H, t, J = 7.2 Hz), 7.23-7.20 (3H, m), 5.06 (1H, dd, J = 7.8, 4.2 Hz), 3.13 (1H, dd, J = 
13.2, 4.8 Hz). 3.06 (1H, dd, J = 14.4, 9.0 Hz), 2.04 (1H, br s). 13C NMR (150 MHz, CDCl3) 
δ 141.38, 138.14, 133.47, 133.19, 129.72, 128.75, 128.38, 128.16, 127.87. 126.86, 126.31, 
126.03, 124.79, 124.28, 75.63, 46.21. IR (neat) νmax 3529.1 (br), 3461.9 (br), 3057.9 (w), 
Ph
OH
2.65
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3025.9 (w), 2914.8 (w), 1601.1 (w), 1494.2 (w). 1360.6 (w), 1077.5 (w), 1043.3 (m), 893.2 
(m), 818.4 (s), 743.5 (s), 727.6 (s), 698.7 (s), 481.6 (s) cm-1. HRMS (DART) for C18H15 
[M+H-H2O]+  calculated: 231.1174, found: 231.1170. [α]20D: -2.515 (c = 1.340, CHCl3, l 
=50 mm).  
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst. Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel ODR-H, 15% MeOH, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – 
analysis  (R)-1-(naphthalen-2-yl)-2-phenylethan-1-ol. 
                   Racemic Material                                      Standard Conditions 
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 (R)-2-phenyl-1-(3,4,5-trimethoxyphenyl)ethan-1-ol (2.66) The 
reaction was performed according to the general procedure (Method 
B) with 2-(3,4,5-trimethoxyphenyl)-5,5-dimethyl-1,3,2-
dioxaborinane (2.94) (84.0 mg, 0.30 mmol, 1.00 equiv.), vinyl lithium (0.210 mL, 1.42 M 
in Et2O, 0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 
1.10 equiv.), palladium (II) acetate (1.30 mg, 0.0060 mmol, 0.020 equiv.), 2.37 (7.60 mg, 
0.0072 mmol, 0.024 equiv.) in THF (1.20 mL, 0.25 M).  The crude mixture was purified 
by silica gel chromatography (10% ethyl acetate in hexanes, stain in CAM) to afford a 
white solid (66.70 mg, 77% yield). 1H NMR (600 MHz, CDCl3) δ 7.31-7.28 (2H, m), 7.24-
7.21 (1H, m), 7.20-7.17 (2H, m), 6.54 (2H, s), 4.82 (1H, t, J = 6.6 Hz), 3.82 (9H, s), 3.00 
(1H, dd, J = 13.2, 5.4 Hz), 2.96 (1H, dd, J = 13.8, 8.4 Hz), 1.94 (1H, d, J = 1.8 Hz). 13C 
NMR (150 MHz, CDCl3) δ 153.32, 139.66, 138.05, 137.38, 129.67, 128.65, 126.80, 
102.91, 75.63, 60.99, 56.23, 46.26. IR (neat) νmax 3462.0 (br), 2939.3 (w), 2836.6 (w), 
1592.2 (m), 1506.7 (m), 1456.5 (m), 1326.3 (m), 1233.5 (m), 1125.3 (s), 1007.6 (s), 701.3 
(w) cm-1. HRMS (DART) for C17H19O3 [M+H-H2O]+  calculated: 271.1334, found: 
271.1327. [α]20D: -1.373 (c = 0.510, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst. Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel ODR-H, 6% MeOH, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – 
analysis of   (R)-2-phenyl-1-(3,4,5-trimethoxyphenyl)ethan-1-ol. 
Ph
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 (R)-1-(4-methoxyphenyl)-2-phenylethan-1-ol (2.67) The 
reaction was performed according to the general procedure (Method 
B) with 2-(4-methoxyphenyl)-5,5-dimethyl-1,3,2-dioxaborinane 
(2.85) (66.0 mg, 0.30 mmol, 1.00 equiv.), vinyl lithium (0.210 mL, 1.42 M in Et2O, 0.30 
mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 1.10 equiv.), 
palladium (II) acetate (1.30 mg, 0.0060 mmol, 0.020 equiv.), (Sp, Sp)-2.37 (7.60 mg, 0.0072 
mmol, 0.024 equiv.) in THF (1.20 mL, 0.25 M).  The crude mixture was purified by silica 
gel chromatography (40% CH2Cl2 in pentane, stain in CAM) to afford a white solid (59.60 
mg, 87% yield). 1H NMR (600 MHz, CDCl3) δ 7.31-7.24 (4H, m), 7.23-7.21 (1H, m), 7.17 
(2H, d, J = 6.6 Hz), 6.87 (2H, d, J = 9.0 Hz), 4.84 (1H, t, 6.6 Hz), 3.80 (3H, s), 3.02-2.96 
(2H, m), 1.92 (1H, br s). 13C NMR (150 MHz, CDCl3) δ 159.21, 138.29, 136.14, 129.63, 
128.60, 127.29, 126.68, 113.91, 75.11, 55.42, 46.15. IR (neat) νmax 3389.0 (br), 3002.2 (w), 
Ph
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2918.0 (w), 2835.9 (w), 1611.4 (m), 1512.2 (s), 1454.2 (w), 1302.3 (w), 1246.0 (s), 1157.1 
(m), 1032.9 (m). 831.9 (m), 699.4 (m) cm-1. HRMS (DART) for C15H15O [M+H-H2O]+  
calculated: 211.1123, found: 211.1123. [α]20D: -2.0386 (c = 1.275, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst. Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 8% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of   (R)-1-(4-methoxyphenyl)-2-phenylethan-1-ol. 
Racemic Material     Standard Conditions 
`                                   
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 (R)-1-(4-chlorophenyl)-2-phenylethan-1-ol (2.69) The reaction 
was performed according to the general procedure (Method B) with 
2-(4-chlorophenyl)-5,5-dimethyl-1,3,2-dioxaborinane (2.86) (67.30 
mg, 0.30 mmol, 1.00 equiv.), vinyl lithium (0.176 mL, 1.72 M in Et2O, 0.30 mmol, 1.00 
equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 1.10 equiv.), palladium 
(II) acetate (1.30 mg, 0.0060 mmol, 0.020 equiv.), (Sp, Sp)-2.37 (7.60 mg, 0.0072 mmol, 
0.024 equiv.) in THF (1.20 mL, 0.25 M).  The crude mixture was purified by silica gel 
chromatography (30% CH2Cl2 in pentane, stain in CAM) to afford a clear oil (46.40 mg, 
66% yield). 1H NMR (600 MHz, CDCl3) δ 7.30-7.20 (7H, m), 7.13 (2H, d, 6.0 Hz), 4.84 
(1H, ddd, J = 8.4, 5.4, 3.0 Hz), 2.97 (1H, dd, J = 13.8, 4.8 Hz), 2.92 (1H, dd, J = 13.8, 8.4 
Hz), 1.95 (1H, d, 2.4 Hz). 13C NMR (150 MHz, CDCl3) δ 142.34, 137.65, 133.36, 129.64, 
128.73, 128.65, 127.43, 126.91, 74.78, 46.24. IR (neat) νmax 3389.5 (br), 3085.1 (w), 3062.2 
(w), 3027.9 (w), 2851.4 (w), 1600.0 (w), 1492.5 (m), 1453.6 (w), 1089.4 (m), 1013.2 (m), 
827.6 (m), 745.7 (m). 699.7 (s), 544.76 (s) cm-1. HRMS (DART) for C14H12Cl [M+H-
H2O]+  calcualted: 215.0628, found: 215.0636. [α]20D: -8.716 (c = 1.845, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst. Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis  
(R)-1-(4-chlorophenyl)-2-phenylethan-1-ol. 
 
Ph
OH
2.69Cl
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Racemic Material         Standard Conditions 
                                      
 
 
 (R)-1-(4-(diphenylamino)phenyl)-2-phenylethan-1-ol (2.70) 
The reaction was performed according to the general procedure 
(Method B) with 4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-N,N-
diphenylaniline (2.91) (107.18 mg, 0.30 mmol, 1.00 equiv), vinyl lithium (0.176 mL, 1.72 
M in Et2O, 0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (75.60 mg, 0.33 
mmol, 1.10 equiv.), palladium (II) acetate (1.30 mg, 0.006 mmol, 0.02 equiv.), (Sp, Sp)-
2.37 (7.60 mg, 0.0072 mmol, 0.024 equiv.) in THF (1.20 mL, 0.25 M).  The crude mixture 
was purified by silica gel chromatography (40% CH2Cl2 in hexanes) to afford a white solid 
(81.0 mg, 75% yield). 1H NMR (600 MHz, CDCl3) δ 7.33-7.31 (2H, m), 7.26-7.22 (10H, 
m), 7.09-7.06 (5H, m), 7.02-7.00 (2H, m), 4.87-4.84 (1H, m), 3.06 (1H, dd, J = 13.6, 4.6 
Hz), 3.01 (1H, dd, J = 13.6, 8.8 Hz), 1.91 (1H, s). 13C NMR (150 MHz, CDCl3) δ 147.9, 
147.4, 138.3, 138.1, 129.7, 129.4, 128.7, 127.0, 126.8, 124.3, 124.3, 124.2, 122.9, 75.2, 
Ph
OH
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46.1. IR (neat) νmax 3383.1 (br), 3061.3 (m), 2922.1 (w), 2854.4(w), 1589.0 (s), 1508.9 (s), 
1314.1 (m), 1277.3 (s), 752.2 (s), 696.0 (s) cm-1. HRMS-(DART) for: C26H22NN1 [M+H-
H2O]+: calculated: 348.1752, found: 348.1763. [α]D20: -7.79 (c =0 .43, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-1-(4-(diphenylamino)phenyl)-2-phenylethan-1-ol.  
                        Racemic Material                      Standard Conditions 
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 (R)-1-(1-methyl-1H-indol-5-yl)-2-phenylethanol (2.71) The 
reaction was performed according to the general procedure (Method 
B) with 5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-1-methyl-1H-
indole (2.95) (75.20 mg, 0.30 mmol, 1.00 equiv.), vinyl lithium (0.210 mL, 1.42 M in Et2O, 
0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 1.10 
equiv.), palladium (II) acetate (1.30 mg, 0.0060 mmol, 0.020 equiv.), (Sp, Sp)-2.37 (7.60 
mg, 0.0072 mmol, 0.024 equiv.) in THF (1.20 mL, 0.25 M). The crude mixture was purified 
by silica gel chromatography (15% ethyl acetate in hexanes, stain in CAM) to afford a 
white solid (64.8 mg, 86% yield). 1H NMR (500 MHz, CDCl3) δ 7.61 (1H, s), 7.630-7.21 
(7H, m), 7.04 (1H, d, J = 3.0 Hz), 6.45 (1H, d, J = 3.0 Hz), 4.99 (1H, t, J = 7.0 Hz), 3.78 
(3H, s), 3.09 (2H, d, J = 7.0 Hz), 1.93 (1H, br s). 13C NMR (150 MHz, CDCl3) δ 138.83, 
136.45, 135.12, 129.62, 129.38, 128,49, 128.48, 126.47, 119.99, 118.41, 109.30, 101.15, 
76.21, 46.42, 32.97 IR (neat) νmax 2960.4 (w), 3383.6 (w), 3025.8 (w), 2919.9 (w), 1512.4 
(m), 1451.7 (w), 1244.5 (w), 1030.9 (w), 721.5 (s), 699.7 (s) cm-1 . HRMS-(DART) for 
C12H18NO [M+H]+ calculated: 252.1379 found: 252.13884. [α]D20: -10.328 (c = 2.08, 
CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OJ-H, 30% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of  (R)-1-(1-methyl-1H-indol-5-yl)-2-phenylethanol.  
Ph
OH
2.71NMe
 244 
 
 
Racemic Material                      Standard Conditions 
                                                   
           
 
 (R)-2-phenyl-1-(o-tolyl)ethan-1-ol (2.72) The reaction was performed 
according to the general procedure (Method B) with 5,5-dimethyl-2-(o-
tolyl)-1,3,2-dioxaborinane (2.87). (61.20 mg, 0.30 mmol, 1.00 equiv.), vinyl lithium (0.176 
mL, 1.72 M in Et2O, 0.30 mmol, 1.00 equiv.), phenyltrifluoromethanesulfonate (74.60 mg, 
0.33 mmol, 1.10 equiv.), palladium (II) acetate (1.30 mg, 0.0060 mmol, 0.010 equiv.), (Sp, 
Sp)-2.37 (7.60 mg, 0.0072 mmol, 0.012 equiv.) in THF (1.20 mL, 0.25 M).  The crude 
mixture was purified by silica gel chromatography (2% ethyl acetate in pentane, stain in 
CAM) to afford a white solid (57.6 mg, 90% yield). 1H NMR (600 MHz, CDCl3) δ 7.60 
(1H, d, J = 7.8 Hz), 7.36 (2H, t, J = 6.6 Hz), 7.33-7.24 (5H, m), 7.18 (1H, d, J= 7.2 Hz), 
5.17 (1H, ddd, J = 5.4, 3.6, 1.8 Hz), 3.06 (1H, dd, J = 14.4, 4.8 Hz), 2.97 (1H, dd, J = 13.8, 
9.0 Hz), 2.33 (3H, s), 1.96 (1H, br s). 13C NMR (150 MHz, CDCl3) δ 142.17, 138.49, 
Ph
OH
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134.49, 130.41, 129.58, 128.66, 127.43, 126.74, 126.48, 125.37, 71.85, 45.15, 19.12. IR 
(neat) νmax 3384.9 (br), 3061.3 (w), 2920.4 (w), 2859.95 (w), 1603.1 (w), 1494.1 (m), 
1454.0 (m), 1076.0 (m), 1038.8 (m), 755.1 (s). 738.2 (m), 698.4 (s) cm-1. HRMS (DART) 
for C15H15 [M+H-H2O]+  calculated: 195.1174, found: 195.1181. [α]20D: +30.812 (c = 
1.760, CHCl3, l =50 mm). 
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst. Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis  
(R)-2-phenyl-1-(o-tolyl)ethan-1-ol. 
Racemic Material        Standard Conditions 
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 (R)-1-(3,5-dimethylphenyl)-2-phenylethan-1-ol (2.73) The 
reaction was performed according to the general procedure (Method 
B) with 2-(3,5-dimethylphenyl)-5,5-dimethyl-1,3,2-dioxaborinane 
(65.4 mg, 0.30 mmol) (2.89), vinylllithium (0.211 mL, 1.42M in diethyl ether, 0.30 mmol), 
phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol), palladium (II) acetate (1.34 mg, 
0.006 mmol), (Sp, Sp)-2.37 (7.60 mg, 0.0072 mmol) in THF (1.2 mL, 0.25 M). The crude 
mixture was purified by silica gel chromatography (40% CH2Cl2 in hexanes) to afford a 
clear oil. (45.4 mg, 67% yield).  1H NMR  (600 MHz, CDCl3) δ 7.34 (2H, t, J = 7.2 Hz), 
7.25-7.28 (3H, m,), 7.02 (2H, s), 6.96 (1H, s), 4.84 (1H, dd, J = 9.0, 4.2 Hz,), 3.05 (1H, dd, 
J = 14.4, 4.8 Hz,), 2.98 (1H, dd, J = 14.4, 9.6 Hz,), 2.36 (6H, s), 1.98 (1H, s).  13C NMR  
(150 MHz, CDCl3) δ 144.0, 138.5, 138.1, 129.6, 129.3, 128.6, 126.7, 123.8, 75.5, 46.2, 
21.4.  IR (neat) νmax 3404 (br), 3060 (w), 3026 (w), 2941 (m), 2859 (w), 2361 (w), 1603 
(m), 1453 (m), 1180 (w), 1051 (m), 849 (s), 748 (m), 698 (s), 507 (m) cm-1;  HRMS-
(DART): for C16H17 [M+H-H2O]+: calculate: 209.1330, found: 209.1320.  [α]20D = +10.24 
(c = 2.835, CHCl3, l = 50 mm). 
Analysis of Stereochemistry 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1’-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst.  Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40).  
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35°C, 210-270 nm) – analysis 
of (R)-1-(3,5-dimethylphenyl)-2-phenylethan-1-ol. 
Ph
OH
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Racemic Material  Standard Conditions  
                
        
 
 (R)-1-(2,6-dimethylphenyl)-2-phenylethan-1-ol (2.74) The reaction 
was  performed according to the general procedure (Method B) with 2-
(2,6-dimethylphenyl)-5,5-dimethyl-1,3,2-dioxaborinane (2.88) (65.4 mg, 
0.30 mmol, 1.00 equiv.), vinyl lithium (0.210 mL, 1.42 M in Et2O, 0.30 mmol, 1.00 equiv.), 
phenyltrifluoromethanesulfonate (74.60 mg, 0.33 mmol, 1.10 equiv.), palladium (II) 
acetate (1.30 mg, 0.0060 mmol, 0.020 equiv.), (Sp, Sp)-2.37 (7.60 mg, 0.0072 mmol,0.024 
equiv.) in THF (1.20 mL, 0.25 M).  The crude mixture was purified by silica gel 
chromatography (40% CH2Cl2 in pentane, stain in CAM) to afford a white solid (50.50 mg, 
74% yield). 1H NMR (600 MHz, CDCl3) δ 7.31 (2H, t, J = 6.6 Hz), 7.26-7.20 (3H, m), 
7.17 (1H, t, J = 7.2 Hz), 7.00 (2H, d, J = 7.8 Hz), 5.32 (1H, ddd, J = 7.8 4.8, 1.8 Hz). 3.22 
(1H, dd, J = 13.8, 9.0 Hz), 3.01 (1H, dd, J = 13.8, 5.4 Hz), 2.43 (6H, s), 1.83 (1H, d, J = 
2.4 Hz). 13C NMR (150 MHz, CDCl3) δ 138.90, 138.80, 136.24, 129.55, 129.52, 128.65, 
Ph
OH
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127.30, 126.66, 72.00, 42.33, 20.96. IR (neat) νmax 3549.2 (br), 3429.9 (br), 3062.1 (w), 
3025.8 (w), 2925.0 (w), 2864.5 (w), 1601.8 (w), 1495.1 (m), 1468.0 (m), 1453.1 (w), 
1045.3 (m) 769.9 (s), 752.6 (s), 700.0 (s) cm-1. HRMS (DART) for C16H17 [M+H-H2O]+  
calculated: 209.1330, found: 209.1323. [α]20D: -6.573 (c = 1.660, CHCl3, l =50 mm).  
Analysis of Stereochemistry: 
Racemic compound was prepared according to the general procedure (Method B) with 
Pd(OAc)2 (5 mol%) and 1,1′-Bis(dicyclohexylphosphino)ferrocene (6 mol%) as the 
catalyst. Absolute stereochemistry was assigned by analogy (see products 2.41, 2.24, and 
2.40). 
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis  
(R)-1-(2,6-dimethylphenyl)-2-phenylethan-1-ol. 
Racemic Material                  Standard Conditions 
                                              
                                   
 
 2.5.4 Compound Spectra 
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CHAPTER 3 
Development of a Platinum-Catalyzed Hydrosilylation of Alkenyl 
Boronates for the Synthesis of Nonracemic Geminal Silylboronates 
 
 
 
3.1 Introduction  
 
 The hydrosilylation of olefins and alkynes has become a widely developed and 
utilized reaction in organic chemistry.  The increase in hydrosilylation methods 
development is because the hydrosilylation of carbon-carbon multiple bonds is considered 
as one of the most efficient methods to synthesize organosilicon compounds.1 The 
increased utility has become apparent in organic chemistry methodology development2, 
but also extensively employed in the industrial setting.  Consequently, olefin 
hydrosilylation is considered the most important reaction in the silicone industry.1 The 
hydrosilylation of olefins has been developed for the synthesis of valuable structures such 
as silicone polymers, oils, and resins in addition to organofunctional silanes and siloxanes.1 
                                                
1 Stein, J.; Gao, Y.; Colborn, R. E.; Hutchins, G.; Lewis, L. N. Platinum Metals Rev. 1997, 41, 66-75 b) 
Stohrer, J. Troegel, D. Coord. Chem. Rev. 2011, 255, 1440-1459	
2 a) Nakajima, Y.; Shimada, S. RSC Adv. 2015, 5, 20603-20616 b) Marciniec, B. Comprehensive Handbook 
on Hydrosilylation, 1st Edition 1992, Pergamon: Oxford, UK., ISBN 9780080402727 
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The industrial synthesis of organosilanes generally focuses on the synthesis of linear, 
achiral silanes. The hydrosilylation of olefins for the synthesis of branched, nonracemic 
organosilanes might have high impact ramifications for the organosilane industry.  Access 
to nonracemic, branched organosilanes might allow for the synthesis of organosilane 
polymers and resins with different chemical and physical properties.  
 The development of methods for the synthesis of branched, nonracemic 
organosilanes can also be useful for the synthesis of pharmaceutically relevant molecules.  
Organosilanes have the ability to undergo a wide-array of transformations, a few examples 
being the Hiyama cross-coupling3 and the Tamao-Fleming oxidation.4  Nonracemic, allylic 
organosilanes are extremely useful reagents for stereospecific transformations to generate 
more complex stereomotifs.  Examples include stereospecific cross-couplings, allylation 
reactions of carbonyl compounds, and annulation reactions.5  
 To access organosilanes, metal-catalyzed enantioselective hydrosilylations of a-
olefins and styrenes have received much attention with new methods continuously being 
developed.  The hydrosilylation of more functionalized olefins would allow for the 
synthesis of new classes of nonracemic organosilane products.  This chapter will discuss 
the development of an enantioselective platinum-catalyzed hydrosilylation of alkenyl 
boronates to synthesize nonracemic geminal silylboronates.   
 
 
 
                                                
3 Nakao, Y.; Hiyama, T. Chem. Soc. Rev. 2011, 40, 4893-4901 
4 a) Ishida, N.; Tanaka, T. Kumada, M.; Tamao, K. Organometallics 1983, 2, 1694-1696 b) Henning, R.; 
Plaut, H.; Flemming, I. J. Chem. Soc., Chem. Commun. 1984, 29-31 
5 Masse, C. E.; Panek, J. S. Chem. Rev. 1995, 95, 1293-1316 
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3.2 Background  
 3.2.1 Asymmetric Metal-Catalyzed Hydrosilylations of Olefins   
 
 As previously mentioned, the hydrosilylation of olefins has received much attention 
within the realm of synthetic organic chemistry methodology development.2 However, 
much of the focus recently has been on the development of new, earth-abundant catalysts 
for the synthesis of linear, achiral organosilanes.6  The focus on earth-abundant catalysts is 
because almost all industrial olefin hydrosilylations use platinum-based catalysts.1  The 
need for earth-abundant catalysts arises because the silicone industry accounts for most of 
the worlds platinum consumption.1  In spite of the industrial use of platinum catalysts, very 
few methodologies for enantioselective, platinum-catalyzed olefin hydrosilylation exist. 
Pioneering work done by Kumada and coworkers in 1971 describe the first enantioselective 
platinum-catalyzed hydrosilylation of olefins.7  Employing a platinum-complex with chiral 
phosphine ligand 3.2, a-methylstyrene underwent a hydrosilylation with 
chlorodimethylsilane to synthesize nonracemic chlorosilane 3.3 (Scheme 3.1, eq. 1).  
Under these conditions the reaction proceeded with low enantioselectivity.  In addition to 
a-methylstyrene, 2-methylbut-1-ene (3.4) underwent the hydrosilylation to furnish 
chlorosilane 3.5 with very low enantioselectivity (Scheme 3.1, eq. 2).    
 
 
 
                                                
6 Du, X.; Huang, Z. ACS Catal. 2017, 7, 1227-1243 
7 Yamamoto, K.; Hayashi, T.; Kumada, M. J. Am. Chem. Soc. 1971, 93, 5301-5302 
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Scheme 3.1 First Platinum-Catalyzed Hydrosilylation of Olefins  
 
 Regardless of enantioselectivity, Kumada’s report represented the first 
enantioselective hydrosilylation of olefins employing platinum catalysis.  Kumada and 
coworkers further investigated the reaction by using different chiral phosphine ligands, 
however, the reactions still suffered from low enantioselectivity.8  To this date, the reaction 
by Kumada and coworkers still remains the only example of an enantioselective platinum-
catalyzed olefin hydrosilylation.   
It is worth noting that as an enantioselective platinum-catalyzed hydrosilylation, 
Kumada and workers also extended the catalyst system for the hydrosilylation of ketones.9  
Employing aryl ketone 3.6 and the same catalytic conditions as the olefin hydrosilylation 
resulted in nonracemic benzylic alcohol 3.7 (Scheme 3.2).  In this case, the product was 
furnished with slightly higher enantioselectivity than the olefin hydrosilylation.  
Scheme 3.2 Platinum-Catalyzed Enantioselective Hydrosilylation of Ketones 
  
                                                
8 Yamamoto, K.; Hayashi, T.; Zembayashi, M.; Kumada, M. J. Organomet. Chem. 1976, 118, 161-181 
9 a) Yamamoto, K.; Hayashi, T.; Kumada, M. J. Organomet. Chem. 1972, 46, C65−C67 b) Yamamoto, K.; 
Hayashi, T.; Kumada, M. J. Organomet. Chem. 1976, 112, 253-262 
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 The development of catalytic, enantioselective methods for olefin hydrosilylation 
did not see immediate success after the seminal report by Kumada and coworkers.  It was 
not until 1991 when Hayashi and coworkers developed a new catalytic system for the 
enantioselective hydrosilylation of olefins.10  Applying a newly developed chiral 
monodentate ligand, (S)-MeO-MOP, to palladium catalysis realized a branched-selective, 
enantioselective hydrosilylation of a-olefins (Scheme 3.3).  Upon formation of the 
nonracemic trichlorosilane, ethanolysis and oxidation generated nonracemic alcohols and 
allowed for the determination of the enantiomer ratio.   
Scheme 3.3 Palladium-Catalyzed Enantioselective Hydrosilylation of Olefins  
 
 While this example represented the first example of an enantioselective palladium-
catalyzed hydrosilylation of a-olefins, the substrate scope was relatively limited.  
However, this prcoess signifies an important advancement in enantioselective palladium 
catalysis.  As depicted in Table 3.1, various n-alkyl substituted olefins (3.8, 3.9, 3.10) 
reacted with good chemoselectivities and excellent enantioselectivity.  Varying the 
substitution to phenethyl (3.11) maintained high enantioselectivity with slightly diminished 
chemoselectivity.  More sterically encumbered vinylcyclohexane (3.12) resulted in 
significantly diminished chemoselectivity with excellent enantioselectivity.  Following this 
highly impactful development, a large number of new palladium-based catalysts have been 
                                                
10 Uozumi, Y.; Hayashi, T. J. Am. Chem. Soc. 1991, 113, 9887-9888 
R
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developed for the enantioselective hydrosilylation of olefins.11  In addition to palladium, 
numerous methods employing rhodium catalysis have also been developed.12 
Table 3.1 Substrate Scope for the First Palladium-Catalyzed Enantioselective 
Hydrosilylation of Olefins  
 
New methods are still being developed for enantioselective hydrosilylations of 
carbon-carbon multiple bonds.  Although not an olefin hydrosilylation, it is worth noting 
that Tomooka and coworkers demonstrated a platinum-catalyzed enantioselective 
hydrosilylation of alkynes.13  Employing a platinum-phosphonite catalyst, an 
enantioselective-at-silicon hydrosilylation of symmetrical alkynes was realized (Scheme 
3.4).  While only a few examples provided good enantioselectivity, this methodology still 
encompasses one of the few enantioselective, platinum-catalyzed hydrosilylations. 
 
 
 
                                                
11 a) Illa, H.; Bell, H. P.; Tietze, L. F. Chem. Rev. 2004, 104, 3453-3516 b) Rudd, M.; Gibson, S. E. Adv. 
Synth. Catal. 2007, 349, 781-791 
12 Naito, T.; Yoneda, T.; Ito, J. – I.; Nishiyama, H. Synlett 2012, 23, 2957-2960 and references within 
13 Igawa, K.; Yoshihiro, D.; Ichikawa, N.; Kokan, N.; Tomooka, K. Angew. Chem. Int. Ed. 2012, 51, 
12745-12748 
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Scheme 3.4 Platinum-Catalyzed Hydrosilylation of Alkynes  
 
 As mentioned above, much effort in the area of hydrosilylation chemistry has 
focused on the use of earth-abundant catalysts for the synthesis of linear, achiral 
organosilanes.  This focus is also applicable for enantioselective hydrosilylations to 
synthesize branched, nonracemic organosilanes.  Lu and coworkers recently reported a 
highly efficient iron-catalyzed enantioselective hydrosilylation of 1,1-disubstituted alkenes 
with excellent efficiency and enantioselectivity (Scheme 3.5, eq. 1).14  The scope of the 
reaction was shown to be quite broad, producing high enantioselectivity when one of the 
R groups was an aromatic group.  When both R groups were alkyl, the enantioselectivity 
was diminished.  This method represents a powerful addition to enantioselective 
hydrosilylations and a significant expansion of the first report by Kumada for the platinum-
catalyzed hydrosilylation of 1,1-disubstituted olefins.  More recently, Buchwald and 
coworkers reported a copper-catalyzed enantioselective hydrosilylation of styrenes and 
heteroaromatic styrenes with excellent enantioselectivity (Scheme 3.5, eq. 2).15  This 
method employs a readily available commercial catalyst and represents the first 
enantioselective hydrosilylation with copper catalysis.  The newly developed copper 
system is a significant addition to the field of asymmetric hydrosilylations and an 
                                                
14 Chen, J.; Cheng, B.; Cao, M.; Lu, Z. Angew. Chem. Int. Ed. 2015, 54, 4661-4664 
15 Gribble Jr., M. W.; Pirnot, M. T.; Bandar, J. S.; Liu, R. Y.; Buchwald, S. L. J. Am. Chem. Soc. 2017, 
139, 2191-2195 
R1
R1
+
R2
Si
R3
H
H
Pt(dba)3 (1%)
Ligand 3.13 or 3.14 (2%)
toluene, r.t.
R1
R1
Si
R2
R1 H
3.13: Ar = 4-(MeO)phenyl
3.14: Ar = 3,5-di(CF3)phenyl
O
P
OO
O
Ar Ar
Ar Ar
Me
Me
Ph
up to 93:7 er
 293 
alternative to palladium catalysis.  Lastly, Lu and coworkers expanded upon the iron-
complex system by using a similar ligand scaffold with cobalt as the metal.  The newly 
developed catalyst allowed for the enantioselective hydrosilylation of a-olefins (Scheme 
3.5, eq. 3).16 The reaction produced excellent enantioselectivity with styrenes, and 
maintained good enantioselectivity even with aliphatic a-olefins.  The examples by Lu, in 
addition to the previously mentioned catalyst systems, represent impactful earth-abundant 
metal-catalyzed enantioselective hydrosilylations.   
Scheme 3.5 Recent Earth-Abundant Metal-Catalyzed Enantioselective Olefin 
Hydrosilylations  
 
                                                
16 Cheng, B.; Lu, P.; Zhang, H.; Cheng, X.; Lu, Z. J. Am. Chem. Soc. 2017, 139, 9439-9442 
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The enantioselective hydrosilylation of simple olefins has extensively been 
developed with a wide variety of metal catalysts.  However, the metal-catalyzed 
enantioselective hydrosilylation of functionalized olefins remains underdeveloped.  The 
enantioselective hydrosilylation of more functionalized olefins could represent a 
significant advance in the field of hydrosilylations.  The chiral product is an organosilane, 
that is a useful functional group handle for further manipulation.   One example that could 
be considered to fall under this category is the metal-catalyzed enantioselective conjugate 
reduction of a,b-unsaturated esters.  Recently, Nishiyama and coworkers reported the 
rhodium-catalyzed enantioselective conjugate reduction of  a,b-unsaturated esters with 
organosilanes (Scheme 3.6, eq. 1).17  Nishiyama’s report represents an enantioselective 
hydrosilylation of functionalized olefins to synthesize tertiary stereocenters.  However, 
during the mechanism, tautomerization to the more stable oxygen-bound rhodium enolate 
occurs.  After subsequent hydrolysis, the organosilane moiety is removed from the reaction 
product.  The development of an enantioselective hydrosilylation of functionalized olefins 
where a nonracemic organosilane is retained in the reaction product might represent an 
impactful methodology (Scheme 3.6, eq. 2). An enantioselective hydrosilylation of alkenyl 
trifluoromethane substrates might incorporate a pharmaceutically-relevant trifluoromethyl 
bioisostere and maintain a silicon-containing carbon stereocenter. Enantioselective alkenyl 
chloride hydrosilylations might furnish nonracemic a-chlorosilanes for further 
manipulation of both functional groups. The potential to incorporate an organoboronate 
moiety into an enantioselective hydrosilylation might also be immensely advantageous.  
                                                
17 Itoh, K.; Tsuruta, A.; Ito, J. – I.; Yamamoto, Y.; Nishiyama, H. J. Org. Chem. 2012, 77, 10914-10919 
and references within 
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The ability to functionalize the organoboronate and organosilicon groups in a divergent 
manner might represent a streamlined route to synthesize functionalized stereocenters.  
Scheme 3.6 Enantioselective Hydrosilylation of Functionalized Olefins 
 
   
 
3.2.2 Synthesis and Utility of Geminal Bis(Metallate) Reagents  
  
 The development of an enantioselective hydrosilylation of alkenyl boronates might 
represent an impactful synthesis of nonracemic geminal silylboronates.  The product of the 
reaction would fall into a class of compounds called geminal bis(metallate) reagents.  The 
enantioselective synthesis of these types of reagents has received much attention recently, 
and the utility of these reagents in the preparation of complex stereomotifs explored. 
 The synthesis of racemic geminal bis(metallate) reagents involving zinc, chromium 
and copper has been extensively studied over the past twenty to thirty years.18  However, a 
significant contribution would be the catalytic synthesis of chemically and 
configurationally stable nonracemic geminal bis(metallate) reagents.  To explore this 
                                                
18 Marek, I.; Normant, J. – F. Chem. Rev. 1996, 96, 3241−3268 
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reagent class, the synthesis of symmetrical, achiral geminal bis(boronates) was studied with 
numerous methods developed.19  It was not until 2011 when Hall and coworkers developed 
a synthesis of unsymmetrical, nonracemic geminal bis(boronates).20 A copper-Walphos 
catalyst promoted the enantioselective conjugate-borylation of boryl-substituted a,b-
unsaturated ester 3.18.  The copper-catalyst system afforded nonracemic geminal 
bis(boronate) 3.20 with good yield and excellent enantioselectivity.   
Scheme 3.7 First Report for the Catalytic Synthesis of Nonracemic Geminal 
Bis(Boronates) 
 
The method by Hall and coworkers represents the first enantioselective synthesis of 
nonracemic geminal bis(boronates) and the functionalization of these products was 
effectively demonstrated.  As depicted in Table 3.2, conversion of 3.20 into the 
trifluoroborate salt allowed for a palladium-catalyzed cross-coupling with aryl and alkenyl 
bromide electrophiles.  Conversion of the pinacol boronic ester into the trifluoroborate salt 
was essential as pinacol boronic ester 3.20 underwent the cross-coupling with complete 
loss of stereoselectivity.  The cross-coupling tolerated sterically encumbered aryl 
electrophiles (3.22), electronically differentiated aryl electrophiles (3.23, 3.24), and 
heterocyclic electrophiles (3.25) with good yields and excellent enantiospecificities.  
                                                
19 a) Shimizu, M.; Hiyama, T. Proc. Jpn. Acad., Ser. B 2008, 84, 75-85  b) Nallagona, R.; Padala, K.; 
Masarwa, A. Org. Biomol. Chem. 2018, 16, 1050-1064 c) Miralles, N.; Maza, R. J.: Fernandez, E. Adv. 
Synth. Catal. 2018, Early View. DOI: 10.1002/adsc.201701390	
20 Lee, J. C. H.; McDonald, R.; Hall, D. G. Nat. Chem. 2011, 3, 894-899 
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Alkenyl bromides of a variety of substitution patterns (3.26, 3.27) produced similar results.  
It is worth noting that a-bromostyrene (3.28) resulted in a less-efficient and enantiospecific 
cross-coupling. 
Table 3.2 Stereoinvertive Cross-Coupling of Nonracemic Geminal Bis(Boronates) 
with Aryl and Alkenyl Halides 
 
The synthetic utility was further demonstrated by conversion of product 3.26 into the 
pinacol boronic ester which allowed for an allylation of benzaldehyde with excellent 
enantiospecificity (not pictured).  Mechanistically intriguing, the stereochemical outcome 
of the cross-coupling was determined to result in a stereoinvertive cross-coupling.  Hall 
and coworkers rationalized this outcome based on precedent by Suginome and Molander 
for the cross-coupling of b-boryl carbonyl compounds.21  The neighboring carbonyl is 
proposed to bind to a potential boronic acid intermediate, which facilitates a stereoinvertive 
transmetallation (Scheme 3.8).  The seminal report by Hall and coworkers represents a 
                                                
21 a) Awano. T.; Ohmura, T.; Suginome, M. J. Am. Chem. Soc. 2010, 132, 13191-13193 b) Sandrock, D. L.; 
Jean-Gerard, L.; Chen, C. – Y.; Dreher, S. D.; Molander, G. A. J. Am. Chem. Soc. 2010, 132, 17108-17110 
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highly impactful addition to the synthesis of stable, isolable nonracemic geminal 
bis(metallates).  
Scheme 3.8 Proposal for a Stereoinvertive Transmetallation  
 
In 2013, Yun and coworkers reported an alternative strategy for the synthesis of 
nonracemic geminal bis(boronates).22  The approach employed similar conditions to the 
previously developed enantioselective hydroboration of b-substituted styrenes.23  
Switching to alkenyl diaminonaphthalene boronates (Bdan) realized the enantioselective 
hydroboration for the synthesis of nonracemic geminal bis(boronates) (Scheme 3.9).  The 
reaction proceeded with complete regiocontrol producing excellent yields and 
enantioselectivity.  Conducting the reaction with either styrenyl or alkyl substituted alkenyl 
boronates provide products with high enantioselectivity.   
Scheme 3.9 Copper-Catalyzed Hydroboration of Alkenyl Diaminonaphthalene 
Boronates  
 
                                                
22 Feng, X.; Jeon, H.; Yun, J. Angew. Chem. Int. Ed. 2013, 52, 3989-3992 
23 Noh, D.; Yoon, S. K.; Won, J.; Lee, J. Y.; Yun, J. Chem. Asian. J. 2011, 6, 1967-1969 
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 With regards to the synthetic utility of these products, Yun and coworkers carried 
out the selective homologation of geminal bis(boronate) 3.31 with lithiated propargyl 
chloride 3.32.  Stereoretentive 1,2-migration onto the alkyne and elimination of the 
chloride afforded the allenyl bis(boronate) 3.33. (Scheme 3.10, eq. 1).  Product 3.33 
represents a versatile vicinal bis(boronate) with electronically differentiated 
organoboronates for further functionalization.  In addition to homologation, conversion of 
the pinacol boronic ester into the trifluoroborate salt 3.34 allowed for a palladium-catalyzed 
cross-coupling with iodobenzene.  Using similar conditions to the cross-coupling reported 
by Hall and coworkers produced benzylic organoboronate 3.35 in low yield.  The reaction 
also suffered from a small erosion of stereochemistry, but unlike Hall’s occurred by a 
stereoretentive transmetallation.  The observed stereochemical outcome highlights and 
reinforces the proposal by Hall and coworkers that the carbonyl coordination is essential 
for a stereoinvertive transmetallation (Scheme 3.8).  The carbonyl coordination might also 
assist in increasing the reactivity of the cross-coupling.  
Scheme 3.10 Functionalization of Nonracemic Geminal Bis(Boronates)  
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 While unsymmetrical, nonracemic geminal bis(boronates) have been shown to be 
useful towards further functionalization, to this date, the work done by Hall and Yun are 
the only reported methods for the synthesis of these reagents.  Further studies on the 
divergent functionalization of the two electronically differentiated organoboronate groups 
could have a profound impact towards the synthesis of complex stereomotifs.  
 An alternative approach to the divergent reactivity of differentiated geminal 
bis(boronates) could be realized by instead using two different metal groups.  For this to 
be feasible, both metal groups would require the capacity to undergo subsequent 
transformations similarly to organoboronates.  Within the realm of configurationally stable 
and isolable geminal bis(metallates), geminal silylboronates could represent an easily 
accessible alternative.  The first synthesis of a nonracemic, isolable geminal silylboronate 
was reported in 1983 by Matteson and coworkers.24  Employing (+)-pinane-diol derived 
organoboronate 3.36 and chlorosilyllithium 3.37, the homologation occured with a 73:27 
diastereomer ratio (Scheme 3.11).  Analysis of the reaction stereoselectivity was carried 
out by oxidation to the nonracemic silyl alcohol 3.39 and comparison to a known 
compound.  It is worth noting that Soderquist and coworkers reported the asymmetric 
hydroboration of alkenylsilanes with (+)-diisopinocampheylborane with similar 
diastereoselectivities.  However, the product had to be oxidized to the corresponding silyl 
alcohol to be isolated.25 
 
                                                
24 Tsai, D. J. S.; Matteson, D. S. Organometallics 1983, 2, 236-241 
25 Lee, S. – J. H.; Soderquist, J. A. Tetrahedron 1988, 44, 4033-4042 
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Scheme 3.11 First Reported Synthesis of Nonracemic Geminal Silylboronates 
 
 A general method for the synthesis of nonracemic, isolable geminal silylboronates 
was elusive until work done by Aggarwal and coworkers in 2011.26  Although 
stoichiometric (-)-sparteine is required to induce selectivity, the silylboration of lithiated 
carbamates was capable of synthesizing nonracemic geminal silylboronates with excellent 
enantioselectivity (Scheme 3.12).   
Scheme 3.12 Synthesis of Nonracemic Geminal Silylboronates by an Enantioselective 
Lithiation of Carbamates  
 
 The synthetic utility was demonstrated through Zweifel olefinations with a variety 
of stereochemically-defined organolithium reagents.  These reactions produced highly 
valuable nonracemic allylic silanes of differing alkene substitution patterns (Scheme 3.13).  
 
                                                
26 Binanzer, M.; de Ceglie, M. C.; Gallanti, M.; Glasspoole, B. W.; Kendrick, S. J. F.; Sonawane, R. P.; 
Vazquez-Romero, A.; Webster, M. P.; Aggarwal, V. K. Org. Lett. 2011, 13, 1490-1493 
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Scheme 3.13 Zweifel Olefinations of Geminal Silylboronates  
 
 More recently, Aggarwal and coworkers expanded upon on the first report with 
subsequent lithiation-borylation reactions of nonracemic geminal silylboronates for the 
synthesis of stereotriads and stereopentads.27  Carbamate 3.46 was readily prepared from 
commercially available Roche ester.  Next, enantioselective lithiation and silylboration 
furnished 3.47 with two contiguous stereocenters (Scheme 3.14).  Further homologation of 
3.47 with either enantiomer of lithiated carbamate produced stereotriad 3.48.  The 
organoboronate and organosilane groups might be perceived as masked hydroxyl groups, 
and all eight stereoisomers of stereotriad 3.48 were synthesized impressively with excellent 
diastereoselectivity.  Merging 3.48 with reagent 3.49 generated a stereopentad motif, and 
subsequent oxidations arrived at tetrol 3.50 with excellent diastereoselectivity.   
 
 
 
                                                
27 Millan, A.; Grigol Martinez, P. D.; Aggarwal, V. K. Chem. Eur. J. 2017, 24, 730-735 
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Scheme 3.14 Lithiation-Borylation Strategy for the Synthesis of Nonracemic 
Silylboronates and Stereopentads 
 
 Alternative organoboronate functionalizations might be applied for the 
incorporation of heteroatoms, alkenes or carbon groups into the synthesized stereomotifs.28  
The method developed by Aggarwal and coworkers represents an efficient, although non-
catalytic, synthesis of nonracemic geminal silylboronates.  The synthetic utility was 
elegantly demonstrated through the synthesis of complex stereomotifs.  
 Based on the work done by Aggarwal, Blakemore and coworkers recently 
developed a different system for the enantioselective synthesis of geminal silylboronates.29  
When employing organoboronate 3.51, BOX-ligand 3.53 promoted the silylboration of 
lithiated benzoates.  However, this reaction only afforded product 3.40 in moderate 
enantioselectivity (Scheme 3.15). 
 
                                                
28 Sandford, C.; Aggarwal, V. K. Chem. Commun. 2017, 53, 5481-5494 
29 Barsamian, A. L.; Wu, Z.; Blakemore, P. R. Org. Biomol. Chem. 2015, 13, 3781-3786. 
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Scheme 3.15 BOX-Ligand Enabled Enantioselective Lithiation and Synthesis of 
Nonracemic Geminal Silylboronates  
 
 Lastly, within the area of enantioselective lithiation, Aggarwal and coworkers more 
recently developed a new alternative to using (-)-sparteine.30  Employing a proline-derived 
directing group embedded in chloromethylsilyl precursor 3.54, affected an enantioselective 
lithiation to produce diastereomeric lithium complex 3.55 (Scheme 3.16).  Treatment of 
this complex with an external organoboronate produces activated complex 3.56.  
Subsequent 1,2-migration furnished the desired nonracemic geminal silylboronate with 
excellent diastereoselectivity.  The newly developed method represents a powerful addition 
to enantioselective lithiation by employing a readily available directing group from an 
inexpensive chiral pool. This approach also avoids using increasingly scarce sparteine as 
the chiral auxiliary.31    
Scheme 3.16 Proline-Derived Directing Group for Enantioselective Lithiation  
 
                                                
30 Bootwicha, T.; Feilner, J. M.; Myers, E. L.; Aggarwal, V. K. Nat. Chem. 2017, 9, 896-902 
31 Ritter, S. K. C&EN 2017, 95, 18-20 
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Another appealing feature to this method is the ease with which the directing group 
can be removed under mild photoredox conditions.  Removal of the directing group 
afforded the stable and diversifiable methoxy silane group as displayed in 3.58 (Scheme 
3.17, eq. 1).  The synthetic utility was expanded through iterative silylborations and 
lithiation-borylation procedures to form compounds with contiguous stereocenters 
(Scheme 3.17, eq. 2).  Silylboration of 3.59, followed by directing group removal and 
enantioselective lithiation-borylation provided 3.60 with excellent diastereoselectivity.  
Performing an analogous sequence, followed by a Matteson homologation, provided 
stereotetrad 3.61 with good yield and excellent diastereoselectivity.  A one-pot m-CPBA 
oxidation of the organosilane and organoboronate groups afforded the triol (not pictured).  
The described iterative procedure was conducted to synthesize a variety of compounds of 
differing relative stereochemical configurations.   
Scheme 3.17 Utility of Proline-Derived Directed Enantioselective Lithiation and 
Silylboration 
 
 The work done by Aggarwal and coworkers provides a highly stereoselective 
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synthesize nonracemic geminal silylboronates in a catalytic fashion is highly desirable.  
The development of a catalytic system for the synthesis of nonracemic geminal 
silylboronates was elusive until 2013.  Hoveyda and coworkers developed an elegant 
copper-catalyzed borylation of alkenylsilanes.32 A copper-NHC ligand complex (3.62, 
3.63, or 3.64) successfully promoted the hydroboration of alkenylsilanes with excellent 
enantioselectivity to produce geminal silylboronates (Scheme 3.18, eq. 1).  For the 
observed regioselective outcome, the alkenylsilane required aryl substitution to facilitate 
aryl stabilization of the organocopper intermediate.  The aryl stabilization was shown to 
work synchronously with the ligand scaffold to affect the regiochemical outcome.  With 
alkyl-substituted alkenylsilanes, the regioisomeric outcome observed resulted in the 
synthesis of vicinal silylboronates with excellent enantioselectivity (Scheme 3.18, eq. 2).  
The regiochemical outcome was rationalized through silicon stabilization of the 
organocopper intermediate in addition to ligand effects.  
 
 
 
 
 
                                                
32 Meng, F.; Jang, H.; Hoveyda, A. H. Chem. Eur. J. 2013, 19, 3204-3214 
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Scheme 3.18 First Report of a Catalytic, Enantioselective Synthesis of Nonracemic 
Geminal Silylboronates  
 
 To demonstrate the utility of geminal silylboronates, Hoveyda and coworkers 
carried out the formal synthesis of natural product bruguierol A (Scheme 3.19).  From a 
readily available aryl acetylene, protosilylation provided the requisite alkenylsilane (not 
pictured).   The aforementioned enantioselective copper-catalyzed hydroboration afforded 
nonracemic geminal silylboronate 3.65 in excellent regio- and enantioselectivity.  
Subsequent Zweifel olefination provided allyl silane 3.66, and a linear selective 
hydroformylation-reduction sequence arrived at alcohol 3.67 with good yields.  Oxidation 
of the organosilicon group (3.68) and oxidative lactonization provided nonracemic lactone 
3.69 in good yield.  Methyllithium carbonyl addition and subsequent Lewis-acid mediated 
cyclization afforded tricylic 3.70 in good overall yield.  The last step to the natural product 
3.71 had previously been reported.33 The seminal report by Hoveyda and coworkers for the 
                                                
33 Hu, B; Xing, S.; Ren, J.; Wang, Z. Tetrahedron 2010, 66, 5671-5674 
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catalytic synthesis of nonracemic geminal silylboronates was shown to be efficient and 
impactful for application towards the synthesis of natural products.  
Scheme 3.19 Synthetic Utility of Geminal Silylboronates by the Synthesis of Natural 
Product Bruguierol A 
  
 It is worth noting that Yun and coworkers reported an isolated example of 
nonracemic geminal silylboronate synthesis by the diborylation of silyl-protected aryl 
acetylenes.34  For this method, trimethylsilyl protected phenylacetylene reacted under the 
influence of a copper-DuPhos catalyst to produce nonracemic geminal silylboronate 3.74 
with good enantioselectivity (Scheme 3.20).  However, under these reaction conditions, 
unreacted intermediate 3.75 was also observed.  The report by Yun and coworkers only 
included one enantioselective example and even for the racemic diborylation, the scope 
was limited to aryl acetylenes.    
                                                
34 Jung, H. – Y.; Yun, J. Org. Lett. 2012, 14, 2606-2609 
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Scheme 3.20 Enantioselective Diborylation of Silyl-Protected Aryl Acetylenes  
 
 The copper-catalyzed hydroboration method developed by Hoveyda and coworkers 
was shown to be limited to styrenyl silanes, and the copper-catalyzed diborylation by Yun 
and coworkers limited to aryl acetylenes.  Taking this into account, a general method for 
the catalytic synthesis of nonracemic geminal silylboronates bearing any substitution is 
still desirable.  Recently, Lan, Liu and coworkers reported the copper-NHC complex 
catalyzed diborylation of aldehydes to synthesize a-hydroxy organoboronate intermediates 
(Scheme 3.21, eq. 1).35  Subsequent treatment of the a-hydroxy organoboronate with 
another equivalent of diboron reagent or silylboron reagent promotes a deoxygenative 
borylation/silylation to synthesize geminal bis(boronates) or geminal silylboronates 
respectively.  The method was expanded to include one example of an enantioselective 
diborylation of hydrocinnamaldehyde 3.76 with a copper-DTBM Segphos catalyst 
(Scheme 3.21, eq. 2).  The diborylation synthesized nonracemic a-hydroxy organoboronate 
3.77 with excellent enantioselectivity; subsequent silylation produced nonracemic geminal 
silylboronate 3.40.  While the deoxygenative silylation generated nonracemic geminal 
silylboronate 3.40 with excellent enantioselectivity, the reaction suffered from low 
                                                
35 Wang, L.; Zhang, T.; Sun, W.; He, Z.; Xia, C.; Lan, Y.; Liu, C. J. Am. Chem. Soc. 2017, 139, 5257-5264 
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efficiency.  In addition to low efficiency, it also required the use of 2.5 equivalents of a B-
B and B-Si bonded reagent, the latter being quite expensive.  x 
Scheme 3.21 Synthesis of Nonracemic Geminal Silylboronates via Deoxygenative 
Silylation of a-Hydroxy Organoboronates 
 
The current technology for the synthesis of nonracemic geminal silylboronates has 
been shown to be highly enantioselective, however, limitations still exist.  The 
development of a general catalytic method for the synthesis of geminal silylboronates 
containing a variety of substitutions could represent an impactful contribution towards the 
synthesis and utility of these reagents.  Furthermore, employing inexpensive reagents and 
readily available starting materials is highly desirable.  
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3.2.3 Synthetic Utility of Organosilanes and Geminal 
Silylboronates 
 
Silicon has received much attention in synthetic organic chemistry throughout the 
years.36  The utility of silicon has been demonstrated extensively through its use as 
protecting groups for alcohols and alkynes, in the context of silyl enol ethers for 
Mukaiyama Aldol reactions, as Lewis-acids for carbonyl additions amongst a plethora of 
other applications.  A variety of transformations have been developed transform 
organosilanes into useful functional groups in organic chemistry.  One such example is the 
widely-developed Peterson olefination for the synthesis of stereochemically defined 
alkenes.37 Adapting organosilane transformations to geminal silylboronates could greatly 
expand upon the synthetic utility of these reagents for the synthesis of biologically relevant 
molecules.  In addition to target synthesis, adapting organosilane reactions to geminal 
silylboronates might uncover new modes of reactivity.    
While organosilanes have the ability to undergo 1,2-metallate rearrangements 
similar to organoboronates, silicon suffers from the inability to be as easily activated by 
nucleophiles.  The reluctance towards activation results in lower reactivity in 1,2-
migrations.  Developing new methods to functionalize organosilanes through 1,2-metallate 
rearrangements might represent powerful additions to synthetic organic chemistry and 
immensely expand the utility of organosilane reagents.  Nonetheless, one of the widely 
developed and applied transformations of organosilanes is the Tamao-Fleming oxidation.4 
                                                
36 Barbero, A.; Walter, D.; Fleming, I. Chem. Rev. 1997, 97, 2063-2192.  
37 a) Peterson, D. J.; J. Org. Chem. 1968, 33, 780-784 b) Ager, D. J. Synthesis 1999, 5, 384-398 c) van 
Staden, L. F.; Gravestock, D.; Ager, D. J. Chem. Soc. Rev. 2002, 31, 195-200	
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Tamao and coworkers reported that treating haloorganosilanes with hydrogen peroxide and 
fluoride promotes the stereorententive oxidation of the organosilane (Scheme 3.22).  
Independently, Fleming and coworkers reported a two-pot sequence employing phenyl-
substituted organosilanes.  Fluorination of the phenyl group in situ produces an 
organofluorosilane and subsequent treatment with a peroxide promotes the oxidation of the 
organosilane group. 
Scheme 3.22 Tamao-Fleming Oxidation of Organosilanes  
 
 The two methods complement each other for the oxidation of organosilane groups 
bearing different substituents.  In regards to nonracemic organosilanes, numerous 
applications of the Tamao-Fleming oxidation for the synthesis of nonracemic alcohols have 
been reported.  Alkenylsilane oxidation allows for the use of alkenylsilanes as masked 
ketones.38 In addition to the procedures developed by Tamao and Fleming, numerous 
variants of these reaction conditions have been developed and allow oxidations of 
organosilanes bearing specific functional groups.    
 Another widely developed transformation of organosilanes, and a fundamental 
organometallic reaction, is the Hiyama cross-coupling (Scheme 3.23, eq. 1).39  Addition to 
the organosilane with a sufficient fluoride source will form an activated organosilicate 
complex that engages in transmetallation.  Subsequent reductive elimination furnishes the 
desired cross-coupling product (Scheme 3.23, eq. 1).  The Hiyama cross-coupling has been 
                                                
38 Kumada, M.; Tamao, K. Tet. Lett. 1984, 25, 321-324 
39 a) Yoshida, J.; Tamao, K.; Yamamoto, H.; Kakui, T.; Uchida, T.; Kumada, M. Organometallics 1982, 1, 
542-549 b) Hatanaka, Y.; Hiyama, T. J. Org. Chem. 1988, 53, 918-920 c) Nakao, Y.; Hiyama, T. Chem. 
Soc. Rev. 2011, 40, 4893-4901 
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shown to be versatile by avoiding organometallics such as organomagnesium or 
organolithium reagents, and utilizes readily available organosilane starting materials.  
Denmark and coworkers greatly expanded upon the Hiyama cross-coupling by developing 
a fluoride free cross-coupling of organosilanes (Scheme 3.23, eq. 2).40  Denmark and 
coworkers employed organosilanols whereby treatment with base forms organosilanoates.  
The organosilanoates are then competent to undergo transmetallation under mild 
conditions to promote the desired cross-coupling.   
Scheme 3.23 Transition-Metal Catalyzed Cross-Coupling of Organosilanes: Hiyama-
Denmark Cross-Coupling  
 
 The development of organosilanoate cross-couplings has immensely increased the 
utility of cross-coupling reactions with organosilanes, most notably for the pharmaceutical 
industry to avoid the use of fluoride.  Denmark and coworkers showcased organosilanoates 
for the stereospecific cross-coupling of nonracemic allylic organosilanoates (Scheme 
3.24).41  Employing a palladium-dibenzylideneacetone derived catalyst, promoted a g-
selective syn transmetallation with a variety of aryl electrophiles to generate nonracemic 
tertiary allylic stereocenters.  The observed high regioselectivity was rationalized by a six-
membered transition state depicted in Scheme 3.24.  The allylic cross-coupling by 
                                                
40 Regens, C. S.; Denmark, S. E. Acc. Chem. Res. 2008, 41, 1486-1499 
41 Werner, N. S.; Denmark, S. E.; J. Am. Chem. Soc. 2010, 132, 3612-3620 
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Denmark represents a powerful utilization of nonracemic allylic organosilanes, and adds 
to other widely developed reactions.5 
Scheme 3.24 Stereospecific Cross-Coupling of Nonracemic Allylic Silanoates 
 
In the report by Denmark, the synthesis of nonracemic allylic organosilanoate 3.78 
required nine synthetic steps, including an enzymatic resolution.  Nonracemic geminal 
silylboronates might provide a streamlined route to 3.78 for the elegant allylic cross-
coupling developed by Denmark, amongst other uses of nonracemic allylic organosilanes.  
From nonracemic geminal silylboronate 3.80, using the conditions developed by Aggarwal 
for the Zweifel olefination might produce nonracemic allylic organosilane 3.81 with the 
indicated olefin geometry (Scheme 3.25).  Subsequent removal of the phenyl group from 
silicon and hydrolysis might provide the nonracemic allylic organosilanol 3.82.  If a one-
step, catalytic route to 3.80 could be developed, the cross-coupling precursor 3.82 would 
be produced in a streamlined four synthetic steps without the need of an enzymatic 
resolution. 
Scheme 3.25 Proposed Streamlined Synthesis of Nonracemic Allylic Silanol 
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 In addition to synthetic organic chemistry, organosilanes have been incorporated 
into drug targets in the pharmaceutical industry.   Silicon has been widely used as a 
bioisostere to carbon due to the similar covalent bonding and geometry.  The similar 
bonding and geometry can be exploited to increase the lipophilicity of drugs by 
incorporating silicon instead of carbon.42 In addition to the advantage of increased 
lipophilicity, Skrydstrup and coworkers have done extensive studies on silanediol motifs 
as bioisosteres for the tetrahedral intermediate involved in enzymatic hydrolysis (Scheme 
3.26).43  Hydroxyethylene (3.84), hydrated difluoroketone (3.85), phosphinate (3.86) and 
silanediol motifs (3.87) are commonly explored tetrahedral intermediates in the 
pharmaceutical industry.   Silanediol motifs have received considerable attention, most 
notably in the development of peptide mimics.   
Scheme 3.26 Common Tetrahedral Intermediates as Bioisosteres 
 
 Silanediols as peptide mimics is highlighted by inhibition studies of a HNE 
protease, an important protein for peptide degradation, studied by Skrydstrup and 
                                                
42 a) Mills, J. S.; Showell, G. A. Expert Opin. Invest. Drugs 2004, 13, 1149-1157 b) Reḿond, E.; Martin, 
C.; Martinez, J.; Cavelier, F. Chem. Rev. 2016, 116, 11654-11684 c) Ramesh, R.; Reddy, D. S. J. Med. 
Chem. 2017, ASAP DOI:10.1021/acs.jmedchem.7b00718 
43 a) Nielsen, L.; Skrydstrup, T. J. Am. Chem. Soc. 2008, 130, 13145-13151 b) Hernandez, D.; Lindsay, K. 
B.; Nielsen, L.; Mittag, T.; Bjerglund, K. Friis, S.; Mose, R.; Skrydstrup, T. J. Org. Chem. 2010, 75, 3283-
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coworkers (Scheme 3.27).44  Peptide 3.88 underwent noncompetitive binding of the 
protease with high potency, but suffered from poor selectivity.  The same results were 
observed with the diphenylsilane motif 3.89.  However, switching to the silanediol motif 
3.90 changed the mode of inhibition entirely to uncompetitive binding.   The change in the 
mode of protein inhibition produced excellent selectivity while maintaining similar 
potency.  The study by Skrydstrup reinforces the increasing use of silicon in the 
pharmaceutical industry for the synthesis of carbon bioisosteres, silanediol motifs as well 
a-silyl amino acids. 
Scheme 3.27 Inhibition Studies of HNE Protease by Silanediol Motifs  
 
 The incorporation of nonracemic organosilanes into pharmaceutically relevant 
molecules expands the potential for nonracemic geminal silylboronates to have a profound 
impact not only in synthetic organic chemistry but in drug development.  These nonracemic 
geminal silylboronates have the potential to undergo a wide array of the known 
                                                
44 Min, G. K.; Hernandez, D.; Skrydstrup T. Acc. Chem. Res. 2013, 46, 457-470 
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organoboronate functionalizations28 to then incorporate functionalized silicon-containing 
carbon stereocenters into products (Scheme 3.28).  To highlight a few of many potential 
examples, oxidation might produce the nonracemic silyl alcohols (3.92) and amination 
might afford silyl amines (3.93).  The amination of geminal silylboronates might provide 
a streamlined synthesis of the nonracemic silyl amine derivative that Skrydstrup and 
coworkers employed for the aforementioned studies.  Activation of the geminal 
silylboronate by employing conditions developed by Aggarwal and coworkers and 
nucleophilic addition to Eschenmosher salt might generate nonracemic b-amino 
organosilanes (3.94).  In addition to Eschenmosher salt, nucleophilic addition to 
electrophilic fluorinating reagents could allow access to fluorinated nonracemic 
organosilanes (3.95) combining two widely used bioisosteres.  Nonracemic geminal 
silylboronates have potential reactivity to be widely explored and developed for the 
synthesis of pharmaceutically relevant molecules.  
Scheme 3.28 Synthetic Utility of Nonracemic Geminal Silylboronates 
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3.3 Development of an Enantioselective Hydrosilylation of Alkenyl 
Boronates for the Synthesis of Nonracemic Geminal Silylboronates45 
 
 3.3.1 Reaction Discovery, Optimization, and Scope45  
 
 The development of a new method for the enantioselective hydrosilylation of 
functionalized olefins might represent a significant addition to synthetic organic chemistry.  
More specifically, a regio- and enantioselective hydrosilylation of alkenyl boronates for 
the synthesis of nonracemic geminal silylboronates could be powerful based on the 
aforementioned synthetic utility.  Based on precedent from Morken and coworkers on the 
enantioselective diboration of alkenyl boronates46,  the hydrosilylation of alkenyl boronates 
was explored.  In the diboration report, a platinum-phosphonite catalyst effectively 
promoted the enantioselective diboration47 of alkenyl boronates with 
bis(catecholato)diboron (Scheme 3.29, eq. 1); subsequent boron ester exchange with 
pinacol, afforded nonracemic tris(organoboronates) with excellent enantioselectivity. It 
was hypothesized that by simply replacing the diboron reagent with an organosilane could 
allow for an enantioselective hydrosilylation for the synthesis of nonracemic geminal 
silylboronates (Scheme 3.29, eq. 2).  Realization of this hypothesis, assuming well 
precedented “hydride-first” insertion48, would rely on the formation of a stabilized a-boryl-
                                                
45 Szymaniak, A. A.; Zhang, C.; Coombs, J. R.; Morken, J. P. ACS Catal. 2018, 8, 2897-2901 
46 Coombs, J. R.; Zhang, L.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 16140-16143	
47 Coombs, J. R.; Haeffner, F.; Kliman, L. T.; Morken, J. P. J. Am. Chem. Soc. 2013, 135, 11222-11231 
48 a) Chalk, A. J.; Harrod, J. F. J. Am. Chem. Soc. 1965, 87, 16-21 b) Chalk, A. J.; Harrod, J. F. J. Am. 
Chem. Soc. 1965, 87, 1133-1133 c) Taylor, R. B.; Roy, A. K.  J. Am. Chem. Soc. 2002, 124, 9510-9524 d) 
Taige, M. A.; Ahrens, S.; Strassner, T. J. Organomet. Chem. 2011, 696, 2918-2927 e) Meister, T. K.; 
Riener, K.; Gigler, P.; Stohrer, J.; Herrmann, W. A.; Kuhn, F. E. ACS Catal. 2016, 6, 1274-1284	
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organoplatinum intermediate.  As described in Chapter 1 of this dissertation, the formation 
of a-boryl organometallic species and a-boryl anions benefit from stabilization by the 
adjacent boron group.  For the insertion into an alkenyl organoboronate, this stabilization 
might dictate regioselectivity to form an a-boryl organoplatinum species and afford a 
geminal silylboronate. 
Scheme 3.29 Inspiration for the Development of an Enantioselective Hydrosilylation 
of Alkenyl Boronates   
 
 To probe this hypothesis, the experiments in Scheme 3.30 were conducted 
employing similar conditions to the enantioselective diboration of alkenyl boronates.  With 
dimethylphenylsilane used as the organosilane source, the platinum-catalyzed 
hydrosilylation furnished geminal silylboronate 3.40 with full conversion and complete 
regiocontrol (Scheme 3.30, eq. 1).  The initial hydrosilylation of (E)-alkenyl boronate 3.97 
produced geminal silylboronate 3.40 with modest enantioinduction.  Under the same 
reaction conditions, (Z)-alkenyl boronate 3.98 provided similar reactivity, but with a slight 
boost in enantioselectivity. (Scheme 3.30, eq. 2).  Surprisingly, the two olefin isomers of 
starting material resulted in the same enantiomer of product.  The observed 
stereoconvergence to one enantiomer suggests that the catalyst is not sensitive to the 
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orientation of the pinacol boronate group.  Instead, the catalyst reacts with the same face 
of the olefin with the benzyl substituent aligned similarly for both isomers of substrate.49a 
Scheme 3.30 Initial Discovery of a Platinum-Catalyzed Enantioselective 
Hydrosilylation of Alkenyl Boronates   
 
 Even though the (Z)-alkenyl boronate gave higher enantioselectivity, the synthesis 
of these boronates  starting materials is less developed than for the E isomer.49b There have 
been a plethora of methods developed for the synthesis of (E)-alkenyl boronates  through 
alkyne hydroborations, borylation reactions, a boron-Wittig reaction amongst other 
methods.50  Taking this into account, it was highly desirable to optimize the reaction 
conditions for reaction of the readily prepared (E)-alkenyl boronates  
 The process of optimizing the platinum-catalyzed hydrosilylation of (E)-alkenyl 
boronates began through first investigating general classes of chiral ligands for the reaction 
(Table 3.3).  Employing commonly used chiral monodentate ligand (S)-MonoPhos (3.99) 
                                                
49 a) Park, J. K.; Lackey, H. H.; Ondrusek, B. A.; McQuade, D. T. J. Am. Chem. Soc. 2011, 133, 2410-2413 
b) Obligacion, J. V.; Neely, J. M.; Yazdani, A. N.; Pappas, I. Chirik, P. J. J. Am. Chem. Soc. 2015, 137, 
5855-5858 and references within  
50 For recent reviews: a) Barbeyron, R.; Benedetti, E.; Cossy, J.; Vasseur, J. –J.; Arseniyadis, S.; Smietana, 
M. Tetrahedron 2014, 70, 8431-8452 b) Yoshida, H. ACS Catal. 2016, 6, 1799-1811.  For recent 
publications and references within: a) Ang, N. W. J.; Buettner, C. S.; Docherty, S.; Bismuto, A.; Carney, J. 
R.; Docherty, J. H.; Cowley, M. J.; Thomas, S. P. Synthesis 2018, 50, 803-808 b) Murray, S. A.; Luc, E. C. 
M.; Meek, S. J. Org. Lett. 2018, 20, 469-472 c) Coombs, J. R.; Zhang, L.; Morken, J. P. Org. Lett. 2015, 
17, 1708-1711  
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afforded geminal silylboronate product 3.40 although the reaction was racemic (Table 3.3, 
entry 2).  Monodentate ligand (R)-SiPhos (3.100) resulted in no product formation (Table 
3.3, entry 3).  Hemilabile bidentate ligands were of interest as these types of ligands have 
been employed in palladium-catalyzed olefin hydrosilylations.11 Analyzing the ligand used 
by Hayashi for the palladium-catalyzed hydrosilylation, (R)-OMe-MOP (3.101), resulted 
in trace product formation (Table 3.3, entry 4).  (R)-Quinap (3.102) also resulted in no 
product formation (Table 3.3, entry 5).  Lastly, using hemilabile bidentate ligand PPFA 
(3.103) resulted in substantial product formation, although once again product 3.40 was 
racemic (Table 3.3, entry 6).  With these data, the TADDOL-derived ligand class was 
chosen for further ligand optimization.  
Table 3.3 Initial Investigation into Chiral Ligands for the Platinum-Catalyzed 
Enantioselective Hydrosilylation of Alkenyl Boronates   
 
Entry Ligand Yield 3.40 (%)a e.r.b 
1 3.96 > 95 62:38 
2 3.99 50 50:50 
3 3.100 < 5 n.d. 
4 3.101 < 10 n.d. 
5 3.102 < 5 n.d. 
6 3.103 42 50:50 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratio determined on the oxidized silyl alcohol using chiral SFC analysis.  
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 The first analysis of the TADDOL-derived ligand backbone focused on the aryl 
substituents of the phosphonite ligands.  Decreasing the steric bulk of the TADDOL-
derived phosphonite aryl substituents from 3,5-di(i-propyl)phenyl (3.96) to phenyl (3.104) 
substitution resulted in an increase in enantioselectivity (Table 3.4, entry 1 vs. 2).  Further 
tuning the aryl substituent to a 3,5-xylyl (3.105) group resulted in a further increase in 
enantioselectivity (Table 3.4, entry 3).  With the aryl substitutions of ligands 3.104 and 
3.105, the electronic properties of the phosphorus atom in these ligands was analyzed by 
employing phosphoramidite ligands in the reaction.  Phenyl-substituted pyrrolidine-
derived phosphoramidite (3.106) resulted in a significant increase in enantioselectivity as 
compared to the phosphonite analog (Table 3.4, entry 4 vs. 2).  A similar trend was 
observed with the 3,5-xylyl substituted phosphoramidite (3.107) resulting in higher 
enantioselectivity (Table 3.4, entry 5 vs. 3).  Ligand 3.107 also achieved the highest 
enantioselectivity yet at a 89:11 ratio.  The increased enantioselectivity with 
phosphoramidite ligands might be due to better ability to donate to a platinum (II) oxidative 
addition adduct.  BINOL-derived phosphoramidite ligands have been suggested to be 
slightly weaker donors than tricyclohexylphosphine.51 Having a better donating ligand 
might result in a stronger, shorter Pt-P bond thus creating a more rigid chiral environment. 
The TADDOL-derived phosphoramidite ligand class was then further analyzed by varying 
the substitution on the nitrogen group.  Replacing the pyrrolidine substituent with a 
dimethylamino group phosphoramidite (3.108) resulted in similar efficiency and 
enantioselectivity (Table 3.4, entry 6 vs. 5).  However, extending the steric bulk to 
diethylamino (3.109) resulted in a significant decrease in both reactivity and 
                                                
51 Filipuzzi, S.; Pregosin, P. S.; Albinati, A.; Rizzato, S. Organometallics 2006, 25, 5955-5964 
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enantioselectivity (Table 3.4, entry 7).  Lastly, incorporation of stereogenicity on the 
nitrogen substituent was studied.  Proline-derived ligand 3.110 resulted in similar 
enantioselectivity as the parent pyrrolidine substitution (Table 3.4, entry 8).  The opposite 
relative configuration of the two stereochemical elements was analyzed with ligand 3.111.  
Probing the opposite configuration resulted in a substantial match-mismatch case with the 
other stereocenter on the ligand and resulted in a significantly lower enantioselectivity 
(Table 3.4, entry 9). 
Table 3.4 Investigation of TADDOL-Derived Ligands for the Platinum-Catalyzed 
Enantioselective Hydrosilylation of Alkenyl Boronates   
 
Entry Ligand Yield 3.40 (%)a e.r.b 
1 3.96 > 95 62:38 
2 3.104 > 95 76:24 
3 3.105 > 95 85:15 
4 3.106 70 86:14 
5 3.107 > 95 89:11 
6 3.108 80 88:12 
7 3.109 40 58:42 
8 3.110 60 90:10 
9 3.111 70 30:70 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratio determined on the oxidized silyl alcohol using chiral SFC analysis.  
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Knowing that the TADDOL-derived phosphoramidite ligands were more selective 
than the phosphonite analogs in the platinum-catalyzed hydrosilylation of alkenyl 
boronates, the aryl substituents were further investigated.  Employing -3,5-di(ethyl)phenyl 
substituted phosphoramidite (3.112) showed that subtle increases in the steric component 
from 3,5-xylyl substitution results in a substantial decrease in enantioselectivity (Table 3.5, 
entry 3 vs 2).  It is worth noting that for this ligand investigation, pyrrolidine and 
dimethylamino derived phosphoramidite ligands did not result in statistically significant 
changes in enantioselectivity (see Table 3.4).  The dimethylamino phosphoramidite ligands 
used in this analysis were employed since the ligands were previously synthesized in our 
laboratory.  Further increasing the steric encumbrance of the aryl substituents to 3,5-di(i-
propyl)phenyl (3.113) and 3,5-di(t-butyl)phenyl (3.114) resulted in increasingly 
diminished enantioselectivity  (Table 3.5, entries 4-5).  Relocating the steric bulk to the 
para position of the arene with p-tolyl ligand (3.115) resulted in a similar outcome as with 
the parent phenyl-substituted phosphoramidite (Table 3.5, entry 6 vs. 1).  
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Table 3.5 Investigation of the Aryl Substituents of the TADDOL-Derived 
Phosphoramidite Ligands  
 
Entry Ligand Yield 3.40 (%)a e.r.b 
1 3.106 70 86:14 
2 3.107 > 95 89:11 
3 3.112 > 95 78:22 
4 3.113 > 95 72:28 
5 3.114 > 95 64:36 
6 3.115 90 84:16 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratio determined on the oxidized silyl alcohol using chiral SFC analysis.  
 
 
To achieve higher enantioselectivity from ligand development, further 
manipulation of the steric bulk at the meta positions of the arene, but with similar steric 
parameters as xylyl substitution was necessary.  However, before undertaking further ligand 
design, a more in depth analysis of the reaction conditions was conducted.  
In an effort to increase the enantioselectivity, changing the reaction temperature 
was first investigated.  Decreasing the temperature of the platinum-catalyzed 
hydrosilylation with ligand 3.107 to 50°C did not result in an increase in enantioselectivity 
(Table 3.6, entry 2).  Further decreasing the temperature to room temperature did produce 
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a boost in enantioselectivity but the yield of 3.40 was very low (Table 3.6, entry 3).  
Decreasing the amount of ligand improved the efficiency when the reaction was conducted 
at room temperature; but with a slight decrease in enantioselectivity (Table 3.6, entry 4).  
At room temperature with 6% ligand, the excess ligand equivalent might coordinate to 
platinum after oxidative addition.  At elevated temperature, the ligand might readily 
coordinate and dissociate in equilibrium, allowing for olefin binding.  However, at room 
temperature with excess ligand this equilibrium favors the doubly ligated platinum 
intermediate resulting in inhibition of catalysis.  Tentatively supporting ligand inhibition, 
increasing the amount of ligand (1:4) at room temperature resulted in no product formation 
(Table 3.6, entry 5).  With 6% ligand loading, increasing the concentration also improved 
the efficiency at room temperature while maintaining similar enantioselectivity (Table 3.6, 
entry 6 vs. 3).  Increased reaction concentration might promote precipitation of free ligand, 
thus slowing down catalyst inhibition.  Maintaining six-percent ligand loading, further 
analysis of the reaction conditions was conducted by using different solvents.  The less 
polar solvent, methyl tert-butyl ether, produced higher efficiency and similar 
enantioselectivity at room temperature (Table 3.6, entry 7).   The higher reactivity might 
be a result of heightened ligand insolubility in a less polar ethereal solvent.  Diethyl ether 
was more efficient but slightly less selective than tetrahydrofuran (Table 3.6, entry 8).  
Different ethereal solvents such as 1,4-dioxane produced sluggish reaction efficiency 
(Table 3.6, entry 9).  More polar solvent N,N-dimethylformamide produced both lower 
yield and enantioselectivity (Table 3.6, entry 10).  1,4-Dioxane and DMF might coordinate 
to platinum intermediates and slow down catalysis.  With methyl tert-butyl ether being 
most efficient and enantioselective at room temperature, the temperature was further 
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decreased to 4°C.  However, at this temperature the reaction yield suffered significantly 
and actually produced lower enantioselectivity (Table 3.6, entry 11).  Trying to improve 
the reaction at 4°C by lowering the ligand-loading in methyl tert-butyl ether, resulted in 
much lower enantioselectivity (Table 3.6, entry 12).  The worse reactivity at 4°C might be 
a result of decreased ligand solubility and dissociation from platinum allowing for a 
background reaction to occur.  From investigation of the reaction conditions, methyl tert-
butyl ether as the solvent and 6% ligand loading with 3% platinum complex were chosen 
as optimal for the hydrosilylation.  
Table 3.6 Investigation of the Reaction Conditions with Ligand 3.107  
 
Entry Temp. (°C) Solvent 
Concentration 
(Molar) 
Ligand 
% 
Yield 3.40 
(%)a e.r.
b 
1 70 THF 0.2 6 > 95 89:11 
2 50 THF 0.2 6 > 95 88:12 
3 r.t. THF 0.2 6 14 93:7 
4 r.t. THF 0.2 3.2 71 91:9 
5 r.t. THF 0.2 12 < 5 n.d. 
6 r.t. THF 0.67 6 73 91:9 
7 r.t. MTBE 0.67 6 90 91:9 
8 r.t. Et2O 0.67 6 89 89:11 
9 r.t. 1,4-dioxane 0.67 6 40 89:11 
10 r.t. DMF 0.67 6 57 84:16 
11 4 MTBE 0.67 6 24 87:13 
12 4 MTBE 0.67 3.2 45 72:28 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratio determined on the oxidized silyl alcohol using chiral SFC analysis.  
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 Further analysis of the reaction conditions was conducted by employing different 
diol ligands on the alkenyl boronate with a variety of phosphoramidite ligands.  With 
phenyl substituted phosphoramidite ligand 3.106, reaction of neopentyl boronic ester 3.116 
occured in low reaction yield and significantly diminished enantioselectivity (Table 3.7, 
entry 1).  Optimal 3,5-xylyl ligand 3.107 reestablished higher enantioselectivity but the 
reaction efficiency still suffered (Table 3.7, entry 2).  The result with ligand 3.107 produced 
comparable enantioselectivity to the pinacol boronic ester derived starting materials (Table 
3.4, entry 5).  Similarly to the pinacol boronic ester substrate, increasing the steric bulk to 
the 3,5-di(i-propyl)phenyl ligand (3.113) with substrate 3.116 resulted in a decrease in 
enantioselectivity (Table 3.7, entry 3).  A derivative of pinacol, 3,4-diethyl-hexanediol, 
was synthesized (3.117) and subjected to the optimal reaction conditions.  However, 
substrate 3.117 suffered from lower reactivity and enantioselectivity (Table 3.7, entry 4).  
Consequently, varying the organoboronate starting material generally resulted in lower 
reactivity and in most cases worse enantioselectivity.  
Table 3.7 Investigation of the Nature of the Alkenyl Boronate for the Platinum-
Catalyzed Enantioselective Hydrosilylation  
 
Entry Ligand Substrate Yield (%)a e.r.b 
1 3.106 3.116 36 60:40 
2 3.107 3.116 37 88:12 
3 3.113 3.116 26 80:20 
4 3.107 3.117 63 81:19 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratio determined on the oxidized silyl alcohol using chiral SFC analysis.  
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 After further investigating the reaction conditions and nature of the alkenyl 
boronate for the platinum-catalyzed enantioselective hydrosilylation, a final ligand 
investigation was conducted.  Pyrrolidine derived phosphoramidite ligands were chosen 
due to ease of synthesis and the inexpensive nature of the starting material.   For the aryl 
groups of the TADDOL-derived ligands, it is hypothesized that s-donating or withdrawing 
groups do not have a major impact on ligand electronics because the aryl substituents are 
three bonds removed from the phosphorus atom.  However, the electronic nature of the 
arene ring could have an impact on conformational biases of the ligand structure through 
p-p type interactions.  The 3,5-xylyl substituted phosphoramidite ligand was shown to be 
most optimal with the phenyl derivative being slightly less selective.   Taking this into 
account, ligands with electronically different but sterically similar 3,5-substitutions were 
synthesized.   
To probe the arene electronics, 3,5-di(fluoro)phenyl ligand (3.118) was synthesized 
and subjected to the optimal platinum-catalyzed hydrosilylation reaction conditions 
(methyl tert-butyl ether, room temperature).   However, use of electronically differentiated 
ligand 3.118 resulted in no increase in enantioselectivity observed (Table 3.8, entry 1 vs. 
2).  The electronics were then adjusted, with the electronic donating aryl ether ligand 3,5-
di(methoxy)phenyl ligand 3.119 being used.  Employing the same reaction conditions 
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resulted in a slightly lower enantioselectivity compared to the 3,5-xylyl substitution (Table 
3.8, entry 3).  Extending the steric bulk was accomplished through the synthesis of 3,5-
di(ethoxy)phenyl ligand 3.120.  Reaction conditions of tetrahydrofuran as the solvent at 
70°C were chosen for ligand 3.120 since there were a greater number of ligands 
investigated with these conditions to draw comparison (Tables 3.4 and 3.5).  Under these 
reaction conditions, ligand 3.120 provided good efficiency with a slight boost in 
enantioselectivity compared to the optimal ligand (Table 3.8, entry 5 vs. 4).  Further 
increasing the sterics of the aryl ether substituent to 3,5-di(isopropoxy)phenyl (3.121) 
resulted in a slight decrease in enantioselectivity (Table 3.8, entry 6).  With ligand 3.120 
having achieved higher enantioselectivity, it was subjected to the optimal reaction 
conditions.  At room temperature in methyl tert-butyl ether the platinum-catalyzed 
hydrosilylation produced higher enantioselectivity (Table 3.8, entry 7).   
Table 3.8 Ligand Investigation for the Platinum-Catalyzed Enantioselective 
Hydrosilylation of Alkenyl Boronates   
 
Entry Ligand Solvent Temp. (°C) Yield 3.40 (%)a e.r.b 
1 3.107 MTBE r.t. 90 91:9 
2 3.118 MTBE r.t. 61 83:17 
3 3.119 MTBE r.t. 88 87:13 
4 3.107 THF 70 > 95 89:11 
5 3.120 THF 70 87 8:92c 
6 3.121 THF 70 80 90:10 
7 3.120 MTBE r.t. 89 6:94c 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratio determined on the oxidized silyl alcohol using chiral SFC analysis.  
cent-Ligand 3.120 used for the reaction  
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With a newly optimal ligand for the platinum-catalyzed enantioselective 
hydrosilylation of alkenyl boronate 3.97, the reaction solvents were further investigated.  
Tetrahydrofuran, toluene and cyclohexane produced similar efficiencies and 
enantioselectivity as methyl tert-butyl ether (Table 3.9, entries 1-4).  Only the chlorinated 
solvent 1,2-dichloroethane suffered with regards to both reactivity and enantioselectivity 
(Table 3.9, entry 5).  It was then of interest for the alkenyl boronate to contain simple n-
alkyl groups as these substrates would allow for greater generality of the reaction.    
Employing n-butyl substituted alkenyl boronate 3.122 with cyclohexane as the solvent and 
ligand 3.120 produced good yield and enantioselectivity (Table 3.9, entry 6).  However, 
3,5-di(isopropoxy)phenyl ligand (3.121) resulted in higher enantioselectivity for substrate 
3.122 (Table 3.9, entry 7).  Ligand 3.121 was then tested with a variety of solvents for n-
butyl substrate 3.122.  Methyl tert-butyl ether, tetrahydrofuran and toluene all produced 
good reactivity and excellent enantioselectivity (Table 3.9, entries 8-10).   
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Table 3.9 Solvent Analysis with Optimal Ligands for the Platinum-Catalyzed 
Enantioselective Hydrosilylation of Alkenyl Boronates   
 
Entry Ligand Substrate Solvent Yield (%)a e.r.b 
1 3.120 3.97 MTBE 89 6:94c 
2 3.120 3.97 THF 93 6:94c 
3 3.120 3.97 toluene 94 7:93c 
4 3.120 3.97 cyclohexane 99 6:94c 
5 3.120 3.97 DCE 64 9:91c 
6 3.120 3.122 cyclohexane 72 7:93c 
7 3.121 3.122 cyclohexane 73 95:5 
8 3.121 3.122 MTBE 99 95:5 
9 3.121 3.122 THF 88 95:5 
10 3.121 3.122 toluene 78 95:5 
aYield determined by 1H-NMR with respect to 1,1,2,2-tetrachloroethane as an internal standard. 
bEnantiomer ratio determined on the oxidized silyl alcohol using chiral SFC analysis.  
cent-Ligand 3.120 used for the reaction  
 
 
 The results with substrates 3.97 and 3.122 show that the platinum-catalyzed 
enantioselective hydrosilylation is not sensitive to solvent choice.   Solvent insensitivity is 
an appealing feature of the reaction and allows for potential telescoped reaction sequences 
that require specific solvents.  Careful analysis of the data for both substrates showed that 
methyl tert-butyl ether was overall slightly more efficient for the reaction.  More 
importantly, methyl tert-butyl ether was most efficient with n-butyl substrate 3.122 to 
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explore the generality of the reaction.  Methyl tert-butyl ether also is an industrially friendly 
solvent as a safer choice for employing ethereal solvents.52  Taking these features into 
account, methyl tert-butyl ether was chosen to explore the substrate scope of the 
enantioselective platinum-catalyzed hydrosilylation of alkenyl boronates.  
 To explore the generality of the reaction, a variety of alkenyl boronates bearing 
different functionalities were synthesized.  The reaction was carried out by pre-complexing 
tris(dibenzylideneacetone)platinum (0) and ligand 3.121 at 80°C for 15 minutes and 
subsequent cooling to room temperature.  The reaction vial was then charged with the 
organosilane and alkenyl boronate for a room temperature reaction for 14 hours.  It is worth 
noting that addition of the organosilane after the catalyst pre-complexation is essential.  
Addition of the organosilane during the catalyst pre-complexation resulted in lower 
reaction efficiency potentially due to catalyst dimerization after oxidative addition. 
 With the optimal conditions and reaction sequence developed, the scope of the 
reaction was explored as depicted in Table 3.10.  The reaction tolerated both benzyl (3.40) 
and n-butyl (3.123) substituted alkenyl boronates with excellent reactivity and high 
enantioselectivity.  Interestingly, simple vinyl boronic acid pinacol ester (3.124) engages 
in the reaction efficiently and with excellent enantioselectivity. Product 3.124 highlights a 
potentially synthetically useful methyl-substituted nonracemic geminal silylboronate.  
Addition of steric bulk to the alkenyl boronate (3.125, 3.126) results in much lower 
reactivity and enantioselectivity.  Even though the silicon group could also stabilize the 
platinum-carbon bond, trimethylsilyl substituted alkenyl boronate (3.127) maintains high 
chemoselectivity.  Although from the increased steric encumbrance, product 3.127 suffers 
                                                
52 a) Henderson, R. K. et al. Green. Chem. 2011, 13, 854-862 b) Clark, J. H. et al. Sustain Chem Process, 
2016, 4:7, 1-24 
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from lower enantioselectivity.  Adjusting the steric bulk slightly further from the alkenyl 
boronate (3.128) reestablishes high reactivity and enantioselectivity.  A variety of 
functional groups such as alkyl halides (3.129, 3.130) and protected alcohols (3.131) are 
tolerated in the reaction with excellent yields and enantioselectivity.  Interestingly, terminal 
olefins (3.132) can be incorporated into the substrate with excellent results and only trace 
terminal olefin hydrosilylation occurs.  The observed chemoselectivity might be a result of 
the alkenyl boronate being a more polarized olefin and conjugating group.  This 
polarization might make the alkenyl organoboronate more reactive towards 
hydrosilylation.  b-Boryl ester substrates (3.133) can react with high enantioselectivity 
although with diminished yields a result of the regioisomeric insertion.  Different ester 
substrates (3.134) and ketones (3.135) attached to the alkenyl boronates are tolerated with 
excellent reactivity and enantioselectivity.  No carbonyl reduction is observed which is 
common with platinum/organosilane catalysis.  Heterocycle containing substrates (3.136, 
3.137) are also capable of undergoing the hydrosilylation with good reactivity and 
enantioselectivity.  An interesting substrate, trans-1,2-diborylethylene engages in the 
reaction efficiently to synthesize 1,2-diboryl organosilane 3.138.  With the optimal catalyst 
system for mono-alkenyl boronates, the reaction to form 3.138 suffers from slightly 
diminished enantioselectivity.  Lastly, at both room temperature and elevated temperatures, 
more substituted alkenyl boronates (3.139) fail to react under these conditions.   
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Table 3.10 Substrate Scope for the Platinum-Catalyzed Enantioselective 
Hydrosilylation of Alkenyl Boronates   
 
 
Isolated yields and enantiomer ratios are the average of two experiments.  Enantiomer ratio determined 
using chiral SFC analysis on either directly the geminal silylboronate or the oxidized silyl alcohol.  aLigand 
3.120 used for the reaction.  bReaction conducted at 70°C.  cReaction run at room temperature and 70°C. 
 
 With the scope of the reaction with alkenyl boronates explored, the nature of the 
organosilane reagent was then considered.  Employing substrate 3.97 and optimal ligand 
3.120, benzyldimethylsilane (3.140) underwent the platinum-catalyzed hydrosilylation 
with good efficiency and comparable enantioselectivity as with dimethylphenylsilane.  
Benzyldimethylsilane reagents have been shown to be useful for Hiyama-cross couplings 
as the benzyl group is mildly hydrolyzed in situ to organofluorosilanes for 
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transmetallation.53 More specifically, olefination of the organoboron moiety in 3.140 and 
mild hydrolysis of the benzylsilane group could allow for a more efficient synthesis of 
nonracemic allylic silanols for cross-coupling (Scheme 3.25).41 With triethylsilane (3.141) 
enantioselectivity suffered in the reaction with ligand 3.120.  Methyldiphenylsilane (3.142) 
underwent the reaction with only moderately lower enantioselectivity than 
dimethylphenylsilane.  The synthetic utility of methyldiphenylsilane could be displayed by 
a one-pot hydrosilylation and amination of the organoboronate to synthesize a silylamine.  
Hydrolysis of the diphenylsilane moiety would then produce an a-amino silanediol in three 
steps.  These a-amino silanediols have been previously elaborated to be common 
bioisosteres in the pharmaceutical industry (Scheme 3.26).  
Table 3.11 Scope of Organosilanes for the Platinum-Catalyzed Enantioselective 
Hydrosilylation of Alkenyl Boronates   
  
 
Isolated yields and enantiomer ratios are the average of two experiments.  Enantiomer ratio determined 
using chiral SFC analysis on the oxidized silyl alcohol.   
 
                                                
53 For the utility of BnMe2Si- group in cross-coupling, see: a) Machacek, M. R.; Ball, Z. T.; Trost, B. M. 
Org. Lett. 2003, 5, 1895-1898. b) Tymonko, S. A.; Denmark, S. E. J. Am. Chem. Soc. 2005, 127, 8004-8005. 
c) Nakao, Y.; Hiyama, T. Chem. Soc. Rev. 2011, 40, 4893-4901 
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 While trans-1,2-disubtituted alkenyl boronates were shown to work well under 
these catalytic hydrosilylation conditions, it was of interest to explore other types of alkenyl 
boronates.  Styrenyl organoboronate 3.143 underwent the platinum-catalyzed 
hydrosilylation with modest reactivity (Scheme 3.12, eq.1).  Surprisingly, the reaction 
product was found to be racemic.  The racemic outcome could be due the styrenyl substrate 
being a competent ligand for platinum, promoting dissociation of the chiral phosphine 
ligand.  Additionally, the styrenyl subsrate might go through an alternative insertion into 
the Pt-Si bond, resulting in a non-selective reaction.  The reactivity of styrenyl 
organoboronate 3.143 highslights that the platinum-catalyzed synthesis of nonracemic 
geminal silylboronates is a complementary approach to the copper catalysis developed by 
Hoveyda and coworkers. The copper catalysis was capable of producing geminal 
silylboronates when employing styrenyl substrates.  Dienyl organoboronate 3.145 
underwent the hydrosilylation reaction with severely diminished reactivity (Scheme 3.12, 
eq. 2).  The diminished reactivity could be the result of insertion into the platinum-hydride 
to form a stabilized p-allyl platinum intermediate which might inhibit catalysis.  Lastly, 
1,1-disubstituted alkenyl boronate 3.148 also suffered from poor reactivity for the 
hydrosilylation (Scheme 3.12, eq. 3).   
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Table 3.12 Challenging Substrates for the Platinum-Catalyzed Enantioselective 
Hydrosilylation of Alkenyl Boronates   
  
 To further explore the utility of the platinum-catalyzed hydrosilylation of alkenyl 
boronates, it was of interest to expand the scope of the organosilane moiety.  As alluded to 
earlier, the scope of organosilanes presented allow for the silicon moiety to be further 
transformed.  However, the incorporation of chlorosilanes or alkoxysilanes into the 
reaction could be powerful as the silicon could be readily derivatized.  Employing substrate 
3.97 and optimal ligand 3.120, the scope of different silanes was investigated.  
Diphenylsilane (3.150) only resulted in trace formation of the geminal silylboronate under 
these conditions.  The low reactivity could be from potential competitive insertion into the 
product silicon-hydrogen bond, which may result in catalyst deactivation.  
Diethoxyphenylsilane (3.151) and chloro(di-tert-butyl)silane (3.152) resulted in no product 
formation under the depicted catalytic conditions.  Both of these silane starting materials 
could suffer from competitive insertion into the silicon-oxygen and silicon-chlorine bonds 
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respectively, and inhibition of catalysis.  Lastly, dimethylvinylsilane (3.153) also suffered 
from no product formation.  While these silanes would have further increased the impact 
of the enantioselective hydrosilylation of alkenyl boronates through direct product 
functionalization, the organosilanes competent in the reaction allow for the further 
functionalization of the silicon moiety.  With the scope of the platinum-catalyzed 
hydrosilylation of alkenyl boronates demonstrated, the synthetic utility of this process was 
investigated. 
Table 3.13 Further Investigation to the Scope of Silanes for the Platinum-Catalyzed 
Enantioselective Hydrosilylation of Alkenyl Boronates   
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3.3.2 Synthetic Utility and Mechanistic Considerations45 
 
As mentioned before, the synthesis of nonracemic geminal silylboronates is highly 
desirable for the application of these products towards the synthesis of functionalized 
stereocenters.  The organoboronate moiety of the geminal silylboronate has the potential 
to undergo a wide variety of the transformations developed for organoboron reagents.  
Additionally, silicon’s decreased reactivity in 1,2-metallate rearrangements can be taken 
advantage of for divergent functionalizations of the metal groups.  Taking the reactivity 
differences into account, functionalizations of nonracemic geminal silylboronate 3.40 were 
undertaken.  Oxidation of the organoboronate to silyl alcohol 3.154 proceeded with good 
yield and stereospecificity (Scheme 3.31).  These silyl alcohol products have been shown 
to be useful chiral auxillaries for diastereoselective oxocarbenium ion allylation 
reactions.54  Amination of the organoboronate moiety to silylamine 3.155 proceeded 
efficiently with good yield and enantiospecificity.55  Silylamine products have received 
much attention in the pharmaceutical industry as described earlier.  In addition to 
heteroatom incorporation, a modified procedure for the Matteson homologation afforded 
the nonracemic vicinal silylboronate 3.156 with good yield.56  The effect of sodium triflate 
additives has been demonstrated to aid in organoboron “ate” complex formation through 
binding to the oxygen of the boron ligand and increasing the Lewis acidity of the 
organoboronate.56b 
                                                
54 Cossrow, J.; Rychnovsky, S. D. Org. Lett. 2002, 4, 147-150 
55 This is a modification of the following reference and its details will be reported separately: Mlynarski, S. 
N.; Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449-16451 
56 (a) Mah, R. W. H.; Matteson, D. S. J. Am. Chem. Soc. 1963, 85, 2599-2603 (b) For effect of sodium 
triflate: Lovinger, G. J.; Aparece, M. D.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 3153-3160 
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Scheme 3.31 Functionalizations of Nonracemic Geminal Silylboronates 
 
 With the vicinal silylboronate, the divergent functionalizations of the 
organoboronate and organosilane groups was explored.  Amination of the vicinal 
silylboronate 3.156 afforded the vicinal silylamine 3.157 with good yield after Boc 
protection of the nitrogen group.  Subsequently, an anhydrous Tamao-Fleming oxidation57 
and cyclization on the Boc group afforded the oxazolidinone 3.158 with good yield and 
enantiospecificity.  The aforementioned procedure could represent an efficient method for 
the preparation of nonracemic oxazolidinones that have differing substitution compared to 
the typical amino-acid derived oxazolidinones used as chiral auxillaries.   
Scheme 3.32 Functionalization of the Organoboronate and Organosilane Groups  
  
 To further explore the utility of the platinum-catalyzed enantioselective 
hydrosilylation, it was of interest to explore a one-pot hydroboration-hydrosilylation 
procedure.  To probe this, the reaction depicted in Scheme 3.33 was conducted.  Starting 
                                                
57 ) a) Smitrovich, J. H.; Woerpel, K. A. J. Org. Chem. 1996, 61, 6044-6046. b) Walleser, P.; Bruckner, R. 
Eur. J. Org. Chem. 2014, 15, 3210-3224 
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from commercially available 3-phenyl-1-propyne (3.159), a neat dicyclohexylborane 
catalyzed alkyne hydroboration58 furnished the requisite alkenyl boronate. Next, the 
enantioselective platinum-catalyzed hydrosilylation was conducted in toluene and the one-
pot procedure further extended to include amination of the organoboronate. Silylamine 
3.155 was obtained in excellent yield and enantioselectivity.  The one-pot procedure 
highlights the insensitivity of the hydrosilylation reaction to borane impurities and the 
ability to use different solvents in the reaction to accommodate for subsequent 
transformations.   
Scheme 3.33 One-Pot Telescoped Synthesis of Silylamine 
  
To broaden the applicability and utility of the reaction, it was of interest to conduct 
a large-scale, enantioselective hydrosilylation without the aid of a glove-box.  To 
demonstrate this, the platinum pre-catalyst and ligand were weighed in the open air.  The 
flask was then purged with nitrogen, the solvent introduced and the platinum catalyst 
stirred for fifteen minutes at 80°C.  Subsequent cooling to room temperature and addition 
of the starting materials allowed for a reaction at room temperature for 16 hours.  As 
depicted in Scheme 3.34, the reaction proceeded with excellent reactivity and 
enantioselectivity and delivered 4.04 grams of material without the aid of a glove-box. The 
large-scale reaction provided almost identical results to the small-scale reaction conducted 
                                                
58 Shirakawa, K.; Arase, A.; Hoshi, M. Synthesis, 2004, 11, 1814-1820 
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in the glove-box.  It is worth noting that the catalyst-loading was reduced to 1% and the 
solvent volume reduced while maintaining high reactivity and enantioselectivity.  These 
two features attest to the ability of this reaction to be conducted potentially on larger scales. 
Scheme 3.34 Large-Scale, Glove-Box Free Platinum-Catalyzed Hydrosilylation 
 
With the synthetic utility of the platinum-catalyzed hydrosilylation of alkenyl 
boronates for the synthesis of nonracemic geminal silylboronates demonstrated, the 
mechanism of the reaction was studied.   It is proposed that the catalytic cycle begins with 
oxidative addition of the phosphine-ligated platinum (0) complex 3.160 with the 
organosilane to form platinum (II) complex 3.161 (Figure 3.1).  Subsequently, 
enantiodetermining binding of the alkenyl boronate to platinum (II) complex 3.161 occurs.  
Assuming well-precedented “hydride first” olefin insertion48 then forms the a-boryl 
stabilized organoplatinum (II) intermediate 3.162.   Reductive elimination furnishes the 
nonracemic geminal silylboronate 3.163 and regenerates platinum (0) complex 3.160 to 
restart the catalytic cycle.   
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Figure 3.1 Proposed Mechanism for the Platinum-Catalyzed Hydrosilylation of 
Alkenyl Boronates   
 
 With alkenyl boronates being new substrates for the enantioselective 
hydrosilylation of olefins, it was of interest to study the alkenyl boronate insertion into the 
platinum-hydride.  To probe this, deuterodimethylphenylsilane (3.164) was synthesized 
from the corresponding chlorodimethylphenylsilane and lithium aluminum deuteride.59  
Deuterodimethylphenylsilane was then used in the standard reaction conditions to reveal 
the deuterium incorporation and relative stereochemistry of the reaction product (Scheme 
3.35, eq. 1).  Analysis of the geminal silylboronate 3.165 by 1H-NMR and 2H-NMR showed 
that the reaction produced one diastereomer of 3.165 with no deuterium scrambling.  While 
olefin insertion into a Pt-Si bond has been demonstrated, the reaction employed a 
bis(silyl)platinum complex and styrene at elevated temperatures (120°C) producing low 
yields.60  In contrast, extensive studies recently by Roy48c, Strassner48d, and Kuhn48e in 
addition to theoretical studies by Sakaki61 provide strong evidence for olefin insertion into 
the Pt-H bond in platinum-catalyzed hydrosilylations.  In line with the 2,1-insertion into a 
                                                
59 Takale, B. S.; Tao, S. M.; Yu, X. Q.; Feng, X. J.; Jin, T.; Bao, M.; Yamamoto, Y. Org. Lett. 2014, 16, 
2558-2561	
60 Yamashita, H.; Goto, M.; Tanaka, M. Organometallics 1997, 16, 4696-4704 
61 Mizoe, N.; Sugimoto, M.; Sakaki, S. Organometallics 1998, 17, 2510-2523 
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Pt-D observed by Kuhn48e, if the hydrosilylation of alkenyl boronate 3.97 proceeded 
through a Pt-Si insertion, deuterium scrambling and olefin migration might be observed in 
some quantity as a consequence of b-elimination (Scheme 3.35, eq. 2). Intermediate 3.166 
also has a heightened propensity to undergo b-elimination due to the benzylic C-H bonds 
forming a conjugated system.  Taking into account the previous mechanistic work and no 
b-elimination products observed suggest olefin insertion into the Pt-H bond.  
Consequently, the deuterosilylation experiment supports the hypothesis that platinum-
catalyzed enantioselective hydrosilylation of alkenyl boronates proceeds by insertion into 
the platinum-hydride to form a stabilized a-boryl organoplatinum (II) intermediate.  The 
insertion also occurs by a syn addition as the relative configuration of the reaction product 
was confirmed by the synthesis of an authentic racemic sample.   
Scheme 3.35 Deuterosilylation Experiment for the Platinum-Catalyzed 
Hydrosilylation of Alkenyl Boronates  
  
 The authentic deuterosilylation product was synthesized by the deuteroboration of 
(Z)-alkenylsilane 3.169 which afforded deuteroorganoborane 3.170 (Scheme 3.36, eq. 1).  
Subsequent oxidation of the organoborane intermediate furnishes racemic deuterated silyl 
alcohol 3.171.  Analysis of this reaction shows that the deuteroboration of (Z)-alkenylsilane 
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3.169 produced the racemic syn deuterated silyl alcohol 3.171 (Scheme 3.6, eq. 2).  
Analysis of the platinum-catalyzed hydrosilylation from a syn insertion of the (E)-alkenyl 
boronate into the platinum-hydride furnished geminal silylboronate intermediate 3.165 
(Scheme 3.36, eq. 3).  After oxidation, the nonracemic syn silyl alcohol 3.171 was formed.  
Analysis of these two reaction products by 1H-NMR showed that both reactions produced 
the same diastereomer.  The 1H-NMR data supports the hypothesis that the platinum-
catalyzed hydrosilylation of alkenyl boronates undergoes a syn insertion likely to form an 
a-boryl stabilized organoplatinum (II) intermediate.   
Scheme 3.36 Preparation of Authentic Deuterosilylation Product and Reaction 
Analysis  
  
Having gained insight on the mechanism of the platinum-catalyzed hydrosilylation, 
it was of interest to understand the stereochemical outcome.  A tentative model for 
enantioselectivity is proposed based upon the crystal structure of a platinum-TADDOL 
phosphonite complex used in the diboration of alkenes (Figure 3.2).47 The model is 
proposed assuming olefin insertion in the platinum-hydride previously elaborated.  It is 
thought that the critical steric component for enantioselectivity is directing the R group 
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away from the aryl and pyrrolidine groups.  For the (E)-alkenyl boronate, the boronate 
group is situated between the aryl and pyrrolidine groups.  As described previously in this 
chapter (Scheme 3.30), the two isomers of alkenyl boronate afford the same enantiomer of 
product.   Consequently, the positioning of the boronate is not a critical feature for high 
enantioselectivity.  The alignment of the insertion into the platinum-hydride proposed in 
Figure 3.2 is consistent with the observed stereochemical outcome.  
 
Figure 3.2 Stereochemical Model for the Enantioselective Platinum-Catalyzed 
Hydrosilylation of Alkenyl Boronates  
 
3.4 Conclusion  
 
 The development of a platinum-catalyzed enantioselective hydrosilylation of 
alkenyl boronates has been presented.  This methodology was shown to be effective for the 
synthesis of a wide array of nonracemic geminal silylboronates from readily available 
starting materials.  The hydrosilylation was shown to be applicable towards the telescoped 
synthesis of pharmaceutically relevant nonracemic silylamine products.  The synthetic 
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utility was also showcased by divergent functionalization of the geminal dimetallic reagent.  
The scalability of the reaction was demonstrated by a large-scale enantioselective 
hydrosilylation without the aid of a glove-box.   
 The hydrosilylation of olefins is a well-studied and widely-developed process for 
applications in the silane industry.  The development of enantioselective methods for the 
hydrosilylation of olefins has also been demonstrated for utility in natural product 
synthesis.  The enantioselective hydrosilylation of alkenyl boronates presented provides a 
new alternative for the hydrosilylation of functionalized olefins.  Further studies on the 
hydrosilylation of differentially substituted alkenyl boronates is highly desired as the 
divergent functionalization has been showcased.  The development of enantioselective 
hydrosilylations of unexplored functionalized olefins could also have a profound impact 
on synthetic organic chemistry and add to a widely-developed area of chemistry.   
 
3.5 Experimental  
3.5.1 General Information 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), Varian 
Gemini-600 (600 MHz), or Varian Inova-500 (500 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.24 ppm). 
Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, m = multiplet), and coupling constants (Hz). 13C 
NMR spectra were recorded on either a Varian Gemini-500 (125 MHz), Varian Gemini-
600 (150 MHz) or a Varian Inova-500 (125 MHz) spectrometer with complete proton 
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decoupling. Chemical shifts are reported in ppm with the solvent resonance as the internal 
standard (CDCl3: 77.2 ppm). 11B NMR spectra were recorded on a Varian Gemini-500 
(128 MHz) or Varian Gemini-600 (160 MHz) spectrometer. Infrared (IR) spectra were 
recorded on a Bruker alpha-P Spectrometer. Frequencies are reported in wavenumbers (cm-
1) as follows: strong (s), broad (br), medium (m), and weak (w). Optical rotations were 
measured on a Rudolph Analytical Research Autopol IV Polarimeter. High-resolution 
mass spectrometry (DART) was performed at the Mass Spectrometry Facility, Boston 
College, Chestnut Hill, MA. Liquid chromatography was performed using forced flow 
(flash chromatography) on silica gel (SiO2, 230 x 450 Mesh) purchased from Silicycle. 
Thin layer chromatography (TLC) was performed on 25 µm silica gel aluminum backed 
plates from Silicycle. Small-scale silica gel columns performed using large-volume pipet 
(Fisher Catalog # 22-378893).  Visualization was performed using ultraviolet light (254 
nm), ceric ammonium molybdate (CAM) in ethanol or phosphomolybdic acid, cerium(IV) 
sulfate in ethanol with sulfuric acid (Seebach), and potassium permanganate in 10% 
sodium hydroxide. 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector with 
isopropanol or methanol as the modifier.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon unless stated otherwise. Tetrahydrofuran (THF), diethyl 
ether (Et2O), dichloromethane (DCM) and toluene were purified using Pure Solv MD-4 
solvent purification system, from Innovative Technology, Inc., by passing the solvent 
through two activated alumina columns after purging with argon. Palladium (II) acetate 
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was purchased from Strem Chemicals, Inc. and used without further purification. Reagents 
were purchased from Aldrich, Alfa Aesar, Acros, Oakwood, Strem, Combi-Blocks, TCI 
America and used without further purification.  
 
 3.5.2 Experimental Procedures 
 1. Procedure for Preparation of Pt(dba)3  
 Pt(dba)3 was prepared according to a literature procedure with a slight modification.  
Sodium acetate (2.11 g, 25.7 mmol, 18.0 equiv), tetrabutylammonium chloride (1.19 g, 
4.29 mmol, 3.00 equiv.) and trans, trans-dibenzylideneacetone (2.35 g, 10.01 mmol, 7.00 
equiv.) were added to a 250 mL two-neck round bottom flask equipped with a stir bar and 
condenser.  The solids were dissolved in methanol (65 mL) and heated to 70°C until full 
dissolution.  In a separate vial, potassium tetrachloroplatinate (593 mg, 1.43 mmol, 1.00 
equiv.) was dissolved in water (4.0 mL), heated gently with a heat gun for full dissolution 
and charged into the reaction flask.  The reaction was heated to 70°C for 3 hours.  After 
allowing to cool to room temperature, the reaction was concentrated to approximately half 
the volume.  The solids were then filtered using a fritted funnel and washed with copious 
amounts of methanol (about 750 mL) and water (50 mL), until no yellow 
benzylideneacetone was observed.  The resulting solid was placed on high-vacuum for 24 
hours to remove all methanol and water, to afford a dark brown solid. (572 mg, 45%).   All 
spectral data was in accordance with the literature.47,62 
                                                
62 Lewis, L. N.; Krafft, T. A.; Huffman, J. C. Inorg. Chem. 1992, 31, 3555-3557 
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 2. Procedures for Preparation of TADDOL-Ligands 
 
1-bromo-3,5-diethoxybenzene (3.172) To a flame-dried 250 mL 
round bottom flask equipped with a stir bar was added 1-bromo-
3,5-dimethoxybenzene (2.17 g, 10.0 mmol, 1.00 equiv.), the flask 
purged with N2 and then DCM (10 mL) was added.  The reaction flask was cooled to 0°C 
and boron tribromide (5.51 g, 22.0 mmol, 2.20 equiv.) was added.  The reaction was 
warmed to room temperature and allowed to stir overnight.  The reaction was then cooled 
to -78°C, quenched with methanol and concentrated under reduced pressure.  The crude 
mixture was redissolved in ethyl acetate, washed with water, dried over sodium sulfate, 
filtered and concentrated under reduced pressure.  The crude product 1,3-
dihydroxybromobenzene was used in the subsequent step without further purification. 
To a 250 mL round bottom flask equipped with a stir bar was added 5-
bromoresorcinol (1.89 g, 10.0 mmol, 1.00 equiv.), potassium carbonate, (5.53 g, 40.0 
mmol, 4.0 equiv.) and DMF (40 mL).  Iodoethane (6.24 g, 40.0 mmol, 4.0 equiv.) was then 
added and the reaction heated to 60°C for 18 hours.  The reaction was cooled, diluted in 
ethyl acetate, washed with water, dried over sodium sulfate, filtered and concentrated under 
reduced pressure.  The crude mixture was purified by silica gel chromatography (5% ethyl 
acetate in pentane) to afford a clear, yellow oil. (2.45 g, 82%)  
1H NMR (600 MHz, CDCl3): δ 6.64 (s, 2H), 6.36 (s, 1H), 3.98 (q, J = 7.0 Hz, 4H), 1.39 
(t, J = 7.0 Hz, 6H).  13C NMR (151 MHz, CDCl3): δ 160.67, 122.98, 110.40, 100.77, 63.91, 
14.83.      IR (neat): νmax 2980 (w), 2932 (w), 2881 (w), 1595 (m), 1573 (s), 1479 (m), 1439 
Br
O O MeMe
3.172
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(m), 1277 (s), 1048 (s), 816 (m), 676(m) cm-1.  HRMS (DART) for C10H13BrO2 [M+H]+: 
calculated: 245.0177, found: 245.0188. 
 
1-bromo-3,5-diispropoxybenzene (3.173) The compound was 
prepared as above but using 2-iodopropane in place of iodoethane.  
The crude mixture was purified by silica gel chromatography (2-3% 
ethyl acetate in pentane) to afford a clear yellow oil. (10.9 g, 99%) All spectra was in 
accordance with the literature.63 
 
 (4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(bis(3,5 
diethoxyphenyl)methanol) (3.174)  (R,R)-3,5-Di-
ethoxyphenylTADDOL was prepared according to the literature 
procedure with a slight modification.64 (S,S)-3,5-Di-
ethoxyphenylTADDOL was prepared in a likewise manner.  To a 
flame-dried 100 mL two-neck round bottom flask equipped with a stir bar was added 
magnesium turnings (263 mg, 10.83 mmol, 5.4 equiv.), sealed, and then flame-dried again.  
Under N2, a crystal of iodine in THF was added followed by 1-bromo-3,5-
diethoxybromobenzene (2.21 g, 9.00 mmol, 4.5 equiv.) in THF (15 mL).  The reaction 
flask was gently heated with a heat-gun to initiate and then heated to 80°C for 3 hours.  The 
reaction was cooled to 0°C, dimethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-
dicarboxylate (436 mg, 2 mmol, 1.00 equiv.) in THF (5 mL) was added and allowed to heat 
                                                
63 Cavanagh, C. W.; Aukland, M. H.; Hennessy, A.; Procter, D. J. Chem. Commun. 2015, 51, 9272-9275 
64	Sun, C.; Potter, B.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 6534-6537	
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at 80°C overnight.  The reaction was cooled to room temperature and quenched with a 
saturated ammonium chloride solution.  The aqueous layer was extracted with ethyl 
acetate, dried over sodium sulfate, filtered and concentrated under reduced pressure.  The 
crude extract was purified by silica gel chromatography (15-25% ethyl acetate in pentane) 
to afford the title compound as a white solid. (927 mg, 56%) 
1H NMR (600 MHz, CDCl3) δ  6.71 (s, 4H), 6.51 (s, 4H), 6.36 (s, 2H), 6.28 (s, 2H), 4.57 
(s, 2H), 3.92-4.00 (m, 8H), 3.85-3.91 (m, 8H), 3.83 (s, 2H), 1.31-1.39 (m, 24H), 1.13 (s, 
6H).  13C NMR (151 MHz, CDCl3): δ 159.74, 159.32, 147.84, 145.22, 109.47, 107.56, 
106.66, 100.55, 100.33, 81.67, 78.33, 63.63, 63.52, 27.55, 15.03, 14.94.  IR (neat): νmax 
3304 (br), 2978 (s), 2931 (w), 2987 (w), 1591 (s), 1439 (s), 1389 (m), 1341 (w), 1164 (s), 
1113 (m), 889 (w), 741 (s) cm-1.  HRMS (ESI) for C47H61O11 [M+H-H2O]+: calculated: 
801.4213, found: 801.4213.  [α]20D: +16.89 (c = 1.26, CHCl3, l = 50 mm). 
 
 ((4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(bis(3,5-
diisopropoxyphenyl)methanol) (3.175) (R,R)-3,5-Di-
isopropoxyphenylTADDOL was prepared in accordance to the 
procedure above.  The crude mixture was purified by silica gel 
chromatography (5-10% ethyl acetate in hexane) to afford a white 
solid. (3 g, 61%) 
1H NMR (600 MHz, CDCl3) δ  6.69 (d, J = 2.2 Hz, 4H), 6.52 (d, J = 2.2 Hz, 4H), 6.36 (t, 
J = 2.2 Hz, 2H), 6.28 (t, J = 2.2 Hz, 2H). 4.61 (s, 2H), 4.45-4.51 (m, 4H), 4.36-4.41 (m, 
4H), 3.69 (s, 2H), 1.23-1.31 (m, 48H), 1.05 (s, 6H).  13C NMR (151 MHz, CDCl3): δ 
158.70, 158.21, 148.14, 145.07, 109.69, 109.34, 107.90, 103.57, 103.06, 81.63, 78.35, 
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70.08, 69.92, 27.34, 22.43, 22.22, 22.18, 22.12.  IR (neat): νmax 3312 (br), 2975 (m), 2931 
(w), 1591 (s), 1439 (m), 1371 (m), 1331 (m), 1244 (w), 1182 (m), 1113 (s), 963 (s), 840 
(w) cm-1.  HRMS (ESI) for C55H77O11 [M+H-H2O]+: calculated: 913.5461, found: 
913.5460.  [α]20D: -10.86 (c = 1.18, CHCl3, l = 50 mm). 
 
1-((3aR,8aR)-4,4,8,8-tetrakis(3,5-diethoxyphenyl)-2,2-
dimethyltetrahydro-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepin-6-yl)pyrrolidine (3.120)  (R,R)-
diethoxyTADDOLphoshporamidite was prepared according to a 
literature procedure.64 (S,S)-diethoxyTADDOLphoshporamidite 
was prepared in a likewise manner.  To a 100 mL round bottom 
flask equipped with a stir bar was added (R,R)-diethoxyTADDOL (927 mg, 1.13 mmol, 
1.00 equiv.) and purged with N2 three times.  The solid was dissolved in THF (10 mL), 
cooled to 0°C and charged with triethylamine (0.536 mL, 3.85 mmol, 3.40 equiv.) and 
phosphorus trichloride (0.099 mL, 1.13 mmol, 1.00 equiv.).  The solution was stirred for 
three hours at room temperature, cooled to 0°C and pyrrolidine (0.940 mL, 11.31 mmol, 
10.0 equiv.) was added.  The reaction was allowed to stir at room temperature overnight.  
The reaction mixture was filtered over a pad of celite with ether and concentrated under 
reduced pressure.   The crude mixture was purified by silica gel chromatography (1-15% 
ethyl acetate in pentane, with 1% triethylamine) and further recrystallized with 1% ethyl 
acetate in pentane to afford a white solid. (666 mg, 64%)  
1H NMR (600 MHz, CDCl3): δ 6.92 (d, J = 2.2 Hz, 2H), 6.75 (d, J = 2.2 Hz, 2H), 6.64 (s, 
4H), 6.28-6.33 (m, 4H), 5.15 (dd, J = 8.5, 3.3 Hz, 1H), 4.72 (d, J = 8.5 Hz, 1H), 4.02 – 3.83 
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(m, 16H), 3.37-3.40 (m, 2H), 3.30 – 3.20 (m, 2H), 1.89 – 1.72 (m, 4H), 1.43 – 1.30 (m, 
27H), 0.40 (s, 3H).   13C NMR (151 MHz, CDCl3): δ 159.80, 159.37, 159.34, 159.02, 
149.32, 148.83, 144.16, 111.56, 108.57, 108.10, 108.07, 106.51, 106.43, 100.93, 100.24, 
100.06, 99.92, 83.09, 83.07, 82.61, 82.47, 81.73, 81.45, 81.40, 63.62, 63.54, 63.50, 63.45, 
45.16, 45.06, 27.91, 26.31, 26.28, 25.69, 15.03, 15.01.  31P NMR (243 MHz, CDCl3): δ 
134.20.  IR (neat): νmax 2978 (w), 2933 (w), 2877 (w), 1590 (s), 1443 (m), 1390 (m), 1371 
(w), 1039 (s), 995 (s), 884(m) cm-1.  HRMS (ESI) for C51H69NO12P [M+H]+: calculated: 
918.4557, found: 918.4554.  [α]20D: -81.50 (c = 1.07, CHCl3, l = 50 mm). 
 
1-((3aR,8aR)-4,4,8,8-tetrakis(3,5-diisopropoxyphenyl)-2,2-
dimethyltetrahydro-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepin-6-yl)pyrrolidine (3.121) (R,R)-3,5-
diisopropxyTADDOLphosphoramidite was prepared in 
accordance to the procedure above (1.00 mmol), to afford a white 
solid. (550 mg, 53%) 
1H NMR (600 MHz, CDCl3): δ 6.89 (s, 2H), 6.73 (s, 2H), 6.60-6.61 (m, 4H), 6.27-6.32 
(m, 4H), 5.20 (dd, J = 8.5, 3.0 Hz, 1H), 4.72 (d, 1H), 4.38-4.47 (m, 8H), 3.35-3.38 (m, 
2H), 3.22-3.27 (m, 2H), 1.77-1.82 (m, 4H), 1.32 (s, 3H), 1.24-1.30 (m, 48H), 0.39 (s, 3H).  
13C NMR (151 MHz, CDCl3): δ 158.78, 158.32, 158.26, 157.96, 149.29, 148.70, 144.41, 
144.16, 111.40, 109.63, 109.38, 107.61, 107.51, 104.29, 103.04, 102.88, 102.62, 83.07, 
83.04, 82.68, 82.55, 81.57, 81.52, 70.07, 69.91, 69.85, 69.78, 45.12, 45.02, 27.78, 26.28, 
26.25, 25.41, 22.43, 22.38, 22.36, 22.31, 22.20, 22.16, 22.12.  31P NMR (243 MHz, 
CDCl3): δ 133.73.  IR (neat): νmax 2975, (m), 2932 (w), 2872 (w), 1590 (s), 1439 (s), 1382 
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(m), 1347 (m), 1289 (w), 1251 (w), 1182 (s), 1151 (s), 1114 (s), 1026 (m), 10006 (m), 845 
(m) 786 (s) cm-1.  HRMS (ESI) for C59H85NO12P [M+H]+: calculated: 1030.5806, found: 
1030.5805.  [α]20D: -69.53 (c = 1.04, CHCl3, l = 50 mm). 
 
 3. Procedures for Preparation of Alkenyl Boronates 
 
 
 (E)-4,4,5,5-tetramethyl-2-(3-phenylprop-1-en-1-yl)-1,3,2-
dioxaborolane (3.97) In a glove-box, to an oven-dried round bottom 
flask equipped with a stir bar, Schwartz’s reagent (129 mg, 0.5 mmol, 0.05 equiv.), 
pinacolborane (1.45 mL, 10 mmol, 1.00 equiv) and 3-phenyl-1-propyne (1.49 mL, 12 
mmol, 1.20 equiv) were added.  The round bottom flask was sealed, and heated to 60°C 
under N2 for 12 hours.  The reaction was allowed to cool, diluted with Et2O, passed through 
a pad of silica gel and concentrated under reduced pressure.  The crude mixture was 
purified by silica gel chromatography (3-5% ethyl acetate in hexanes) to afford the title 
compound as a clear oil (1.55g, 65%) All spectral data was in accordance with the 
literature.65 
                                                
65 Kiesewetter, E. T.; O’Brien, R. V.; Yu, E. C.; Meek, S. J.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. 
Soc. 2013, 135, 6026-6029 
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Starting material alkenyl boronates for 3.12366, 3.12550c, 3.12650c, 3.12767, 3.12868, 3.12946, 
3.13068, 3.13168 were prepared according to the procedure above, and the spectra are in 
accordance with the literature.   
Compound 3.124 utilized commercially available vinyl boronic acid pinacol ester.  
 
 
 (E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-3-en-1-yl 4-oxopentanoate (3.178) In an oven-
dried 250 mL round-bottom flask containing the alcohol (E)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)but-3-en-1-ol69 (1.19g, 6.00 mmol, 1.00 equv) and 4-oxopentanoic acid 
(1.05g, 9.00 mmol, 1.5 equiv) was added DCM (30 mL).  The flask was cooled to 0°C and 
DMAP (146.6 mg, 1.20 mmol, 0.20 equiv) and N,N’-dicyclohexylcarbodiimide (2.48 g, 
12.0 mmol, 2.00 equiv) were added sequentially, and the flask was allowed to warm to 
room temperature and stirred overnight.  The mixture was cooled to 4°C in a freezer for 
two hours, and the resulting solid was vacuum filtered and washed with cold hexanes (10 
mL).  The filtrate was collected and purified by silica gel chromatography (20 – 33% ethyl 
acetate in hexanes) to afford a white solid. (1.27g 71%)  
                                                
66 Edelstein, E. K.; Namirembe, S.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 5027-5030 
67 Lawson, J. R.; Wilkins, L. C.; Melen, R. L. Chem. Eur. J. 2017, 23, 10997-11000 
68 Kageyuki, I.; Takaki, K.; Yoshida, H. Org. Lett. 2014, 16, 3512-3515 
69 Hydrozironcation of 3-butyn-1-ol done in an analogous fashion: Shen. X.; Nguyen, T. T.; Koh, M. J.; Xu, 
D.; Speed, A. W. H.; Schrock, R. R.; Hoveyda, A. H. Nature, 2017, 541, 380-385	
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1H NMR (600 MHz, CDCl3): δ 6.54 (dt, J = 18.0, 6.4 Hz, 1H), 5.50 (d, 1H), 4.13 (t, J = 
6.7 Hz, 2H), 2.72 (t, J = 6.6 Hz, 2H), 2.55 (t, J = 6.6 Hz, 2H), 2.44-2.48 (m, 2H), 2.16 (s, 
3H), 1.25 (s, 12H).  13C NMR (151 MHz, CDCl3): δ 206.64, 172.72, 148.96, 83.30, 63.24, 
38.04, 34.87, 29.96, 28.07, 24.87.  11B NMR: (192 MHz, CDCl3): δ 29.64.  IR (neat): νmax 
2978 (w), 2973 (w), 1735 (m), 1719 (m), 1640 (m), 1579 (w), 1390 (s), 1358 (s), 1143 (s), 
849(w) cm-1.  HRMS (ESI) for C15H26BO5 [M+H]+: calculated: 297.1873, found: 
297.1874. 
 
 
methyl (E)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hex-5-enoate (3.181) The commercially available 
carboxylic acid was esterified according to a literature procedure70, and the boronic ester 
was synthesized by the hydrozirconation procedure above from the alkyne.  All spectra 
data is in accordance to the literature.71 
 
 
                                                
70 Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature, 2014, 505, 386-390 
71 Jang, H.; Zhugralin, A. R.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 7859-7871	
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 (E)-4,4,5,5-tetramethyl-2-(5-(thiophen-2-yl)pent-1-en-1-yl)-
1,3,2-dioxaborolane (3.184) The alkyne was synthesized from 
the procedure above, starting from the iodo-alkyne72 adapted 
from a literature procedure. The resulting alkyne was then subjected to the 
hydrozirconation procedure above and the crude mixture was purified by silica gel 
chromatography (1% ethyl acetate in hexanes) to afford a colorless oil. (209.4 mg, 68%) 
1H NMR (600 MHz, CDCl3): δ 7.10 (dd, J = 5.2, 1.2 Hz, 1H), 6.90 (dd, J = 5.1, 3.4 Hz, 
1H), 6.75-6.81 (m, 1H), 6.63 (dt, J = 17.9, 6.4 Hz, 1H), 5.47 (d, 1H), 2.83 (t, J = 7.7 Hz, 
2H), 2.23 (q, J = 7.1 Hz, 2H), 1.79-1.84 (m, 2H), 1.27 (s, 12H).  13C NMR (151 MHz, 
CDCl3): δ 153.38, 145.18, 126.67, 124.14, 122.90, 83.08, 35.04, 30.13, 29.33, 24.80.  11B 
NMR: (192 MHz, CDCl3): δ 29.64.  IR (neat): νmax 2977 (w), 2930 (w), 2857 (w), 1638 
(m), 1397 (s), 1319 (s), 1144 (w), 849 (m), 692 (m) cm-1.  HRMS (DART) for C15H24BO2S 
[M+H]+: calculated: 279.1590, found: 279.1585. 
 
 
                                                
72 McCabe, J. M.; Brummond, K. M. Tetrahedron, 2006, 62, 10541-10554 
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 (E)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-
en-1-yl)pyridine (3.186) This compound was synthesized 
according to a literature procedure.50c  The aldehyde was 
synthesized using a literature procedure from the corresponding commercially available 
alcohol.73 The crude mixture was purified by silica gel chromatography (20 – 30% ethyl 
acetate in hexanes) to afford a clear oil. (345 mg, 26%)  
1H NMR (600 MHz, CDCl3) δ  8.50 (d, J = 5.0 Hz, 1H), 7.54-7.57 (m, 1H), 7.12 (d, J = 
7.8 Hz, 1H), 7.07-7.09 (m, 1H), 6.69 (dt, J = 18.0, 6.3 Hz, 1H), 5.49 (d, J = 18.0 Hz, 1H), 
2.89 (t, J = 9.3 Hz, 2H), 2.63 – 2.52 (m, 2H), 1.25 (s, 12H).  13C NMR (151 MHz, CDCl3): 
δ 161.45, 153.24, 149.44, 136.477, 122.96, 121.26, 83.24, 37.04, 35.76, 24.94.  11B NMR: 
(160 MHz, CDCl3) δ 26.07.  IR (neat): νmax 2978 (w), 2931 (w), 1637 (m), 1360 (s), 1318 
(s), 1270 (s), 1164 (w), 970 (w), 749 (s) cm-1.  HRMS (DART) for C15H23BO2N [M+H]+: 
calculated: 260.1822, found: 260.1835. 
 
 
 
 
                                                
73 Hoover, J. M.; Ryland, B. L.; Stahl, S. S. J. Am. Chem. Soc. 2013, 135, 2357-2367 
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 (E)-4,4,5,5-tetramethyl-2-(penta-1,4-dien-1-yl)-1,3,2-
dioxaborolane (3.187) This compound was synthesized according 
to the procedure above from the commercially available alkyne, and the crude reaction 
mixture was purified by silica gel chromatography (5% ethyl acetate in hexanes) to afford 
a colorless oil. (853.3 mg, 88%) 
1H NMR (600 MHz, CDCl3): δ 6.64 (dt, J = 17.9, 6.1 Hz, 1H), 5.79-5.86 (m, 1H), 5.48 (d, 
J = 18.0 Hz, 1H), 5.02-5.07 (m, 2H), 2.90 (t, J = 6.4 Hz, 2H), 1.26 (s, 12H).  13C NMR 
(151 MHz, CDCl3): δ 151.78, 135.60, 116.39, 83.32, 40.06, 25.02.  11B NMR: (192 MHz, 
CDCl3): δ 29.64.  IR (neat): νmax 2080 (w), 2978 (w), 2931 (w), 2895 (w), 1633 (m), 1358 
(s), 1319 (s), 1143 (s), 996 (m), 848(m) cm-1.  HRMS (DART) for C11H20BO2 [M+H]+: 
calculated: 195.1556, found: 195.1547. 
 
ethyl (E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)acrylate (3.188)  This substrate was prepared according to a 
literature procedure, and all spectra matched the literature.74 
 
(Z)-2-(hex-3-en-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(3.189) This substrate was prepared according to a literature 
procedure, and all spectra matched the literature.75 
                                                
74 Lee, J.-E.; Kwon, J.; Yun, J. Chem. Commun. 2008, 0, 733-734 
75 Bismuto, A.; Thomas, S. P.; Cowley, M. J. Angew. Chem. Int. Ed. 2016, 55, 15356-15359	
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3.5.3 Procedures for the Hydrosilylation of Alkenyl Boronates, 
Determination of Absolute Stereochemistry, and Characterization of 
Reaction Products  
  
Method A: Procedure for Hydrosilylation of Alkenyl Boronates  
In a glove box, Pt(dba)3 (5.4 mg, 0.006 mmol, 0.03 equiv.) and (R,R)-3,5-
diethoxyTADDOLphoshoramidite (11.0 mg, 0.012 mmol, 0.06 equiv.) were added to an 
oven-dried two-dram vial equipped with a stir bar, dissolved in tert-butyl methyl ether 
(0.60 mL) and sealed with a teflon screw cap.  A solution of (E)-4,4,5,5-tetramethyl-2-(3-
phenylprop-1-en-1-yl)-1,3,2-dioxaborolane was prepared (61.3 mg in 0.50 mL, add 0.40 
mL for 48.8 mg, 0.20 mmol, 1.00 equiv.) in a one-dram vial.  Outside the glove box, the 
metal-ligand solution was heated to 80°C for 10 minutes, and allowed to cool to room 
temperature.  Under N2, the platinum-ligand complex was charged with (E)-4,4,5,5-
tetramethyl-2-(3-phenylprop-1-en-1-yl)-1,3,2-dioxaborolane solution (0.40 mL) and 
dimethylphenylsilane (0.038 mL, 0.24 mmol, 1.20 equiv.), sealed with a septa and tape, 
and allowed to stir at room temperature for 14 hours.  The reaction mixture was diluted 
with ether, filtered through a silica gel pipette plug and concentrated under reduce pressure.  
Pt(dba)3 (3%)
Ligand  3.121 (6%) 
HSiMe2Ph (1.2 equiv)
MTBE, r.t., 14 h
R
Bpin R
Bpin
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iPr)phenyl
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O
P
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Ar Ar
Ar Ar
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The crude mixture was purified by silica gel chromatography (large volume pipet, 20% 
dichloromethane in hexanes) to afford a clear oil. (69.2 mg, 91%)  
 
 (R)-dimethyl(phenyl)(3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl)silane (3.40) 1H NMR (600 MHz, CDCl3) 
δ 7.47-7.48 (m, 2H), 7.27-7.34 (m, 3H), 7.23 (t, J = 7.6 Hz, 2H), 7.07-7.17 (m, 3H), 2.63-
2.73 (m, 1H), 2.39-2.50 (m, 1H), 1.92 – 1.82 (m, 1H), 1.57-1.67 (m, 1H), 1.22 (s, 6H), 1.18 
(s, 6H), 0.70 (d, J = 12.4 Hz, 1H), 0.30 (s, 3H), 0.29 (s, 3H).  13C NMR (151 MHz, CDCl3): 
δ 142.81, 139.04, 134.04, 128.98, 128.74, 129.38, 127.79, 125.78, 83.02, 39.65, 28.25, 
25.41, 24.49, -2.06, -3.13.  11B NMR: (160 MHz, CDCl3) δ 34.83.  IR (neat): νmax 3067 
(w), 2976 (m), 2927 (m), 1479 (w), 1378 (s), 1370 (s), 1307 (s), 1143 (s), 966 (w), 814 (s), 
698 (s) cm-1.  HRMS (DART) for C23H37BO2SiN [M+H]+: calculated: 398.2687, found: 
398.267.  [α]20D: +21.39 (c = 1.05, CHCl3, l = 50 mm). 
 
Determination of Absolute Stereochemistry  
Absolute stereochemistry was determined by comparison of the organoboronate optical 
rotation with the literature.26 (Measured: [α]20D: +21.39 (c = 1.05, CHCl3, l = 50 mm), 
Literature [α]20D: +24.0 (c = 1.00, CHCl3), 97:3 er for (R)-dimethyl(phenyl)(3-phenyl-1-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)silane.  The absolute stereochemistry 
was assigned to be (R)-dimethyl(phenyl)(3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl)silane. 
 
 
BpinPh
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Method B: Procedure for the Oxidation of Geminal Silylboronates  
SFC analysis was performed on the oxidized silylboronate.  In a scintillation vial 
equipped with a stir bar and containing (R)-dimethyl(phenyl)(3-phenyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)silane was added THF (3 mL).  The reaction 
vial was cooled to 0°C, charged with 3M sodium hydroxide (0.5 mL) and 29-32% hydrogen 
peroxide (0.50 mL) and allowed to stir at room temperature for 3 hours.  The vial was then 
cooled to 0°C, and quenched with sodium thiosulfate (0.25 mL).  The reaction solution was 
diluted with diethyl ether, and both organic and aqueous phase was passed through a silica 
gel large volume pipet to remove the aqueous layer.  The organic extract was concentrated 
under reduced pressure, and the crude reaction mixture purified by silica gel 
chromatography (large volume pipet, 10% ethyl acetate in hexanes) to afford a clear oil. 
(24.0 mg, 89%) 
 (S)-1-(dimethyl(phenyl)silyl)-3-phenylpropan-1-ol (3.154)  
1H NMR (600 MHz, CDCl3) δ 7.55 (d, J = 8.4 Hz, 2H), 7.34-7.43 (m, 
3H), 7.24-7.31 (m, 2H), 7.15-7.21 (m, 3H), 3.54 (t, J = 7.0 Hz, 1H), 2.85-2.96 (m, 1H), 
2.58-2.68 (m, 1H), 1.77-1.92 (m, 2H), 1.08 (br s, 1H), 0.35 (s, 6H), 0.34 (s, 6H).  13C NMR 
(151 MHz, CDCl3): δ 142.34, 136.66, 134.35, 129.62, 128.72, 128.60, 128.17, 126.01, 
65.09, 35.44, 33.47, -5.23, -5.49.  IR (neat): 3578 (br), 3066 (w), 2954 (m), 2851 (m), 1453 
(m), 1427 (m), 1257 (s), 1112 (s), 829 (s), 698 (s) cm-1.  HRMS (DART) for C17H26OSiN 
[M+NH4]+: calculated: 288.1784, found: 288.1792.  [α]20D:  +5.36 (c = 1.20, CHCl3, l = 50 
mm). 
 
OH
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Analysis of Stereochemistry: 
Racemic compound was prepared according to the hydrosilylation procedure (Method A) 
described using racemic ligand.  Racemic ligand 3.107 was prepared by adding equal 
amounts of both enantiomers into a vial, dissolved in acetonitrile and then concentrated 
under reduced pressure.  The solid was then placed on high vacuum to obtain a well 
dispersed mixture of ligand enantiomers.  
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-1-(dimethyl(phenyl)silyl)-3-phenylpropan-1-ol. 
    
                
RACEMIC            NONRACEMIC 
 
 (R)-dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)hexyl)silane (3.123) Reaction carried out using (R,R)-3,5-
diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 equiv.) according to 
the procedure above (Method A).  The crude reaction was purified by silica gel 
n-butyl
Bpin
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 366 
chromatography (large volume pipet, 5-20% dichloromethane in hexanes) to afford a clear 
oil. (59.5 mg, 86%)  
1H NMR (600 MHz, CDCl3) δ 7.49-7.57 (m, 2H), 7.29-7.36 (m, 3H), 1.49-1.60 (m, 1H), 
1.28-1.37(m, 2H), 1.17-1.27 (m, 11H), 1.16 (s, 6H), 0.84 (t, J = 6.8 Hz, 3H), 0.64 (dd, J = 
11.9, 2.7 Hz, 1H), 0.31 (s, 3H), 0.30 (s, 3H).  13C NMR (151 MHz, CDCl3): δ 139.38, 
134.05, 128.92, 127.76, 82.89, 33.12, 31.82, 25.99, 25.30, 24.89, 22.76, 14.25, -2.13, -3.06.  
11B NMR: (160 MHz, CDCl3) δ 34.42.  IR (neat): 3069 (w), 3049 (w), 2923, (m), 2855 
(w), 1480 (w), 1378 (m), 1348 (s), 1304 (s), 1143 (s), 956 (w), 832 (s), 698 (s) cm-1.  HRMS 
(DART) for C20H39BO2SiN [M+NH4]+: calculated: 364.2843, found: 364.2855.  [α]20D: 
+13.11 (c = 1.19, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 
 (S)-1-(dimethyl(phenyl)silyl)hexan-1-ol (3.190) 
1H NMR (600 MHz, CDCl3) δ 7.52-7.62 (m, 2H), 7.31-7.42 (m, 3H), 
3.51 (t, J = 7.1 Hz, 1H), 1.48-1.59 (m, 2H), 1.18-1.35 (m, 6H), 1.07 (br s, 1H), 0.87 (t, J = 
7.0, 3H), 0.35 (s, 3H), 0.34 (s, 3H).  13C NMR (151 MHz, CDCl3): δ 137.02, 134.33, 
129.49, 128.09, 65.71, 33.58, 31.91, 26.71, 22.83, 14.26, -5.14, -5.44.  IR (neat): 3441 (br), 
3069 (w), 3051 (w), 3011 (m), 2956 (m), 2855 (w), 1427 (w), 1248 (s), 1112 (s), 916 (w), 
n-butyl
OH
3.190
SiMe2Ph
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831 (s), 754 (s), 733 (s), 699 (s) cm-1.  HRMS (DART) for C14H28OSiN [M+NH4]+: 
calculated: 254.194, found 254.1929.  [α]20D: +2.34 (c = 1.26, CHCl3, l = 50 mm). 
Chiral SFC (Chiracel OD-H, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-1-(dimethyl(phenyl)silyl)hexan-1-ol. 
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 (R)-dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)silane (3.124) Reaction carried out using (R,R)-3,5-
diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 equiv.) according to 
the procedure above (Method A).  The crude reaction was purified by silica gel 
chromatography (large volume pipet, 15% dichloromethane in hexanes) to afford a clear 
oil. (40.6 mg, 70%)  
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1H NMR (600 MHz, CDCl3) δ 7.50-7.59 (m, 2H), 7.29-7.38 (m, 3H), 1.20 (s, 6H), 1.18 (s, 
6H), 1.02 (d, J = 7.3 Hz, 3H), 0.61 (q, J = 7.2 Hz, 1H), 0.33 (s, 6H).  13C NMR (126 MHz, 
CDCl3): δ 139.15, 134.07, 128.93, 127.75, 82.88, 25.20, 24.98, 9.53, -2.34, -3.56.  11B 
NMR: (160 MHz, CDCl3) δ 34.58.  IR (neat): 3069 (w), 3048 (w), 2976 (m), 2933 (m), 
2873 (w), 1465 (w), 1305 (m), 1278 (s), 1248 (s), 1144 (s), 1111 (m), 971 (m), 814 (s) 699 
(s) cm-1.  HRMS (DART) for C16H31BO2SiN [M+NH4]+: calculated: 308.2217, found: 
308.2225.  [α]20D: +10.39 (c = 1.02, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (S)-1-(dimethyl(phenyl)silyl)ethan-1-ol (3.191)  
1H NMR (600 MHz, CDCl3) δ 7.53-7.60 (m, 2H), 7.34-7.43 (m, 3H), 3.69 
(q, J = 7.5 Hz, 1H), 1.29 (d, J = 7.5 Hz, 3H), 1.03 (br s, 1H), 0.34 (s, 3H), 0.33 (s, 3H).  
13C NMR (126 MHz, CDCl3): δ 136.69, 134.33, 129.57, 128.13, 61.37, 19.68, -5.50, -5.90.  
IR (neat): 3387 (br), 3069 (w), 3052 (w), 2957 (m), 2925 (w), 2859 (w), 1457 (w), 1248 
(w), 1215 (w), 1114 (w), 832 (s), 812 (s), 774 (s), 700 (s), 600 (w) cm-1.  HRMS (DART) 
for C10H17OSi [M+H]+: calculated: 181.1049, found 181.014.  [α]20D: -12.73 (c = 0.83, 
CHCl3, l = 50 mm). 
Chiral SFC (Chiracel OJ-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-1-(dimethyl(phenyl)silyl)ethan-1-ol. 
Me OH
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 (R)-(2-cyclohexyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2 
yl)ethyl)dimethyl(phenyl)silane (3.125) Reaction carried out using 
(R,R)-3,5-diethoxyTADDOLphosphoramidite (11 mg, 0.012 mmol, 0.06 equiv.) according 
to the procedure above (Method A). The crude reaction was purified by silica gel 
chromatography (large volume pipet, 5-20% dichloromethane in hexanes) to afford a clear 
oil. (45.4 mg, 61%) 
1H NMR (600 MHz, CDCl3): δ 7.50-7.59 (m, 2H), 7.27-7.36 (m, 3H), 1.74 (d, J = 13.1 
Hz, 1H), 1.58-1.71 (m, 4H), 1.49-1.57 (m, 1H), 1.06-1.24 (m, 17H), 0.79-0.88 (m, 1H), 
0.73-0.79 (m, 1H), 0.66-0.73 (m, 1H), 0.31 (d, J = 3.2 Hz, 6H).  13C NMR (151 MHz, 
CDCl3): δ 139.34, 134.06, 128.92, 127.76, 82.91, 40.55, 34.03, 33.36, 32.44, 26.94, 26.69, 
26.61, 25.23, 24.99, -2.14, -3.06.  11B NMR (192 MHz, CDCl3): δ 34.00.  IR (neat): νmax 
3069 (w), 3050 (w), 2977 (w), 2920(m), 1448 (w), 1370 (m), 1307 (s), 1143 (s), 1112(m), 
General Info
Log Author
Log Date
Report By
11/7/2017 12:42:27 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
OJ-H, 100 bar,  5% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
OJ-H
AAS-VII-094-1
P1: 1B
Temp
Flow
% Modifier
Pressure
35.1
3
5
100
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 49.3256 9178.558 3.7 941.0513 0.0049
2 50.6744 9429.5328 4.32 830.3715 0.0057
Total: 100 18608.0908
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-094-2_11-7-2017_12_42_27 PM.tta
General Info
Log Author
Log Date
Report By
11/7/2017 12:56:35 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
OJ-H, 100 bar,  5% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
OJ-H
AAS-VII-099-1
P1: 3B
Temp
Flow
% Modifier
Pressure
35.1
3
5
101
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 4.336 687.387 3.71 90.4779 0.0048
2 95.664 15165.5789 4.33 1397.1265 0.0056
Total: 100 15852.9659
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-099-1_11-7-2017_12_56_35 PM.tta
General Info
Log Author
Log Date
Report By
11/7/2017 12:42:27 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
OJ-H, 100 bar,  5% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
OJ-H
AAS-VII-094-1
P1: 1B
Temp
Flow
% Modifier
Pressure
35.1
3
5
100
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 49.3256 9178.558 3.7 941.0513 0.0049
2 50.6744 9429.5328 4.32 830.3715 0.0057
Total: 100 18608.0908
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-094-2_11-7-2017_12_42_27 PM.tta
General Info
Log Author
Log Date
Report By
11/7/2017 12:56:35 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
OJ-H, 100 bar,  5% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
OJ-H
AAS-VII-099-1
P1: 3B
Temp
Flow
% Modifier
Pressure
35.1
3
5
101
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 4.336 687.387 3.71 90.4779 0.0048
2 95.664 15165.5789 4.33 1397.1265 0.0056
Total: 100 15852.9659
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-099-1_11-7-2017_12_56_35 PM.tta
Bpin
SiMe2Ph
3.125
 370 
815 (s), 699 (s) cm-1.  HRMS (DART) for C22H41BO2SiN [M+NH4]+: calculated: 
390.3000, found: 390.2997.  [α]20D: +11.45 (c = 1.02, CHCl3, l = 50 mm). 
Analysis of Stereochemistry:  
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (S)-2-cyclohexyl-1-(dimethyl(phenyl)silyl)ethan-1-ol (3.192) 
1H NMR (600 MHz, CDCl3): δ 7.53-7.60 (m, 2H), 7.32-7.43 (m, 3H), 
3.68 (d, J = 9.9 Hz, 1H), 1.77-1.89 (m, 1H), 1.58-1.74 (m, 4H), 1.45-1.57 (m, 2H), 1.07-
1.34 (m, 4H), 0.92-1.01 (m, 2H), 0.68-0.82 (m, 1H), 0.34 (s, 3H), 0.33 (s, 3H).  13C NMR 
(151 MHz, CDCl3): δ 136.98, 134.34, 129.49, 128.09, 62.39, 41.07, 34.83, 34.09, 32.17, 
26.89, 26.69, 26.39, -5.28, -5.57.  IR (neat):  3450 (w), 3068 (w), 3048(w), 2920(s), 2849 
(m), 1448 (w), 1247 (m), 1113 (m), 839 (m), 813 (s), 699 (s) cm-1.  HRMS (DART) for 
C16H30OSiN [M+NH4]+: calculated: 280.2097, found: 280.2095.  [α]20D:  +9.13 (c =1.02, 
CHCl3, l = 50 mm). 
Chiral SFC (Chiracel AD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-2-cyclohexyl-1-(dimethyl(phenyl)silyl)ethan-1-ol. 
OH
SiMe2Ph
3.192
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 (R)-(3,3-dimethyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butyl)dimethyl(phenyl)silane (3.126) Reaction carried out using 
(R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 equiv.) 
according to the procedure above (Method A).  The crude reaction was purified by silica 
gel chromatography (large volume pipet, 5-10% dichloromethane in hexanes) to afford a 
clear oil. (16.2 mg, 23%) 
1H NMR (600 MHz, CDCl3): δ 7.50-7.59 (m, 2H), 7.29-7.36 (m, 3H), 1.58 (dd, J = 13.4, 
11.2 Hz, 1H), 1.23 (d, J = 13.4 Hz, 1H), 1.18 (s, 6H), 1.15 (s, 6H), 0.77 (s, 9H), 0.63 (d, J 
= 11.1 Hz, 1H), 0.31 (d, J = 2.7 Hz, 6H).  13C NMR (151 MHz, CDCl3): δ 138.93, 133.94, 
128.73, 127.49, 82.74, 77.22, 77.01, 76.80, 39.56, 31.97, 28.96, 25.12, 24.94, -2.44, -3.41.  
11B NMR (192 MHz, CDCl3): δ 34.00.  IR (neat): νmax 3022 (w), 2977 (w), 2956 (w), 
2866(w), 1476 (w), 1350 (s), 1297 (s), 1247 (m), 1144(s), 835 (s), 816 (s) cm-1.  HRMS 
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(DART) for C20H39BO2SiN [M+NH4]+: calculated: 364.2843, found: 364.2846.  [α]20D: -
0.51 (c = 1.01, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (S)-1-(dimethyl(phenyl)silyl)-3,3-dimethylbutan-1-ol (3.193) 
1H NMR (600 MHz, CDCl3): δ 7.52-7.62 (m, 2H), 7.33-7.42 (m, 3H), 
3.70-3.79 (m, 1H), 1.39-1.48 (m, 2H), 0.92 (s, 9H), 0.32 (s, 3H), 0.31 (s, 3H).  13C NMR 
(151 MHz, CDCl3): δ 136.72, 134.18, 129.33, 127.92, 62.80, 46.83, 31.43, 29.97, -5.60, -
5.87.  IR (neat): 3591 (w), 3483 (w), 3069(w), 2953(m), 2902 (w), 2868 (w), 1467 (w), 
1427 (w), 1364 (w), 1248 (s), 1113 (m), 788 (s), 699 (s) cm-1.  HRMS (DART) for 
C14H28OSiN [M+NH4]+: calculated: 254.194, found 254.1943.  [α]20D:  +0.97 (c =0.41, 
CHCl3, l = 50 mm). 
Chiral SFC (Chiracel AD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-1-(dimethyl(phenyl)silyl)-3,3-dimethylbutan-1-ol. 
tBu
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 (R)-(2-(dimethyl(phenyl)silyl)-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)ethyl)trimethylsilane (3.127) Reaction carried 
out using (R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 
equiv.) according to the procedure above at 70°C (Method A).  The crude reaction was 
purified by silica gel chromatography (large volume pipet, 5-15% dichloromethane in 
hexanes) to afford a clear oil. (52.9 mg, 73%) 
1H NMR (500 MHz, CDCl3): δ 7.49-7.58 (m, 2H), 7.27-7.36 (m, 3H), 1.20 (s, 6H), 1.18 
(s, 6H),  0.77-0.81 (m, 1H), 0.59 (d, J = 11.6 Hz, 1H), 0.44 (d, J = 14.6 Hz, 1H), 0.32 (d, J 
= 5.9, 6H), -0.09 (d, J = 1.6 Hz, 9H).  13C NMR (126 MHz, CDCl3): δ 139.20, 134.16, 
128.94, 127.73, 83.03, 25.52, 25.23, 10.95, -1.65, -2.13, -3.65.  11B NMR (192 MHz, 
CDCl3): δ 34.10.  IR (neat): νmax 3069 (w), 3023 (w), 2977 (w), 2900(w), 1426 (w), 1341 
(s), 1246 (s), 1143 (s), 990(w), 832 (s), 699 (s) cm-1.  HRMS (DART) for C19H39BO2Si2N 
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[M+NH4]+: calculated: 380.2612, found: 380.2621.  [α]20D: -5.03 (c = 1.03, CHCl3, l = 50 
mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (S)-1-(dimethyl(phenyl)silyl)-2-(trimethylsilyl)ethan-1-ol (3.194) 
1H NMR (600 MHz, CDCl3): δ 7.54-7.58 (m, 2H), 7.33-7.44 (m, 3H), 
3.72 (ddd, J = 12.8, 5.8, 2.8 Hz, 1H), 0.63-0.96 (m, 3H), 0.33 (s, 3H), 0.32 (s, 3H), 0.04 (s, 
9H).  13C NMR (151 MHz, CDCl3): δ 136.94, 134.40, 129.51, 128.11, 63.06, 20.96, -0.50, 
-5.46, -5.95.  IR (neat):  3594(w), 3473(w), 3069 (w), 3022(w), 2953(w), 2897 (w), 1427 
(w), 1246 (s), 1113 (m), 943 (w), 831 (s), 700 (s) cm-1.  HRMS (DART) for C13H25Si2O 
[M+NH4]+: calculated: 253.1444, found 253.1440.  [α]20D:  -1.26 (c =1.66, CHCl3, l = 50 
mm). 
Chiral SFC (Chiracel ODR-H, 0% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-1-(dimethyl(phenyl)silyl)-2-(trimethylsilyl)ethan-1-ol. 
Me3Si
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 (R)-dimethyl(4-methyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pentyl)(phenyl)silane (3.128) Reaction carried 
out using (R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 
mg, 0.012 mmol, 0.06 equiv.) according to the procedure above (Method A).  The crude 
reaction was purified by silica gel chromatography (large volume pipet, 10-20% 
dichloromethane in hexanes) to afford a clear oil. (55.4 mg, 80%)  
1H NMR (600 MHz, CDCl3) δ 7.70-7.53 (m, 2H), 7.29-7.36 (m, 3H), 1.42-1.60 (m, 2H), 
1.29-1.40 (m, 2H), 1.20 (s, 6H), 1.10-1.18 (m, 7H), 0.75-0.84 (m, 6H), 0.59 (dd, J = 11.8, 
3.3 Hz, 1H), 0.32 (s, 3H), 0.31 (s, 3H).  13C NMR (151 MHz, CDCl3): δ 139.40, 134.05, 
128.92, 127.76, 82.89, 42.85, 27.84, 25.34, 24.85, 23.78, 23.17, 22.42, -2.14, -3.02.  11B 
NMR: (160 MHz, CDCl3) δ 34.61.  IR (neat): 3069 (w), 3049 (w), 2976 (m), 2954 (m), 
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2687 (w), 1480 (w), 1378 (w), 1348 (s), 1304 (s), 1248 (m), 1143 (s), 1112 (m), 814 (s), 
699 (s) cm-1.  HRMS (DART) for C20H39BO2SiN [M+NH4]+: calculated: 364.2843, found: 
364.285.  [α]20D: +12.16 (c = 1.11, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate product. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel AD-H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-dimethyl(4-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentyl)(phenyl)silane. 
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 (R)-(5-chloro-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentyl)dimethyl(phenyl)silane (3.129) Reaction carried out 
using (R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 mg, 
0.012 mmol, 0.06 equiv.) according to the procedure above (Method A).  The crude 
reaction was purified by silica gel chromatography (large volume pipet, 20% 
dichloromethane in hexanes) to afford a clear oil. (61.7 mg, 84%)  
1H NMR (600 MHz, CDCl3) δ 7.49-7.57 (m, 2H), 7.31-7.38 (m, 3H), 3.45 (t, J = 6.8 Hz, 
2H), 1.63-1.78 (m, 2H), 1.43-1.63 (m, 2H), 1.25-1.40 (m, 2H), 1.21 (s, 6H), 1.17 (s, 6H), 
0.64 (dd, J = 11.9, 2.8 Hz, 1H), 0.33 (s, 3H), 0.32 (s, 3H).  13C NMR (151 MHz, CDCl3): 
δ 139.04, 133.99, 129.02, 127.81, 83.02, 45.26, 32.62, 30.55, 25.36, 25.32, 24.89, -2.12, -
3.19.  11B NMR: (160 MHz, CDCl3) δ 34.58. IR (neat): 3068 (w), 2976 (m), 2956 (m), 
2857 (w), 1445 (w), 1350 (s), 1305 (s), 1143 (s), 1112 (m), 967 (w), 816 (s), 699 (m) cm-
1.  HRMS (DART) for C19H32BClO2SiN [M+NH4]+: calculated: 384.2297, found: 
384.2315.  [α]20D: +35.85 (c = 1.03, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (S)-5-chloro-1-(dimethyl(phenyl)silyl)pentan-1-ol (3.195) 
1H NMR (600 MHz, CDCl3) δ 7.52-7.59 (m, 2H), 7.33-7.43 (m, 3H), 
3.46-3.56 (m, 3H), 1.65-1.87 (3H), 1.54 (q, J = 7.6 Hz, 2H), 1.39-
Bpin
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1.49 (m, 1H), 1.06 (br s, 1H), 0.35 (s, 3H), 0.34 (s, 3H).  13C NMR (151 MHz, CDCl3): δ 
136.65, 134.31, 129.63, 128.18, 65.44, 45.19, 32.82, 32.64, 24.46, -5.22, -5.49.  IR (neat): 
3426 (br), 3086 (w), 3069 (w), 2954 (m), 2861 (w), 1145 (m), 1407 (w), 1248 (s), 1112 
(s), 933 (w), 833 (s), 777 (s), 700 (s) cm-1.  HRMS (DART) for C13H25ClOSiN [M+NH4]+: 
calculated: 274.1394, found 274.1398.  [α]20D: +4.09 (c = 1.29, CHCl3, l = 50 mm). 
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-5-chloro-1-(dimethyl(phenyl)silyl)pentan-1-ol.  
  
         
    RACEMIC                          NONRACEMIC 
 
 (R)-(4-bromo-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butyl)dimethyl(phenyl)silane (3.130) Reaction carried out using 
(R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 
mmol, 0.06 equiv.) according to the procedure above (Method A). The crude reaction was 
purified by silica gel chromatography (large volume pipet, 20% dichloromethane in 
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hexanes) to afford a clear oil. (69.1 mg, 87%) 
1H NMR (600 MHz, CDCl3): δ 7.56 – 7.48 (m, 2H), 7.30-7.38 (m, 3H), 3.27-3.36 (m, 2H), 
1.86-1.98 (m, 1H), 1.71-1.81 (m, 1H), 1.59-1.68 (m, 1H), 1.41-1.51 (m, 1H), 1.20 (s, 6H), 
1.17 (s, 6H), 0.64 (dd, J = 12.0, 3.4 Hz, 1H), 0.34 (s, 3H), 0.33 (s, 3H).  13C NMR (151 
MHz, CDCl3): δ 138.76, 134.00, 129.09, 127.84, 83.11, 36.21, 33.54, 25.33, 24.89, 24.79, 
-2.17, -3.17.  11B NMR (192 MHz, CDCl3): δ 34.20.  IR (neat): νmax 3069 (w), 3048 (w), 
2977 (w), 2932 (w), 1480 (w), 1351 (s), 1254 (s), 1144 (s), 1112(w), 835 (m), 817 (m) cm-
1.  HRMS (DART) for C18H34BBrO2SiN [M+NH4]+: calculated: 414.1635, found: 
414.1650.  [α]20D: +20.98 (c = 1.05, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate product. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel OJ-H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-(4-bromo-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butyl)dimethyl(phenyl)silane 
 
 
 380 
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 (R)-tert-butyl(4-(dimethyl(phenyl)silyl)-4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)butoxy)dimethylsilane (3.131) Reaction 
carried out using (R,R)-3,5-diisopropoxyTADDOLphosphoramidite 
(12.4 mg, 0.012 mmol, 0.06 equiv.) according to the procedure above (Method A).  The 
crude reaction was purified by silica gel chromatography (large volume pipet, 25-50% 
dichloromethane in hexanes) to afford a clear oil. (77.1 mg, 86%)  
1H NMR (600 MHz, CDCl3) δ 7.48-7.57 (m, 2H), 7.30-7.36 (m, 3H), 3.47-3.58 (m, 2H), 
1.56-1.65 (m, 1H), 1.46-1.56 (m, 1H), 1.34-1.45 (m, 2H), 1.20 (s, 6H), 1.16 (s, 6H), 0.86 
(s, 9H), 0.63 (dd, J = 12.0, 3.0 Hz, 1H), 0.32 (d, J = 1.9 Hz, 6H), 0.00 (s, 6H).  13C NMR 
(151 MHz, CDCl3): δ 139.17, 134.04, 128.95, 127.77, 82.93, 63.23, 36.50, 26.17, 25.31, 
24.39, 22.28, 18.52, -2.15, -3.08, -5.02, -5.04.  11B NMR: (160 MHz, CDCl3) δ 34.49.  IR 
(neat): 3069 (w), 3052 (w), 2977 (w), 2953 (m), 2856 (w), 1470 (w), 1378 (s), 1249 (s), 
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1143 (s), 1099 (s), 969 (w), 823 (s), 773 (s), 663 (m) cm-1.  HRMS (DART) for 
C24H49BO3Si2N [M+NH4]+: calculated: 466.3344, found: 466.3365.  [α]20D: +30.68 (c = 
1.08, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (S)-4-((tert-butyldimethylsilyl)oxy)-1-
(dimethyl(phenyl)silyl)butan-1-ol (3.196)   
1H NMR (600 MHz, CDCl3) δ 7.51-7.63 (m, 2H), 7.32-7.40 (m, 3H), 
3.59-3.68 (m, 2H), 3.50 (dd, J = 11.3, 2.1 Hz, 1H), 2.19 (br s, 1H), 1.59-1.75 (m, 3H), 0.89 
(s, 9H), 0.34 (s, 3H), 0.33 (s, 3H), 0.05 (d, J = 1.9 Hz, 6H).  13C NMR (151 MHz, CDCl3): 
δ 137.32, 134.36, 129.39, 128.03, 65.07, 63.42, 30.77, 30.73, 26.13, 18.51, -5.15, -5.23, -
5.29.  IR (neat): 3427 (br), 3087 (w), 3020 (m), 2953 (m), 2867 (m), 1462 (w), 1360 (w), 
1302 (s), 1098 (s), 1004 (w), 830 (s), 772 (s), 698 (s) cm-1.  HRMS (DART) for 
C18H35O2Si2 [M+H]+: calculated: 339.2176, found 339.2187.  [α]20D: +1.55 (c = 1.18, 
CHCl3, l = 50 mm). 
Chiral SFC (Chiracel OJ-H, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-4-((tert-butyldimethylsilyl)oxy)-1-(dimethyl(phenyl)silyl)butan-1-ol.  
OH
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 (R)-dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)pent-4-en-1-yl)silane (3.132) Reaction carried out using (R,R)-
3,5-diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 equiv.) according 
to the procedure above (Method A). The crude reaction was purified by silica gel 
chromatography (large volume pipet, 2-15% dichloromethane in hexanes) to afford a clear 
oil. (39.0 mg, 59%) 
1H NMR (600 MHz, CDCl3): δ 7.50-7.56 (m, 2H), 7.27-7.34 (m, 3H), 5.70-5.81 (m, 1H), 
4.82-5.03 (m, 2H), 2.05-2.19 (m, 1H), 1.89-2.01 (m, 1H), 1.61-1.71 (m, 1H), 1.36-1.46 (m, 
1H), 1.20 (s, 6H), 1.16 (s, 6H), 0.68 (dd, J = 12.1, 3.2 Hz, 1H), 0.32 (d, J = 4.2 Hz, 6H).  
13C NMR (151 MHz, CDCl3): δ 139.13, 139.06, 134.05, 128.98, 127.79, 114.92, 82.98, 
37.46, 25.54, 25.33, 24.96, -2.11, -3.09.  11B NMR (192 MHz, CDCl3): δ 34.30.  IR (neat): 
General Info
Log Author
Log Date
Report By
7/19/2017 12:30:35 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
OJ-H, 100 bar,  2%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
11
IPA
OJ-H
AAS-VII-001-1
P1: 2B
Temp
Flow
% Modifier
Pressure
35.2
3
2
99
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 50.3974 4358.336 3.65 443.5166 0.0049
2 49.6026 4289.5939 4.17 392.294 0.0056
Total: 100 8647.9299
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-001-4_7-19-2017_12_30_35 PM.tta
General Info
Log Author
Log Date
Report By
11/8/2017 11:38:38 AM
current_User
Report Date
Method Name
Notes
11/8/2017
EKE.met
OJ-H, 100 bar,  2% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
OJ-H
AAS-VII-050-1
P1: 3B
Temp
Flow
% Modifier
Pressure
35
3
2
103
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 5.1347 577.4277 3.64 52.0909 0.0052
2 94.8653 10668.1874 4.15 811.0523 0.0059
Total: 100 11245.6151
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-050-1_11-8-2017_11_38_38 AM.tta
General Info
Log Author
Log Date
Report By
7/19/2017 12:30:35 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
OJ-H, 100 bar,  2%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
11
IPA
OJ-H
AAS-VII-001-1
P1: 2B
Temp
Flow
% Modifier
Pressure
35.2
3
2
99
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 50.3974 4358.336 3.65 443.5166 0.0049
2 49.6026 4289.5939 4.17 392.294 0.0056
Total: 10 8647.9299
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-001-4_7-19-2017_12_30_35 PM.tta
General Info
Log Author
Log Date
Report By
11/8/2017 11:38:38 AM
current_User
Report Date
Method Name
Notes
11/8/2017
EKE.met
OJ-H, 100 bar,  2% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
OJ-H
AAS-VII-050-1
P1: 3B
Temp
Flow
% Modifier
Pressure
35
3
2
103
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 5. 347 577 4277 3.64 52.0909 0.0052
2 94.8653 10668.1874 4.15 811.0523 0.0059
Total: 100 11245.6151
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-050-1_11-8-2017_11_38_38 AM.ttaBpin
3.132
SiMe2Ph
 383 
νmax 3070 (w), 3049 (w), 2972 (w), 2925(m), 1639 (w), 1350 (m), 1306 (m), 1143 (s), 
1112(m), 848 (m), 699 (m) cm-1. HRMS (DART) for C19H35NO2BSi [M+NH4]+: 
calculated: 348.2530, found: 348.2538.  [α]20D: +14.97 (c = 1.08, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate product. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel AD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-
yl)silane. 
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ethyl (R)-3-(dimethyl(phenyl)silyl)-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propanoate (3.133) Reaction carried out using 
(R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 
mmol, 0.06 equiv.) according to the procedure above at 70°C (Method A).  The crude 
reaction was purified by silica gel chromatography (5% ethyl acetate in hexanes) to afford 
a clear oil. (29.1 mg, 40%)  
1H NMR (600 MHz, CDCl3) δ 7.51 (dd, J = 6.4, 3.0 Hz, 2H), 7.27-7.38 (m, 3H), 3.94-4.14 
(m, 2H), 2.49 (dd, J = 17.3, 12.8 Hz, 1H), 2.24 (dd, J = 17.3, 3.8 Hz, 1H), 1.19-1.25 (m, 
9H), 1.16 (s, 6H), 1.00 (dd, J = 12.8, 3.8 Hz, 1H), 0.34 (d, J = 1.5 Hz, 6H).  13C NMR (151 
MHz, CDCl3): δ 175.00, 138.13, 134.01, 129.25, 127.95, 83.21, 60.53, 31.12, 25.22, 24.90, 
14.47, -2.26, -3.54.  11B NMR: (160 MHz, CDCl3) δ 30.36.  IR (neat): 3070 (w), 3051 (w), 
2977 (m), 2928 (m), 2852 (w), 1732 (s), 1427 (w), 1370 (s), 1337 (s), 1248 (s), 1139 (s), 
1035 (m), 971 (m), 835 (s), 753 (s), 700 (s), 666 (s), cm-1.  HRMS (ESI) for 
C19H31BO4SiNa [M+Na]+: calculated: 385.1995, found: 385.199493.  [α]20D: +16.59 (c = 
1.16, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate product. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel AD-H, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of ethyl (R)-3-(dimethyl(phenyl)silyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propanoate. 
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Note: the racemic trace contains the peak for the other regioisomer of hydrosilylation (ethyl 3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate) that is difficult to isolate from the silylboronate. 
 
 
methyl  (R)-6-(dimethyl(phenyl)silyl)-6-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)hexanoate (3.134) Reaction carried out 
using (R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 
mg, 0.012 mmol, 0.06 equiv.) according to the procedure above (Method A). The crude 
reaction was purified by silica gel chromatography (large volume pipet, 5% ethyl acetate 
in hexanes) to afford a clear oil. (65.6 mg, 84%) 
1H NMR (600 MHz, CDCl3): δ 7.45-7.58 (m, 2H), 7.37-7.34 (m, 3H), 3.63 (s, 3H), 2.19-
2.26 (m, 2H), 1.50-1.61 (m, 3H), 1.27-1.41 (m, 2H), 1.21-1.27 (m, 1H), 1.20 (s, 6H), 1.17 
(s, 6H) 0.62 (dd, J = 12.0, 2.9 Hz, 1H), 0.31 (s, 3H), 0.30 (s, 3H).  13C NMR (151 MHz, 
CDCl3): δ 176.84, 141.56, 136.44, 131.42, 130.23, 85.39, 54.00, 36.66, 35.30, 28.10, 27.75, 
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27.41, 27.32, 0.30, -0.70.  11B NMR (192 MHz, CDCl3): δ 34.20.  IR (neat): νmax 3068 (w), 
3048 (w), 2976 (w), 2930 (w), 1739 (m), 1590 (w), 1370 (s), 1306 (m), 1143(s), 1112 (m), 
846 (s) cm-1.  HRMS (ESI) for C21H35BO4SiNa [M+Na]+: calculated: 413.2295, found: 
413.2298.  [α]20D: +17.42 (c = 1.03, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate product. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel AD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of methyl (R)-6-(dimethyl(phenyl)silyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hexanoate. 
    
     
  RACEMIC            NONRACEMIC 
 
General Info
Log Author
Log Date
Report By
7/29/2017 4:44:38 PM
current_User
Report Date
Method Name
Notes
11/13/2017
EKE.met
aD-H, 100 bar,  5%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
11
IPA
AD-H
CZ-1-214
P1: 1C
Temp
Flow
% Modifier
Pressure
35.2
3
5
98
Peak Info
Peak No % Area Area T (min) Height (mV) K'
1 48.8245 3287.0061 2.4 555.986 0.0024
2 51.1755 3445.288 2.94 477.3556 0.0029
Total: 100 6732.2941
TharSFC
C:\Program Files\SuperChrom\logs\Data\CZ\CZ-1-214-1_7-29-2017_4_44_38 PM.tta
General Info
Log Author
Log Date
Report By
7/29/2017 4:52:25 PM
current_User
Report Date
Method Name
Notes
11/13/2017
EKE.met
aD-H, 100 bar,  5%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
11
IPA
AD-H
CZ-1-213
P1: 1C
Temp
Flow
% Modifier
Pressure
35
3
5
99
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 4.4398 407.0907 2.42 73.5027 0.0024
2 95.5602 8762.0366 2.96 1129.1088 0.0029
Total: 100 9169.1273
TharSFC
C:\Program Files\SuperChrom\logs\Data\CZ\CZ-1-213-1_7-29-2017_4_52_25 PM.tta
General Info
Log Author
Log Date
Report By
7/29/2017 4:44:38 PM
current_User
Report Date
Method Name
Notes
11/13/2017
EKE.met
aD-H, 100 bar,  5%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
11
IPA
AD-H
CZ-1-214
P1: 1C
Temp
Flow
% Modifier
Pressure
35.2
3
5
98
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 48.8245 3287.0061 2.4 555 986 0.0024
2 51.1755 3445.288 2.94 477.3556 0.0029
Total: 100 6732.2941
TharSFC
C:\Program Files\SuperChrom\logs\Data\CZ\CZ-1-214-1_7-29-2017_4_44_38 PM.tta
General Info
Log Author
Log Date
Report By
7/29/2017 4:52:25 PM
current_User
Report Date
Method Name
Notes
11/13/2017
EKE.met
aD-H, 100 bar,  5%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
11
IPA
AD-H
CZ-1-213
P1: 1C
Temp
Flow
% Modifier
Pressure
35
3
5
99
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 4.4398 407.0907 2.42 73.5027 0.0024
2 95.5602 8762.0366 2.96 1129.1088 0.0029
Total: 100 9169.1273
TharSFC
C:\Program Files\SuperChrom\logs\Data\CZ\CZ-1-213-1_7-29-2017_4_52_25 PM.tta
 387 
 (R)-4-(dimethyl(phenyl)silyl)-4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)butyl 4-oxopentanoate (3.135) 
Reaction carried out using (R,R)-3,5-
diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 equiv.) according to 
the procedure above (Method A). The crude reaction was purified by silica gel 
chromatography (large volume pipet, 15%-20% ethyl acetate in hexanes) to afford a clear 
oil. (71.8 mg, 83%) 
1H NMR (600 MHz, CDCl3): δ 7.45-7.58 (m, 2H), 7.30-7.39 (m, 3H), 3.93-4.02 (m, 2H), 
2.68 (t, J = 6.7 Hz, 2H), 2.51 (t, J = 6.7 Hz, 2H), 2.16 (s, 3H), 1.64-1.73 (m, 1H), 1.43-1.61 
(m, 1H), 1.45-1.53 (m, 1H), 1.36-1.41 (m, 1H), 1.20 (s, 6H), 1.17 (s, 6H), 0.62 (dd, J = 
11.8, 3.3 Hz, 1H), 0.31 (s, 3H), 0.30 (s, 3H).  13C NMR (151 MHz, CDCl3): δ 206.68, 
172.75, 138.81, 133.89, 128.93, 127.71, 82.95, 64.63, 38.06, 31.84, 29.97, 28.10, 25.23, 
24.80, 22.29, -2.22, -3.33.  11B NMR (192 MHz, CDCl3): δ 34.10.  IR (neat): νmax 3069 
(w), 3049 (w), 2976 (w), 2867 (w), 1734 (s), 1721 (s), 1351 (s), 1306 (m), 1143(s), 1112 
(w), 836 (m) cm-1.  HRMS (ESI) for C23H37BO5SiNa [M+Na]+: calculated: 455.2401, 
found: 455.2405.  [α]20D: +15.37 (c = 1.03, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate product. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel AD-H, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-4-(dimethyl(phenyl)silyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butyl 4-
oxopentanoate. 
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 (R)-2-(4-(dimethyl(phenyl)silyl)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)butyl)pyridine (3.137)  Reaction carried out 
using (R,R)-3,5-diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 
equiv.) according to the procedure above (Method A).  The crude reaction was purified by 
silica gel chromatography (large volume pipet, 5-10% ethyl acetate in hexanes) to afford a 
clear oil. (48.9 mg, 62%)  
1H NMR (600 MHz, CDCl3) δ 8.47 (d, J = 4.8 Hz, 1H), 7.43-7.55 (m, 3H), 7.27-7.35 (m, 
2H), 6.99-7.08 (m, 2H), 2.64-2.79 (m, 2H), 1.72-1.82 (m, 1H), 1.55-1.69 (m, 2H), 1.34-
1.44 (m, 1H), 1.19 (s, 6H), 1.15 (s, 6H), 0.66-0.71 (m, 1H), 0.30 (s, 6H).  13C NMR (151 
MHz, CDCl3): δ 162.62, 149.31, 139.12, 136.32, 134.03, 128.91, 127.76, 122.73, 120.97, 
82.93, 38.45, 33.42, 25.88, 25.35, 24.98, -2.09, -3.14.  11B NMR: (160 MHz, CDCl3) δ 
31.05.  IR (neat): 3068 (w), 3045 (w), 2976 (m), 2925 (m), 2854 (w), 1589 (m), 1473 (w), 
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1459 (w), 1349 (s), 1304 (s), 1143 (s), 1111 (m), 967 (w), 815 (s), 699 (s) cm-1.  HRMS 
(DART) for C23H35BO2SiN [M+H]+: calculated: 396.2534, found: 396.2551.  [α]20D: 
+15.92 (c = 1.17, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel AD-H, 15% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-2-(4-(dimethyl(phenyl)silyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butyl)pyridine. 
   
              
RACEMIC                     NONRACEMIC 
 
 
General Info
Log Author
Log Date
Report By
7/10/2017 6:36:56 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
AD-H, 100 bar,  15%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
19
IPA
AD-H
CZ-1-194
P1: 1C
Temp
Flow
% Modifier
Pressure
34.9
3
15
102
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 50.4067 5775.0746 2.05 1355.4842 0.0018
2 49.5933 5681.876 2.44 1180.5614 0.0022
Total: 100 11456.9506
TharSFC
C:\Program Files\SuperChrom\logs\Data\CZ\CZ-1-194-1_7-10-2017_6_36_56 PM.tta
General Info
Log Author
Log Date
Report By
11/7/2017 3:32:57 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
AD-H, 100 bar,  15% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
AD-H
AAS-VII-088-1
P1: 1B
Temp
Flow
% Modifier
Pressure
35.1
3
15
104
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 5.1445 408.195 2.07 68.7968 0.0022
2 94.8555 7526.3499 2.43 1126.773 0.0026
Total: 100 7934.5449
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-088-1_11-7-2017_3_32_57 PM.tta
General Info
Log Author
Log Date
Report By
7/10/2017 6:36:56 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
AD-H, 100 bar,  15%  IPA 3.0 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
19
IPA
AD-H
CZ-1-194
P1: 1C
Temp
Flow
% Modifier
Pressure
34.9
3
15
102
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 50.4067 5775.0746 2.05 1355.4842 0.0018
2 49.5933 5681.876 2.44 1180.5614 0.0022
Total: 100 11456.9506
TharSFC
C:\Program Files\SuperChrom\logs\Data\CZ\CZ-1-194-1_7-10-2017_6_36_56 PM.tta
General Info
Log Author
Log Date
Report By
11/7/2017 3:32:57 PM
current_User
Report Date
Method Name
Notes
11/7/2017
EKE.met
AD-H, 100 bar,  15% IPA, 3 mL/min, 35 deg C
Injection Info
Inj Vol
Solvent
Column
Sample
Well location
10
IPA
AD-H
AAS-VII-088-1
P1: 1B
Temp
Flow
% Modifier
Pressure
35.1
3
15
104
Peak Info
Peak No % Area Area RT (min) Height (mV) K'
1 5.1445 408.195 2.07 68.7968 0.0022
2 94.8555 7526.3499 2.43 1126.773 0.0026
Total: 100 7934.5449
TharSFC
C:\Program Files\SuperChrom\logs\Data\AAS\AAS-VII-088-1_11-7-2017_3_32_57 PM.tta
 390 
 (R)-dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-5-(thiophen-2-yl)pentyl)silane (3.136)  
Reaction carried out using (R,R)-3,5-
diisopropoxyTADDOLphosphoramidite (12.4 mg, 0.012 mmol, 0.06 equiv.) according to 
the procedure above (Method A).  The crude reaction was purified by silica gel 
chromatography (large volume pipet, 5-15% dichloromethane in hexanes) to afford a clear 
oil. (59.3 mg, 74%) 
1H NMR (600 MHz, CDCl3): δ 7.49-7.60 (m, 2H), 7.27-7.35 (m, 3H), 7.08 (dd, J = 5.1, 
1.2 Hz, 1H), 6.89 (dd, J = 5.2, 3.4 Hz, 1H), 6.73 (d, J = 3.3 Hz, 1H), 2.75 (t, J = 7.6 Hz, 
2H), 1.50-1.72 (m, 2H), 1.39-1.49 (m, 1H), 1.32-1.39 (m, 1H), 1.22-1.32 (m, 2H), 1.20 (s, 
6H), 1.16 (s, 6H), 0.65 (dd, J = 12.0, 3.2 Hz, 1H), 0.34 (s, 3H), 0.33 (s, 3H).  13C NMR 
(151 MHz, CDCl3): δ 145.94, 139.21, 134.02, 128.97, 127.79, 126.75, 124.08, 122.82, 
82.93, 32.82, 31.71, 29.96, 25.75, 25.28, 24.89, -2.10, -3.14.  11B NMR (192 MHz, CDCl3): 
δ 34.20.  IR (neat): νmax 3068 (w), 3021 (w), 2977 (w), 2928(w), 1440 (w), 1349 (s), 1247 
(m), 1144 (s), 968(m), 835 (s), 697 (s) cm-1.  HRMS (DART) for C23H39BO2SSiN 
[M+NH4]+: calculated: 432.2564, found: 432.2577.  [α]20D: +14.13 (c = 1.04, CHCl3, l = 
50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed directly on the silylboronate product. Racemic product was 
synthesized according to the procedure above (Compound 3.154).   
Chiral SFC (Chiracel ODR-H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(thiophen-2-
yl)pentyl)silane.  
S Bpin
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 (S)-benzyldimethyl(3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl)silane (3.140)  Reaction carried out using 
(S,S)-3,5-diethoxyoxyTADDOLphosphoramidite (11.0 mg, 0.012 mmol, 0.06 equiv.) 
according to the procedure above (Method A).  The crude reaction was purified by silica 
gel chromatography (large volume pipet, 15-30% dichloromethane in hexanes) to afford a 
clear oil. (62 mg, 79%)  
1H NMR (600 MHz, CDCl3) δ 7.30 (t, J = 7.6 Hz, 2H), 7.17-7.24 (m, 5H), 7.07 (t, J = 7.4 
Hz, 1H), 6.99 (d, J = 7.5 Hz, 2H), 2.69-2.82 (m, 1H), 2.43-2.56 (m, 1H), 2.09-2.21 (m, 
2H), 1.87-1.99 (m, 1H), 1.66-1.76 (m, 1H), 1.30 (s, 6H), 1.29 (s, 6H), 0.53 (dd, J = 12.3, 
2.9 H, 0.00 (d, J = 2.0 Hz, 1H)z, 6H).  13C NMR (151 MHz, CDCl3): δ 142.91, 140.40, 
128.75, 128.45, 128.38, 128.31, 125.85, 124.05, 83.04, 39.78, 28.32, 25.50, 25.32, 24.97, 
-3.19, -3.59.  11B NMR: (160 MHz, CDCl3) δ 34.39.  IR (neat): 3082 (w), 3060 (w), 2976 
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(m), 2925 (m), 1600 (w), 1493 (m), 1350 (s), 1305 (s), 1142 (s), 993 (w), 830 (s), 697 (s) 
cm-1.  HRMS (DART) for C24H39BO2SiN [M+NH4]+: calculated: 412.2843, found: 
412.2844.  [α]20D: -17.42 (c = 1.03, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (R)-1-(benzyldimethylsilyl)-3-phenylpropan-1-ol (3.197) 
1H NMR (600 MHz, CDCl3) δ 7.27-7.34 (m, 2H), 7.17-7.24 (m, 5H), 
7.09 (t, J = 7.4 Hz, 1H), 7.02 (d, J = 7.4 Hz, 2H), 3.40 (dd, J = 11.1, 3.0 Hz, 1H), 2.88-2.98 
(m, 1H), 2.58-2.70 (m, 1H), 2.11-2.25 (m, 2H), 1.73-1.92 (m, 2H), 1.08 (br s, 1H), 0.04 (s, 
3H), 0.01 (s, 3H).  13C NMR (151 MHz, CDCl3): δ 142.30, 139.83, 128.70, 128.65, 128.56, 
128.30, 126.07, 124.39, 64.52, 35.62, 33.49, 23.48, -5.44, -5.80.  IR (neat): 3457 (br), 3081 
(w), 3060 (w), 2999 (m), 2953 (m), 2922 (w), 1599 (m), 1493 (s), 1247 (s), 1056 (m), 798 
(s), 698 (s) cm-1.  HRMS (DART) for C18H25OSi [M+H]+: calculated: 285.1675, found 
285.1663.  [α]20D: -15.98 (c = 1.33, CHCl3, l = 50 mm). 
Chiral SFC (Chiracel OJ-H, 12% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-1-(benzyldimethylsilyl)-3-phenylpropan-1-ol. 
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 (S)-methyldiphenyl(3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl)silane (3.142) Reaction carried out using 
(S,S)-3,5-diethoxyoxyTADDOLphosphoramidite (11.0 mg, 0.012 mmol, 0.06 equiv.) 
according to the procedure above (Method A).  The crude reaction was purified by silica 
gel chromatography (large volume pipet, 20-33% dichloromethane in hexanes) to afford a 
clear oil. (71.7 mg, 81%)  
1H NMR (600 MHz, CDCl3) δ 7.49-7.56 (m, 4H), 7.29-7.39 (m, 6H), 7.26 (t, J = 8.6 Hz, 
2H), 7.16-7.20 (m, 1H), 7.12 (d, J = 7.6 Hz, 2H), 2.69-2.08 (m, 1H), 2.46-2.55 (m, 1H), 
1.96-2.05 (m, 1H), 1.72-1.81 (m, 1H), 1.15 (s, 6H), 1.03-1.12 (m, 7H), 0.63 (s, 3H).  13C 
NMR (151 MHz, CDCl3): δ 142.57, 137.16, 137.08, 135.03, 134.95, 129.20, 128.82, 
128.40, 127.84, 127.77, 125.84, 83.08, 39.64, 28.52, 25.24, 24.81, -3.94.  11B NMR: (160 
MHz, CDCl3) δ 34.58.  IR (neat): 3085 (w), 3068 (w), 3024 (w), 2926 (m), 2859 (m), 1480 
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(w), 1370 (m) 1351 (s), 1308 (s), 1143 (s), 1109 (m), 846 (m), 698 (s) cm-1.  HRMS 
(DART) for C28H39BO2SiN [M+NH4]+: calculated: 460.2843, found: 460.2851.  [α]20D: -
10.24 (c = 1.02, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate obtained according to procedure 
above (Method B) and purified by silica gel chromatography (large volume pipet, 10% 
ethyl acetate in hexanes) to afford a clear oil.  Racemic product was synthesized according 
to the procedure above (Compound 3.154).   
 (R)-1-(methyldiphenylsilyl)-3-phenylpropan-1-ol (3.198) 
1H NMR (600 MHz, CDCl3) δ 7.61 (d, J = 6.8 Hz, 2H), 7.57 (d, J = 7.1 
Hz, 2H), 7.32-7.45 (m, 6H), 7.25-7.31 (m, 2H), 7.13-7.22 (m, 3H), 3.88-3.98 (m, 1H), 2.89-
3.00 (m, 1H), 2.60-2.73 (m, 1H), 1.88-1.99 (m, 2H), 1.20 (d, J = 5.1 Hz, 1H), 0.62 (s, 3H).  
13C NMR (151 MHz, CDCl3): δ 142.20, 135.29, 135.13, 134.97, 134.73, 129.86, 129.83, 
128.76, 128.58, 128.24, 126.01, 64.09, 35.42, 33.45, -6.43.  IR (neat): 3438 (br), 3067 (w), 
3024 (w), 2924 (w), 2851 (w), 1495 (w), 1427 (m), 1251 (m), 1111 (s), 998 (m), 788 (m), 
728 (m), 698 (s) cm-1.  HRMS (DART) for C22H28OSiN [M+NH4]+: calculated: 350.194, 
found 350.1941.  [α]20D: -5.19 (c = 1.08, CHCl3, l = 50 mm). 
Chiral SFC (Chiracel OD-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (R)-1-(methyldiphenylsilyl)-3-phenylpropan-1-ol.   
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 3.5.4 Procedure for Gram-Scale Hydrosilylation Outside of Glove-
Box 
 
 A 100 mL two-neck round bottom flask equipped with a stir bar and condenser was 
flame-dried.  Pt(dba)3 (107 mg, 0.119 mmol, 0.01 equiv) and (R,R)-3,5- 
diethoxyTADDOLphoshoramidite (219 mg, 0.238 mmol, 0.02 equiv) were weighed out 
open to air, and transferred to the flame-dried round bottom flask.  The round bottom flask 
was purged of air by vacuum and back-filled with nitrogen three times.  Under nitrogen, 
MTBE (10 mL) was added and the reaction was allowed to reflux at 80°C for 10 minutes.  
The reaction flask was cooled to room temperature, and (E)-4,4,5,5-tetramethyl-2-(3-
phenylprop-1-en-1-yl)-1,3,2-dioxaborolane (2.91g, 11.9 mmol, 1.00 quiv) was added as a 
solution of MTBE. (8 mL) Dimethylphenylsilane (2.19 mL, 14.3 mmol, 1.20 equiv) was 
then added and the reaction was allowed to stir at room temperature overnight for 16 hours.  
The reaction was then diluted with ether, filtered through a pad of silica and concentrated 
under reduced pressure.  The crude mixture was then purified by silica gel chromatography 
(20-50% dichloromethane in hexanes) to afford a clear oil. (4.036g, 89%)  
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O
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O
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EtO
EtO
EtO
OEt
OEt
EtO OEt
P N
(2%)
3.120
MTBE (0.67M), r.t., 16 h
B
SiMe2Ph
O
O
3.97
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Analysis of Stereochemistry: 
The enantioselectivity was determined by the oxidation of about 20 mg of purified 
silylboronate according to the procedure above (Method B), and purified by silica gel 
chromatography (large volume pipet, 10% ethyl acetate in hexanes) to afford a clear oil. 
 (S)-1-(dimethyl(phenyl)silyl)-3-phenylpropan-1-ol (3.154)  
 
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-1-(dimethyl(phenyl)silyl)-3-phenylpropan-1-ol. 
 See Compound 3.154 for racemic SFC trace.  
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 3.5.5 Transformations of Geminal Silylboronates 
 1. Amination 
tert-butyl-(S)-(1-(dimethyl(phenyl)silyl)-3 
phenylpropyl)carbamate (3.155) In a glove box, potassium tert-
butoxide (27 mg, 0.24 mmol, 1.50 equiv) was added to an oven dried two-dram vial 
equipped with a stir, dissolved in toluene (0.50 mL) and sealed with a teflon screw cap.  
Outside the glove box, a solution of methoxyamine (1.53 M in THF, 0.157 mL, 0.24 mmol, 
1.50 equiv.) was added, followed by (R)-dimethyl(phenyl)(3-phenyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)silane (62.1 mg, 0.16 mmol, 1.00 equiv.) in a 
solution of toluene (0.5 mL).  The reaction was sealed with tape, and heated to 80°C for 14 
hours.  The reaction was allowed to cool to room temperature, and di-tert-butyl dicarbonate 
(1.0 M in THF, 0.240 mL, 0.24 mmol, 1.50 equiv.) was added and allowed to stir at room 
temperature for 1.5 hours.  The reaction mixture was diluted with diethyl ether, filtered 
through a celite pipet plug and concentrated under reduced pressure.  The crude mixture 
was purified by silica gel chromatography (large volume pipet, 3% ethyl acetate in 
hexanes) to afford a clear solid. (41 mg, 72%)  
1H NMR (600 MHz, CDCl3) δ  7.47- 7.54 (m, 2H), 7.34-7.43 (m, 3H), 7.23-7.28 (m, 2H), 
7.09-7.21 (m, 3H), 4.25 (d, J = 10.4 Hz, 1H), 3.37-3.48 (m, 1H), 2.69-2.82 (m, 1H), 2.50-
2.62 (m, 1H), 1.74-1.88 (m, 1H), 1.51-1.60 (m, 1H), 1.45 (s, 9H), 0.35 (s, 3H), 0.33 (s, 
3H).  13C NMR (126 MHz, CDCl3): δ 156.42, 142.49, 136.38, 134.23, 129.59, 128.63, 
128.50, 128.14, 125.90, 79.14, 40.74, 34.04, 34.00, 28.63, -4.43, -5.04.  IR (neat): 3428 
(br), 3066 (w), 3012 (w), 2927 (w), 2852 (w), 1692 (s), 1494 (s), 1453 (m), 1377 (m), 1215 
(m), 1166 (s), 1014 (w), 829 (m), 749 (s), 698 (s) cm-1.  HRMS (DART) for C22H32SiNO2 
NHBoc
SiMe2Ph
Ph
3.155
 399 
[M+H]+: calculated: 370.2202, found 370.2216. [α]20D: +0.63 (c = 1.08, CHCl3, l = 50 
mm). 
Analysis of Stereochemistry: 
The enantioselectivity was determined directly on the silylamine.  
Chiral SFC (Chiracel AD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of tert-butyl (S)-(1-(dimethyl(phenyl)silyl)-3-phenylpropyl)carbamate. 
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 2. Homologation 
 (R)-dimethyl(phenyl)(4-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)butan-2-yl)silane (3.156) Starting material 
derived from procedure VI.  In a glove box, sodium trifluoromethanesulfonate (516 mg, 
3.00 mmol, 2.00 equiv.) was added to an oven dried 100 mL round bottom flask equipped 
with a stir bar.  Outside the glove box under N2, (R)-dimethyl(phenyl)(3-phenyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)silane (571 mg, 1.50 mmol, 1.00 equiv.) was 
added as a solution of THF (7.5 mL), followed by bromochloromethane (0.975 mL, 15.0 
mmol, 10.0 equiv.).  The reaction flask was cooled to -78°C and was charged with n-
butyllithium (6.00 mL, 15.0 mmol, 10.0 equiv) dropwise using a syringe pump over 15 
minutes.  The reaction was kept at -78°C and stirred for 1 hour, and then allowed to warm 
to room temperature and stir for 14 hours.  The reaction was cooled to 0°C, and quenched 
with a saturated ammonium chloride solution.  The aqueous phase was extracted with 
diethyl ether and the combined extracts were washed with brine, dried over sodium sulfate, 
filtered and concentrated under reduced pressure.  The crude reaction mixture was purified 
by silica gel chromatography (33% dichloromethane in hexanes) to afford a clear oil.  (426 
mg, 72%) 
1H NMR (500 MHz, CDCl3) δ 7.50-7.55 (m, 2H), 7.31-7.37 (m, 3H), 7.21-7.27 (m, 2H), 
7.13-7.18 (m, 1H), 7.07-7.12 (m, 2H), 2.66 (ddd, J = 13.3, 11.5, 5.1 Hz, 1H), 2.47 (ddd, J 
= 13.3, 11.4, 5.5 Hz, 1H), 1.72-1.83 (m, 1H), 1.49-1.61 (m, 1H), 1.25 (s, 6H), 1.24 (s, 6H), 
1.01 (dd, J = 16.2, 5.6 Hz, 1H), 0.83 (dd, J = 16.2, 8.4 Hz, 1H), 0.30 (s, 3H), 0.29 (s, 3H).  
13C NMR (126 MHz, CDCl3): δ 143.39, 139.06, 134.29, 128.91, 128.55, 128.38, 127.82, 
125.68, 83.21, 35.84, 35.11, 25.25, 25.02, 20.44, -3.73, -4.32.  11B NMR: (160 MHz, 
SiMe2Ph
Ph
Bpin
3.156
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CDCl3) δ 34.26.  IR (neat): 3085 (w), 3025 (w), 3002 (m), 2924 (w), 2856 (w), 1495 (w), 
1453 (w), 1360 (s), 1320 (s), 1248 (m), 1215 (m), 1143 (s), 968 (m), 831 (s), 699 (s) cm-1.  
HRMS (DART) for C24H39BO2SiN [M+NH4]+: calculated: 412.2843, found: 412.2846.  
[α]20D: +3.48 (c = 1.03, CHCl3, l = 50 mm). 
  
 3. Amination  
 tert-butyl-(S)-(2-(dimethyl(phenyl)silyl)-4-
phenylbutyl)carbamate (3.157) This compound was synthesized 
in according to the procedure above (0.40 mmol)  The crude mixture was purified by silica 
gel chromatography (large volume pipet, 5% ethyl acetate in hexane) to afford a clear oil. 
(117.5 mg, 77%) 
1H NMR (500 MHz, CDCl3) δ 7.46-7.56 (m, 2H), 7.34-7.42 (m, 3H), 7.22-7.29 (m, 2H), 
7.16-7.21 (m, 1H), 7.10 (d, J = 7.2 Hz, 2H), 4.29 (br s, 1H), 3.23-3.40 (m, 2H), 2.61-2.71 
(m, 1H), 2.50-2.60 (m, 1H), 1.74-1.85 (m, 1H), 1.59-1.70 (m, 1H), 1.44 (s, 9H), 1.05-1.15 
(m, 1H), 0.35 (s, 3H), 0.34 (s, 3H).  13C NMR (126 MHz, CDCl3): δ 156.03, 142.51, 
138.08, 133.98, 129.32, 128.56, 128.48, 128.12, 125.93, 79.09, 41.15, 35.44, 30.14, 28.61, 
26.70, -3.93, -3.76.  IR (neat): 3424 (br), 3067 (w), 3024 (w), 2975 (m), 2925 (w), 1700 
(s), 1498 (s), 1365 (m), 1249 (s), 1168 (s), 1111 (m), 833 (m), 699 (s) cm-1.  HRMS 
(DART) for C23H34O2SiN [M+NH4]+: calculated: 384.2359, found 384.2359.  [α]20D: +4.61 
(c = 1.12, CHCl3, l = 50 mm). 
 
 
SiMe2Ph
Ph
NHBoc
3.157
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 4. Tamao-Fleming Oxidation 
 (S)-5-phenethyloxazolidin-2-one (3.158) This compound was 
synthesized according to a literature procedure.  In a glove box, 
potassium hydride (138 mg, 3.41 mmol, 6.20 equiv.) was added to an oven dried 4-dram 
vial equipped with a stir bar and dissolved in DMF (1.5 mL).  Outside the glove box under 
N2, the vial was cooled to 0°C and charged with tert-butyl hydrogen peroxide (5.5M in 
nonane, 0.620 mL, 3.41 mmol, 6.20 equiv.) dropwise.  After 10 minutes of stirring and 
complete evolution of hydrogen, potassium fluoride (64 mg, 1.10 mmol, 2.00 equiv) was 
added as a solid and tert-butyl (R)-(2-(dimethyl(phenyl)silyl)-4-phenylbutyl)carbamate 
(210 mg, 0.55 mmol, 1.00 equiv) was added as a solution of DMF (1.5 mL).  The vial was 
resealed, purged with N2 and heated to 60°C for 1.5 hours under N2.  The reaction was 
allowed to cool to room temperature, diluted with ethyl acetate, filtered through a celite 
pad and concentrated under reduced pressure.  The resulting crude mixture was purified by 
silica gel chromatography (dichloromethane – 33% ethyl acetate in dichloromethane) to 
afford a white solid. (77.8 mg, 74%).  
1H NMR (400 MHz, CDCl3) δ 7.13-7.33 (m, 5H), 5.10 (br s, 1H), 4.53-4.68 (m, 1H), 3.63 
(t, J = 8.4, 1H), 3.22 (t, J = 8.2 Hz, 1H), 2.78-2.90 (m, 1H), 2.65-2.78 (m, 1H), 2.06-2.20 
(m, 1H), 1.85-1.99 (m, 1H).  13C NMR (126 MHz, CDCl3): 160.28, 140.65, 128.76, 128.62, 
126.44, 76.29, 46.08, 36.87, 31.20.  IR (neat): 3277 (br), 3061 (w), 3026 (w), 2924 (m), 
2856 (w), 1743 (s), 1491 (m), 1453 (m), 1377 (w), 1238 (s), 1079 (m), 746 (s), 699 (s) cm-
1.  HRMS (DART) for C11H14O2N [M+H]+: calculated: 192.1205, found 192.102.  [α]20D: 
-30.67 (c = 1.07, CHCl3, l = 50 mm). 
 
Ph
O
NH
O3.158
 403 
Analysis of Stereochemistry: 
The stereospecificity was determined directly on the oxazolidinone. 
Chiral SFC (Chiracel AS-H, 30% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (S)-5-phenethyloxazolidin-2-one. 
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 3.5.6 Procedure for one-pot hydroboration-hydrosilylation-
amination 
 
In a glove-box, an oven-dried 2 dram vial equipped with a stir bar was charged with 3-
phenyl-1-propyne (11.6 mg, 0.10 mmol, 1.0 equiv), pinacolborane (13.4 mg, 0.105 mmol, 
1.05 equiv) and dicyclohexylborane (0.89 mg, 0.05 mmol, 0.05 equiv), and sealed with a 
teflon septa cap.  In a separate oven-dried 2 dram vial equipped with a stir bar, Pt(dba)3 
(2.7 mg, 0.03 mmol, 0.03 equiv), (S,S)-Di-ethoxyTADDOLphosphoramidite (5.5 mg, 0.06 
mmol, 0.06 equiv) and toluene (0.20 mL) were added.  In an oven-dried 1 dram vial, a 
stock solution of dimethylphenylsilane (32.8 mg, 0.24 mmol, 1.20 equiv.) in toluene (0.20 
mL, add 0.10 mL) was prepared. Outside under nitrogen, the hydroboration was stirred for 
2 hours at room temperature.  During the hydroboration, the platinum-ligand solution was 
complexed for 20 minutes at 80°C, and then allowed to cool to room temperature.    The 
hydroboration was then diluted in toluene (0.20 mL), and transferred under nitrogen to the 
platinum-ligand complex, rinsed with toluene (0.10 mL) and transferred.  
Dimethylphenylsilane solution (0.10 mL) was then added to the reaction mixture, the vial 
sealed and allowed to stir for 16 hours at room temperature.   
Pt(dba)3 (3%)
O
OO
O
OEt
EtO
EtO
EtO
OEt
OEt
EtO OEt
P N
(6%)
3.120
toluene, r.t., 16 h
NHBoc
SiMe2Ph
HBCy2 (5%)
HBpin
KOtBu
H2N-OMe
toluene, 80ºC, 16 h
then Boc2O, r.t, 1 h3.159 3.155
 405 
The sealed reaction vial was then taken in the glove-box, and potassium tert-butoxide 
(16.8 mg, 0.15 mmol, 1.50 equiv) was added.  Outside the glove-box under nitrogen, 
methoxyamine (0.075 mL, 2.0 M in THF, 0.15 mmol, 1.50 equiv) was added.  The vial 
was then sealed, heated to 80°C for 16 hours.  The reaction was allowed to cool to room 
temperature, and under nitrogen Boc-anhydride (0.15 mL, 0.15 mmol, 1.50 equiv) was 
added and stirred for 1 hour at room temperature.  The reaction mixture was then filtered 
through a celite pipet plug with diethyl ether, and concentrated under reduced pressure.  
The crude reaction mixture was then purified by silica gel chromatography (large volume 
pipet, 5% ethyl acetate in hexanes) to afford a white solid. (26.7 mg, 72%) 
Analysis of Stereochemistry: 
The enantioselectivity was determined directly on the silylamine.  
Chiral SFC (Chiracel AD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of tert-butyl (S)-(1-(dimethyl(phenyl)silyl)-3-phenylpropyl)carbamate. 
  
See Compound 3.155 for racemic SFC trace.  
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 3.5.7 Preparation of Deuterated Silane and Deuterosilylation 
Experiment 
 
 Dimethylphenyldeuterosilane was prepared according to a literature and the spectra 
were in accordance.59 
 
dimethyl(phenyl)((1S,2S)-3-phenyl-1-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)propyl-2-d)silane (3.165) Reaction 
carried out using (S,S)-3,5-diethoxyTADDOLphosphoramidite 
(5.5 mg, 0.06 mmol, 0.06 equiv.) according to the procedure above (Method A). The crude 
reaction was purified by silica gel chromatography (large volume pipet, 1% ethyl acetate 
in hexanes) to afford a clear oil. (36.6 mg, 96%) 
1H NMR (600 MHz, CDCl3): δ 7.47-7.53 (m, 2H), 7.30-7.36 (m, 3H), 7.25 (t, J = 7.5 Hz, 
2H), 7.14-7.18 (m, 1H), 7.12 (d, J = 7.5 Hz, 2H), 2.70 (dd, J = 13.4, 5.1 Hz, 1H), 2.46 (dd, 
Si
Cl
Me Me
LiAlD4
Et2O
Si
D
Me Me
3.199 3.200
Bpin
+
Pt(dba)3 (3%)
O
OO
O
OEt
EtO
EtO
EtO
OEt
OEt
EtO OEt
P N
(6%)
3.120
MTBE, r.t., 16 h
B
SiMe2Ph
O
OD
3.97
Me2PhSiD
3.164 3.165
B
SiMe2Ph
O
OD
3.165
 407 
J = 13.4, 9.6 Hz, 1H), 1.88 (m, 1H), 1.22 (s, 6H), 1.20 (s, 6H), 0.71 (d, J = 12.0 Hz, 1H), 
0.33 (s, 3H), 0.32 (s, 3H).  13C NMR (151 MHz, CDCl3): δ 142.70, 138.95, 133.93, 128.88, 
128.64, 128.28, 127.70, 125.68, 82.93, 39.48, 27.90, 27.77, 27.64, 25.32, 24.85, -2.14, -
3.21.  2H NMR (77 MHz, CDCl3): δ 1.64.  11B NMR (192 MHz, CDCl3): δ 34.40.  IR 
(neat): νmax 3085 (w), 3067 (w), 2977 (w), 2926(w), 1602 (w), 1346 (s), 1306 (s), 1141 (s), 
832 (m), 731 (m), 698 (s) cm-1.  HRMS (DART) for C23H36DBO2SiN [M+NH4]+: 
calculated: 399.2749, found: 399.2759.  [α]20D: -21.26 (c = 1.22, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: 
SFC analysis was performed on the oxidized silylboronate according to procedure above 
(Method B) and purified by silica gel chromatography (large volume pipet, 10% ethyl 
acetate in hexanes) to afford a clear oil.  
  (1R,2S)-1-(dimethyl(phenyl)silyl)-3-phenylpropan-2-d-1-ol (3.171) 
1H NMR (600 MHz, CDCl3): δ 7.52-7.63 (m, 2H), 7.34-7.45 (m, 3H), 
7.24-7.32 (m, 2H), 7.12-7.24 (m, 3H), 3.54 (dd, J = 11.3, 4.4 Hz, 1H), 
2.90 (dd, J = 13.7, 5.1 Hz, 1H), 2.62 (dd, J = 13.6, 9.3 Hz, 1H), 1.83 (m, 1H), 1.06 (d, J = 
5.0 Hz, 1H), 0.35 (s, 3H), 0.34 (s, 3H).  13C NMR (126 MHz, CDCl3): δ 142.09, 136.42, 
134.11, 129.38, 128.48, 128.36, 127.94, 125.77, 64.83, 34.99, 34.84, 34.68, 33.16, -5.46, -
5.71.  2H NMR (77 MHz, CDCl3): δ 1.83.  IR (neat):  3422 (w), 3067 (w), 3025(w), 
2955(w), 2920 (w), 2362 (w), 1603 (w), 1454 (m), 1427 (m), 1248 (m), 1113 (m), 816(s), 
735 (s) cm-1.  HRMS (DART) for C17H25DOSiN [M+NH4]+: calculated: 289.1846, found: 
289.1841.  [α]20D:  -15.94 (c =0.63, CHCl3, l = 50 mm 
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) – analysis 
of (1R,2S)-1-(dimethyl(phenyl)silyl)-3-phenylpropan-2-d-1-ol. 
OHPh
SiMe2Ph
D
3.171
 408 
 
See Compound 3.154 for racemic trace.  
    NONRACEMIC 
 
 
 (rac)-1-(dimethyl(phenyl)silyl)-3-phenylpropan-2-d-1-ol (rac 3.171)  
In a glove-box, (Z)-dimethyl(phenyl)(3-phenylprop-1-en-1-yl)silane76 
(50.4 mg, 0.20 mmol, 1.7 equiv.) was dissolved in THF (1.0 mL), charged with BD3×THF 
(1.0 M in THF, 0.120 mL, 0.12 mmol, 1.0 equiv) and allowed to stir for 4 hours at room 
temperature.  Outside the glove box under nitrogen, the reaction vial was cooled to 0°C, 
charged with 3M sodium hydroxide (0.5 mL) and 29-32% hydrogen peroxide (0.50 mL) 
and allowed to stir at room temperature for 3 hours.  The vial was then cooled to 0°C, and 
                                                
76 Kubota, K.; Yamamoto, E.; Ito, H. Adv. Synth. Catal. 2013, 355, 3527-3531 
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quenched with sodium thiosulfate (0.25 mL).  The reaction solution was diluted with 
diethyl ether, and both organic and aqueous phase was passed through a silica gel large 
volume pipet to remove the aqueous layer.  The organic extract was concentrated under 
reduced pressure, and the crude reaction mixture purified by silica gel chromatography 
(large volume pipet, 5% ethyl acetate in hexanes) to afford a clear oil. (47.1 mg, 85%) 
1H NMR (600 MHz, CDCl3): δ 7.55-7.61 (m, 2H), 7.38-7.44 (m, 3H), 7.27-7.32 (m, 2H), 
7.18-7.23 (m, 3H), 3.54 (dd, J = 11.3, 5.1 Hz, 1H), 2.90 (dd, J = 13.7, 5.1 Hz, 1H), 2.62 
(dd, J = 13.6, 9.3 Hz, 1H), 1.83 (m, 1H), 1.07 (d, J = 5.2 Hz, 1H), 0.35 (s, 3H), 0.34 (s, 3H) 
13C NMR (126 MHz, CDCl3): δ 142.33, 136.65, 134.35, 129.62, 128.72, 128.60, 128.17, 
126.01, 65.04, 35.19, 35.06, 34.93, 33.38, -5.23, -5.49.  2H NMR (61 MHz, CDCl3): δ 1.84.  
IR (neat): 3499 (br), 3085 (w), 3066 (m), 3025 (w), 2955 (w), 2855 (w), 1602 (w), 1495 
(s), 1427 (s), 1248 (s), 1112 (s), 1013 (s), 777 (s), 698 (s) cm-1.  HRMS (DART) for 
C17H25DOSiN [M+NH4]+: calculated: 289.1846, found: 289.1841.   
 
 3.5.8 Compound Spectra  
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